[
    {
        "a": "[Glucagon-like peptide-2] [displayed] [Sodium-Potassium-Chloride Cotransporter] activity in the intestinal epithelium.",
        "b": "[GLP-2] [displayed] [Sodium-Potassium-Chloride Cotransporter] activity in the intestinal epithelium.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8324621238325839,
        "token(a ~ b)": 0.8400932400932402,
        "domain": "1.1"
    },
    {
        "a": "[Magnesium carbonate] [was found] in samples containing [Progesterone].",
        "b": "[MgCO3] [was found] in samples containing [Progesterone].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8085349001089056,
        "token(a ~ b)": 0.7450980392156863,
        "domain": "1.1"
    },
    {
        "a": "[Oxamide] [included] [Chlorophyll b] in the sample matrix.",
        "b": "[ethanediamide] [included] [Chlorophyll b] in the sample matrix.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8182266009852218,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "1.1"
    },
    {
        "a": "[Axitinib] [induced] [Autism Spectrum Disorder] symptoms in the mouse model.",
        "b": "[Inlyta] [induced] [Autism Spectrum Disorder] symptoms in the mouse model.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8529567161146109,
        "token(a ~ b)": 0.722943722943723,
        "domain": "1.1"
    },
    {
        "a": "[Xylene] [inhibited] [iodobenzene] metabolism in rat liver microsomes.",
        "b": "[dimethylbenzene] [inhibited] [iodobenzene] metabolism in rat liver microsomes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8186091673873732,
        "token(a ~ b)": 0.7858585858585858,
        "domain": "1.1"
    },
    {
        "a": "[Ethylamine] [was critical for] the synthesis of [Tyrosine] in vitro.",
        "b": "[aminoethane] [was critical for] the synthesis of [Tyrosine] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8289045736871824,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "1.1"
    },
    {
        "a": "[Iodide ion] [accelerated] the reaction rate with [benzylamine] under alkaline conditions.",
        "b": "[I-] [accelerated] the reaction rate with [benzylamine] under alkaline conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8482706012245307,
        "token(a ~ b)": 0.8713768115942029,
        "domain": "1.1"
    },
    {
        "a": "[Dehydroepiandrosterone] [was positively associated with] [Acetic anhydride] concentration in the plasma.",
        "b": "[DHEA] [was positively associated with] [Acetic anhydride] concentration in the plasma.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8263601532567051,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "1.1"
    },
    {
        "a": "[Radium ion] [induced] the formation of [nitrite ion] in aqueous solution.",
        "b": "[Ra2+] [induced] the formation of [nitrite ion] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8618514236161295,
        "token(a ~ b)": 0.8285714285714285,
        "domain": "1.1"
    },
    {
        "a": "[Triethylamine] [was critical for] the synthesis of [Dimethyl sulfide] in the reaction mixture.",
        "b": "[N,N-Diethylethanamine] [was critical for] the synthesis of [Dimethyl sulfide] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8355257388695667,
        "token(a ~ b)": 0.7307692307692308,
        "domain": "1.1"
    },
    {
        "a": "[Ciprofloxacin] [was employed] to treat [Bevacizumab] resistance in metastatic cancer.",
        "b": "[Cipro] [was employed] to treat [Bevacizumab] resistance in metastatic cancer.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8967799642218246,
        "token(a ~ b)": 0.8999032882011606,
        "domain": "1.1"
    },
    {
        "a": "[Fumarate] [was critical for] the reduction of [bromate] in the reaction mixture.",
        "b": "[fumaric acid] [was critical for] the reduction of [bromate] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8334137757667169,
        "token(a ~ b)": 0.8444444444444444,
        "domain": "1.1"
    },
    {
        "a": "[Nitrite ion] [admitted] [Lead] into the reaction mixture.",
        "b": "[NO2\u2212] [admitted] [Lead] into the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.816114491773721,
        "token(a ~ b)": 0.6601307189542484,
        "domain": "1.1"
    },
    {
        "a": "[Calcium carbonate] [was linked to] [Nitrosyl cation] in the reaction mixture.",
        "b": "[CaCO3] [was linked to] [Nitrosyl cation] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8445221445221445,
        "token(a ~ b)": 0.7954545454545454,
        "domain": "1.1"
    },
    {
        "a": "[Citrate] [affected] [Nitric oxide] signaling in endothelial cells.",
        "b": "[CIT] [affected] [Nitric oxide] signaling in endothelial cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8583641770331274,
        "token(a ~ b)": 0.8633928571428571,
        "domain": "1.1"
    },
    {
        "a": "[Levomilnacipran] [was employed] in the synthesis of [Sonidegib] for clinical trials.",
        "b": "[Fetzima] [was employed] in the synthesis of [Sonidegib] for clinical trials.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8197584291701939,
        "token(a ~ b)": 0.6657142857142857,
        "domain": "1.1"
    },
    {
        "a": "[Nonadecanoic acid] [induced] the accumulation of [Zinc] in the liver.",
        "b": "[Nonadecylic acid] [induced] the accumulation of [Zinc] in the liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9229449028151169,
        "token(a ~ b)": 0.8612836438923395,
        "domain": "1.1"
    },
    {
        "a": "[Lysine] [was linked to] [Platinum(II) ion] in the reaction mixture.",
        "b": "[Lys] [was linked to] [Platinum(II) ion] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9019457013574661,
        "token(a ~ b)": 0.9620563035495715,
        "domain": "1.1"
    },
    {
        "a": "[Tin(II) ion] [bound] to [Dichromate] during the redox reaction.",
        "b": "[Sn2+] [bound] to [Dichromate] during the redox reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7984466374269006,
        "token(a ~ b)": 0.6637596899224807,
        "domain": "1.1"
    },
    {
        "a": "[Gastrin-releasing peptide] [bound] to [Nitrosyl sulfate] in the experimental assay.",
        "b": "[GRP] [bound] to [Nitrosyl sulfate] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7996518177163339,
        "token(a ~ b)": 0.7095238095238096,
        "domain": "1.1"
    },
    {
        "a": "[Interleukin-6] [coordinated] the response of [Immunoglobulin D] in peripheral blood.",
        "b": "[IL-6] [coordinated] the response of [Immunoglobulin D] in peripheral blood.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8477853457172343,
        "token(a ~ b)": 0.844812925170068,
        "domain": "1.1"
    },
    {
        "a": "[Phenethylamine] [produced] [dihydroxyacetone] in vitro.",
        "b": "[2-phenylethan-1-amine] [produced] [dihydroxyacetone] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8310930735930737,
        "token(a ~ b)": 0.6954787234042553,
        "domain": "1.1"
    },
    {
        "a": "[Isoleucine] [was capable] of binding to [Aniline] under acidic conditions.",
        "b": "[Ile] [was capable] of binding to [Aniline] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8574640522875818,
        "token(a ~ b)": 0.8362573099415205,
        "domain": "1.1"
    },
    {
        "a": "[Epinephrine] [preceded] [Epidermal stem cell] differentiation in the developing tissue.",
        "b": "[Adrenaline] [preceded] [Epidermal stem cell] differentiation in the developing tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8571132492351853,
        "token(a ~ b)": 0.8492063492063492,
        "domain": "1.1"
    },
    {
        "a": "[Nitrite] [bound] to [Vinyl chloride] under acidic conditions.",
        "b": "[Nitrite ion] [bound] to [Vinyl chloride] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9072336265884653,
        "token(a ~ b)": 0.9523809523809523,
        "domain": "1.1"
    },
    {
        "a": "[Glyceraldehyde 3-phosphate dehydrogenase] [was found in] the [chloroplast] of spinach leaves.",
        "b": "[GAPDH] [was found in] the [chloroplast] of spinach leaves.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6875881060879258,
        "token(a ~ b)": 0.5885668276972624,
        "domain": "1.1"
    },
    {
        "a": "[Nitroxyl] [joined] [Dimethylamine] in aqueous solution.",
        "b": "[azanone] [joined] [Dimethylamine] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8501808905380335,
        "token(a ~ b)": 0.6783625730994152,
        "domain": "1.1"
    },
    {
        "a": "[Cyanide] [was sufficient for] the precipitation of [magnesium chloride] in the reaction mixture.",
        "b": "[cyanide ion] [was sufficient for] the precipitation of [magnesium chloride] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8508057313463305,
        "token(a ~ b)": 0.8966565349544073,
        "domain": "1.1"
    },
    {
        "a": "[Mannose] [was selected] for reaction with [Nitrosyl cation] in the assay.",
        "b": "[D-mannose] [was selected] for reaction with [Nitrosyl cation] in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9841038406827881,
        "token(a ~ b)": 0.8952380952380952,
        "domain": "1.1"
    },
    {
        "a": "[Deoxyribonucleic acid] [affected] [Glutamate] release in cultured neurons.",
        "b": "[DNA] [affected] [Glutamate] release in cultured neurons.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8128654970760234,
        "token(a ~ b)": 0.6947368421052631,
        "domain": "1.1"
    },
    {
        "a": "[Nitrite ion] [identified] [Rhamnose] in the bacterial extract.",
        "b": "[NO2\u2212] [identified] [Rhamnose] in the bacterial extract.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8226315264051113,
        "token(a ~ b)": 0.6947368421052631,
        "domain": "1.1"
    },
    {
        "a": "[Azide ion] [was associated with] [Phenylhydrazine] toxicity in the cell culture assay.",
        "b": "[N3-] [was associated with] [Phenylhydrazine] toxicity in the cell culture assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8232390215148837,
        "token(a ~ b)": 0.7967571644042233,
        "domain": "1.1"
    },
    {
        "a": "[Nitrogen dioxide] [increased] [chloride ion] concentrations in the reaction mixture.",
        "b": "[NO2] [increased] [chloride ion] concentrations in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8312480547774664,
        "token(a ~ b)": 0.7352564102564103,
        "domain": "1.1"
    },
    {
        "a": "[Isopropylamine] [identified] [Bromobenzene] as a reaction intermediate in the process.",
        "b": "[2-aminopropane] [identified] [Bromobenzene] as a reaction intermediate in the process.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8567511425010386,
        "token(a ~ b)": 0.7148148148148148,
        "domain": "1.1"
    },
    {
        "a": "[Benzene] [accelerated] the conversion of [dihydroxyacetone phosphate] in vitro.",
        "b": "[benzol] [accelerated] the conversion of [dihydroxyacetone phosphate] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.843344437041972,
        "token(a ~ b)": 0.7885714285714285,
        "domain": "1.1"
    },
    {
        "a": "[Citrate] [affected] [Progesterone] levels in the experimental group.",
        "b": "[CIT] [affected] [Progesterone] levels in the experimental group.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8585535559448603,
        "token(a ~ b)": 0.8633928571428571,
        "domain": "1.1"
    },
    {
        "a": "[Crotonaldehyde] [increased] [acetate] concentrations in the assay.",
        "b": "[2-butenal] [increased] [acetate] concentrations in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8213811365862567,
        "token(a ~ b)": 0.6947368421052631,
        "domain": "1.1"
    },
    {
        "a": "[Gefitinib] [identified] [Levomilnacipran] as a potential inhibitor in the screening assay.",
        "b": "[Iressa] [identified] [Levomilnacipran] as a potential inhibitor in the screening assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8264604371532083,
        "token(a ~ b)": 0.8043326345213138,
        "domain": "1.1"
    },
    {
        "a": "[Dichromate] [bound] to [tert-Butylamine] under acidic conditions.",
        "b": "[Cr2O7^2-] [bound] to [tert-Butylamine] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7999626196172249,
        "token(a ~ b)": 0.661231884057971,
        "domain": "1.1"
    },
    {
        "a": "[Formamide] [orchestrated] the transport of [potassium chloride] in the in vitro assay.",
        "b": "[methanamide] [orchestrated] the transport of [potassium chloride] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8406583826866664,
        "token(a ~ b)": 0.8277608915906788,
        "domain": "1.1"
    },
    {
        "a": "[Water] [replaced] [decane] in the experimental solvent mixture.",
        "b": "[H2O] [replaced] [decane] in the experimental solvent mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8298429811372334,
        "token(a ~ b)": 0.7815126050420168,
        "domain": "1.1"
    },
    {
        "a": "[Coenzyme A] [was essential in] the reduction of [dichromate] in the mitochondrial assay.",
        "b": "[CoA] [was essential in] the reduction of [dichromate] in the mitochondrial assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.882054444139947,
        "token(a ~ b)": 0.8930851063829788,
        "domain": "1.1"
    },
    {
        "a": "[Interleukin-4] [displayed] affinity for [Estrogen Receptor 1] in the experimental setup.",
        "b": "[IL-4] [displayed] affinity for [Estrogen Receptor 1] in the experimental setup.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8485606599345754,
        "token(a ~ b)": 0.8509803921568628,
        "domain": "1.1"
    },
    {
        "a": "[Interleukin-7] [was sufficient for] [Protein kinase R-like endoplasmic reticulum kinase] activation in T cells.",
        "b": "[IL-7] [was sufficient for] [Protein kinase R-like endoplasmic reticulum kinase] activation in T cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8533400415182254,
        "token(a ~ b)": 0.8741105637657361,
        "domain": "1.1"
    },
    {
        "a": "[Hydrogen iodide] [produced] [acrolein] under acidic conditions.",
        "b": "[HI] [produced] [acrolein] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8297712418300655,
        "token(a ~ b)": 0.75,
        "domain": "1.1"
    },
    {
        "a": "[Methionine] [broadened] the solubility of [1-Octyne] in aqueous solution.",
        "b": "[Met] [broadened] the solubility of [1-Octyne] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8885437676482452,
        "token(a ~ b)": 0.8125,
        "domain": "1.1"
    },
    {
        "a": "[Interleukin-37] [was found] in [T lymphocyte] samples after stimulation.",
        "b": "[IL-37] [was found] in [T lymphocyte] samples after stimulation.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8450179386823222,
        "token(a ~ b)": 0.8140243902439024,
        "domain": "1.1"
    },
    {
        "a": "[Phosphine] [activated] [Carbonic anhydrase] in erythrocyte samples.",
        "b": "[phosphorus trihydride] [activated] [Carbonic anhydrase] in erythrocyte samples.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8023128342245989,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "1.1"
    },
    {
        "a": "[Vanadium(II) ion] [established] the interaction with [Progesterone] in vitro.",
        "b": "[V2+] [established] the interaction with [Progesterone] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8177614977614976,
        "token(a ~ b)": 0.6484623541887593,
        "domain": "1.1"
    },
    {
        "a": "[Arachidonic acid] [impacted] [Lithium chloride] transport in neuronal cells.",
        "b": "[all-cis-5,8,11,14-eicosatetraenoic acid] [impacted] [Lithium chloride] transport in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7846360126360126,
        "token(a ~ b)": 0.5246305418719212,
        "domain": "1.1"
    },
    {
        "a": "[Aluminum] [was genetically correlated with] [Hydrogen sulfide] concentration in groundwater samples.",
        "b": "[Al] [was genetically correlated with] [Hydrogen sulfide] concentration in groundwater samples.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8977175612298072,
        "token(a ~ b)": 0.9620563035495715,
        "domain": "1.1"
    },
    {
        "a": "[Epinephrine] [regulated] [Myeloid Dendritic Cell] function in vitro.",
        "b": "[Adrenaline] [regulated] [Myeloid Dendritic Cell] function in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8481138107416879,
        "token(a ~ b)": 0.82281284606866,
        "domain": "1.1"
    },
    {
        "a": "[Apolipoprotein E] [was overexpressed] in [ER degradation-enhancing alpha-mannosidase-like protein 1] deficient cells.",
        "b": "[APOE] [was overexpressed] in [ER degradation-enhancing alpha-mannosidase-like protein 1] deficient cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8402532123031003,
        "token(a ~ b)": 0.8548387096774193,
        "domain": "1.1"
    },
    {
        "a": "[1,1-Dimethylhydrazine] [produced] [benzoyl chloride] in the reaction mixture.",
        "b": "[unsymmetrical dimethylhydrazine] [produced] [benzoyl chloride] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7899068397356069,
        "token(a ~ b)": 0.7753246753246753,
        "domain": "1.1"
    },
    {
        "a": "[N,N-Dimethylacetamide] [bound] to [Hydrogen fluoride] under acidic conditions.",
        "b": "[Dimethylacetamide] [bound] to [Hydrogen fluoride] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9848101265822784,
        "token(a ~ b)": 0.7857142857142857,
        "domain": "1.1"
    },
    {
        "a": "[Chloroform] [induced] the expression of [Interleukin-7] in immune cells.",
        "b": "[trichloromethane] [induced] the expression of [Interleukin-7] in immune cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.820636874829696,
        "token(a ~ b)": 0.774928774928775,
        "domain": "1.1"
    },
    {
        "a": "[Strontium ion] [was sufficient for] the reaction with [acetylene] under standard laboratory conditions.",
        "b": "[Sr2+] [was sufficient for] the reaction with [acetylene] under standard laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8457507291802708,
        "token(a ~ b)": 0.711304347826087,
        "domain": "1.1"
    },
    {
        "a": "[Alanine] [induced] [N,N-Dimethylacetamide] accumulation in the liver.",
        "b": "[Ala] [induced] [N,N-Dimethylacetamide] accumulation in the liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9006926406926407,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "1.1"
    },
    {
        "a": "[Nitrate] [was linked to] [Glutamine] metabolism in plant roots.",
        "b": "[NO3-] [was linked to] [Glutamine] metabolism in plant roots.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8469427171660071,
        "token(a ~ b)": 0.7352564102564103,
        "domain": "1.1"
    },
    {
        "a": "[Water] [broadened] the solubility of [N-acetylcysteine] in the experimental assay.",
        "b": "[H2O] [broadened] the solubility of [N-acetylcysteine] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8400473689630316,
        "token(a ~ b)": 0.8583916083916083,
        "domain": "1.1"
    },
    {
        "a": "[Tridecane] [replaced] [threonine] in the experimental mixture.",
        "b": "[n-tridecane] [replaced] [threonine] in the experimental mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8507467801016189,
        "token(a ~ b)": 0.8447368421052632,
        "domain": "1.1"
    },
    {
        "a": "[Cyanide ion] [was critical for] the function of [small nuclear RNA] in mammalian cells.",
        "b": "[CN-] [was critical for] the function of [small nuclear RNA] in mammalian cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8433721833721833,
        "token(a ~ b)": 0.770048309178744,
        "domain": "1.1"
    },
    {
        "a": "[Allylamine] [improved] the efficacy of [Ceritinib] in cancer cell lines.",
        "b": "[3-aminoprop-1-ene] [improved] the efficacy of [Ceritinib] in cancer cell lines.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7976873489121675,
        "token(a ~ b)": 0.6809299191374663,
        "domain": "1.1"
    },
    {
        "a": "[Epinephrine] [orchestrated] the signaling of [Androgen Receptor] in cardiac tissue.",
        "b": "[Adrenaline] [orchestrated] the signaling of [Androgen Receptor] in cardiac tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8347736334124927,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "1.1"
    },
    {
        "a": "[Hypobromous acid] [emerged] in the presence of [hydrogen sulfide] during the reaction.",
        "b": "[HOBr] [emerged] in the presence of [hydrogen sulfide] during the reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8294290662887736,
        "token(a ~ b)": 0.7167553191489362,
        "domain": "1.1"
    },
    {
        "a": "[Nitrate] [affected] [chloride] levels in the experimental solution.",
        "b": "[NO3-] [affected] [chloride] levels in the experimental solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8523349389383544,
        "token(a ~ b)": 0.7055555555555556,
        "domain": "1.1"
    },
    {
        "a": "[Fluvastatin] [was genetically correlated with] [Imiquimod] response in the clinical trial.",
        "b": "[Lescol] [was genetically correlated with] [Imiquimod] response in the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8173517917136748,
        "token(a ~ b)": 0.8043478260869565,
        "domain": "1.1"
    },
    {
        "a": "[Interleukin-17] [was genetically correlated with] [Interleukin-33] expression in airway epithelial cells.",
        "b": "[IL-17] [was genetically correlated with] [Interleukin-33] expression in airway epithelial cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.85542695973546,
        "token(a ~ b)": 0.9344012204424104,
        "domain": "1.1"
    },
    {
        "a": "[Potassium] [bound] to the [phosphine] molecule under anaerobic conditions.",
        "b": "[K] [bound] to the [phosphine] molecule under anaerobic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8231587516960651,
        "token(a ~ b)": 0.8447368421052632,
        "domain": "1.1"
    },
    {
        "a": "[Interleukin-4] [bound] to [Interleukin-21] in the receptor assay.",
        "b": "[IL-4] [bound] to [Interleukin-21] in the receptor assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8501556922609554,
        "token(a ~ b)": 0.9190307328605201,
        "domain": "1.1"
    },
    {
        "a": "[Nitronium ion] [admitted] [Nitrosyl cation] into the reaction vessel during the experiment.",
        "b": "[Nitryl ion] [admitted] [Nitrosyl cation] into the reaction vessel during the experiment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8972797309210563,
        "token(a ~ b)": 0.8730434782608696,
        "domain": "1.1"
    },
    {
        "a": "[Methylhydrazine] [accelerated] the dissolution of [magnesium sulfate] in aqueous solution.",
        "b": "[monomethylhydrazine] [accelerated] the dissolution of [magnesium sulfate] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8442471563524194,
        "token(a ~ b)": 0.886039886039886,
        "domain": "1.1"
    },
    {
        "a": "[Dabrafenib] [treated] [Edoxaban]-induced adverse reactions in patients.",
        "b": "[Tafinlar] [treated] [Edoxaban]-induced adverse reactions in patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8424089635854342,
        "token(a ~ b)": 0.7078488372093024,
        "domain": "1.1"
    },
    {
        "a": "[Nitrosonium ion] [induced] the oxidation of [thiosulfate] in acidic solution.",
        "b": "[NO+] [induced] the oxidation of [thiosulfate] in acidic solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.819055944055944,
        "token(a ~ b)": 0.6988636363636364,
        "domain": "1.1"
    },
    {
        "a": "[Nivolumab] [induced] the inhibition of [Oseltamivir] metabolism in vitro.",
        "b": "[Opdivo] [induced] the inhibition of [Oseltamivir] metabolism in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8527055016905887,
        "token(a ~ b)": 0.7608695652173914,
        "domain": "1.1"
    },
    {
        "a": "[Langerhans cell] [bound] to [Interleukin-4] in the skin tissue.",
        "b": "[Langerhans dendritic cell] [bound] to [Interleukin-4] in the skin tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9042229729729729,
        "token(a ~ b)": 0.9337121212121212,
        "domain": "1.1"
    },
    {
        "a": "[Glucose] [was positively associated with] [Formamide] levels in the sample.",
        "b": "[D-glucose] [was positively associated with] [Formamide] levels in the sample.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9845141700404858,
        "token(a ~ b)": 0.8362573099415205,
        "domain": "1.1"
    },
    {
        "a": "[N,N-Dimethylformamide] [replaced] [Phenylhydrazine] in the reaction mixture.",
        "b": "[DMF] [replaced] [Phenylhydrazine] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7750663252893404,
        "token(a ~ b)": 0.703525641025641,
        "domain": "1.1"
    },
    {
        "a": "[Nitric oxide] [accelerated] [citrate] uptake in the experimental system.",
        "b": "[NO] [accelerated] [citrate] uptake in the experimental system.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8437565903761219,
        "token(a ~ b)": 0.763157894736842,
        "domain": "1.1"
    },
    {
        "a": "[Heptadecanoic acid] [produced] [hydroxide] ions in aqueous solution.",
        "b": "[margaric acid] [produced] [hydroxide] ions in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8171195652173914,
        "token(a ~ b)": 0.7351778656126482,
        "domain": "1.1"
    },
    {
        "a": "[Iodobenzene] [bound] to [vasopressin] in the in vitro assay.",
        "b": "[phenyl iodide] [bound] to [vasopressin] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8451238379107231,
        "token(a ~ b)": 0.6689723320158103,
        "domain": "1.1"
    },
    {
        "a": "[Phenylalanine] [replaced] [N,N-Dimethylacetamide] in the experimental mixture.",
        "b": "[Phe] [replaced] [N,N-Dimethylacetamide] in the experimental mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8906255732893047,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "1.1"
    },
    {
        "a": "[Fumarate] [joined] [Vinyl chloride] in the reaction mixture.",
        "b": "[fumaric acid] [joined] [Vinyl chloride] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8288002782971693,
        "token(a ~ b)": 0.7815126050420168,
        "domain": "1.1"
    },
    {
        "a": "[Enkephalin] [was positively associated with] [Substance P] release in dorsal root ganglia.",
        "b": "[ENK] [was positively associated with] [Substance P] release in dorsal root ganglia.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8469519640251348,
        "token(a ~ b)": 0.8043478260869565,
        "domain": "1.1"
    },
    {
        "a": "[Calcium ion] [was associated with] [Copper] accumulation in the mitochondrial matrix.",
        "b": "[Ca2+] [was associated with] [Copper] accumulation in the mitochondrial matrix.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8727045253833596,
        "token(a ~ b)": 0.7602564102564102,
        "domain": "1.1"
    },
    {
        "a": "[Cyclohexanone] [served as] a cofactor for [Vitamin B12] in the enzymatic assay.",
        "b": "[C6H10O] [served as] a cofactor for [Vitamin B12] in the enzymatic assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8240881009938221,
        "token(a ~ b)": 0.7630094043887148,
        "domain": "1.1"
    },
    {
        "a": "[Isobutane] [was critical for] the synthesis of [3-Hexyne] in the catalytic process.",
        "b": "[methylpropane] [was critical for] the synthesis of [3-Hexyne] in the catalytic process.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8346915584415584,
        "token(a ~ b)": 0.7386877828054299,
        "domain": "1.1"
    },
    {
        "a": "[Nonadecane] [was not correlated with] [Heptadecanoic acid] levels in plasma samples.",
        "b": "[n-Nonadecane] [was not correlated with] [Heptadecanoic acid] levels in plasma samples.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8766328600405681,
        "token(a ~ b)": 0.9064807219031994,
        "domain": "1.1"
    },
    {
        "a": "[Bromide] [detected] [Chlorophyll b] in leaf samples.",
        "b": "[bromide ion] [detected] [Chlorophyll b] in leaf samples.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8699469100909023,
        "token(a ~ b)": 0.8782051282051282,
        "domain": "1.1"
    },
    {
        "a": "[Transforming Growth Factor Beta] [induced] the expression of [6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3] in cultured cells.",
        "b": "[TGF-\u03b2] [induced] the expression of [6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3] in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8159233364483481,
        "token(a ~ b)": 0.8331521739130434,
        "domain": "1.1"
    },
    {
        "a": "[Methylamine] [served as] a cofactor for [nitryl fluoride] in the catalytic reaction.",
        "b": "[aminomethane] [served as] a cofactor for [nitryl fluoride] in the catalytic reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8291168129191552,
        "token(a ~ b)": 0.774928774928775,
        "domain": "1.1"
    },
    {
        "a": "[Proline] [accelerated] the reaction involving [thiol] groups in the assay.",
        "b": "[Pro] [accelerated] the reaction involving [thiol] groups in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9104600938967137,
        "token(a ~ b)": 0.9583931133428981,
        "domain": "1.1"
    },
    {
        "a": "[Ipilimumab] [affected] the progression of [Primary Biliary Cholangitis] in patients.",
        "b": "[Yervoy] [affected] the progression of [Primary Biliary Cholangitis] in patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.806483660130719,
        "token(a ~ b)": 0.7351778656126482,
        "domain": "1.1"
    },
    {
        "a": "[Methanethiol] [accelerated] the conversion of [decane] in the reaction mixture.",
        "b": "[methyl mercaptan] [accelerated] the conversion of [decane] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8301127819548872,
        "token(a ~ b)": 0.7539525691699605,
        "domain": "1.1"
    },
    {
        "a": "[Cadmium ion] [affected] [Carbon dioxide] transport in the cellular assay.",
        "b": "[Cd2+] [affected] [Carbon dioxide] transport in the cellular assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8406330095882335,
        "token(a ~ b)": 0.7333333333333334,
        "domain": "1.1"
    },
    {
        "a": "[Sulfur hexafluoride] [induced] the accumulation of [hydrogen fluoride] in the reaction vessel.",
        "b": "[SF6] [induced] the accumulation of [hydrogen fluoride] in the reaction vessel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8180473046828809,
        "token(a ~ b)": 0.6629787234042553,
        "domain": "1.1"
    },
    {
        "a": "[Hydroxide] [joined] [3-Heptyne] molecules in solution.",
        "b": "[OH-] [joined] [3-Heptyne] molecules in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8100761852129633,
        "token(a ~ b)": 0.7821637426900585,
        "domain": "1.1"
    },
    {
        "a": "[Butyric acid] [bound] to [acetate] in the reaction mixture.",
        "b": "[butanoic acid] [bound] to [acetate] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8495383951682486,
        "token(a ~ b)": 0.763157894736842,
        "domain": "1.1"
    },
    {
        "a": "[Azide] [was capable] of reacting with [Tetrachloroethylene] under basic conditions.",
        "b": "[azide ion] [was capable] of reacting with [Tetrachloroethylene] under basic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8456481771240807,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "1.1"
    },
    {
        "a": "[Cyanide] [detected] in the reaction with [Ethane].",
        "b": "[cyanide ion] [detected] in the reaction with [Ethane].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8348449197860962,
        "token(a ~ b)": 0.8607954545454546,
        "domain": "1.1"
    },
    {
        "a": "[Acetamide] [affected] [Water] transport in the renal cortex.",
        "b": "[Acetamide] [affected] [H2O] transport in the renal cortex.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9234370658516255,
        "token(a ~ b)": 0.826797385620915,
        "domain": "1.2"
    },
    {
        "a": "[Warfarin] [broadened] the therapeutic response to [Imatinib] in leukemia patients.",
        "b": "[Warfarin] [broadened] the therapeutic response to [Gleevec] in leukemia patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9369830541678911,
        "token(a ~ b)": 0.8043478260869565,
        "domain": "1.2"
    },
    {
        "a": "[Docosane] [displayed] catalytic activity similar to [Formaldehyde] in the reaction mixture.",
        "b": "[Docosane] [displayed] catalytic activity similar to [methanal] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9567879562892351,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "1.2"
    },
    {
        "a": "[Desvenlafaxine] [improved] depressive symptoms in patients treated with [Larotrectinib].",
        "b": "[Desvenlafaxine] [improved] depressive symptoms in patients treated with [Vitrakvi].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9699413431623168,
        "token(a ~ b)": 0.7214285714285715,
        "domain": "1.2"
    },
    {
        "a": "[Ozone] [replaced] [Chloride ion] in the reaction mixture.",
        "b": "[Ozone] [replaced] [Cl-] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9114356087262492,
        "token(a ~ b)": 0.75,
        "domain": "1.2"
    },
    {
        "a": "[Phosphine] [broadened] the function of [Cysteine] in the enzymatic assay.",
        "b": "[Phosphine] [broadened] the function of [Cys] in the enzymatic assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9661966314140227,
        "token(a ~ b)": 0.8869047619047619,
        "domain": "1.2"
    },
    {
        "a": "[Regorafenib] [included] [Dacarbazine] as a component in the treatment protocol.",
        "b": "[Regorafenib] [included] [DTIC] as a component in the treatment protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9153522504892367,
        "token(a ~ b)": 0.7954545454545454,
        "domain": "1.2"
    },
    {
        "a": "[Avelumab] [was associated with] an increased risk of [Colestipol]-induced hepatotoxicity.",
        "b": "[Avelumab] [was associated with] an increased risk of [Colestid]-induced hepatotoxicity.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9703709508881924,
        "token(a ~ b)": 0.9105882352941177,
        "domain": "1.2"
    },
    {
        "a": "[Meropenem] [was selected] for treatment of [Dabrafenib]-resistant melanoma.",
        "b": "[Meropenem] [was selected] for treatment of [Tafinlar]-resistant melanoma.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9757349454717876,
        "token(a ~ b)": 0.7311783960720131,
        "domain": "1.2"
    },
    {
        "a": "[Nitric oxide] [delayed] the synthesis of [Phosgene] under hypoxic conditions.",
        "b": "[Nitric oxide] [delayed] the synthesis of [carbonyl chloride] under hypoxic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9220206944344875,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "1.2"
    },
    {
        "a": "[Trifluridine/tipiracil] [induced] the development of [Polycystic Kidney Disease] in animal models.",
        "b": "[Trifluridine/tipiracil] [induced] the development of [PKD] in animal models.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9321789321789321,
        "token(a ~ b)": 0.7785675232367414,
        "domain": "1.2"
    },
    {
        "a": "[Tumor-associated Macrophage] [induced] the expression of [Interleukin-13] in lung tissue.",
        "b": "[Tumor-associated Macrophage] [induced] the expression of [IL-13] in lung tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9553086419753086,
        "token(a ~ b)": 0.844812925170068,
        "domain": "1.2"
    },
    {
        "a": "[Warfarin] [was associated with] an increased risk of [Binimetinib] toxicity in elderly patients.",
        "b": "[Warfarin] [was associated with] an increased risk of [MEK162] toxicity in elderly patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9363691326238104,
        "token(a ~ b)": 0.8035714285714286,
        "domain": "1.2"
    },
    {
        "a": "[Hydrogen chloride] [regulated] [Bromate] concentration in the reaction mixture.",
        "b": "[Hydrogen chloride] [regulated] [BrO3-] concentration in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9291410256410256,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "1.2"
    },
    {
        "a": "[Ceritinib] [impacted] the function of [Ceftriaxone] in clinical isolates.",
        "b": "[Ceritinib] [impacted] the function of [Rocephin] in clinical isolates.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9339925799248902,
        "token(a ~ b)": 0.7242553191489361,
        "domain": "1.2"
    },
    {
        "a": "[Hydrogen bromide] [induced] the expression of [Ribosomal RNA] in cultured cells.",
        "b": "[Hydrogen bromide] [induced] the expression of [rRNA] in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9443618501130239,
        "token(a ~ b)": 0.8308080808080808,
        "domain": "1.2"
    },
    {
        "a": "[Bicarbonate] [preceded] [Hydrogen phosphate] in the reaction sequence.",
        "b": "[Bicarbonate] [preceded] [monohydrogen phosphate] in the reaction sequence.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9295640509725017,
        "token(a ~ b)": 0.8043184885290149,
        "domain": "1.2"
    },
    {
        "a": "[Fluoxetine] [was overexpressed] in the presence of [Vortioxetine].",
        "b": "[Fluoxetine] [was overexpressed] in the presence of [Trintellix].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9693922447316766,
        "token(a ~ b)": 0.7308488612836439,
        "domain": "1.2"
    },
    {
        "a": "[L1 cell adhesion molecule] [was genetically associated with] [Glucokinase] in neuronal tissue.",
        "b": "[L1 cell adhesion molecule] [was genetically associated with] [GCK] in neuronal tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9508202555069214,
        "token(a ~ b)": 0.7954545454545454,
        "domain": "1.2"
    },
    {
        "a": "[Ezetimibe] [induced] the expression of [Leuprolide] in cultured cells.",
        "b": "[Ezetimibe] [induced] the expression of [leuprorelin] in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9512502551541131,
        "token(a ~ b)": 0.7351778656126482,
        "domain": "1.2"
    },
    {
        "a": "[Triptorelin] was [was linked to] [Colestipol] resistance in clinical trials.",
        "b": "[Triptorelin] was [was linked to] [Colestid] resistance in clinical trials.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.949000585000585,
        "token(a ~ b)": 0.8952380952380952,
        "domain": "1.2"
    },
    {
        "a": "[Metronidazole] [replaced] [Ponatinib] in the clinical protocol.",
        "b": "[Metronidazole] [replaced] [Iclusig] in the clinical protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9163594470046084,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "1.2"
    },
    {
        "a": "[Beta-hydroxybutyrate] [was negatively associated with] [Deoxynivalenol] levels in patient serum.",
        "b": "[Beta-hydroxybutyrate] [was negatively associated with] [Vomitoxin] levels in patient serum.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9432021922497046,
        "token(a ~ b)": 0.783068783068783,
        "domain": "1.2"
    },
    {
        "a": "[Aldolase B] [regulated] the expression of [Interleukin-12] in immune cells.",
        "b": "[Aldolase B] [regulated] the expression of [IL-12] in immune cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9464567116570259,
        "token(a ~ b)": 0.8308080808080808,
        "domain": "1.2"
    },
    {
        "a": "[Desirudin] [admitted] [Panitumumab] to the clinical trial.",
        "b": "[Desirudin] [admitted] [Vectibix] to the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9314948013103546,
        "token(a ~ b)": 0.7380952380952381,
        "domain": "1.2"
    },
    {
        "a": "[Nilutamide] [induced] a response in [Sickle Cell Disease] patients during the clinical trial.",
        "b": "[Nilutamide] [induced] a response in [SCD] patients during the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9198036006546645,
        "token(a ~ b)": 0.8043478260869565,
        "domain": "1.2"
    },
    {
        "a": "[Ribosomal RNA] [suppressed] [Immunoglobulin E] levels in the patient sample.",
        "b": "[Ribosomal RNA] [suppressed] [IgE] levels in the patient sample.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9224837662337663,
        "token(a ~ b)": 0.722943722943723,
        "domain": "1.2"
    },
    {
        "a": "[Glucokinase] [identified] [Tumor Necrosis Factor Alpha] in the patient sample.",
        "b": "[Glucokinase] [identified] [TNF-\u03b1] in the patient sample.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8922229624694648,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "1.2"
    },
    {
        "a": "[Carbon tetrachloride] [demonstrated] similar reactivity as [Barium ion] in the precipitation assay.",
        "b": "[Carbon tetrachloride] [demonstrated] similar reactivity as [Ba2+] in the precipitation assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.955831637372803,
        "token(a ~ b)": 0.8292207792207792,
        "domain": "1.2"
    },
    {
        "a": "[Lorlatinib] [was employed] to inhibit [Gefitinib] in the kinase assay.",
        "b": "[Lorlatinib] [was employed] to inhibit [Iressa] in the kinase assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9373620809826277,
        "token(a ~ b)": 0.7757475083056479,
        "domain": "1.2"
    },
    {
        "a": "[Bempedoic acid] [affected] [Oxycodone] metabolism in liver microsomes.",
        "b": "[Bempedoic acid] [affected] [Oxy] metabolism in liver microsomes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9369447453954496,
        "token(a ~ b)": 0.82281284606866,
        "domain": "1.2"
    },
    {
        "a": "[Hydrogen bromide] [regulated] the levels of [Trimethylamine] in the experimental solution.",
        "b": "[Hydrogen bromide] [regulated] the levels of [N,N-dimethylmethanamine] in the experimental solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9286605753796765,
        "token(a ~ b)": 0.7913725490196079,
        "domain": "1.2"
    },
    {
        "a": "[Cetuximab] [suppressed] the activity of [Morphine] in the experimental model.",
        "b": "[Cetuximab] [suppressed] the activity of [Morphine sulfate] in the experimental model.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.948062015503876,
        "token(a ~ b)": 0.9643617021276596,
        "domain": "1.2"
    },
    {
        "a": "[Phenoxide ion] [regulated] the concentration of [Manganese(II) ion] in the reaction mixture.",
        "b": "[Phenoxide ion] [regulated] the concentration of [Mn2+] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9319727047146401,
        "token(a ~ b)": 0.7520814061054579,
        "domain": "1.2"
    },
    {
        "a": "[Nitrofurantoin] [was associated with] an increased risk of [Dabrafenib] toxicity in elderly patients.",
        "b": "[Nitrofurantoin] [was associated with] an increased risk of [Tafinlar] toxicity in elderly patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9759119647859145,
        "token(a ~ b)": 0.7630094043887148,
        "domain": "1.2"
    },
    {
        "a": "[Ofatumumab] [suppressed] [Rifampicin] activity in the in vitro assay.",
        "b": "[Ofatumumab] [suppressed] [Rifampin] activity in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9589915966386554,
        "token(a ~ b)": 0.9643617021276596,
        "domain": "1.2"
    },
    {
        "a": "[Macrophage] [was critical for] the activity of [Protein disulfide isomerase] in the immune response.",
        "b": "[Macrophage] [was critical for] the activity of [PDI] in the immune response.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9139867129570101,
        "token(a ~ b)": 0.7076923076923077,
        "domain": "1.2"
    },
    {
        "a": "[Paroxetine] [established] the efficacy of [Prasugrel] in reducing platelet aggregation.",
        "b": "[Paroxetine] [established] the efficacy of [Effient] in reducing platelet aggregation.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9328646934460888,
        "token(a ~ b)": 0.7954545454545454,
        "domain": "1.2"
    },
    {
        "a": "[Edoxaban] [treated] the symptoms associated with [Indomethacin] overdose in animal models.",
        "b": "[Edoxaban] [treated] the symptoms associated with [Indocin] overdose in animal models.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9587784308714541,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "1.2"
    },
    {
        "a": "[Progesterone] [suppressed] [Hexadecane] metabolism in the liver microsomes.",
        "b": "[Progesterone] [suppressed] [n-Hexadecane] metabolism in the liver microsomes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9632928475033739,
        "token(a ~ b)": 0.8713768115942029,
        "domain": "1.2"
    },
    {
        "a": "[Formaldehyde] [regulated] the concentration of [1,4-Benzoquinone] in the reaction mixture.",
        "b": "[Formaldehyde] [regulated] the concentration of [para-benzoquinone] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.941258766221285,
        "token(a ~ b)": 0.815,
        "domain": "1.2"
    },
    {
        "a": "[Acyclovir] [included] [Saxitoxin] in the pharmacological screening panel.",
        "b": "[Acyclovir] [included] [Saxitoxine] in the pharmacological screening panel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.945981981981982,
        "token(a ~ b)": 0.9306418219461698,
        "domain": "1.2"
    },
    {
        "a": "[Ethane] [suppressed] [Oxalic acid] formation in the reaction mixture.",
        "b": "[Ethane] [suppressed] [ethanedioic acid] formation in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9103937455579246,
        "token(a ~ b)": 0.7352564102564103,
        "domain": "1.2"
    },
    {
        "a": "[Nitrosyl bromide] [regulated] [Vanillin] concentrations under acidic conditions.",
        "b": "[Nitrosyl bromide] [regulated] [4-hydroxy-3-methoxybenzaldehyde] concentrations under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.881176588194132,
        "token(a ~ b)": 0.5883180858550316,
        "domain": "1.2"
    },
    {
        "a": "[Interleukin-33] [regulated] the expression of [Regulator of telomere elongation helicase 1] in lung tissue.",
        "b": "[Interleukin-33] [regulated] the expression of [RTEL1] in lung tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8946071231145858,
        "token(a ~ b)": 0.6653225806451613,
        "domain": "1.2"
    },
    {
        "a": "[Ibuprofen] [was employed] to inhibit the activity of [Dutasteride] in the assay.",
        "b": "[Ibuprofen] [was employed] to inhibit the activity of [Avodart] in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9587076253742921,
        "token(a ~ b)": 0.7733580018501387,
        "domain": "1.2"
    },
    {
        "a": "[Pembrolizumab] [was selected] over [Evolocumab] for the clinical trial.",
        "b": "[Pembrolizumab] [was selected] over [Repatha] for the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9322118702553486,
        "token(a ~ b)": 0.7766798418972332,
        "domain": "1.2"
    },
    {
        "a": "[Durvalumab] [was genetically associated with] increased risk of [Dalteparin] hypersensitivity in patients with renal impairment.",
        "b": "[Durvalumab] [was genetically associated with] increased risk of [Fragmin] hypersensitivity in patients with renal impairment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9436593468924722,
        "token(a ~ b)": 0.8135964912280702,
        "domain": "1.2"
    },
    {
        "a": "[Potassium nitrate] [suppressed] [Acetic acid] production in bacterial cultures.",
        "b": "[Potassium nitrate] [suppressed] [ethanoic acid] production in bacterial cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9493464665415885,
        "token(a ~ b)": 0.8140243902439024,
        "domain": "1.2"
    },
    {
        "a": "[Rivaroxaban] [affected] [Axitinib] metabolism in human liver microsomes.",
        "b": "[Rivaroxaban] [affected] [Inlyta] metabolism in human liver microsomes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9334880680525598,
        "token(a ~ b)": 0.7595137420718816,
        "domain": "1.2"
    },
    {
        "a": "[Ceritinib] [induced] apoptosis in [Binimetinib]-treated tumor cells.",
        "b": "[Ceritinib] [induced] apoptosis in [Mektovi]-treated tumor cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9579465248460259,
        "token(a ~ b)": 0.7822410147991543,
        "domain": "1.2"
    },
    {
        "a": "[Bexarotene] [suppressed] [Acenocoumarol] metabolism in liver cells.",
        "b": "[Bexarotene] [suppressed] [Nicoumalone] metabolism in liver cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9321746880570411,
        "token(a ~ b)": 0.7351778656126482,
        "domain": "1.2"
    },
    {
        "a": "[Acalabrutinib] [was genetically associated with] [Regorafenib] resistance in the cell line.",
        "b": "[Acalabrutinib] [was genetically associated with] [Stivarga] resistance in the cell line.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9404997270036495,
        "token(a ~ b)": 0.8035714285714286,
        "domain": "1.2"
    },
    {
        "a": "[Aspirin] [induced] the release of [Methyllycaconitine] in neuronal cultures.",
        "b": "[Aspirin] [induced] the release of [methyllycaconitine citrate] in neuronal cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9525419162880463,
        "token(a ~ b)": 0.8815384615384616,
        "domain": "1.2"
    },
    {
        "a": "[Apalutamide] [regulated] the activity of [Ceftriaxone] in bacterial cultures.",
        "b": "[Apalutamide] [regulated] the activity of [Rocephin] in bacterial cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9403986998916576,
        "token(a ~ b)": 0.7125,
        "domain": "1.2"
    },
    {
        "a": "[Iodate] [was employed] as a reagent to analyze [Acetamide] in the sample.",
        "b": "[Iodate] [was employed] as a reagent to analyze [ethanamide] in the sample.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9671501501501502,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "1.2"
    },
    {
        "a": "[Regorafenib] [was employed] in the synthesis of [Vemurafenib] under acidic conditions.",
        "b": "[Regorafenib] [was employed] in the synthesis of [PLX4032] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9315293843249586,
        "token(a ~ b)": 0.7623299319727892,
        "domain": "1.2"
    },
    {
        "a": "[Ozone] [exhibited] abnormal activity in [Phosphofructokinase, liver type] during the experiment.",
        "b": "[Ozone] [exhibited] abnormal activity in [PFKL] during the experiment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9056923043105533,
        "token(a ~ b)": 0.6387959866220736,
        "domain": "1.2"
    },
    {
        "a": "[Vasopressin] [bound] to [Potassium sulfate] in the renal collecting ducts.",
        "b": "[Vasopressin] [bound] to [K2SO4] in the renal collecting ducts.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8870695128626164,
        "token(a ~ b)": 0.770048309178744,
        "domain": "1.2"
    },
    {
        "a": "[Vinyl chloride] [was employed] as a reactant with [Chloride ion] in the synthesis process.",
        "b": "[Vinyl chloride] [was employed] as a reactant with [Cl-] in the synthesis process.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9484224598045736,
        "token(a ~ b)": 0.8125,
        "domain": "1.2"
    },
    {
        "a": "[Capecitabine] [confirmed] the diagnosis of [Phenylketonuria] in neonatal screening.",
        "b": "[Capecitabine] [confirmed] the diagnosis of [PKU] in neonatal screening.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9325396825396826,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "1.2"
    },
    {
        "a": "[Bempedoic acid] [was genetically associated with] [Pitavastatin] response in hyperlipidemic patients.",
        "b": "[Bempedoic acid] [was genetically associated with] [Livalo] response in hyperlipidemic patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9395438013915244,
        "token(a ~ b)": 0.774928774928775,
        "domain": "1.2"
    },
    {
        "a": "[Everolimus] [treated] [Nilotinib]-induced toxicity in cell cultures.",
        "b": "[Everolimus] [treated] [Tasigna]-induced toxicity in cell cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9196234814706272,
        "token(a ~ b)": 0.7424242424242424,
        "domain": "1.2"
    },
    {
        "a": "[Cemiplimab] [served as] an [Oxycodone] pain reliever during the clinical trial.",
        "b": "[Cemiplimab] [served as] an [Oxy] pain reliever during the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9444594594594594,
        "token(a ~ b)": 0.8509803921568628,
        "domain": "1.2"
    },
    {
        "a": "[Cabazitaxel] [admitted] as an adjuvant to [Encorafenib] in the treatment protocol.",
        "b": "[Cabazitaxel] [admitted] as an adjuvant to [LGX818] in the treatment protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9247760271856658,
        "token(a ~ b)": 0.8113636363636363,
        "domain": "1.2"
    },
    {
        "a": "[Aflatoxin B1] [treated] [Zanamivir] toxicity in cell culture.",
        "b": "[Aflatoxin B1] [treated] [Relenza] toxicity in cell culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9207526881720429,
        "token(a ~ b)": 0.7595137420718816,
        "domain": "1.2"
    },
    {
        "a": "[Leuprolide] [contained] [Oseltamivir] in the clinical formulation.",
        "b": "[Leuprolide] [contained] [Tamiflu] in the clinical formulation.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9195806680881308,
        "token(a ~ b)": 0.7095238095238096,
        "domain": "1.2"
    },
    {
        "a": "[Formic acid] [induced] the accumulation of [Docosane] in the test solution.",
        "b": "[Formic acid] [induced] the accumulation of [n-docosane] in the test solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9523427800269906,
        "token(a ~ b)": 0.8916666666666666,
        "domain": "1.2"
    },
    {
        "a": "[Hydrogen sulfide] [established] the presence of [Peracetic acid] in the reaction mixture.",
        "b": "[Hydrogen sulfide] [established] the presence of [peroxyacetic acid] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9532205710603681,
        "token(a ~ b)": 0.9053708439897699,
        "domain": "1.2"
    },
    {
        "a": "[Paroxetine] [impacted] the pharmacokinetics of [Tucatinib] in clinical trials.",
        "b": "[Paroxetine] [impacted] the pharmacokinetics of [Tukysa] in clinical trials.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.952257855493598,
        "token(a ~ b)": 0.8043478260869565,
        "domain": "1.2"
    },
    {
        "a": "[Larotrectinib] [identified] [Trametinib] as a downstream inhibitor in the assay.",
        "b": "[Larotrectinib] [identified] [Mekinist] as a downstream inhibitor in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9405857000682672,
        "token(a ~ b)": 0.7981366459627328,
        "domain": "1.2"
    },
    {
        "a": "[Familial Hypercholesterolemia] [suppressed] the activity of [Evolocumab] in clinical trials.",
        "b": "[Familial Hypercholesterolemia] [suppressed] the activity of [Repatha] in clinical trials.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9601689708141321,
        "token(a ~ b)": 0.783068783068783,
        "domain": "1.2"
    },
    {
        "a": "[Sulfiredoxin] [contained] [Glycine receptor] in neuronal membranes.",
        "b": "[Sulfiredoxin] [contained] [GlyR] in neuronal membranes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.921829640947288,
        "token(a ~ b)": 0.8362573099415205,
        "domain": "1.2"
    },
    {
        "a": "[Carbon monoxide] [contained] [Methyl isobutyl ketone] in the industrial sample.",
        "b": "[Carbon monoxide] [contained] [MIBK] in the industrial sample.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8971446145434664,
        "token(a ~ b)": 0.6856984478935699,
        "domain": "1.2"
    },
    {
        "a": "[Glucose-6-phosphate isomerase] [induced] the expression of [Telomeric Repeat Binding Factor 2] in the cell culture.",
        "b": "[Glucose-6-phosphate isomerase] [induced] the expression of [TERF2] in the cell culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9224399164054337,
        "token(a ~ b)": 0.7928961748633879,
        "domain": "1.2"
    },
    {
        "a": "[Urea] [coordinated] the function of the [Plasma Membrane] in kidney cells.",
        "b": "[Urea] [coordinated] the function of the [Cell Membrane] in kidney cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9441617742987607,
        "token(a ~ b)": 0.8800813008130082,
        "domain": "1.2"
    },
    {
        "a": "[Natural Killer Cell] [regulated] the activation of [Dendritic epidermal T cell] in the epidermis.",
        "b": "[Natural Killer Cell] [regulated] the activation of [DETC] in the epidermis.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9241356286469069,
        "token(a ~ b)": 0.7219202898550725,
        "domain": "1.2"
    },
    {
        "a": "[Citric acid] [accelerated] the hydrolysis of [Acetic anhydride] in aqueous solution.",
        "b": "[Citric acid] [accelerated] the hydrolysis of [ethanoic anhydride] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9475444984807384,
        "token(a ~ b)": 0.8668546365914787,
        "domain": "1.2"
    },
    {
        "a": "The [azide ion] [contained] [Bromate] in the experimental solution.",
        "b": "The [azide ion] [contained] [BrO3-] in the experimental solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9306825673123218,
        "token(a ~ b)": 0.7260458839406208,
        "domain": "1.2"
    },
    {
        "a": "[Sibutramine] [was associated with] [Ticlopidine] use in elderly patients.",
        "b": "[Sibutramine] [was associated with] [Ticlid] use in elderly patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9546024285154721,
        "token(a ~ b)": 0.8795454545454545,
        "domain": "1.2"
    },
    {
        "a": "[Sotorasib] [contained] [Acyclovir] in the tablet formulation.",
        "b": "[Sotorasib] [contained] [Zovirax] in the tablet formulation.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9633446519524618,
        "token(a ~ b)": 0.763157894736842,
        "domain": "1.2"
    },
    {
        "a": "[Granular cell] [demonstrated] the presence of [Brown adipocyte] markers in the hippocampus.",
        "b": "[Granular cell] [demonstrated] the presence of [brown fat cell] markers in the hippocampus.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9434093712152357,
        "token(a ~ b)": 0.831304347826087,
        "domain": "1.2"
    },
    {
        "a": "[Palmitoleic acid] [affected] the expression of [Mercury(II) ion] in the experimental system.",
        "b": "[Palmitoleic acid] [affected] the expression of [Hg2+] in the experimental system.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.924652504589562,
        "token(a ~ b)": 0.695447409733124,
        "domain": "1.2"
    },
    {
        "a": "[Vilazodone] [was linked to] [Meloxicam] in clinical reports.",
        "b": "[Vilazodone] [was linked to] [Mobic] in clinical reports.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9479549283043676,
        "token(a ~ b)": 0.8043184885290149,
        "domain": "1.2"
    },
    {
        "a": "[Rituximab] [was associated with] [Maple Syrup Urine Disease] in pediatric patients.",
        "b": "[Rituximab] [was associated with] [MSUD] in pediatric patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.915079365079365,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "1.2"
    },
    {
        "a": "[Tryptophan] [produced] [formamide] under acidic conditions.",
        "b": "[Tryptophan] [produced] [methanamide] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9247481607243916,
        "token(a ~ b)": 0.8904761904761904,
        "domain": "1.2"
    },
    {
        "a": "[Immunoglobulin A] [was overexpressed] in [Carbonic anhydrase] deficient mice.",
        "b": "[Immunoglobulin A] [was overexpressed] in [CA] deficient mice.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9302336302865124,
        "token(a ~ b)": 0.7954545454545454,
        "domain": "1.2"
    },
    {
        "a": "[Venetoclax] [regulated] [Idelalisib] metabolism in human liver microsomes.",
        "b": "[Venetoclax] [regulated] [Zydelig] metabolism in human liver microsomes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9205942028985508,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "1.2"
    },
    {
        "a": "[Glyceraldehyde-3-phosphate dehydrogenase] [was employed] to detect [Neuropeptide Y] in the hippocampal tissue.",
        "b": "[Glyceraldehyde-3-phosphate dehydrogenase] [was employed] to detect [NPY] in the hippocampal tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9501157521157522,
        "token(a ~ b)": 0.859375,
        "domain": "1.2"
    },
    {
        "a": "[Nitrosyl bromide] [established] the role of [Benzaldehyde] in the reaction mixture.",
        "b": "[Nitrosyl bromide] [established] the role of [benzenecarbaldehyde] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.94148241316916,
        "token(a ~ b)": 0.7692307692307692,
        "domain": "1.2"
    },
    {
        "a": "[Relugolix] [bound] to [Capecitabine] in the in vitro assay.",
        "b": "[Relugolix] [bound] to [Xeloda] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9118518518518518,
        "token(a ~ b)": 0.7272727272727273,
        "domain": "1.2"
    },
    {
        "a": "[Mitoxantrone] [slowed down] the activity of [Bicalutamide] in prostate cancer cells.",
        "b": "[Mitoxantrone] [slowed down] the activity of [Casodex] in prostate cancer cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9346130030959753,
        "token(a ~ b)": 0.7967571644042233,
        "domain": "1.2"
    },
    {
        "a": "[Enoxaparin] [suppressed] the neurotoxic effects of [Saxitoxin] in neuronal cultures.",
        "b": "[Enoxaparin] [suppressed] the neurotoxic effects of [Saxitoxine] in neuronal cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9741450068399453,
        "token(a ~ b)": 0.9398148148148148,
        "domain": "1.2"
    },
    {
        "a": "[Ivermectin] [induced] the secretion of [Rifampicin] in hepatocytes.",
        "b": "[Ivermectin] [induced] the secretion of [Rifampin] in hepatocytes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9759358288770054,
        "token(a ~ b)": 0.9643617021276596,
        "domain": "1.2"
    },
    {
        "a": "[Durvalumab] [induced] resistance to [Tetrodotoxin] in neuronal tissue.",
        "b": "[Durvalumab] [induced] resistance to [TTX] in neuronal tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9325624716038164,
        "token(a ~ b)": 0.7595137420718816,
        "domain": "1.2"
    },
    {
        "a": "[Alanine] [suppressed] [Deoxyribonucleic acid] synthesis in the cultured cells.",
        "b": "[Alanine] [suppressed] [DNA] synthesis in the cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8987419149482452,
        "token(a ~ b)": 0.7095238095238096,
        "domain": "1.2"
    },
    {
        "a": "[Milnacipran] [served as] an analgesic alternative to [Ibuprofen] in pediatric patients.",
        "b": "[Milnacipran] [served as] an analgesic alternative to [Advil] in pediatric patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9423242369444902,
        "token(a ~ b)": 0.8482905982905983,
        "domain": "1.2"
    },
    {
        "a": "[Nitrosyl bromide] [bound] to [Nitrate] in the reaction mixture.",
        "b": "[Nitrosyl bromide] [bound] to [NO3-] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9300346240814019,
        "token(a ~ b)": 0.8140243902439024,
        "domain": "1.2"
    },
    {
        "a": "[Dimethyl sulfoxide] [bound] to [Lithium aluminum hydride] in the reaction mixture.",
        "b": "[Dimethyl sulfoxide] [bound] to [LiAlH4] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9014571437113217,
        "token(a ~ b)": 0.6714402618657938,
        "domain": "1.2"
    },
    {
        "a": "[Cyclohexane] [replaced] [Sodium phosphate] in the reaction mixture.",
        "b": "[Cyclohexane] [replaced] [Trisodium phosphate] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9290747999851612,
        "token(a ~ b)": 0.8844672657252888,
        "domain": "1.2"
    },
    {
        "a": "[Alectinib] [affected] [Interleukin-32] expression in the treated cell line.",
        "b": "[Alectinib] [influenced] [Interleukin-32] expression in the treated cell line.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9053121475976559,
        "token(a ~ b)": 0.8869047619047619,
        "domain": "1.3"
    },
    {
        "a": "[Heptadecane] [bound] to [Citrate] in the reaction mixture.",
        "b": "[Heptadecane] [coupled] to [Citrate] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.966070497165392,
        "token(a ~ b)": 0.8844672657252888,
        "domain": "1.3"
    },
    {
        "a": "[Cysteine] [produced] [Oxamide] under acidic conditions.",
        "b": "[Cysteine] [synthesized] [Oxamide] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9000629539951573,
        "token(a ~ b)": 0.826797385620915,
        "domain": "1.3"
    },
    {
        "a": "The binding of [glycine receptor] to [epidermal growth factor receptor] was [admitted] in the recent structural study.",
        "b": "The binding of [glycine receptor] to [epidermal growth factor receptor] was [accepted] in the recent structural study.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9618792744573297,
        "token(a ~ b)": 0.9136842105263158,
        "domain": "1.3"
    },
    {
        "a": "The [Copper(II) ion] [established] the catalytic role of [ribose-5-phosphate isomerase] in the reaction mixture.",
        "b": "The [Copper(II) ion] [confirmed] the catalytic role of [ribose-5-phosphate isomerase] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9094205794205795,
        "token(a ~ b)": 0.9276119402985075,
        "domain": "1.3"
    },
    {
        "a": "[Butane] [orchestrated] the reaction with [ethyl acetate] under high pressure.",
        "b": "[Butane] [coordinated] the reaction with [ethyl acetate] under high pressure.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9000775480227535,
        "token(a ~ b)": 0.8140243902439024,
        "domain": "1.3"
    },
    {
        "a": "[Benzaldehyde] [joined] [Magnesium chloride] in the reaction mixture.",
        "b": "[Benzaldehyde] [combined with] [Magnesium chloride] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9054605824022973,
        "token(a ~ b)": 0.8712241653418125,
        "domain": "1.3"
    },
    {
        "a": "[Nitrogen trioxide] [broadened] the solubility range of [acetonitrile] under acidic conditions.",
        "b": "[Nitrogen trioxide] [expanded] the solubility range of [acetonitrile] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9176897609425969,
        "token(a ~ b)": 0.8815384615384616,
        "domain": "1.3"
    },
    {
        "a": "[Rhodopsin] [was positively associated with] [pancreatic polypeptide] concentrations in the hypothalamus.",
        "b": "[Rhodopsin] [was a positive predictor of] [pancreatic polypeptide] concentrations in the hypothalamus.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8981757703081232,
        "token(a ~ b)": 0.8113636363636363,
        "domain": "1.3"
    },
    {
        "a": "The [white adipocyte] [displayed] a response to [Simvastatin] in vitro.",
        "b": "The [white adipocyte] [demonstrated] a response to [Simvastatin] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9130970575368305,
        "token(a ~ b)": 0.7984189723320159,
        "domain": "1.3"
    },
    {
        "a": "[Ribonucleic acid] [identified] [Arabinose] in the cellular extract.",
        "b": "[Ribonucleic acid] [recognized] [Arabinose] in the cellular extract.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9261437908496731,
        "token(a ~ b)": 0.9194444444444444,
        "domain": "1.3"
    },
    {
        "a": "[Pancreatic polypeptide] [was genetically correlated with] [Interleukin-1 beta] expression in mouse pancreatic tissue.",
        "b": "[Pancreatic polypeptide] [was genetically associated with] [Interleukin-1 beta] expression in mouse pancreatic tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9390722569134702,
        "token(a ~ b)": 0.9457215836526182,
        "domain": "1.3"
    },
    {
        "a": "[Bexarotene] [affected] [Sorafenib] metabolism in liver cells.",
        "b": "[Bexarotene] [influenced] [Sorafenib] metabolism in liver cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9069009704756698,
        "token(a ~ b)": 0.8523809523809525,
        "domain": "1.3"
    },
    {
        "a": "[Interleukin-32] [detected] in the cytoplasm of [sodium-lithium countertransporter] expressing cells.",
        "b": "[Interleukin-32] [was found] in the cytoplasm of [sodium-lithium countertransporter] expressing cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.915133190415412,
        "token(a ~ b)": 0.9010752688172043,
        "domain": "1.3"
    },
    {
        "a": "[Interleukin-21] [enhanced] the formation of [bacterial flagellum] in the experimental culture.",
        "b": "[Interleukin-21] [improved] the formation of [bacterial flagellum] in the experimental culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9050739207569485,
        "token(a ~ b)": 0.882962962962963,
        "domain": "1.3"
    },
    {
        "a": "[Acetaldehyde] [produced] [ethane] under anaerobic conditions.",
        "b": "[Acetaldehyde] [generated] [ethane] under anaerobic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9016654539574743,
        "token(a ~ b)": 0.8712241653418125,
        "domain": "1.3"
    },
    {
        "a": "[Transfer RNA] [broadened] the reactivity of [Lithium aluminum hydride] in the catalytic assay.",
        "b": "[Transfer RNA] [expanded] the reactivity of [Lithium aluminum hydride] in the catalytic assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9416028044208579,
        "token(a ~ b)": 0.882962962962963,
        "domain": "1.3"
    },
    {
        "a": "[Calcium ion] [was critical for] the function of [Hydrogen peroxide] in the reaction mixture.",
        "b": "[Calcium ion] [was essential in] the function of [Hydrogen peroxide] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9374119391916944,
        "token(a ~ b)": 0.8918181818181818,
        "domain": "1.3"
    },
    {
        "a": "[Temsirolimus] [was employed] to inhibit [Dabrafenib] activity in vitro.",
        "b": "[Temsirolimus] [was used] to inhibit [Dabrafenib] activity in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9168449197860962,
        "token(a ~ b)": 0.9306418219461698,
        "domain": "1.3"
    },
    {
        "a": "[Thymopentin] [identified] [Enkephalin] in the peptide assay.",
        "b": "[Thymopentin] [recognized] [Enkephalin] in the peptide assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9136416861826697,
        "token(a ~ b)": 0.9194444444444444,
        "domain": "1.3"
    },
    {
        "a": "[Paroxetine] [replaced] [Fluvoxamine] in the treatment regimen.",
        "b": "[Paroxetine] [substituted] [Fluvoxamine] in the treatment regimen.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8905217589428115,
        "token(a ~ b)": 0.8043184885290149,
        "domain": "1.3"
    },
    {
        "a": "[Clopidogrel] [replaced] [Binimetinib] in the treatment protocol.",
        "b": "[Clopidogrel] [substituted] [Binimetinib] in the treatment protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8906610936421504,
        "token(a ~ b)": 0.82281284606866,
        "domain": "1.3"
    },
    {
        "a": "[Everolimus] [increased] [Acalabrutinib] concentrations in plasma.",
        "b": "[Everolimus] [elevated] [Acalabrutinib] concentrations in plasma.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9069670220489893,
        "token(a ~ b)": 0.82281284606866,
        "domain": "1.3"
    },
    {
        "a": "[Tetradecane] [bound] to [Nitrosyl bromide] in the reaction mixture.",
        "b": "[Tetradecane] [coupled] to [Nitrosyl bromide] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9614769544181309,
        "token(a ~ b)": 0.8952380952380952,
        "domain": "1.3"
    },
    {
        "a": "The presence of [Tetracosane] was [identified] in [sodium chloride] crystals.",
        "b": "The presence of [Tetracosane] was [recognized] in [sodium chloride] crystals.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9379148629148629,
        "token(a ~ b)": 0.9206349206349206,
        "domain": "1.3"
    },
    {
        "a": "[Potassium] [was employed] as a catalyst in the synthesis of [tert-Butylamine].",
        "b": "[Potassium] [was used] as a catalyst in the synthesis of [tert-Butylamine].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.913723368591411,
        "token(a ~ b)": 0.9328063241106719,
        "domain": "1.3"
    },
    {
        "a": "[Lead] [replaced] [acetic acid] during the reaction in vitro.",
        "b": "[Lead] [substituted] [acetic acid] during the reaction in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8903846870342772,
        "token(a ~ b)": 0.7935435435435436,
        "domain": "1.3"
    },
    {
        "a": "[Levofloxacin] [increased] the plasma concentration of [Celecoxib].",
        "b": "[Levofloxacin] [boosted] the plasma concentration of [Celecoxib].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9107654664884907,
        "token(a ~ b)": 0.8500000000000001,
        "domain": "1.3"
    },
    {
        "a": "[Formamide] [exhibited] the property of [Bromobenzene] in solution.",
        "b": "[Formamide] [displayed] the property of [Bromobenzene] in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8953266454612184,
        "token(a ~ b)": 0.8523809523809525,
        "domain": "1.3"
    },
    {
        "a": "[Gonadotropin-releasing hormone] [induced] [Triethylamine] release in vitro.",
        "b": "[Gonadotropin-releasing hormone] [evoked] [Triethylamine] release in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9649078329626884,
        "token(a ~ b)": 0.8656126482213439,
        "domain": "1.3"
    },
    {
        "a": "The administration of [Chlorophyll d] [resulted in] an increase in [heptadecanoic acid] levels in the tissue.",
        "b": "The administration of [Chlorophyll d] [led to] an increase in [heptadecanoic acid] levels in the tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9326988167261615,
        "token(a ~ b)": 0.8888888888888888,
        "domain": "1.3"
    },
    {
        "a": "[Isoprene] [produced] [Platinum(II) ion] complexes under acidic conditions.",
        "b": "[Isoprene] [synthesized] [Platinum(II) ion] complexes under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9174448160535117,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "1.3"
    },
    {
        "a": "In the cytoplasm, [GAR1 Ribonucleoprotein] [was located in] the [Sodium-Monocarboxylate Transporter].",
        "b": "In the cytoplasm, [GAR1 Ribonucleoprotein] [was found in] the [Sodium-Monocarboxylate Transporter].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9382050705070507,
        "token(a ~ b)": 0.9534562211981567,
        "domain": "1.3"
    },
    {
        "a": "[Dichloromethane] [preceded] [Hydrogen bromide] in the reaction vessel.",
        "b": "[Dichloromethane] [came before] [Hydrogen bromide] in the reaction vessel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.916509550146667,
        "token(a ~ b)": 0.8656126482213439,
        "domain": "1.3"
    },
    {
        "a": "The activity of [Phosphoribosyl pyrophosphate synthetase 1] [elevated] [eukaryotic elongation factor 2] levels in the cell-free system.",
        "b": "The activity of [Phosphoribosyl pyrophosphate synthetase 1] [amplified] [eukaryotic elongation factor 2] levels in the cell-free system.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9378661710655424,
        "token(a ~ b)": 0.9001831501831502,
        "domain": "1.3"
    },
    {
        "a": "[Morphine] [induced] [Venetoclax] release in vitro.",
        "b": "[Morphine] [triggered] [Venetoclax] release in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8978424288221912,
        "token(a ~ b)": 0.826797385620915,
        "domain": "1.3"
    },
    {
        "a": "The administration of [Fenofibrate] [extended] the sedative effect of [Eszopiclone] in patients with insomnia.",
        "b": "The administration of [Fenofibrate] [prolonged] the sedative effect of [Eszopiclone] in patients with insomnia.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.942003042003042,
        "token(a ~ b)": 0.8925925925925926,
        "domain": "1.3"
    },
    {
        "a": "[Dabrafenib] [was selected] for treatment with [Sonidegib].",
        "b": "[Dabrafenib] [was chosen] for treatment with [Sonidegib].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9317837909274127,
        "token(a ~ b)": 0.914860681114551,
        "domain": "1.3"
    },
    {
        "a": "[Crotonaldehyde] [contained] [Diethylamine] in the reaction mixture.",
        "b": "[Crotonaldehyde] [included] [Diethylamine] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.91990507023705,
        "token(a ~ b)": 0.914860681114551,
        "domain": "1.3"
    },
    {
        "a": "[Alectinib] [was employed] to inhibit [Bevacizumab] activity in clinical trials.",
        "b": "[Alectinib] [was used] to inhibit [Bevacizumab] activity in clinical trials.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9337908961593172,
        "token(a ~ b)": 0.9306418219461698,
        "domain": "1.3"
    },
    {
        "a": "[Tetrachloroethylene] [increased] [Ribonucleic acid] levels in the cell culture.",
        "b": "[Tetrachloroethylene] [augmented] [Ribonucleic acid] levels in the cell culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9168421052631578,
        "token(a ~ b)": 0.8713768115942029,
        "domain": "1.3"
    },
    {
        "a": "The activity of [Sodium-Sulfate Cotransporter] was [was linked to] the development of [Pyramidal neuron] dysfunction in the hippocampus.",
        "b": "The activity of [Sodium-Sulfate Cotransporter] was [was associated with] the development of [Pyramidal neuron] dysfunction in the hippocampus.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.930280600008721,
        "token(a ~ b)": 0.903921568627451,
        "domain": "1.3"
    },
    {
        "a": "[Tin(II) ion] [admitted] [Acetaldehyde] into the reaction mixture.",
        "b": "[Tin(II) ion] [accepted] [Acetaldehyde] into the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9305962854349952,
        "token(a ~ b)": 0.8844672657252888,
        "domain": "1.3"
    },
    {
        "a": "[Calcium] [localized to] [Tin(II) ion] in the cytoplasmic compartment.",
        "b": "[Calcium] [was found in] [Tin(II) ion] in the cytoplasmic compartment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8806349206349207,
        "token(a ~ b)": 0.8620230700976043,
        "domain": "1.3"
    },
    {
        "a": "[Glyceraldehyde-3-phosphate] [preceded] [Hypochlorite] in the oxidation pathway.",
        "b": "[Glyceraldehyde-3-phosphate] [came before] [Hypochlorite] in the oxidation pathway.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9234967141292442,
        "token(a ~ b)": 0.8815384615384616,
        "domain": "1.3"
    },
    {
        "a": "The [chemically pure Cyclopentane] [produced] the [analytical grade Nitrate ion] under controlled laboratory conditions.",
        "b": "The [chemically pure Cyclopentane] [generated] the [analytical grade Nitrate ion] under controlled laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9260971373817224,
        "token(a ~ b)": 0.9127272727272727,
        "domain": "1.3"
    },
    {
        "a": "The [stratum granulosum cell] [exhibited] increased levels of [interleukin-1 beta] in the epidermal layer.",
        "b": "The [stratum granulosum cell] [displayed] increased levels of [interleukin-1 beta] in the epidermal layer.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9393584905660377,
        "token(a ~ b)": 0.9020833333333333,
        "domain": "1.3"
    },
    {
        "a": "The activity of [Cystic fibrosis transmembrane conductance regulator] [was genetically correlated with] [Chloride-Bicarbonate Exchanger] expression in airway cells.",
        "b": "The activity of [Cystic fibrosis transmembrane conductance regulator] [was genetically linked to] [Chloride-Bicarbonate Exchanger] expression in airway cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.946686615843763,
        "token(a ~ b)": 0.9165413533834585,
        "domain": "1.3"
    },
    {
        "a": "The presence of [E2F transcription factor 1] [established] a relationship with [N-cadherin] in neuronal cells.",
        "b": "The presence of [E2F transcription factor 1] [confirmed] a relationship with [N-cadherin] in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.933166963755199,
        "token(a ~ b)": 0.9190207156308852,
        "domain": "1.3"
    },
    {
        "a": "[Cholecystokinin] [induced] the activity of [Succinate dehydrogenase] in neuronal cells.",
        "b": "[Cholecystokinin] [triggered] the activity of [Succinate dehydrogenase] in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9442424242424242,
        "token(a ~ b)": 0.886039886039886,
        "domain": "1.3"
    },
    {
        "a": "[Sulfiredoxin] [was linked to] [Aldolase C] in neuronal tissues.",
        "b": "[Sulfiredoxin] [was associated with] [Aldolase C] in neuronal tissues.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9058943208430914,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "1.3"
    },
    {
        "a": "[Telomeric Repeat Binding Factor 1] [displayed] a strong interaction with [Cytochrome c oxidase] in the mitochondrial extracts.",
        "b": "[Telomeric Repeat Binding Factor 1] [demonstrated] a strong interaction with [Cytochrome c oxidase] in the mitochondrial extracts.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9211429387461652,
        "token(a ~ b)": 0.859375,
        "domain": "1.3"
    },
    {
        "a": "[Epinephrine] [relieved] the response to [Dacarbazine] in melanoma cells.",
        "b": "[Epinephrine] [alleviated] the response to [Dacarbazine] in melanoma cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9246989517010741,
        "token(a ~ b)": 0.844812925170068,
        "domain": "1.3"
    },
    {
        "a": "[Small nucleolar RNA] [was linked to] [Nitrogen trioxide] in cellular stress response.",
        "b": "[Small nucleolar RNA] [was associated with] [Nitrogen trioxide] in cellular stress response.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9156267131214444,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "1.3"
    },
    {
        "a": "The expression of [Protection of telomeres 1] [was increased] in [NAD(P)H:quinone oxidoreductase 1] deficient cells.",
        "b": "The expression of [Protection of telomeres 1] [was upregulated] in [NAD(P)H:quinone oxidoreductase 1] deficient cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.949005385321867,
        "token(a ~ b)": 0.931064958020327,
        "domain": "1.3"
    },
    {
        "a": "[Ceritinib] [was selected] for treatment of [Simvastatin] toxicity in patients.",
        "b": "[Ceritinib] [was chosen] for treatment of [Simvastatin] toxicity in patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9390090238191504,
        "token(a ~ b)": 0.9272727272727272,
        "domain": "1.3"
    },
    {
        "a": "[Dihydroxyacetone phosphate] [was linked to] [Catalase] expression in the liver.",
        "b": "[Dihydroxyacetone phosphate] [was associated with] [Catalase] expression in the liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9274139232860164,
        "token(a ~ b)": 0.8656126482213439,
        "domain": "1.3"
    },
    {
        "a": "[Nitrosyl azide] [produced] [erucic acid] under laboratory conditions.",
        "b": "[Nitrosyl azide] [generated] [erucic acid] under laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9349667234174276,
        "token(a ~ b)": 0.8844672657252888,
        "domain": "1.3"
    },
    {
        "a": "[Levofloxacin] [produced] [Nonsteroidal anti-inflammatory drugs] metabolites in patient samples.",
        "b": "[Levofloxacin] [generated] [Nonsteroidal anti-inflammatory drugs] metabolites in patient samples.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9024869245874401,
        "token(a ~ b)": 0.904170363797693,
        "domain": "1.3"
    },
    {
        "a": "The presence of [2-Pentyne] [produced] [Nitrogen trioxide] under standard laboratory conditions.",
        "b": "The presence of [2-Pentyne] [generated] [Nitrogen trioxide] under standard laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9222671443676599,
        "token(a ~ b)": 0.8966565349544073,
        "domain": "1.3"
    },
    {
        "a": "[Methyl isobutyl ketone] [identified] [Gastrin-releasing peptide] in the tissue sample.",
        "b": "[Methyl isobutyl ketone] [recognized] [Gastrin-releasing peptide] in the tissue sample.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9257919820577516,
        "token(a ~ b)": 0.9365217391304348,
        "domain": "1.3"
    },
    {
        "a": "[Nitrosyl chloride] [affected] [Phenylalanine] metabolism in the experimental assay.",
        "b": "[Nitrosyl chloride] [influenced] [Phenylalanine] metabolism in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9195008408186703,
        "token(a ~ b)": 0.8612836438923395,
        "domain": "1.3"
    },
    {
        "a": "[Estradiol] [contained] [Sodium] ions in the experimental solution.",
        "b": "[Estradiol] [included] [Sodium] ions in the experimental solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9059529193857552,
        "token(a ~ b)": 0.9097222222222222,
        "domain": "1.3"
    },
    {
        "a": "[Magnesium chloride] [produced] [formamide] under acidic conditions.",
        "b": "[Magnesium chloride] [generated] [formamide] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9393313847278042,
        "token(a ~ b)": 0.8545454545454545,
        "domain": "1.3"
    },
    {
        "a": "The administration of [Everolimus] [replaced] [Sipuleucel-T] in the treatment protocol.",
        "b": "The administration of [Everolimus] [substituted] [Sipuleucel-T] in the treatment protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9267007237122179,
        "token(a ~ b)": 0.8468137254901961,
        "domain": "1.3"
    },
    {
        "a": "[Nilotinib] [induced] [Dabrafenib] resistance in melanoma cells.",
        "b": "[Nilotinib] [triggered] [Dabrafenib] resistance in melanoma cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9126515151515152,
        "token(a ~ b)": 0.8612836438923395,
        "domain": "1.3"
    },
    {
        "a": "[Phosphoenolpyruvate] [activated] [phosphofructokinase, liver type] in the assay.",
        "b": "[Phosphoenolpyruvate] [stimulated] [phosphofructokinase, liver type] in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9725800847752067,
        "token(a ~ b)": 0.9190207156308852,
        "domain": "1.3"
    },
    {
        "a": "[Darolutamide] [was linked to] [Sonidegib] in recent oncology trials.",
        "b": "[Darolutamide] [was associated with] [Sonidegib] in recent oncology trials.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9097285902503295,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "1.3"
    },
    {
        "a": "[Gemcitabine] [identified] [Duchenne Muscular Dystrophy] as a potential therapeutic target in the recent clinical study.",
        "b": "[Gemcitabine] [recognized] [Duchenne Muscular Dystrophy] as a potential therapeutic target in the recent clinical study.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9346376811594203,
        "token(a ~ b)": 0.9476190476190476,
        "domain": "1.3"
    },
    {
        "a": "[Copper(II) ion] [produced] [benzoyl chloride] in the reaction mixture.",
        "b": "[Copper(II) ion] [synthesized] [benzoyl chloride] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8910819595326638,
        "token(a ~ b)": 0.8656126482213439,
        "domain": "1.3"
    },
    {
        "a": "[Dodecane] [replaced] [Nonadecane] in the reaction mixture.",
        "b": "[Dodecane] [substituted] [Nonadecane] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9279872494506741,
        "token(a ~ b)": 0.8074454428754814,
        "domain": "1.3"
    },
    {
        "a": "[Lenvatinib] [broadened] the therapeutic range of [Sonidegib] in advanced cancer patients.",
        "b": "[Lenvatinib] [expanded] the therapeutic range of [Sonidegib] in advanced cancer patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9198734340694822,
        "token(a ~ b)": 0.8674242424242424,
        "domain": "1.3"
    },
    {
        "a": "[Lomitapide] [reduced] the incidence of [Familial Hypercholesterolemia] in pediatric patients.",
        "b": "[Lomitapide] [lowered] the incidence of [Familial Hypercholesterolemia] in pediatric patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9630582183773673,
        "token(a ~ b)": 0.886039886039886,
        "domain": "1.3"
    },
    {
        "a": "The activity of [retinal pigment epithelium] was [detected] in the presence of [inositol-requiring enzyme 1].",
        "b": "The activity of [retinal pigment epithelium] was [observed] in the presence of [inositol-requiring enzyme 1].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9508821453775583,
        "token(a ~ b)": 0.8914431673052363,
        "domain": "1.3"
    },
    {
        "a": "The [thiyl radical] [demonstrated] reactivity towards [tryptophan] under oxidative conditions.",
        "b": "The [thiyl radical] [manifested] reactivity towards [tryptophan] under oxidative conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9182526467262823,
        "token(a ~ b)": 0.815,
        "domain": "1.3"
    },
    {
        "a": "[Atezolizumab] [improved] the efficacy of [Fondaparinux] in patients with recurrent thrombosis.",
        "b": "[Atezolizumab] [enhanced] the efficacy of [Fondaparinux] in patients with recurrent thrombosis.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9028267297457127,
        "token(a ~ b)": 0.8977011494252873,
        "domain": "1.3"
    },
    {
        "a": "The activity of [Zinc sulfate] was [was linked to] the regulation of [Malate dehydrogenase] in the mitochondrial matrix.",
        "b": "The activity of [Zinc sulfate] was [was associated with] the regulation of [Malate dehydrogenase] in the mitochondrial matrix.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9191758241758242,
        "token(a ~ b)": 0.8897435897435897,
        "domain": "1.3"
    },
    {
        "a": "[Ethylamine] [bound] to [Gonadotropin-releasing hormone] in the assay.",
        "b": "[Ethylamine] [coupled] to [Gonadotropin-releasing hormone] in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9419981325863678,
        "token(a ~ b)": 0.904170363797693,
        "domain": "1.3"
    },
    {
        "a": "[Fluoxetine] [affected] [Lomitapide] metabolism in the liver.",
        "b": "[Fluoxetine] [influenced] [Lomitapide] metabolism in the liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9087736771739033,
        "token(a ~ b)": 0.8447368421052632,
        "domain": "1.3"
    },
    {
        "a": "[Olaparib] [affected] [Midostaurin] metabolism in vitro.",
        "b": "[Olaparib] [influenced] [Midostaurin] metabolism in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9078933915791431,
        "token(a ~ b)": 0.8666666666666667,
        "domain": "1.3"
    },
    {
        "a": "The [Fragile X Mental Retardation Protein] [bound] to [Growth Hormone] in the synaptic compartment.",
        "b": "The [Fragile X Mental Retardation Protein] [interacted] with [Growth Hormone] in the synaptic compartment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9248486854643757,
        "token(a ~ b)": 0.8583916083916083,
        "domain": "1.3"
    },
    {
        "a": "[Fructose] [exhibited] the response of [Keratinocyte] to UV exposure.",
        "b": "[Fructose] [displayed] the response of [Keratinocyte] to UV exposure.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9017253278122843,
        "token(a ~ b)": 0.8523809523809525,
        "domain": "1.3"
    },
    {
        "a": "[Benzene] [produced] [Titanium(III) chloride] under standard laboratory conditions.",
        "b": "[Benzene] [synthesized] [Titanium(III) chloride] under standard laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9178586893633125,
        "token(a ~ b)": 0.8523809523809525,
        "domain": "1.3"
    },
    {
        "a": "[Sodium] [produced] [2-Butyne] in the reaction vessel.",
        "b": "[Sodium] [synthesized] [2-Butyne] in the reaction vessel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8753654970760234,
        "token(a ~ b)": 0.826797385620915,
        "domain": "1.3"
    },
    {
        "a": "[Hypochlorous acid] [affected] [Lead] accumulation in soil samples.",
        "b": "[Hypochlorous acid] [influenced] [Lead] accumulation in soil samples.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9203020224962145,
        "token(a ~ b)": 0.8362573099415205,
        "domain": "1.3"
    },
    {
        "a": "[Glucose-6-phosphate isomerase] [was linked to] [Interleukin-38] expression in immune cells.",
        "b": "[Glucose-6-phosphate isomerase] [was associated with] [Interleukin-38] expression in immune cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9234255206723627,
        "token(a ~ b)": 0.8914431673052363,
        "domain": "1.3"
    },
    {
        "a": "[Deoxyribonucleic acid] [included] [small nucleolar RNA] fragments in the experimental assay.",
        "b": "[Deoxyribonucleic acid] [comprised] [small nucleolar RNA] fragments in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9200853942866544,
        "token(a ~ b)": 0.8766666666666667,
        "domain": "1.3"
    },
    {
        "a": "[Heptane] [increased] [glycine] levels in the solution.",
        "b": "[Heptane] [elevated] [glycine] levels in the solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9310033670033669,
        "token(a ~ b)": 0.8043184885290149,
        "domain": "1.3"
    },
    {
        "a": "[Sulfur dioxide] [induced] [ammonium nitrate] formation in the reaction vessel.",
        "b": "[Sulfur dioxide] [triggered] [ammonium nitrate] formation in the reaction vessel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9083919362400374,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "1.3"
    },
    {
        "a": "[Magnesium citrate] [increased] [Nitrosyl hydride] levels in cultured cells.",
        "b": "[Magnesium citrate] [elevated] [Nitrosyl hydride] levels in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9198374104274771,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "1.3"
    },
    {
        "a": "[Water] [produced] [Allylamine] under laboratory conditions.",
        "b": "[Water] [generated] [Allylamine] under laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8872975658221559,
        "token(a ~ b)": 0.8545454545454545,
        "domain": "1.3"
    },
    {
        "a": "[NAD(P)H:quinone oxidoreductase 1] [upregulated] [E2F transcription factor 1] expression in cultured cells.",
        "b": "[NAD(P)H:quinone oxidoreductase 1] [increased] [E2F transcription factor 1] expression in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9574036228723005,
        "token(a ~ b)": 0.9030303030303031,
        "domain": "1.3"
    },
    {
        "a": "[Vascular Endothelial Growth Factor A] [promoted] [Apolipoprotein E] expression in vitro.",
        "b": "[Vascular Endothelial Growth Factor A] [augmented] [Apolipoprotein E] expression in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9304883601380628,
        "token(a ~ b)": 0.8713768115942029,
        "domain": "1.3"
    },
    {
        "a": "[Hydrogen peroxide] [bound] to [Peroxynitrite] in the in vitro assay.",
        "b": "[Hydrogen peroxide] [coupled] to [Peroxynitrite] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9769651436631904,
        "token(a ~ b)": 0.9012059369202227,
        "domain": "1.3"
    },
    {
        "a": "[Ponatinib] [established] a link with [Axitinib] in clinical studies.",
        "b": "[Ponatinib] [confirmed] a link with [Axitinib] in clinical studies.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8900486874253111,
        "token(a ~ b)": 0.8861689106487147,
        "domain": "1.3"
    },
    {
        "a": "[Glutathione] [preceded] [tert-Butylamine] in the reaction mixture.",
        "b": "[Glutathione] [came before] [tert-Butylamine] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9145269189765458,
        "token(a ~ b)": 0.8656126482213439,
        "domain": "1.3"
    },
    {
        "a": "[Nitryl chloride] [was selected] for reaction with [cyanide ion] in the experimental protocol.",
        "b": "[Nitryl chloride] [was chosen] for reaction with [cyanide ion] in the experimental protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9356489517612697,
        "token(a ~ b)": 0.9306418219461698,
        "domain": "1.3"
    },
    {
        "a": "[Relugolix] [slowed down] the metabolism of [Aspirin] in the human liver.",
        "b": "[Relugolix] [decelerated] the metabolism of [Aspirin] in the human liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9040680780406808,
        "token(a ~ b)": 0.7827380952380952,
        "domain": "1.3"
    },
    {
        "a": "[Gonadotropin-releasing hormone] [was found] in [phosphine] samples after extraction.",
        "b": "[Gonadotropin-releasing hormone] [detected] in [phosphine] samples after extraction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9437305831423478,
        "token(a ~ b)": 0.8713768115942029,
        "domain": "1.3"
    },
    {
        "a": "[Desirudin] [inhibited] [Dutasteride] metabolism in human liver microsomes.",
        "b": "[Desirudin] [suppressed] [Dutasteride] metabolism in human liver microsomes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8955748194014448,
        "token(a ~ b)": 0.8901515151515151,
        "domain": "1.3"
    },
    {
        "a": "[Xylose] [preceded] [Nitrogen dioxide] exposure in the experimental setup.",
        "b": "[D-xylose] [preceded] [NO2] exposure in the experimental setup.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7879381803110617,
        "token(a ~ b)": 0.6303258145363408,
        "domain": "1.4"
    },
    {
        "a": "[Phenethylamine] [improved] the symptoms of [Borderline Personality Disorder] in adolescent patients.",
        "b": "[2-phenylethan-1-amine] [improved] the symptoms of [BPD] in adolescent patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7554100883061279,
        "token(a ~ b)": 0.5586734693877551,
        "domain": "1.4"
    },
    {
        "a": "[Dinitrogen trioxide] [produced] [Docosane] under specific laboratory conditions.",
        "b": "[N2O3] [produced] [n-docosane] under specific laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7779411764705882,
        "token(a ~ b)": 0.5891304347826087,
        "domain": "1.4"
    },
    {
        "a": "[Iodobenzene] [identified] [Oxamide] in the reaction mixture.",
        "b": "[phenyl iodide] [identified] [ethanediamide] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7732586016976608,
        "token(a ~ b)": 0.4487179487179487,
        "domain": "1.4"
    },
    {
        "a": "[Nitrogen dioxide] [orchestrated] the degradation of [Hexane] in the reaction vessel.",
        "b": "[NO2] [orchestrated] the degradation of [n-hexane] in the reaction vessel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8280505715799833,
        "token(a ~ b)": 0.648611111111111,
        "domain": "1.4"
    },
    {
        "a": "The [Perhydroxyl radical] [was able] to oxidize [Methane] under specific conditions.",
        "b": "The [hydroperoxyl radical] [was able] to oxidize [CH4] under specific conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.879133017729509,
        "token(a ~ b)": 0.7167553191489362,
        "domain": "1.4"
    },
    {
        "a": "[Formaldehyde] [joined] [Fructose] molecules during the condensation reaction.",
        "b": "[methanal] [joined] [D-fructose] molecules during the condensation reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8041179872758819,
        "token(a ~ b)": 0.6303258145363408,
        "domain": "1.4"
    },
    {
        "a": "[Small nucleolar RNA] [affected] [Nitrosyl hydride] metabolism in vitro.",
        "b": "[snoRNA] [affected] [azanone] metabolism in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7437536231884058,
        "token(a ~ b)": 0.41610360360360366,
        "domain": "1.4"
    },
    {
        "a": "[Glutamine] [coordinated] the interaction with [Nitrosyl bromide] in the assay.",
        "b": "[Gln] [coordinated] the interaction with [NOBr] in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8304531380610882,
        "token(a ~ b)": 0.5588547189819725,
        "domain": "1.4"
    },
    {
        "a": "[Tetradecane] [broadened] the effects of [Aniline] exposure in aquatic organisms.",
        "b": "[n-tetradecane] [broadened] the effects of [phenylamine] exposure in aquatic organisms.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8270851753610375,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "1.4"
    },
    {
        "a": "[Dehydroepiandrosterone] [accelerated] the degradation of [2-Butyne] in vitro.",
        "b": "[DHEA] [accelerated] the degradation of [dimethylacetylene] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7973012652984143,
        "token(a ~ b)": 0.46908602150537637,
        "domain": "1.4"
    },
    {
        "a": "[Heptane] [affected] [Copper] levels in the experimental system.",
        "b": "[n-heptane] [affected] [Cu] levels in the experimental system.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8283822302558399,
        "token(a ~ b)": 0.7055555555555556,
        "domain": "1.4"
    },
    {
        "a": "[Palmitic acid] [was linked to] [Piperidine] metabolism in human liver microsomes.",
        "b": "[hexadecanoic acid] [was linked to] [hexahydroazepine] metabolism in human liver microsomes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7741982173053223,
        "token(a ~ b)": 0.6251572327044025,
        "domain": "1.4"
    },
    {
        "a": "[Small nucleolar RNA] [was sufficient for] [Strontium ion] transport in the test system.",
        "b": "[snoRNA] [was sufficient for] [Sr2+] transport in the test system.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7678030303030304,
        "token(a ~ b)": 0.5210622710622711,
        "domain": "1.4"
    },
    {
        "a": "[Thiyl radical] [broadened] the reactivity of [Dimethylamine] in aqueous solution.",
        "b": "[RS\u2022] [broadened] the reactivity of [N-methylmethanamine] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7873888571661636,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "1.4"
    },
    {
        "a": "[Calcium] [broadened] the distribution of [Chloride] in the extracellular matrix.",
        "b": "[Ca] [broadened] the distribution of [Cl-] in the extracellular matrix.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8650263722251201,
        "token(a ~ b)": 0.7272727272727273,
        "domain": "1.4"
    },
    {
        "a": "[Tropylium radical cation] [activated] [Allylamine] in the reaction mixture.",
        "b": "[Tropylium radical] [activated] [3-aminoprop-1-ene] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8837320574162679,
        "token(a ~ b)": 0.5904255319148937,
        "domain": "1.4"
    },
    {
        "a": "[Ethylamine] [was critical for] the reaction with [Glyoxal] under acidic conditions.",
        "b": "[aminoethane] [was critical for] the reaction with [ethanedial] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8011363636363635,
        "token(a ~ b)": 0.5483091787439613,
        "domain": "1.4"
    },
    {
        "a": "[Dichlorine monoxide] [broadened] the range of [Camphor] solubility in water.",
        "b": "[Cl2O] [broadened] the range of [bornan-2-one] solubility in water.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7618458445172334,
        "token(a ~ b)": 0.5527295285359801,
        "domain": "1.4"
    },
    {
        "a": "[Gonadotropin-releasing hormone] [induced] [Oxalic acid] accumulation in neuronal cells.",
        "b": "[GnRH] [induced] [ethanedioic acid] accumulation in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8156761646313886,
        "token(a ~ b)": 0.5075396825396825,
        "domain": "1.4"
    },
    {
        "a": "[Decane] [produced] [Dodecane] under high-pressure conditions.",
        "b": "[n-decane] [produced] [n-dodecane] under high-pressure conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8230498533724341,
        "token(a ~ b)": 0.7157894736842105,
        "domain": "1.4"
    },
    {
        "a": "[Nonane] [was genetically correlated with] [Oxalic acid] metabolism in human cells.",
        "b": "[n-Nonane] [was genetically correlated with] [ethanedioic acid] metabolism in human cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8733232931726908,
        "token(a ~ b)": 0.678030303030303,
        "domain": "1.4"
    },
    {
        "a": "[Peracetic acid] [induced] [Carbon monoxide] production in the reaction vessel.",
        "b": "[peroxyacetic acid] [induced] [CO] production in the reaction vessel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8012257967678992,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "1.4"
    },
    {
        "a": "[Acetaldehyde] [preceded] [Bromide] in the reaction sequence.",
        "b": "[ethanal] [preceded] [bromide ion] in the reaction sequence.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7898066811011445,
        "token(a ~ b)": 0.6947368421052631,
        "domain": "1.4"
    },
    {
        "a": "[Hydrogen fluoride] [emerged] as a contaminant in [Nitrate ion] solutions during the experiment.",
        "b": "[HF] [emerged] as a contaminant in [NO3-] solutions during the experiment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7914586014586014,
        "token(a ~ b)": 0.6714402618657938,
        "domain": "1.4"
    },
    {
        "a": "[Isoprene] [joined] [Dimethylamine] in the reaction mixture.",
        "b": "[2-methyl-1,3-butadiene] [joined] [N-methylmethanamine] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7336111111111112,
        "token(a ~ b)": 0.5080515297906603,
        "domain": "1.4"
    },
    {
        "a": "[Tridecanoic acid] [was employed] to modify [Acetaldehyde] content in the reaction mixture.",
        "b": "[n-tridecanoic acid] [was employed] to modify [ethanal] content in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8553760998038106,
        "token(a ~ b)": 0.7242553191489361,
        "domain": "1.4"
    },
    {
        "a": "[Tetradecane] [exhibited] a strong interaction with [Citric acid] in aqueous solution.",
        "b": "[n-tetradecane] [exhibited] a strong interaction with [2-hydroxypropane-1,2,3-tricarboxylic acid] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.770868292133566,
        "token(a ~ b)": 0.5538461538461539,
        "domain": "1.4"
    },
    {
        "a": "[Water] [broadened] the absorption spectrum of [Chlorophyll b] in vitro.",
        "b": "[H2O] [broadened] the absorption spectrum of [Chl b] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7991138144705668,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "1.4"
    },
    {
        "a": "[Erucic acid] [served as] a substrate for [Proline] metabolism in liver tissue.",
        "b": "[cis-13-docosenoic acid] [served as] a substrate for [Pro] metabolism in liver tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8264380335590227,
        "token(a ~ b)": 0.6840513983371126,
        "domain": "1.4"
    },
    {
        "a": "[Nitroxyl] [was positively associated with] [Calcitonin gene-related peptide] levels in plasma samples.",
        "b": "[azanone] [was positively associated with] [CGRP] levels in plasma samples.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7555848488992205,
        "token(a ~ b)": 0.5218855218855218,
        "domain": "1.4"
    },
    {
        "a": "[Lithium aluminum hydride] [broadened] the reactivity range of [Iodide ion] in solution.",
        "b": "[LiAlH4] [broadened] the reactivity range of [I-] in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.80080308086426,
        "token(a ~ b)": 0.5733333333333334,
        "domain": "1.4"
    },
    {
        "a": "[Peroxynitrite] [was genetically correlated with] [Pyrrolysine] in mammalian cells.",
        "b": "[ONOO-] [was genetically correlated with] [Pyl] in mammalian cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7710631645503535,
        "token(a ~ b)": 0.5716783216783217,
        "domain": "1.4"
    },
    {
        "a": "[Chromium(II) ion] [was genetically associated with] [1-Decyne] in the reaction mixture.",
        "b": "[chromous ion] [was genetically associated with] [C10H18] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7900720620842573,
        "token(a ~ b)": 0.5885668276972624,
        "domain": "1.4"
    },
    {
        "a": "[Hydrazine] [interacted] with [Interleukin-21] during the assay.",
        "b": "[N2H4] [interacted] with [IL-21] during the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7677119565217392,
        "token(a ~ b)": 0.5533333333333333,
        "domain": "1.4"
    },
    {
        "a": "[Nitrosyl cation] [was employed] as a catalyst for the synthesis of [tridecanoic acid] in the reaction mixture.",
        "b": "[NO+] [was employed] as a catalyst for the synthesis of [n-tridecanoic acid] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8465622624038465,
        "token(a ~ b)": 0.6924165251839276,
        "domain": "1.4"
    },
    {
        "a": "[Acetophenone] [broadened] the toxicity of [Cyanide] in cell cultures.",
        "b": "[1-phenylethanone] [broadened] the toxicity of [cyanide ion] in cell cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8426729153199742,
        "token(a ~ b)": 0.6352040816326531,
        "domain": "1.4"
    },
    {
        "a": "[N-Methyl-2-pyrrolidone] [bound] to [Dihydrogen phosphate] in the assay.",
        "b": "[NMP] [bound] to [monobasic phosphate] in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7685866468475164,
        "token(a ~ b)": 0.487510766580534,
        "domain": "1.4"
    },
    {
        "a": "[N-acetylcysteine] [exhibited] an interaction with [Citrate] in the binding assay.",
        "b": "[NAC] [exhibited] an interaction with [CIT] in the binding assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8060074431765756,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "1.4"
    },
    {
        "a": "[Ca3(PO4)2] [affected] [BHB] metabolism in neuronal cells.",
        "b": "[Calcium phosphate] [affected] [Beta-hydroxybutyrate] metabolism in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6756752555613023,
        "token(a ~ b)": 0.4397840531561462,
        "domain": "1.4"
    },
    {
        "a": "[Ethylene oxide] [stimulated] the expression of [Tricosane] in the cell culture.",
        "b": "[oxirane] [stimulated] the expression of [n-Tricosane] in the cell culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8150387323943662,
        "token(a ~ b)": 0.6603864734299516,
        "domain": "1.4"
    },
    {
        "a": "[Sulfur trioxide] [joined] [Tin(II) chloride] during the reaction.",
        "b": "[SO3] [joined] [SnCl2] during the reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6707033616458342,
        "token(a ~ b)": 0.41610360360360366,
        "domain": "1.4"
    },
    {
        "a": "[Glycine] [preceded] [Formic acid] formation in the reaction mixture.",
        "b": "[Gly] [preceded] [methanoic acid] formation in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9272745753819922,
        "token(a ~ b)": 0.8043184885290149,
        "domain": "1.4"
    },
    {
        "a": "[Toluene] [extended] the effect of [Beryllium ion] in the test system.",
        "b": "[methylbenzene] [extended] the effect of [Be2+] in the test system.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7789625762811558,
        "token(a ~ b)": 0.5455813953488372,
        "domain": "1.4"
    },
    {
        "a": "[Ammonium nitrate] [was employed] to synthesize [Glucose] in the reaction vessel.",
        "b": "[NH4NO3] [was employed] to synthesize [D-glucose] in the reaction vessel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.764113235667174,
        "token(a ~ b)": 0.5885668276972624,
        "domain": "1.4"
    },
    {
        "a": "[Methionine] [localized to] [Acetoacetate] in mitochondrial membranes.",
        "b": "[Met] [localized to] [acetoacetic acid] in mitochondrial membranes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8783465162665932,
        "token(a ~ b)": 0.5386100386100386,
        "domain": "1.4"
    },
    {
        "a": "[Ca3(PO4)2] [bound] to [Ca] in the simulated extracellular environment.",
        "b": "[Calcium phosphate] [bound] to [Calcium] in the simulated extracellular environment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8266480829420971,
        "token(a ~ b)": 0.6215644820295982,
        "domain": "1.4"
    },
    {
        "a": "[Calcium phosphate] [contained] [Chlorophyll d] in the solution.",
        "b": "[Ca3(PO4)2] [contained] [Chl d] in the solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6933858401084011,
        "token(a ~ b)": 0.5333333333333333,
        "domain": "1.4"
    },
    {
        "a": "[Lead] [joined] [Dinitrogen pentoxide] molecules in solution.",
        "b": "[Pb] [joined] [N2O5] molecules in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6781966869652726,
        "token(a ~ b)": 0.478030303030303,
        "domain": "1.4"
    },
    {
        "a": "[Leucine] [improved] the absorption of [Octadecane] in the intestinal mucosa.",
        "b": "[Leu] [improved] the absorption of [n-octadecane] in the intestinal mucosa.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9048250014825358,
        "token(a ~ b)": 0.7827380952380952,
        "domain": "1.4"
    },
    {
        "a": "[Nitrate] [affected] [Cyclohexane] metabolism in liver cells.",
        "b": "[NO3-] [affected] [hexahydrobenzene] metabolism in liver cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8522913233295746,
        "token(a ~ b)": 0.48,
        "domain": "1.4"
    },
    {
        "a": "[Chlorophyll b] [coordinated] the activity of [Alkoxyl radical] in the reaction mixture.",
        "b": "[Chl b] [coordinated] the activity of [RO\u2022] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8558268202385849,
        "token(a ~ b)": 0.6629787234042553,
        "domain": "1.4"
    },
    {
        "a": "[Bromobenzene] [coordinated] the synthesis of [Nitryl iodide] in the laboratory experiment.",
        "b": "[phenyl bromide] [coordinated] the synthesis of [NO2I] in the laboratory experiment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7934065934065934,
        "token(a ~ b)": 0.5267857142857143,
        "domain": "1.4"
    },
    {
        "a": "[1-Heptyne] [activated] [Fumarate] conversion in the mitochondria.",
        "b": "[C7H12] [activated] [fumaric acid] conversion in the mitochondria.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7805194805194805,
        "token(a ~ b)": 0.5170731707317073,
        "domain": "1.4"
    },
    {
        "a": "[Palmitoleic acid] [exhibited] interaction with [Thiocyanate] in the binding assay.",
        "b": "[hexadec-9-enoic acid] [exhibited] interaction with [SCN-] in the binding assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7740834767641998,
        "token(a ~ b)": 0.5747126436781609,
        "domain": "1.4"
    },
    {
        "a": "[1,1-Dimethylhydrazine] [bound] to the [Carbonyl Group] in the catalytic assay.",
        "b": "[unsymmetrical dimethylhydrazine] [bound] to the [carbonyl functional group] in the catalytic assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7519177215189873,
        "token(a ~ b)": 0.6802083333333333,
        "domain": "1.4"
    },
    {
        "a": "[Oxamide] [induced] [Tryptophan] accumulation in the cultured cells.",
        "b": "[ethanediamide] [induced] [Trp] accumulation in the cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8266973953760608,
        "token(a ~ b)": 0.570630081300813,
        "domain": "1.4"
    },
    {
        "a": "[Titanium(II) ion] [affected] [Barium ion] transport in the experimental assay.",
        "b": "[Ti2+] [affected] [Ba2+] transport in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8173813693117764,
        "token(a ~ b)": 0.5201465201465201,
        "domain": "1.4"
    },
    {
        "a": "[Triethylamine] [was positively associated with] [Carbonyl Sulfide] levels in the reaction mixture.",
        "b": "[N,N-Diethylethanamine] [was positively associated with] [COS] levels in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8094927503636065,
        "token(a ~ b)": 0.5168504901960784,
        "domain": "1.4"
    },
    {
        "a": "[Chloroform] [was employed] as a solvent for [Formamide] in the crystallization experiment.",
        "b": "[trichloromethane] [was employed] as a solvent for [methanamide] in the crystallization experiment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8001484789720085,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "1.4"
    },
    {
        "a": "[1,1-Dimethylhydrazine] [affected] [Hypochlorous acid] levels in the solution.",
        "b": "[unsymmetrical dimethylhydrazine] [affected] [HOCl] levels in the solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7761538461538462,
        "token(a ~ b)": 0.5666666666666667,
        "domain": "1.4"
    },
    {
        "a": "[Acetamide] [was employed] to extract [Undecane] from the mixture.",
        "b": "[ethanamide] [was employed] to extract [n-undecane] from the mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8269433465085639,
        "token(a ~ b)": 0.722943722943723,
        "domain": "1.4"
    },
    {
        "a": "[N,N-Dimethylformamide] [affected] [Toluene] metabolism in the liver.",
        "b": "[DMF] [affected] [methylbenzene] metabolism in the liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7728480901249779,
        "token(a ~ b)": 0.5083333333333333,
        "domain": "1.4"
    },
    {
        "a": "[Dithiothreitol] [accelerated] the degradation of [Thymopentin] in the experimental assay.",
        "b": "[DTT] [accelerated] the degradation of [TP5] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7974253925988213,
        "token(a ~ b)": 0.5626477541371158,
        "domain": "1.4"
    },
    {
        "a": "[Tryptophan] [activated] [Isoleucine] metabolism in the cell-free assay.",
        "b": "[Trp] [activated] [Ile] metabolism in the cell-free assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8580779054916986,
        "token(a ~ b)": 0.608974358974359,
        "domain": "1.4"
    },
    {
        "a": "[Tropylium radical cation] [identified] [Nitrite] in the reaction mixture.",
        "b": "[Tropylium radical] [identified] [Nitrite ion] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9271031594975258,
        "token(a ~ b)": 0.8782051282051282,
        "domain": "1.4"
    },
    {
        "a": "[Acetate] [was employed] to neutralize [Hypochlorite] in the test solution.",
        "b": "[ethanoate] [was employed] to neutralize [ClO-] in the test solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.802103519668737,
        "token(a ~ b)": 0.6387959866220736,
        "domain": "1.4"
    },
    {
        "a": "[Ammonia] [served as] [Selenate] in the catalytic process.",
        "b": "[NH3] [served as] [SeO4^2-] in the catalytic process.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7608089351550641,
        "token(a ~ b)": 0.5218855218855218,
        "domain": "1.4"
    },
    {
        "a": "[Aluminum] [broadened] the antimicrobial spectrum of [peroxyacetic acid] in hospital settings.",
        "b": "[Al] [broadened] the antimicrobial spectrum of [Peracetic acid] in hospital settings.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8668766513697678,
        "token(a ~ b)": 0.8713768115942029,
        "domain": "1.4"
    },
    {
        "a": "[Iodide] [was employed] as a substitute for [Progesterone] in the experimental assay.",
        "b": "[I-] [was employed] as a substitute for [Pregn-4-ene-3,20-dione] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.834619230360109,
        "token(a ~ b)": 0.5683023872679045,
        "domain": "1.4"
    },
    {
        "a": "[Hexadecane] [induced] the reduction of [Dithiothreitol] levels in the sample.",
        "b": "[n-Hexadecane] [induced] the reduction of [DTT] levels in the sample.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7941471571906353,
        "token(a ~ b)": 0.6266061980347695,
        "domain": "1.4"
    },
    {
        "a": "[2-Butyne] [was found] in the presence of [Manganese(II) ion] during the reaction.",
        "b": "[dimethylacetylene] [was found] in the presence of [Mn2+] during the reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7684859007028647,
        "token(a ~ b)": 0.5302603800140746,
        "domain": "1.4"
    },
    {
        "a": "[Trimethylamine] [enhanced] [Tetradecane] concentrations in the test solution.",
        "b": "[N,N-dimethylmethanamine] [enhanced] [n-tetradecane] concentrations in the test solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8212705272255834,
        "token(a ~ b)": 0.6840513983371126,
        "domain": "1.4"
    },
    {
        "a": "[Ozone] [affected] [1-Octyne] levels in the sample.",
        "b": "[O3] [affected] [C8H14] levels in the sample.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7995206971677559,
        "token(a ~ b)": 0.6345864661654135,
        "domain": "1.4"
    },
    {
        "a": "[FADH2] [bound] to [Hypochlorous acid] in the reaction mixture.",
        "b": "[Flavin adenine dinucleotide] [bound] to [HOCl] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6889589169000935,
        "token(a ~ b)": 0.4334415584415584,
        "domain": "1.4"
    },
    {
        "a": "[Substance P] [coordinated] the activity of [Chlorophyll b] in the photosynthetic complex.",
        "b": "[SP] [coordinated] the activity of [Chl b] in the photosynthetic complex.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8254287163876206,
        "token(a ~ b)": 0.75,
        "domain": "1.4"
    },
    {
        "a": "[Nitrogen trioxide] [was critical for] the synthesis of [Methanethiol] in the reaction mixture.",
        "b": "[dinitrogen trioxide] [was critical for] the synthesis of [methyl mercaptan] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8192039122940634,
        "token(a ~ b)": 0.6809116809116809,
        "domain": "1.4"
    },
    {
        "a": "[Cyclohexylamine] [prolonged] the effect of [Methionine] in the neuronal assay.",
        "b": "[aminocyclohexane] [prolonged] the effect of [Met] in the neuronal assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8346405117020834,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "1.4"
    },
    {
        "a": "[Methylhydrazine] [prolonged] the effect of [Beta-hydroxybutyrate] in neuronal cells.",
        "b": "[Monomethylhydrazine] [prolonged] the effect of [BHB] in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8135681071765357,
        "token(a ~ b)": 0.6606918238993711,
        "domain": "1.4"
    },
    {
        "a": "[Nitrous oxide] [was employed] as an oxidant instead of [Peracetic acid] in the reaction.",
        "b": "[N2O] [was employed] as an oxidant instead of [peroxyacetic acid] in the reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8343749487624521,
        "token(a ~ b)": 0.7661538461538462,
        "domain": "1.4"
    },
    {
        "a": "[NO+] [coordinated] the activation of [HNO3] in acidic solution.",
        "b": "[Nitrosyl cation] [coordinated] the activation of [Nitric acid] in acidic solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7845441086379416,
        "token(a ~ b)": 0.5295238095238095,
        "domain": "1.4"
    },
    {
        "a": "[Methionine] [bound] to [Glyceraldehyde-3-phosphate] in the reaction mixture.",
        "b": "[Met] [bound] to [G3P] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8326165046794094,
        "token(a ~ b)": 0.5533333333333333,
        "domain": "1.4"
    },
    {
        "a": "[Hydrogen sulfide] [bound] [Histidine] residues at physiological pH.",
        "b": "[hydrosulfide ion] [bound] [His] residues at physiological pH.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8300284629981025,
        "token(a ~ b)": 0.569377990430622,
        "domain": "1.4"
    },
    {
        "a": "[Phenoxide ion] [admitted] [N-acetylcysteine] into the reaction mixture.",
        "b": "[phenolate] [admitted] [NAC] into the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7733799533799532,
        "token(a ~ b)": 0.570630081300813,
        "domain": "1.4"
    },
    {
        "a": "[Aluminum] [produced] [Calcium phosphate] crystals in the test solution.",
        "b": "[Al] [produced] [Ca3(PO4)2] crystals in the test solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8077050935316655,
        "token(a ~ b)": 0.6267232237539766,
        "domain": "1.4"
    },
    {
        "a": "[Aspartic acid] [broadened] the activity of [Acetyl chloride] in the reaction mixture.",
        "b": "[Asp] [broadened] the activity of [ethanoyl chloride] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8813929636255218,
        "token(a ~ b)": 0.6958333333333333,
        "domain": "1.4"
    },
    {
        "a": "[Duchenne Muscular Dystrophy] [was genetically associated with] [Gastric cancer] in the study population.",
        "b": "[DMD] [was genetically associated with] [Stomach cancer] in the study population.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8024893770604038,
        "token(a ~ b)": 0.5885668276972624,
        "domain": "1.4"
    },
    {
        "a": "[2-Butyne] [was employed] as a reagent with [1-Nonyne] in the synthetic protocol.",
        "b": "[dimethylacetylene] [was employed] as a reagent with [non-1-yne] in the synthetic protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8057151425572477,
        "token(a ~ b)": 0.6418238993710692,
        "domain": "1.4"
    },
    {
        "a": "[Phosphine] [induced] the expression of [Threonine] in cultured cells.",
        "b": "[phosphorus trihydride] [induced] the expression of [Thr] in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7909797932330827,
        "token(a ~ b)": 0.634469696969697,
        "domain": "1.4"
    },
    {
        "a": "[Pb2+] [broadened] the spectrum of [Chl b] absorption in the solution.",
        "b": "[Lead(II) ion] [broadened] the spectrum of [Chlorophyll b] absorption in the solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7767260646330414,
        "token(a ~ b)": 0.6061980347694633,
        "domain": "1.4"
    },
    {
        "a": "[Chlorophyll a] [produced] [Vanillin] under laboratory conditions.",
        "b": "[Chl a] [produced] [4-hydroxy-3-methoxybenzaldehyde] under laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8327605557490615,
        "token(a ~ b)": 0.48120567375886525,
        "domain": "1.4"
    },
    {
        "a": "[Calcium phosphate] [was employed] as a carrier for [Acetophenone] in drug delivery studies.",
        "b": "[Ca3(PO4)2] [was employed] as a carrier for [1-phenylethanone] in drug delivery studies.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8297595520421608,
        "token(a ~ b)": 0.5478609625668449,
        "domain": "1.4"
    },
    {
        "a": "[Hydrogen gas] [detected] in the presence of [Dehydroepiandrosterone] during the reaction.",
        "b": "[H2] [detected] in the presence of [DHEA] during the reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7730383553742842,
        "token(a ~ b)": 0.5155775075987842,
        "domain": "1.4"
    },
    {
        "a": "[Acetylene] [broadened] the solubility range of [Dimethylformamide] in the reaction mixture.",
        "b": "[ethyne] [broadened] the solubility range of [DMF] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8231941631923764,
        "token(a ~ b)": 0.6884531590413943,
        "domain": "1.4"
    },
    {
        "a": "[Diethylamine] [coordinated] the catalytic activity of [Lithium] in the reaction mixture.",
        "b": "[N,N-diethanamine] [coordinated] the catalytic activity of [Li] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8306515529830137,
        "token(a ~ b)": 0.6442307692307692,
        "domain": "1.4"
    },
    {
        "a": "[Isopropylamine] [enhanced] [Magnesium ion] uptake in cultured cells.",
        "b": "[2-aminopropane] [enhanced] [Mg2+] uptake in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.784192546583851,
        "token(a ~ b)": 0.478021978021978,
        "domain": "1.4"
    },
    {
        "a": "[Citric acid] [produced] [xylene] under acidic conditions.",
        "b": "[2-hydroxypropane-1,2,3-tricarboxylic acid] [produced] [dimethylbenzene] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7342741407375531,
        "token(a ~ b)": 0.35141509433962265,
        "domain": "1.4"
    },
    {
        "a": "The [motor neuron] [displayed] an interaction with [Fragile X Mental Retardation Protein] during synaptic development.",
        "b": "The [efferent neuron] [displayed] an interaction with [FMR1 protein] during synaptic development.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.859057115318494,
        "token(a ~ b)": 0.5943204868154158,
        "domain": "1.4"
    },
    {
        "a": "[tert-Butylamine] [was sufficient for] [Chlorine dioxide] reduction in the experimental setup.",
        "b": "[2-methyl-2-propanamine] [was sufficient for] [ClO2] reduction in the experimental setup.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7817109336464351,
        "token(a ~ b)": 0.5747126436781609,
        "domain": "1.4"
    },
    {
        "a": "[Bromate] was [was linked to] [Tin(II) chloride] toxicity in aquatic environments.",
        "b": "[BrO3-] was [was linked to] [SnCl2] toxicity in aquatic environments.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8256451042771297,
        "token(a ~ b)": 0.5075396825396825,
        "domain": "1.4"
    },
    {
        "a": "[3-Octyne] [elevated] the concentration of [vasopressin] in plasma.",
        "b": "[Oct-3-yne] [increased] the concentration of [vasopressin] in plasma.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.832193071907543,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "1.5"
    },
    {
        "a": "[Mitoxantrone] [alleviated] the symptoms of [Borderline Personality Disorder] in adult patients.",
        "b": "[Novantrone] [relieved] the symptoms of [Borderline Personality Disorder] in adult patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8255928853754941,
        "token(a ~ b)": 0.703525641025641,
        "domain": "1.5"
    },
    {
        "a": "[Lead] [extended] the exposure time of [Aniline] in the experimental setup.",
        "b": "[Pb] [prolonged] the exposure time of [Aniline] in the experimental setup.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8179312039312039,
        "token(a ~ b)": 0.7,
        "domain": "1.5"
    },
    {
        "a": "[Interferon-gamma] [induced] [Tumor Protein p53] expression in the treated cells.",
        "b": "[IFN-\u03b3] [triggered] [Tumor Protein p53] expression in the treated cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8286613410796417,
        "token(a ~ b)": 0.6209613869188337,
        "domain": "1.5"
    },
    {
        "a": "[Bromine monoxide] [displayed] high affinity for [heptadecanoic acid] in the reaction medium.",
        "b": "[BrO] [demonstrated] high affinity for [heptadecanoic acid] in the reaction medium.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8561612176212677,
        "token(a ~ b)": 0.6445639187574671,
        "domain": "1.5"
    },
    {
        "a": "[Cadmium ion] [broadened] the therapeutic range of [Methyl isobutyl ketone] in the cell culture assay.",
        "b": "[Cd2+] [expanded] the therapeutic range of [Methyl isobutyl ketone] in the cell culture assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8387614147313772,
        "token(a ~ b)": 0.7368421052631579,
        "domain": "1.5"
    },
    {
        "a": "[2-Heptyne] [preceded] [Calcitonin gene-related peptide] release in the assay.",
        "b": "[hept-2-yne] [came before] [Calcitonin gene-related peptide] release in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8377795243648902,
        "token(a ~ b)": 0.7146781789638932,
        "domain": "1.5"
    },
    {
        "a": "[Glyceraldehyde-3-phosphate dehydrogenase] [detected] in [dopaminergic neuron] cultures after stimulation.",
        "b": "[GAPDH] [was found] in [dopaminergic neuron] cultures after stimulation.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6848156211363757,
        "token(a ~ b)": 0.5296774193548387,
        "domain": "1.5"
    },
    {
        "a": "[Glucose] [substituted] [Polychlorinated biphenyls] in the extraction process.",
        "b": "[D-glucose] [replaced] [Polychlorinated biphenyls] in the extraction process.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8029441147088205,
        "token(a ~ b)": 0.7242553191489361,
        "domain": "1.5"
    },
    {
        "a": "[Finasteride] [increased] the therapeutic response to [chloramphenicol] in resistant infections.",
        "b": "[5\u03b1-reductase inhibitor] [augmented] the therapeutic response to [chloramphenicol] in resistant infections.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8200673593159674,
        "token(a ~ b)": 0.6352040816326531,
        "domain": "1.5"
    },
    {
        "a": "[Hydrogen sulfide] [was capable] of interacting with [Acetic acid] in the cellular assay.",
        "b": "[H2S] [was able] to interact with [Acetic acid] in the cellular assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8072309400030345,
        "token(a ~ b)": 0.5555555555555556,
        "domain": "1.5"
    },
    {
        "a": "[Hydrogen sulfide] [bound] to [Substance P] in the synaptic cleft.",
        "b": "[H2S] [coupled] to [Substance P] in the synaptic cleft.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8154248366013072,
        "token(a ~ b)": 0.6071428571428572,
        "domain": "1.5"
    },
    {
        "a": "[Palmitoleic acid] [affected] [Dichlorine monoxide] levels in the reaction mixture.",
        "b": "[hexadec-9-enoic acid] [influenced] [Dichlorine monoxide] levels in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7887733073037271,
        "token(a ~ b)": 0.6537037037037037,
        "domain": "1.5"
    },
    {
        "a": "[NO] [was essential in] the regulation of [CFTR] function in epithelial cells.",
        "b": "[Nitric oxide] [was critical for] the regulation of [CFTR] function in epithelial cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8161875161875162,
        "token(a ~ b)": 0.6907114624505929,
        "domain": "1.5"
    },
    {
        "a": "[Small nuclear RNA] [boosted] [Obinutuzumab] activity in patient-derived cells.",
        "b": "[snRNA] [increased] [Obinutuzumab] activity in patient-derived cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8239530694951719,
        "token(a ~ b)": 0.7125,
        "domain": "1.5"
    },
    {
        "a": "[Chlorophyll b] [bound] to [Protein disulfide isomerase] in the presence of reducing agents.",
        "b": "[Chl b] [coupled] to [Protein disulfide isomerase] in the presence of reducing agents.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.901767056671,
        "token(a ~ b)": 0.8113636363636363,
        "domain": "1.5"
    },
    {
        "a": "[Ezetimibe] [ameliorated] [Encorafenib]-induced side effects in patients.",
        "b": "[Zetia] [alleviated] [Encorafenib]-induced side effects in patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8094291398066076,
        "token(a ~ b)": 0.6148148148148148,
        "domain": "1.5"
    },
    {
        "a": "[Cyanide ion] [produced] [Rhamnose] in the bacterial culture.",
        "b": "[CN-] [generated] [Rhamnose] in the bacterial culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8031217344254034,
        "token(a ~ b)": 0.6303258145363408,
        "domain": "1.5"
    },
    {
        "a": "[Dimethylamine] [identified] [Hydrogen phosphate] as a reaction intermediate in the synthesis.",
        "b": "[N-methylmethanamine] [recognized] [Hydrogen phosphate] as a reaction intermediate in the synthesis.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.80507833655706,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "1.5"
    },
    {
        "a": "In the recent study, [Nitryl fluoride] [established] the catalytic activity of [Sodium borohydride].",
        "b": "In the recent study, [nitrogen dioxide fluoride] [confirmed] the catalytic activity of [Sodium borohydride].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.88,
        "token(a ~ b)": 0.7574675324675324,
        "domain": "1.5"
    },
    {
        "a": "[Molybdate] [broadened] the metabolic range of [toluene] in the reaction mixture.",
        "b": "[tetraoxomolybdate(VI)] [expanded] the metabolic range of [toluene] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8096949591308426,
        "token(a ~ b)": 0.651098901098901,
        "domain": "1.5"
    },
    {
        "a": "[Hexamethylphosphoramide] [was located in] the nucleus of [Phosphofructokinase, muscle type].",
        "b": "[HMPA] [was found in] the nucleus of [Phosphofructokinase, muscle type].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7831867057673509,
        "token(a ~ b)": 0.6773584905660377,
        "domain": "1.5"
    },
    {
        "a": "[Pyrrolysine] [prolonged] the fluorescence of [Chlorophyll b] in the reaction mixture.",
        "b": "[Pyl] [extended] the fluorescence of [Chlorophyll b] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8599134061223899,
        "token(a ~ b)": 0.7167553191489362,
        "domain": "1.5"
    },
    {
        "a": "[Mercury(II) ion] [was critical for] the function of [Magnesium ion] in the cellular assay.",
        "b": "[Hg2+] [was essential in] the function of [Magnesium ion] in the cellular assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7823626373626373,
        "token(a ~ b)": 0.5833333333333333,
        "domain": "1.5"
    },
    {
        "a": "[Isopropylamine] [was essential in] the binding of [Cysteine] to the enzyme.",
        "b": "[2-aminopropane] [was critical for] the binding of [Cysteine] to the enzyme.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.81700706991359,
        "token(a ~ b)": 0.61,
        "domain": "1.5"
    },
    {
        "a": "[Testosterone] [was used] to inhibit [Regorafenib] metabolism in vitro.",
        "b": "[Androst-4-en-17\u03b2-ol-3-one] [was employed] to inhibit [Regorafenib] metabolism in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.781145966709347,
        "token(a ~ b)": 0.5521428571428572,
        "domain": "1.5"
    },
    {
        "a": "[Thiyl radical] [induced] [sodium sulfate] precipitation in solution.",
        "b": "[RS\u2022] [triggered] [sodium sulfate] precipitation in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7552414637098401,
        "token(a ~ b)": 0.6111111111111112,
        "domain": "1.5"
    },
    {
        "a": "[Lysine] [was positively associated with] [Aspirin] in the treatment group.",
        "b": "[Lys] [was a positive predictor of] [Aspirin] in the treatment group.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8871166321601104,
        "token(a ~ b)": 0.7095238095238096,
        "domain": "1.5"
    },
    {
        "a": "[Ribosomal RNA] [was critical for] [Triethylamine] metabolism in the liver.",
        "b": "[rRNA] [was essential in] [Triethylamine] metabolism in the liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7884858420268256,
        "token(a ~ b)": 0.6434210526315789,
        "domain": "1.5"
    },
    {
        "a": "[Vasopressin] [was genetically correlated with] [Interleukin-15] expression in peripheral blood.",
        "b": "[arginine vasopressin] [was genetically associated with] [Interleukin-15] expression in peripheral blood.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8305328341013825,
        "token(a ~ b)": 0.7692307692307692,
        "domain": "1.5"
    },
    {
        "a": "[Pyrrolysine] [replaced] [Gadoleic acid] in the reaction mixture.",
        "b": "[Pyl] [substituted] [Gadoleic acid] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8240404773423641,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "1.5"
    },
    {
        "a": "[Bromobenzene] [was used] to modify [Isobutane] reactivity in organic synthesis.",
        "b": "[phenyl bromide] [was employed] to modify [Isobutane] reactivity in organic synthesis.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8148779069767442,
        "token(a ~ b)": 0.6634615384615384,
        "domain": "1.5"
    },
    {
        "a": "[Lysine] [coupled] with [Benzylamine] under acidic conditions.",
        "b": "[Lys] [bound] with [Benzylamine] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8985649607890694,
        "token(a ~ b)": 0.826797385620915,
        "domain": "1.5"
    },
    {
        "a": "[Leuprolide] [induced] [gastric cancer] in experimental models.",
        "b": "[leuprorelin] [triggered] [gastric cancer] in experimental models.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8053440812061501,
        "token(a ~ b)": 0.5891304347826087,
        "domain": "1.5"
    },
    {
        "a": "[Linoleic acid] [affected] [Nonadecane] levels in the experimental assay.",
        "b": "[Octadecadienoic acid] [influenced] [Nonadecane] levels in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.820551003985826,
        "token(a ~ b)": 0.6742021276595744,
        "domain": "1.5"
    },
    {
        "a": "[Singlet oxygen] [arose] in [Palmitoleic acid] samples under illumination.",
        "b": "[dioxygen (1\u0394g)] [appeared] in [Palmitoleic acid] samples under illumination.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8479636817872112,
        "token(a ~ b)": 0.5253968253968254,
        "domain": "1.5"
    },
    {
        "a": "[Dithiothreitol] effect [was positively correlated with] [Nitric acid] concentration in solution.",
        "b": "[DTT] effect [was a positive predictor of] [Nitric acid] concentration in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8086251429190194,
        "token(a ~ b)": 0.5218855218855218,
        "domain": "1.5"
    },
    {
        "a": "[Hydrogen fluoride] [coordinated] the activity of [Transfer RNA] in the cytoplasm.",
        "b": "[HF] [orchestrated] the activity of [Transfer RNA] in the cytoplasm.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8216104734576757,
        "token(a ~ b)": 0.6689723320158103,
        "domain": "1.5"
    },
    {
        "a": "[Copper] [contained] [Palladium(II) ion] in the reaction mixture.",
        "b": "[Cu] [included] [Palladium(II) ion] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8262515262515262,
        "token(a ~ b)": 0.8447368421052632,
        "domain": "1.5"
    },
    {
        "a": "[Aspirin] [was able] to modulate [Beta-hydroxybutyrate] levels in plasma.",
        "b": "[acetylsalicylic acid] [was capable] to modulate [Beta-hydroxybutyrate] levels in plasma.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7864834319136305,
        "token(a ~ b)": 0.6888888888888889,
        "domain": "1.5"
    },
    {
        "a": "[Relugolix] [boosted] the therapeutic effect of [Gefitinib] in lung cancer models.",
        "b": "[ORGOVYX] [elevated] the therapeutic effect of [Gefitinib] in lung cancer models.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8134146341463414,
        "token(a ~ b)": 0.632051282051282,
        "domain": "1.5"
    },
    {
        "a": "[Arginine] [synthesized] [Deoxyribonucleic acid] in the bacterial cell-free system.",
        "b": "[Arg] [produced] [Deoxyribonucleic acid] in the bacterial cell-free system.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8604099877771958,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "1.5"
    },
    {
        "a": "[Methionine] [broadened] the effect of [Phenylhydrazine] in red blood cells.",
        "b": "[Met] [expanded] the effect of [Phenylhydrazine] in red blood cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8829533727366544,
        "token(a ~ b)": 0.726923076923077,
        "domain": "1.5"
    },
    {
        "a": "[Ethyl acetate] [was able] to chelate [calcium ion] in solution.",
        "b": "[EtOAc] [was capable] of chelating [calcium ion] in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8324393945252088,
        "token(a ~ b)": 0.5455813953488372,
        "domain": "1.5"
    },
    {
        "a": "[Nitrogen trioxide] [impacted] [Magnesium citrate] stability under acidic conditions.",
        "b": "[dinitrogen trioxide] [affected] [Magnesium citrate] stability under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.836804531737001,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "1.5"
    },
    {
        "a": "[Hydrogen peroxide] [evoked] [Dimethylamine] accumulation in the reaction mixture.",
        "b": "[H2O2] [induced] [Dimethylamine] accumulation in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8231037255427499,
        "token(a ~ b)": 0.5625,
        "domain": "1.5"
    },
    {
        "a": "[Heptane] [orchestrated] the synthesis of [Sodium nitrate] in vitro.",
        "b": "[n-heptane] [coordinated] the synthesis of [Sodium nitrate] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.813758981853611,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "1.5"
    },
    {
        "a": "[CO2] [served as] a cofactor for [methyl mercaptan] synthesis in bacteria.",
        "b": "[Carbon dioxide] [functioned as] a cofactor for [methyl mercaptan] synthesis in bacteria.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8067519847295128,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "1.5"
    },
    {
        "a": "[Arachidonic acid] [affected] [Potassium-Chloride Cotransporter] levels in the developing mouse brain.",
        "b": "[all-cis-5,8,11,14-eicosatetraenoic acid] [influenced] [Potassium-Chloride Cotransporter] levels in the developing mouse brain.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7819762550689568,
        "token(a ~ b)": 0.5352159468438538,
        "domain": "1.5"
    },
    {
        "a": "[Magnesium] [contained] [Platinum(II) ion] in the reaction mixture.",
        "b": "[Mg] [included] [Platinum(II) ion] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8295220300519407,
        "token(a ~ b)": 0.8043184885290149,
        "domain": "1.5"
    },
    {
        "a": "[Nitrogen trioxide] [contained] [Chromium(II) ion] in trace amounts.",
        "b": "[dinitrogen trioxide] [included] [Chromium(II) ion] in trace amounts.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.824676310741688,
        "token(a ~ b)": 0.7857142857142857,
        "domain": "1.5"
    },
    {
        "a": "[Benzamide] [was employed] to synthesize [azide] ion in the laboratory.",
        "b": "[benzenecarboxamide] [was used] to synthesize [azide] ion in the laboratory.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8212177370442751,
        "token(a ~ b)": 0.678030303030303,
        "domain": "1.5"
    },
    {
        "a": "[Arginine] [produced] [malic acid] in the mitochondria.",
        "b": "[Arg] [generated] [malic acid] in the mitochondria.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8743717525694997,
        "token(a ~ b)": 0.8161764705882353,
        "domain": "1.5"
    },
    {
        "a": "[Escitalopram] [ameliorated] [Baloxavir marboxil]-resistant influenza symptoms in patients.",
        "b": "[Lexapro] [alleviated] [Baloxavir marboxil]-resistant influenza symptoms in patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8158782829371065,
        "token(a ~ b)": 0.6846153846153846,
        "domain": "1.5"
    },
    {
        "a": "[Nitrogen dioxide] [was employed] to synthesize [Trifluoroacetic anhydride] in the laboratory.",
        "b": "[NO2] [was used] to synthesize [Trifluoroacetic anhydride] in the laboratory.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8096777408931299,
        "token(a ~ b)": 0.7630094043887148,
        "domain": "1.5"
    },
    {
        "a": "[Nitronium ion] [displayed] [Gonadotropin-releasing hormone] activity in the in vitro assay.",
        "b": "[Nitryl ion] [showed] [Gonadotropin-releasing hormone] activity in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8898622947662381,
        "token(a ~ b)": 0.8353174603174603,
        "domain": "1.5"
    },
    {
        "a": "[Dostarlimab] [admitted] [Zidovudine] into the treatment protocol for advanced cancer.",
        "b": "[Jemperli] [accepted] [Zidovudine] into the treatment protocol for advanced cancer.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8167122443261418,
        "token(a ~ b)": 0.6527777777777778,
        "domain": "1.5"
    },
    {
        "a": "[Acetamide] [synthesized] [Camphor] in the reaction vessel.",
        "b": "[ethanamide] [produced] [Camphor] in the reaction vessel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8277430865298839,
        "token(a ~ b)": 0.6947368421052631,
        "domain": "1.5"
    },
    {
        "a": "[Azide] [emerged] as a contaminant in [N,N-Dimethylformamide] samples during storage.",
        "b": "[azide ion] [appeared] as a contaminant in [N,N-Dimethylformamide] samples during storage.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8188453159041396,
        "token(a ~ b)": 0.774928774928775,
        "domain": "1.5"
    },
    {
        "a": "[Vasopressin] [induced] [Methionine] accumulation in the cultured cells.",
        "b": "[arginine vasopressin] [triggered] [Methionine] accumulation in the cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7967635246869833,
        "token(a ~ b)": 0.7038043478260869,
        "domain": "1.5"
    },
    {
        "a": "[Sodium] [replaced] [Phenylhydrazine] in the reaction mixture.",
        "b": "[Na] [substituted] [Phenylhydrazine] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7812582940043703,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "1.5"
    },
    {
        "a": "[Interleukin-36] [demonstrated] an interaction with [Potassium-Chloride Cotransporter] in cultured cells.",
        "b": "[IL-36] [exhibited] an interaction with [Potassium-Chloride Cotransporter] in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8212763580505517,
        "token(a ~ b)": 0.7260894170911149,
        "domain": "1.5"
    },
    {
        "a": "[NO+] [expanded] the binding capacity of [Interleukin-8] in immune cells.",
        "b": "[Nitrosyl cation] [broadened] the binding capacity of [Interleukin-8] in immune cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8205976548733173,
        "token(a ~ b)": 0.6358620689655172,
        "domain": "1.5"
    },
    {
        "a": "[Benzene] [established] the interaction with [Tetradecane] in solution.",
        "b": "[benzol] [confirmed] the interaction with [Tetradecane] in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8242109201699762,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "1.5"
    },
    {
        "a": "[CO2] [elevated] the activity of [PGD] in erythroid cells.",
        "b": "[Carbon dioxide] [raised] the activity of [PGD] in erythroid cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.799891787745622,
        "token(a ~ b)": 0.722943722943723,
        "domain": "1.5"
    },
    {
        "a": "[Barium ion] [produced] [Hexamethylphosphoramide] under acidic conditions.",
        "b": "[Ba2+] [synthesized] [Hexamethylphosphoramide] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8347352350078383,
        "token(a ~ b)": 0.6088372093023255,
        "domain": "1.5"
    },
    {
        "a": "[CIT] [was associated with] [Histidine] in plasma samples.",
        "b": "[Citrate] [was linked to] [Histidine] in plasma samples.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8439802955665026,
        "token(a ~ b)": 0.6880570409982174,
        "domain": "1.5"
    },
    {
        "a": "[N2O] [prolonged] the expression of [phenylethene] in the assay.",
        "b": "[Nitrous oxide] [extended] the expression of [phenylethene] in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8195505378840647,
        "token(a ~ b)": 0.6908033826638478,
        "domain": "1.5"
    },
    {
        "a": "[Diethylcarbamazine] [was used] to treat [Abiraterone] toxicity in patients with liver dysfunction.",
        "b": "[DEC] [was employed] to treat [Abiraterone] toxicity in patients with liver dysfunction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8268398268398269,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "1.5"
    },
    {
        "a": "[N,N-Dimethylformamide] [was able] to interact with [1-Decyne] under experimental conditions.",
        "b": "[DMF] [was capable] of interacting with [1-Decyne] under experimental conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7797132616487454,
        "token(a ~ b)": 0.5218855218855218,
        "domain": "1.5"
    },
    {
        "a": "[Glyoxal] [broadened] the effect of [Desirudin] in the coagulation assay.",
        "b": "[ethanedial] [expanded] the effect of [Desirudin] in the coagulation assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8170510585305105,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "1.5"
    },
    {
        "a": "[Hydrogen sulfide] [coupled] with [Copper] ions under acidic conditions.",
        "b": "[H2S] [bound] with [Copper] ions under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8007797270955166,
        "token(a ~ b)": 0.569377990430622,
        "domain": "1.5"
    },
    {
        "a": "[Ethane] [joined] [cyclopentane] in the reaction mixture.",
        "b": "[C2H6] [combined with] [cyclopentane] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8676048060598146,
        "token(a ~ b)": 0.6703296703296704,
        "domain": "1.5"
    },
    {
        "a": "[Ribonucleic acid] [was associated with] [Dinitrogen pentoxide] in the reaction mixture.",
        "b": "[RNA] [was linked to] [Dinitrogen pentoxide] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8045674132630654,
        "token(a ~ b)": 0.6236363636363637,
        "domain": "1.5"
    },
    {
        "a": "[Dehydroepiandrosterone] [replaced] [Isobutane] in the reaction mixture.",
        "b": "[DHEA] [substituted] [Isobutane] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6904239766081871,
        "token(a ~ b)": 0.5218855218855218,
        "domain": "1.5"
    },
    {
        "a": "[Methyl isobutyl ketone] was [was associated with] [Ammonia] production in the reaction vessel.",
        "b": "[MIBK] was [was linked to] [Ammonia] production in the reaction vessel.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8031389991133593,
        "token(a ~ b)": 0.6209613869188337,
        "domain": "1.5"
    },
    {
        "a": "[Hemoglobin Subunit Beta] [served as] a cofactor for [transketolase] in red blood cells.",
        "b": "[HBB] [functioned as] a cofactor for [transketolase] in red blood cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8153711023276241,
        "token(a ~ b)": 0.7148148148148148,
        "domain": "1.5"
    },
    {
        "a": "[Methyl isobutyl ketone] [produced] [Erucic acid] in the reaction mixture.",
        "b": "[MIBK] [generated] [Erucic acid] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7793801899065056,
        "token(a ~ b)": 0.6071428571428572,
        "domain": "1.5"
    },
    {
        "a": "[Phosphoribosyl pyrophosphate synthetase 1] [was genetically correlated with] [Neural stem cell] differentiation potential in vitro.",
        "b": "[PRPS1] [was genetically associated with] [Neural stem cell] differentiation potential in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7895812968393614,
        "token(a ~ b)": 0.5878787878787879,
        "domain": "1.5"
    },
    {
        "a": "[Mg2+] [bound] [Fe] in the reaction mixture.",
        "b": "[Magnesium ion] [coupled] [Fe] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7968662232076866,
        "token(a ~ b)": 0.59375,
        "domain": "1.5"
    },
    {
        "a": "The [Corneocyte] [displayed] properties of a [Granular cell] under high magnification.",
        "b": "The [keratinocyte (dead)] [manifested] properties of a [Granular cell] under high magnification.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8731714757393051,
        "token(a ~ b)": 0.7158333333333333,
        "domain": "1.5"
    },
    {
        "a": "[NO2] [impacted] [GH] secretion in the anterior pituitary.",
        "b": "[Nitrogen dioxide] [affected] [GH] secretion in the anterior pituitary.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7992409116255643,
        "token(a ~ b)": 0.6303258145363408,
        "domain": "1.5"
    },
    {
        "a": "[Ciprofloxacin] [was used] to treat [Regorafenib]-resistant tumors in the experimental model.",
        "b": "[Cipro] [was employed] to treat [Regorafenib]-resistant tumors in the experimental model.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8867481113503756,
        "token(a ~ b)": 0.8489795918367347,
        "domain": "1.5"
    },
    {
        "a": "[Tetracosane] [emerged] as a regulator of [nonadecanoic acid] metabolism in the cell culture.",
        "b": "[n-tetracosane] [appeared] as a regulator of [nonadecanoic acid] metabolism in the cell culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8506150326205147,
        "token(a ~ b)": 0.8333333333333333,
        "domain": "1.5"
    },
    {
        "a": "The [azide ion] [was positively associated with] [C8H14] in the reaction mixture.",
        "b": "The [Azide] [was positively correlated with] [C8H14] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8814574314574314,
        "token(a ~ b)": 0.8253968253968254,
        "domain": "1.5"
    },
    {
        "a": "[Interleukin-10] [bound] [Collagen Type I Alpha 1 Chain] in the extracellular matrix.",
        "b": "[IL-10] [coupled] [Collagen Type I Alpha 1 Chain] in the extracellular matrix.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8410377073906485,
        "token(a ~ b)": 0.774928774928775,
        "domain": "1.5"
    },
    {
        "a": "[Potassium] [boosted] the expression of [Glyceraldehyde 3-phosphate dehydrogenase] in the cytosol.",
        "b": "[K] [augmented] the expression of [Glyceraldehyde 3-phosphate dehydrogenase] in the cytosol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8267988222957168,
        "token(a ~ b)": 0.8064516129032258,
        "domain": "1.5"
    },
    {
        "a": "The administration of [Dimethylformamide] [evoked] a response to [Rivaroxaban] in the clinical trial.",
        "b": "The administration of [DMF] [induced] a response to [Rivaroxaban] in the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8879325583160725,
        "token(a ~ b)": 0.7186609686609686,
        "domain": "1.5"
    },
    {
        "a": "[Hydrogen iodide] [induced] [Crotonaldehyde] formation in the reaction mixture.",
        "b": "[HI] [triggered] [Crotonaldehyde] formation in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8128474807644577,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "1.5"
    },
    {
        "a": "[Peracetic acid] [orchestrated] the synthesis of [vasopressin] in vitro.",
        "b": "[peroxyacetic acid] [coordinated] the synthesis of [vasopressin] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8562039312039312,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "1.5"
    },
    {
        "a": "[Hexane] [contained] [Palmitoleic acid] in the analyzed mixture.",
        "b": "[n-hexane] [included] [Palmitoleic acid] in the analyzed mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.883173076923077,
        "token(a ~ b)": 0.7352564102564103,
        "domain": "1.5"
    },
    {
        "a": "[Trimethylamine] [broadened] the reactivity of [tetrachloroethylene] under acidic conditions.",
        "b": "[N,N-dimethylmethanamine] [expanded] the reactivity of [tetrachloroethylene] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8225298336285242,
        "token(a ~ b)": 0.6888888888888889,
        "domain": "1.5"
    },
    {
        "a": "[2-Heptyne] [was positively associated with] [Propyne] in the reaction mixture.",
        "b": "[hept-2-yne] [was positively correlated with] [Propyne] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8612153609305508,
        "token(a ~ b)": 0.7478260869565218,
        "domain": "1.5"
    },
    {
        "a": "[Peroxynitrite] [coordinated] the assembly of the [cytoskeleton] in cultured cells.",
        "b": "[ONOO-] [orchestrated] the assembly of the [cytoskeleton] in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8043747070662514,
        "token(a ~ b)": 0.5785953177257526,
        "domain": "1.5"
    },
    {
        "a": "[Zinc] [produced] [fumarate] in the mitochondrial matrix.",
        "b": "[Zn] [generated] [fumarate] in the mitochondrial matrix.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8160133667502089,
        "token(a ~ b)": 0.7679924242424243,
        "domain": "1.5"
    },
    {
        "a": "[Vemurafenib] [influenced] the expression of [Nilotinib] in the experimental protocol.",
        "b": "[PLX4032] [affected] the expression of [Nilotinib] in the experimental protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7878294573643411,
        "token(a ~ b)": 0.6141666666666667,
        "domain": "1.5"
    },
    {
        "a": "[Oleic acid] [boosted] [Xylose] transport in the experimental assay.",
        "b": "[cis-9-octadecenoic acid] [stimulated] [Xylose] transport in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7905271199388846,
        "token(a ~ b)": 0.5574712643678161,
        "domain": "1.5"
    },
    {
        "a": "[Interleukin-23] [evoked] the activation of [Natural Killer Cell] in the tumor microenvironment.",
        "b": "[IL-23] [induced] the activation of [Natural Killer Cell] in the tumor microenvironment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8442751039809864,
        "token(a ~ b)": 0.7281632653061225,
        "domain": "1.5"
    },
    {
        "a": "[Decane] [broadened] the reactivity of [Manganese(II) ion] in aqueous solution.",
        "b": "[n-decane] [expanded] the reactivity of [Manganese(II) ion] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9220601265822784,
        "token(a ~ b)": 0.7450980392156863,
        "domain": "1.5"
    },
    {
        "a": "[Nonane] [was capable] of interacting with [Isoprene] under standard laboratory conditions.",
        "b": "[n-Nonane] [was able] to interact with [Isoprene] under standard laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8427349932015247,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "1.5"
    },
    {
        "a": "[Glyoxal] [affected] [Hypochlorous acid] production in the reaction mixture.",
        "b": "[Glyoxal] [influenced] [HOCl] production in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8725101214574899,
        "token(a ~ b)": 0.6071428571428572,
        "domain": "1.6"
    },
    {
        "a": "[Interferon-gamma] [joined] [eRF1] into a signaling complex in vitro.",
        "b": "[Interferon-gamma] [combined with] [Eukaryotic release factor 1] in a signaling complex in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8698110644771334,
        "token(a ~ b)": 0.6278571428571429,
        "domain": "1.6"
    },
    {
        "a": "[Sodium borohydride] [enhanced] the activity of [Sodium] in the catalytic reaction.",
        "b": "[Sodium borohydride] [improved] the activity of [Na] in the catalytic reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.906596309287784,
        "token(a ~ b)": 0.7891682785299807,
        "domain": "1.6"
    },
    {
        "a": "[Mipomersen] [broadened] the activity range of [Metamizole] in hepatic cells.",
        "b": "[Mipomersen] [expanded] the activity range of [Dipyrone] in hepatic cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.892760101583631,
        "token(a ~ b)": 0.6634615384615384,
        "domain": "1.6"
    },
    {
        "a": "[Nitroxyl] [boosted] [hydrogen sulfide] production in the cellular assay.",
        "b": "[Nitroxyl] [activated] [H2S] production in the cellular assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8554720871998821,
        "token(a ~ b)": 0.6477272727272727,
        "domain": "1.6"
    },
    {
        "a": "[Malate] [increased] the solubility of [Trichloroethylene] in aqueous solution.",
        "b": "[Malate] [boosted] the solubility of [1,1,2-Trichloroethene] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9099850548831354,
        "token(a ~ b)": 0.675,
        "domain": "1.6"
    },
    {
        "a": "[Dehydroepiandrosterone] [contained] [Piperidine] as a core structure.",
        "b": "[Dehydroepiandrosterone] [included] [Hexahydroazepine] as a core structure.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9036630036630037,
        "token(a ~ b)": 0.6829787234042553,
        "domain": "1.6"
    },
    {
        "a": "[Lithium chloride] [bound] to [Camphor] in the reaction mixture.",
        "b": "[Lithium chloride] [coupled] to [bornan-2-one] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.90343959247287,
        "token(a ~ b)": 0.6267232237539766,
        "domain": "1.6"
    },
    {
        "a": "[Epinephrine] [produced] a response via [Epidermal Growth Factor Receptor] signaling in neuronal cells.",
        "b": "[Epinephrine] [generated] a response via [EGFR] signaling in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8681558922233424,
        "token(a ~ b)": 0.6634615384615384,
        "domain": "1.6"
    },
    {
        "a": "[Gamma-aminobutyric acid] [established] the interaction with [Fragile X Mental Retardation Protein] in neuronal cells.",
        "b": "[Gamma-aminobutyric acid] [confirmed] the interaction with [FMR1 protein] in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8699213952345861,
        "token(a ~ b)": 0.65625,
        "domain": "1.6"
    },
    {
        "a": "[Alcohol dehydrogenase] [detected] in [Telomeric Repeat Binding Factor 2] samples after treatment.",
        "b": "[Alcohol dehydrogenase] [was found] in [TERF2] samples after treatment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8721245220239184,
        "token(a ~ b)": 0.6352040816326531,
        "domain": "1.6"
    },
    {
        "a": "[C-reactive protein] [preceded] [Interleukin-38] in the inflammatory response.",
        "b": "[C-reactive protein] [came before] [IL-38] in the inflammatory response.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8887606837606838,
        "token(a ~ b)": 0.6856984478935699,
        "domain": "1.6"
    },
    {
        "a": "[Catalase] [accelerated] the reaction rate of [myoglobin] in muscle tissue.",
        "b": "[Catalase] [sped up] the reaction rate of [Mb] in muscle tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8669511494252874,
        "token(a ~ b)": 0.6856984478935699,
        "domain": "1.6"
    },
    {
        "a": "[Triiodothyronine] [boosted] the phagocytic activity of [alveolar macrophage] in vitro.",
        "b": "[Triiodothyronine] [increased] the phagocytic activity of [pulmonary macrophage] in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9044785014899958,
        "token(a ~ b)": 0.7525027808676307,
        "domain": "1.6"
    },
    {
        "a": "[Calcium ion] [produced] [Bromine monoxide] in the reaction mixture.",
        "b": "[Calcium ion] [generated] [BrO] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8809631544925662,
        "token(a ~ b)": 0.6303258145363408,
        "domain": "1.6"
    },
    {
        "a": "[Alkoxyl radical] [stimulated] the production of [Gadoleic acid] in neuronal cells.",
        "b": "[Alkoxyl radical] [activated] the production of [11-eicosenoic acid] in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9287874291613386,
        "token(a ~ b)": 0.7069716775599129,
        "domain": "1.6"
    },
    {
        "a": "[E-cadherin] expression [was upregulated] in [Cytochrome c] treated cells.",
        "b": "[E-cadherin] expression [was increased] in [Cyt c] treated cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9164013144658305,
        "token(a ~ b)": 0.722943722943723,
        "domain": "1.6"
    },
    {
        "a": "The [carbonyl group] [elevated] the levels of [2-pentyne] in the reaction mixture.",
        "b": "The [carbonyl group] [boosted] the levels of [1,3-pentadiyne] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9201213987373942,
        "token(a ~ b)": 0.6416666666666666,
        "domain": "1.6"
    },
    {
        "a": "[Deoxyribonucleic acid] [coordinated] the assembly of [isobutane] molecules in vitro.",
        "b": "[Deoxyribonucleic acid] [orchestrated] the assembly of [methylpropane] molecules in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8953242835595777,
        "token(a ~ b)": 0.6606918238993711,
        "domain": "1.6"
    },
    {
        "a": "[Ribonucleic acid] [broadened] the spectrum of [hydrogen sulfate] interactions in the cell.",
        "b": "[Ribonucleic acid] [expanded] the spectrum of [bisulfate] interactions in the cell.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9035952601615251,
        "token(a ~ b)": 0.6958333333333333,
        "domain": "1.6"
    },
    {
        "a": "[Small nuclear RNA] [broadened] the distribution of [Chlorophyll a] in the cytoplasm.",
        "b": "[Small nuclear RNA] [expanded] the distribution of [Chl a] in the cytoplasm.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9285056759545924,
        "token(a ~ b)": 0.75,
        "domain": "1.6"
    },
    {
        "a": "[Docetaxel] [admitted] [Pemetrexed] into the cytoplasm of tumor cells.",
        "b": "[Docetaxel] [accepted] [Alimta] into the cytoplasm of tumor cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8999134199134199,
        "token(a ~ b)": 0.703525641025641,
        "domain": "1.6"
    },
    {
        "a": "[Phenylhydrazine] [was capable] of interacting with [Dodecane] under acidic conditions.",
        "b": "[Phenylhydrazine] [was able] to interact with [n-dodecane] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9191791303143609,
        "token(a ~ b)": 0.7543800539083558,
        "domain": "1.6"
    },
    {
        "a": "[Lovastatin] [alleviated] [Ticlopidine]-induced symptoms in patients.",
        "b": "[Lovastatin] [relieved] [Ticlid]-induced symptoms in patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9047333287348922,
        "token(a ~ b)": 0.7078488372093024,
        "domain": "1.6"
    },
    {
        "a": "[Thyrotropin-releasing hormone] [broadened] the functional range of [Sodium-Dependent Vitamin C Transporter] in neuronal cells.",
        "b": "[Thyrotropin-releasing hormone] [expanded] the functional range of [SLC23A1] in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8690989350754574,
        "token(a ~ b)": 0.6115954664341761,
        "domain": "1.6"
    },
    {
        "a": "[Regorafenib] [was positively associated with] [Imatinib] clearance in the patient cohort.",
        "b": "[Regorafenib] [was a positive predictor of] [Gleevec] clearance in the patient cohort.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.877078008240799,
        "token(a ~ b)": 0.6309328968903437,
        "domain": "1.6"
    },
    {
        "a": "[FADH2] [contained] [Chlorophyll b] in the reaction mixture.",
        "b": "[FADH2] [included] [Chl b] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8820208083233293,
        "token(a ~ b)": 0.763157894736842,
        "domain": "1.6"
    },
    {
        "a": "[Phenethylamine] [established] the interaction with [1-Butyne] in the binding assay.",
        "b": "[Phenethylamine] [confirmed] the interaction with [ethynylethane] in the binding assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8928123600537393,
        "token(a ~ b)": 0.6629787234042553,
        "domain": "1.6"
    },
    {
        "a": "[Regorafenib] [served as] a [Diethylstilbestrol] analog in the experimental model.",
        "b": "[Regorafenib] [functioned as] a [DES] analog in the experimental model.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8645042511164548,
        "token(a ~ b)": 0.6714402618657938,
        "domain": "1.6"
    },
    {
        "a": "[Magnesium chloride] [produced] [Tropylium radical cation] under acidic conditions.",
        "b": "[Magnesium chloride] [generated] [Tropylium radical] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9299805046792998,
        "token(a ~ b)": 0.8140243902439024,
        "domain": "1.6"
    },
    {
        "a": "[Methane] [broadened] the activity spectrum of [Erucic acid] in cultured hepatocytes.",
        "b": "[Methane] [expanded] the activity spectrum of [cis-13-docosenoic acid] in cultured hepatocytes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.876656346749226,
        "token(a ~ b)": 0.6657142857142857,
        "domain": "1.6"
    },
    {
        "a": "[Phenoxide ion] [synthesized] [Acetyl chloride] in the organic reaction mixture.",
        "b": "[Phenoxide ion] [manufactured] [ethanoyl chloride] in the organic reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8899104637728998,
        "token(a ~ b)": 0.678030303030303,
        "domain": "1.6"
    },
    {
        "a": "[Thyrotropin-releasing hormone] [interacted] with [Immunoglobulin D] during the immune assay.",
        "b": "[Thyrotropin-releasing hormone] [coupled] with [IgD] during the immune assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9108434576176512,
        "token(a ~ b)": 0.6777188328912467,
        "domain": "1.6"
    },
    {
        "a": "[Sunitinib] [induced] the activity of [Brigatinib] in the cellular assay.",
        "b": "[Sunitinib] [triggered] the activity of [Alunbrig] in the cellular assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8919468659194687,
        "token(a ~ b)": 0.6603864734299516,
        "domain": "1.6"
    },
    {
        "a": "[NOP10 ribonucleoprotein] [was essential in] the activation of [Interleukin-27] during the immune response.",
        "b": "[NOP10 ribonucleoprotein] [was critical for] the activation of [IL-27] during the immune response.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9140655449502028,
        "token(a ~ b)": 0.7658802177858439,
        "domain": "1.6"
    },
    {
        "a": "[Toluene] [produced] [Nitryl chloride] under controlled laboratory conditions.",
        "b": "[Toluene] [generated] [NO2Cl] under controlled laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8709425684180242,
        "token(a ~ b)": 0.6111111111111112,
        "domain": "1.6"
    },
    {
        "a": "[Progesterone] [bound] to [Oxalic acid] in the reaction mixture.",
        "b": "[Progesterone] [coupled] to [ethanedioic acid] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9001609039482799,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "1.6"
    },
    {
        "a": "[Nitric acid] [prolonged] the stability of [Tropylium radical cation] under acidic conditions.",
        "b": "[Nitric acid] [extended] the stability of [Tropylium radical] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8895560034274267,
        "token(a ~ b)": 0.8125,
        "domain": "1.6"
    },
    {
        "a": "In the recent study, [Interleukin-1] [affected] [Phosphoenolpyruvate] levels in the neuronal model.",
        "b": "In the recent study, [Interleukin-1] [influenced] [PEP] levels in the neuronal model.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9073110186835677,
        "token(a ~ b)": 0.6736559139784947,
        "domain": "1.6"
    },
    {
        "a": "[Everolimus] [was employed] as an alternative to [Temsirolimus] in the clinical trial.",
        "b": "[Everolimus] [was used] as an alternative to [Torisel] in the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9089398973119904,
        "token(a ~ b)": 0.7608695652173914,
        "domain": "1.6"
    },
    {
        "a": "[Mercury(II) ion] [replaced] [Hydrosulfide ion] in the protein complex.",
        "b": "[Mercury(II) ion] [substituted] [HS-] in the protein complex.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8664624928662603,
        "token(a ~ b)": 0.6309328968903437,
        "domain": "1.6"
    },
    {
        "a": "[Tinzaparin] [increased] the activity of [Zanamivir] in the mouse model.",
        "b": "[Tinzaparin] [boosted] the activity of [Relenza] in the mouse model.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8731372549019608,
        "token(a ~ b)": 0.648611111111111,
        "domain": "1.6"
    },
    {
        "a": "[Lovastatin] [was critical for] the function of [Praziquantel] in hepatic cells.",
        "b": "[Lovastatin] [was essential in] the function of [PZQ] in hepatic cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8809832069339112,
        "token(a ~ b)": 0.7158333333333333,
        "domain": "1.6"
    },
    {
        "a": "[Immunoglobulin A] [was linked to] [Nicotinic acetylcholine receptor] function in the hippocampus.",
        "b": "[Immunoglobulin A] [was associated with] [nAChR] function in the hippocampus.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8620660912586379,
        "token(a ~ b)": 0.5880893300248139,
        "domain": "1.6"
    },
    {
        "a": "[Iron] [affected] [Dimethyl sulfoxide] metabolism in the cell culture.",
        "b": "[Iron] [influenced] [DMSO] metabolism in the cell culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8662626638163398,
        "token(a ~ b)": 0.569377990430622,
        "domain": "1.6"
    },
    {
        "a": "[Dehydroepiandrosterone] [emerged] as an activator of [Iodobenzene] metabolism in the assay.",
        "b": "[Dehydroepiandrosterone] [appeared] as an activator of [phenyl iodide] metabolism in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9190270464007059,
        "token(a ~ b)": 0.709051724137931,
        "domain": "1.6"
    },
    {
        "a": "[Zanamivir] [bound] to [Zinc ion] in the experimental assay.",
        "b": "[Zanamivir] [coupled] to [Zn2+] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8990479288657558,
        "token(a ~ b)": 0.7084257206208426,
        "domain": "1.6"
    },
    {
        "a": "[Ipilimumab] [was negatively associated with] [Rheumatoid Arthritis] severity in the patient cohort.",
        "b": "[Ipilimumab] [was a negative predictor of] [RA] severity in the patient cohort.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.881404241328292,
        "token(a ~ b)": 0.6041666666666667,
        "domain": "1.6"
    },
    {
        "a": "In the experimental setup, [Hexadecane] [activated] the metabolic rate of [fast-twitch muscle fiber].",
        "b": "In the experimental setup, [Hexadecane] [stimulated] the metabolic rate of [Type II muscle fiber].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9083947170227227,
        "token(a ~ b)": 0.76,
        "domain": "1.6"
    },
    {
        "a": "[Polycystic Kidney Disease] [was genetically correlated with] [Sipuleucel-T] administration in patients.",
        "b": "[Polycystic Kidney Disease] [was genetically associated with] [Provenge] administration in patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9261404682274248,
        "token(a ~ b)": 0.7148148148148148,
        "domain": "1.6"
    },
    {
        "a": "[Vilazodone] [displayed] a strong interaction with [Ticlopidine] in clinical studies.",
        "b": "[Vilazodone] [demonstrated] a strong interaction with [Ticlid] in clinical studies.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9053577227749419,
        "token(a ~ b)": 0.7148148148148148,
        "domain": "1.6"
    },
    {
        "a": "The [glucose-6-phosphate dehydrogenase] [induced] the activity of [Follicular dendritic cell] in the spleen.",
        "b": "The [glucose-6-phosphate dehydrogenase] [triggered] the activity of [FDC] in the spleen.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8988455988455988,
        "token(a ~ b)": 0.7408234126984127,
        "domain": "1.6"
    },
    {
        "a": "[Cholestyramine] [was employed] to treat [Mebendazole] toxicity in pediatric patients.",
        "b": "[Cholestyramine] [was used] to treat [Mebendazolum] toxicity in pediatric patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9188175959652563,
        "token(a ~ b)": 0.844812925170068,
        "domain": "1.6"
    },
    {
        "a": "[Cetuximab] [was essential in] the treatment of [Spinal Muscular Atrophy].",
        "b": "[Cetuximab] [was critical for] the treatment of [SMA].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8679031973149621,
        "token(a ~ b)": 0.6,
        "domain": "1.6"
    },
    {
        "a": "[Interleukin-18] [coordinated] the expression of [Interleukin-17] in activated T cells.",
        "b": "[Interleukin-18] [orchestrated] the expression of [IL-17] in activated T cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9144861280219317,
        "token(a ~ b)": 0.7824074074074074,
        "domain": "1.6"
    },
    {
        "a": "[Nitric oxide] [led to] an increase in [Nitrogen dioxide] levels in the experimental setup.",
        "b": "[Nitric oxide] [resulted in] an increase in [NO2] levels in the experimental setup.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.893101743460139,
        "token(a ~ b)": 0.6956521739130435,
        "domain": "1.6"
    },
    {
        "a": "[Peroxyl radical] [detected] in [azide] samples during the experiment.",
        "b": "[Peroxyl radical] [was found] in [azide ion] samples during the experiment.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8876825396825396,
        "token(a ~ b)": 0.8043184885290149,
        "domain": "1.6"
    },
    {
        "a": "[Dopamine] [was selected] as a binding partner for [L1 cell adhesion molecule] in the in vitro assay.",
        "b": "[Dopamine] [was chosen] as a binding partner for [L1CAM] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8797422180592476,
        "token(a ~ b)": 0.7913725490196079,
        "domain": "1.6"
    },
    {
        "a": "Exposure to [Zn2+] [suppressed] [Bromate]-induced oxidative stress in cultured cells.",
        "b": "Exposure to [Zn2+] [repressed] [BrO3-]-induced oxidative stress in cultured cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9199271603575764,
        "token(a ~ b)": 0.7510504201680672,
        "domain": "1.6"
    },
    {
        "a": "[Nitrogen dioxide] [affected] [Nitroxyl anion] levels in the reaction mixture.",
        "b": "[Nitrogen dioxide] [influenced] [azanone anion] levels in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9082769907337567,
        "token(a ~ b)": 0.678030303030303,
        "domain": "1.6"
    },
    {
        "a": "[Hydrogen sulfate] [broadened] the metabolic role of [Galactose] in yeast cells.",
        "b": "[Hydrogen sulfate] [expanded] the metabolic role of [D-galactose] in yeast cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9302858999350226,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "1.6"
    },
    {
        "a": "[Interleukin-27] [bound] to the [Pyramidal neuron] in the hippocampal region.",
        "b": "[Interleukin-27] [interacted] with the [Pyramidal cell] in the hippocampal region.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8837453462055794,
        "token(a ~ b)": 0.7993468795355587,
        "domain": "1.6"
    },
    {
        "a": "[Sipuleucel-T] [was critical for] the therapeutic effect of [Vismodegib] in advanced cancer patients.",
        "b": "[Sipuleucel-T] [was essential in] the therapeutic effect of [Erivedge] in advanced cancer patients.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9003001399041003,
        "token(a ~ b)": 0.6992337164750958,
        "domain": "1.6"
    },
    {
        "a": "[Vasoactive intestinal peptide] [was positively associated with] [Colony-forming unit-erythroid] counts in the bone marrow.",
        "b": "[Vasoactive intestinal peptide] [was a positive predictor of] [CFU-E] counts in the bone marrow.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8869123365146695,
        "token(a ~ b)": 0.5328759291023442,
        "domain": "1.6"
    },
    {
        "a": "The activity of [Ponatinib] [established] the function of [Meperidine] in the pain management protocol.",
        "b": "The activity of [Ponatinib] [confirmed] the function of [Demerol] in the pain management protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.907319639830042,
        "token(a ~ b)": 0.7350943396226415,
        "domain": "1.6"
    },
    {
        "a": "[Copper] [detected] the presence of [Cyanide] in the reaction mixture.",
        "b": "[Copper] [observed] the presence of [cyanide ion] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8875438075438075,
        "token(a ~ b)": 0.7,
        "domain": "1.6"
    },
    {
        "a": "[Finasteride] [prolonged] the effect of [Triptorelin] in prostate tissue.",
        "b": "[Finasteride] [extended] the effect of [Trelstar] in prostate tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9108634812068115,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "1.6"
    },
    {
        "a": "[Pembrolizumab] [elevated] the activity of [Bexarotene] in the clinical trial.",
        "b": "[Pembrolizumab] [boosted] the activity of [Targretin] in the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9005310097987443,
        "token(a ~ b)": 0.6240053050397878,
        "domain": "1.6"
    },
    {
        "a": "[Citrate] [resulted in] increased [Coenzyme A] concentrations in the experimental assay.",
        "b": "[Citrate] [led to] increased [CoA] concentrations in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8958229665071771,
        "token(a ~ b)": 0.7250000000000001,
        "domain": "1.6"
    },
    {
        "a": "[ATP synthase] [was not sufficient for] the function of [Cytochrome c oxidase] in mitochondria.",
        "b": "[ATP synthase] [was not adequate for] the function of [Complex IV] in mitochondria.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8826062143310083,
        "token(a ~ b)": 0.726923076923077,
        "domain": "1.6"
    },
    {
        "a": "[N-acetylcysteine] [induced] [Succinic acid] accumulation in the mitochondria.",
        "b": "[N-acetylcysteine] [triggered] [butanedioic acid] accumulation in the mitochondria.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.908109360518999,
        "token(a ~ b)": 0.6840513983371126,
        "domain": "1.6"
    },
    {
        "a": "Recent studies showed that [Iodobenzene] [established] the interaction with [Methyl isobutyl ketone] in catalytic systems.",
        "b": "Recent studies showed that [Iodobenzene] [confirmed] the interaction with [MIBK] in catalytic systems.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8893806357745859,
        "token(a ~ b)": 0.7225806451612904,
        "domain": "1.6"
    },
    {
        "a": "[Levomilnacipran] [exhibited] an interaction with [Dabrafenib] in the clinical study.",
        "b": "[Levomilnacipran] [displayed] an interaction with [Tafinlar] in the clinical study.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8985268131348925,
        "token(a ~ b)": 0.6828399122807017,
        "domain": "1.6"
    },
    {
        "a": "[Growth Hormone] [confirmed] the presence of [brown adipocyte] markers in the tissue sample.",
        "b": "[Growth Hormone] [established] the presence of [brown fat cell] markers in the tissue sample.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8814342238794057,
        "token(a ~ b)": 0.7631313131313131,
        "domain": "1.6"
    },
    {
        "a": "[Dopaminergic neuron] [displayed] morphological changes in the [mitochondrion].",
        "b": "[Dopaminergic neuron] [demonstrated] morphological changes in the [mitochondria].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9110586029067042,
        "token(a ~ b)": 0.7078488372093024,
        "domain": "1.6"
    },
    {
        "a": "[Myoglobin] [produced] [Zinc finger protein 143] in the presence of hemin.",
        "b": "[Myoglobin] [manufactured] [ZNF143] in the presence of hemin.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8598856084101986,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "1.6"
    },
    {
        "a": "[Deoxyribonucleic acid] [served as] a template for [acetaldehyde] synthesis in vitro.",
        "b": "[Deoxyribonucleic acid] [functioned as] a template for [ethanal] synthesis in vitro.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9045127524694088,
        "token(a ~ b)": 0.7450980392156863,
        "domain": "1.6"
    },
    {
        "a": "[Nitrogen trioxide] [affected] [Nitryl fluoride] concentrations in the test solution.",
        "b": "[Nitrogen trioxide] [influenced] [nitrogen dioxide fluoride] concentrations in the test solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8856837477258945,
        "token(a ~ b)": 0.6907114624505929,
        "domain": "1.6"
    },
    {
        "a": "[Gamma-aminobutyric acid] [induced] [Telomeric Repeat Binding Factor 1] expression in neural cells.",
        "b": "[Gamma-aminobutyric acid] [triggered] [TERF1] expression in neural cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8872506660274362,
        "token(a ~ b)": 0.6484110885733604,
        "domain": "1.6"
    },
    {
        "a": "[Atezolizumab] [was positively associated with] [Borderline Personality Disorder] in the clinical study.",
        "b": "[Atezolizumab] [was a positive predictor of] [BPD] in the clinical study.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8662702770893008,
        "token(a ~ b)": 0.6352040816326531,
        "domain": "1.6"
    },
    {
        "a": "[Granular cell] [prolonged] the activity of [Alcohol dehydrogenase] in the hippocampus.",
        "b": "[Granular cell] [lengthened] the activity of [ADH] in the hippocampus.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8738097688895424,
        "token(a ~ b)": 0.6117021276595744,
        "domain": "1.6"
    },
    {
        "a": "[Aspirin] [affected] the function of [Rucaparib] in cancer cells.",
        "b": "[Aspirin] [influenced] the function of [Rubraca] in cancer cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9130895334174022,
        "token(a ~ b)": 0.634469696969697,
        "domain": "1.6"
    },
    {
        "a": "[Interleukin-7] [was sufficient for] activation of [Proton-coupled amino acid transporter 1] in immune cells.",
        "b": "[Interleukin-7] [was adequate for] activation of [SLC36A1] in immune cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8413980931822269,
        "token(a ~ b)": 0.6411483253588517,
        "domain": "1.6"
    },
    {
        "a": "[Cabazitaxel] [induced] the accumulation of [Diethylcarbamazine] in the cytoplasm.",
        "b": "[Cabazitaxel] [triggered] the accumulation of [DEC] in the cytoplasm.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8853548073524213,
        "token(a ~ b)": 0.7076923076923077,
        "domain": "1.6"
    },
    {
        "a": "[Interleukin-37] [induced] [interneuron] differentiation in the developing cortex.",
        "b": "[Interleukin-37] [triggered] [IN] differentiation in the developing cortex.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8977153326462842,
        "token(a ~ b)": 0.7351778656126482,
        "domain": "1.6"
    },
    {
        "a": "[Aflatoxin B1] [activated] [Paracetamol] metabolism in human liver microsomes.",
        "b": "[Aflatoxin B1] [stimulated] [Acetaminophen] metabolism in human liver microsomes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.886937388815323,
        "token(a ~ b)": 0.6657142857142857,
        "domain": "1.6"
    },
    {
        "a": "[Indomethacin] [was employed] as an anticoagulant in combination with [Enoxaparin].",
        "b": "[Indomethacin] [was used] as an anticoagulant in combination with [Lovenox].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8931377102181893,
        "token(a ~ b)": 0.7939560439560439,
        "domain": "1.6"
    },
    {
        "a": "[Nitrite] [affected] [Allylamine] metabolism in cultured hepatocytes.",
        "b": "[Nitrite] [influenced] [3-aminoprop-1-ene] metabolism in cultured hepatocytes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.874168374869637,
        "token(a ~ b)": 0.5226495726495727,
        "domain": "1.6"
    },
    {
        "a": "[Ethylamine] [boosted] [Zinc sulfate] uptake in cell cultures.",
        "b": "[Ethylamine] [augmented] [ZnSO4] uptake in cell cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.884639968041546,
        "token(a ~ b)": 0.6703296703296704,
        "domain": "1.6"
    },
    {
        "a": "[Trametinib] [established] the efficacy of [Relugolix] in advanced cancer models.",
        "b": "[Trametinib] [proved] the efficacy of [ORGOVYX] in advanced cancer models.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8684771951438618,
        "token(a ~ b)": 0.6657142857142857,
        "domain": "1.6"
    },
    {
        "a": "[Lovastatin] [facilitated] the uptake of [Nilutamide] in hepatic cells.",
        "b": "[Lovastatin] [enabled] the uptake of [Nilandron] in hepatic cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.890832266325224,
        "token(a ~ b)": 0.7351778656126482,
        "domain": "1.6"
    },
    {
        "a": "[Acetate] [produced] [Pyrrolysine] in the bacterial culture.",
        "b": "[Acetate] [synthesized] [Pyl] in the bacterial culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8848663101604278,
        "token(a ~ b)": 0.6703296703296704,
        "domain": "1.6"
    },
    {
        "a": "[Citrate] [bound] to [Nitrate] in the presence of magnesium ions.",
        "b": "[Citrate] [coupled] to [NO3-] in the presence of magnesium ions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8941942970822281,
        "token(a ~ b)": 0.7250000000000001,
        "domain": "1.6"
    },
    {
        "a": "The [hydroperoxyl radical] [orchestrated] the differentiation of [Regulatory B cell] populations in peripheral blood.",
        "b": "The [hydroperoxyl radical] [coordinated] the differentiation of [Breg] populations in peripheral blood.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9011149282217245,
        "token(a ~ b)": 0.6884531590413943,
        "domain": "1.6"
    },
    {
        "a": "[Glucagon-like peptide-1] [emerged] as a modulator of [Protein kinase R-like endoplasmic reticulum kinase] signaling in neuronal cells.",
        "b": "[Glucagon-like peptide-1] [appeared] as a modulator of [PERK] signaling in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8693486590038314,
        "token(a ~ b)": 0.6450892857142857,
        "domain": "1.6"
    },
    {
        "a": "[Lenvatinib] [replaced] [Pembrolizumab] in the second-line therapy protocol.",
        "b": "[Lenvatinib] [substituted] [MK-3475] in the second-line therapy protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8522782984859408,
        "token(a ~ b)": 0.5725683890577508,
        "domain": "1.6"
    },
    {
        "a": "[Atezolizumab] [was genetically correlated with] [Ibrutinib] response in patients with lymphoma.",
        "b": "[Atezolizumab] [was genetically associated with] [Imbruvica] response in patients with lymphoma.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9124063670411985,
        "token(a ~ b)": 0.7574675324675324,
        "domain": "1.6"
    },
    {
        "a": "[Dabrafenib] [accelerated] the uptake of [Sipuleucel-T] in the experimental model.",
        "b": "[Dabrafenib] [sped up] the uptake of [Provenge] in the experimental model.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8666267154072033,
        "token(a ~ b)": 0.61,
        "domain": "1.6"
    },
    {
        "a": "[Leuprolide] [replaced] [Rheumatoid Arthritis] therapy in the clinical protocol.",
        "b": "[Leuprolide] [substituted] [RA] therapy in the clinical protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8844789081885857,
        "token(a ~ b)": 0.6236363636363637,
        "domain": "1.6"
    },
    {
        "a": "[Interleukin-6] [recognized] the interaction with [NHP2 ribonucleoprotein] during the assay.",
        "b": "[Interleukin-6] [identified] the interaction with [NHP2] during the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8900052226139182,
        "token(a ~ b)": 0.7913725490196079,
        "domain": "1.6"
    },
    {
        "a": "[Carbon monoxide] [accelerated] the activity of [Sodium chloride] in the experimental setup.",
        "b": "[CO] [sped up] the activity of [NaCl] in the experimental setup.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.766104447776112,
        "token(a ~ b)": 0.5255813953488373,
        "domain": "1.7"
    },
    {
        "a": "[Acrolein] [induced] the expression of [Bromate] in cell culture.",
        "b": "[propenal] [triggered] the expression of [BrO3-] in cell culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7876923076923077,
        "token(a ~ b)": 0.46575984990619135,
        "domain": "1.7"
    },
    {
        "a": "[Glyoxal] [was associated with] [Nitryl bromide] in the reaction mixture.",
        "b": "[ethanedial] [was linked to] [nitrogen dioxide bromide] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7618207762557077,
        "token(a ~ b)": 0.474025974025974,
        "domain": "1.7"
    },
    {
        "a": "[MgSO4] [interacted] with [n-butane] under high pressure conditions.",
        "b": "[Magnesium sulfate] [coupled] with [butane] under high pressure conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8178532090431802,
        "token(a ~ b)": 0.5507246376811594,
        "domain": "1.7"
    },
    {
        "a": "[monohydrogen phosphate] [was negatively associated with] [phenyl iodide] in the reaction mixture.",
        "b": "[Hydrogen phosphate] [was negatively correlated with] [iodobenzene] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7997309358526019,
        "token(a ~ b)": 0.5725683890577508,
        "domain": "1.7"
    },
    {
        "a": "[Cytochrome P450] [orchestrated] the expression of [Vascular Endothelial Growth Factor A] in endothelial cells.",
        "b": "[CYP] [coordinated] the expression of [VEGFA] in endothelial cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7707400752176871,
        "token(a ~ b)": 0.451875,
        "domain": "1.7"
    },
    {
        "a": "The activity of [Nitrous acid] was [detected] in the presence of [Nitryl fluoride] during the reaction.",
        "b": "The activity of [HNO2] was [observed] in the presence of [nitrogen dioxide fluoride] during the reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8867576394792179,
        "token(a ~ b)": 0.5839947089947091,
        "domain": "1.7"
    },
    {
        "a": "[Ethylene oxide] [accelerated] the reaction rate of [Arabinose] in the experimental mixture.",
        "b": "[Oxirane] [sped up] the reaction rate of [Arabinofuranose] in the experimental mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7963902664052589,
        "token(a ~ b)": 0.55,
        "domain": "1.7"
    },
    {
        "a": "[Permanganate] [served as] a marker for [Water] in the cellular assay.",
        "b": "[MnO4-] [functioned as] a marker for [H2O] in the cellular assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.735934065934066,
        "token(a ~ b)": 0.5148148148148148,
        "domain": "1.7"
    },
    {
        "a": "The mitochondrial fraction of [Vitamin B12] [contained] significant amounts of [Formate].",
        "b": "The mitochondrial fraction of [Cobalamin] [included] significant amounts of [HCOO-].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8912791251639951,
        "token(a ~ b)": 0.4895238095238095,
        "domain": "1.7"
    },
    {
        "a": "[Colestipol] [ameliorated] the adverse effects of [Olaparib] in clinical trials.",
        "b": "[Colestid] [relieved] the adverse effects of [Lynparza] in clinical trials.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.871921568627451,
        "token(a ~ b)": 0.5403726708074534,
        "domain": "1.7"
    },
    {
        "a": "[ZnSO4] [broadened] the regulatory range of [snoRNA] in the nucleus.",
        "b": "[Zinc sulfate] [expanded] the regulatory range of [small nucleolar RNA] in the nucleus.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7925432241862264,
        "token(a ~ b)": 0.5104895104895105,
        "domain": "1.7"
    },
    {
        "a": "[Magnesium] [served as] a cofactor for [2-Octyne] metabolism in the reaction mixture.",
        "b": "[Mg] [functioned as] a cofactor for [methylpentylethyne] metabolism in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8102115787026274,
        "token(a ~ b)": 0.5733333333333334,
        "domain": "1.7"
    },
    {
        "a": "[H2O2] [included] [hexahydrobenzene] in the reaction mixture.",
        "b": "[Hydrogen peroxide] [comprised] [cyclohexane] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7845421472022152,
        "token(a ~ b)": 0.37777777777777777,
        "domain": "1.7"
    },
    {
        "a": "[Magnesium chloride] [was negatively associated with] [Phenylhydrazine] in the reaction mixture.",
        "b": "[MgCl2] [was negatively correlated with] [hydrazinobenzene] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8187613019891501,
        "token(a ~ b)": 0.5733333333333334,
        "domain": "1.7"
    },
    {
        "a": "The [Radium ion] [was genetically associated with] the [Vanadium(II) ion] in the synthesized crystal lattice.",
        "b": "The [Ra2+] [was genetically linked to] the [V2+] in the synthesized crystal lattice.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8442181671539469,
        "token(a ~ b)": 0.49725274725274726,
        "domain": "1.7"
    },
    {
        "a": "The [Imiquimod] molecule [interacted] with the [Ezetimibe] compound in solution.",
        "b": "The [Aldara] molecule [coupled] with the [Zetia] compound in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8517857142857143,
        "token(a ~ b)": 0.4895330112721417,
        "domain": "1.7"
    },
    {
        "a": "The [azide ion] [disrupted] the structure of [Mb] under acidic conditions.",
        "b": "The [Azide] [broke apart] the structure of [myoglobin] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8880147670814589,
        "token(a ~ b)": 0.6158536585365854,
        "domain": "1.7"
    },
    {
        "a": "[Urea] [enhanced] the secretion of [1-Pentyne] in the test system.",
        "b": "[carbamide] [improved] the secretion of [1-Pentyn] in the test system.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8048701298701298,
        "token(a ~ b)": 0.5609090909090909,
        "domain": "1.7"
    },
    {
        "a": "[Norepinephrine] [was associated with] [Gastrin] release in the hypothalamus.",
        "b": "[Noradrenaline] [was related to] [GAST] release in the hypothalamus.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8659725473767219,
        "token(a ~ b)": 0.5555555555555556,
        "domain": "1.7"
    },
    {
        "a": "[Triethylamine] [facilitated] the activation of [fluoride] in the reaction mixture.",
        "b": "[N,N-Diethylethanamine] [enabled] the activation of [fluoride ion] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8503412250400202,
        "token(a ~ b)": 0.5790816326530612,
        "domain": "1.7"
    },
    {
        "a": "[Calcitonin gene-related peptide] [displayed] an interaction with [fluoride] in the in vitro assay.",
        "b": "[CGRP] [showed] an interaction with [fluoride ion] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7724839205109089,
        "token(a ~ b)": 0.6442307692307692,
        "domain": "1.7"
    },
    {
        "a": "In the experimental setup, [D-mannose] [augmented] the effect of [n-docosane] on cell viability.",
        "b": "In the experimental setup, [Mannose] [boosted] the effect of [Docosane] on cell viability.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9118545751633987,
        "token(a ~ b)": 0.7222222222222222,
        "domain": "1.7"
    },
    {
        "a": "The administration of [Levofloxacin] [recognized] the presence of [Tinzaparin] in the bloodstream.",
        "b": "The administration of [Levaquin] [identified] the presence of [Innohep] in the bloodstream.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.906043956043956,
        "token(a ~ b)": 0.5437037037037037,
        "domain": "1.7"
    },
    {
        "a": "The [nucleolar organizer] [facilitated] the localization of the [Cell Membrane] during mitosis.",
        "b": "The [nucleolus] [enabled] the localization of the [Plasma Membrane] during mitosis.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8723227565079181,
        "token(a ~ b)": 0.6677551020408163,
        "domain": "1.7"
    },
    {
        "a": "[Proline] [displayed] increased affinity for [cyclohexanone] under acidic conditions.",
        "b": "[Pro] [exhibited] increased affinity for [C6H10O] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8391862082670906,
        "token(a ~ b)": 0.5218855218855218,
        "domain": "1.7"
    },
    {
        "a": "[Nitryl chloride] [emerged] in the presence of [3-Heptyne] during the reaction.",
        "b": "[NO2Cl] [appeared] in the presence of [hept-3-yne] during the reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8016588985389127,
        "token(a ~ b)": 0.5130190007037297,
        "domain": "1.7"
    },
    {
        "a": "[Norepinephrine] [prolonged] the survival of [Stratum lucidum cell] in culture.",
        "b": "[Noradrenaline] [extended] the survival of [SLC] in culture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8571192942079019,
        "token(a ~ b)": 0.42789968652037613,
        "domain": "1.7"
    },
    {
        "a": "The presence of [bornan-2-one] [elevated] the concentration of [methylbenzene] in the reaction mixture.",
        "b": "The presence of [camphor] [boosted] the concentration of [toluene] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8859793775613307,
        "token(a ~ b)": 0.5208211143695014,
        "domain": "1.7"
    },
    {
        "a": "[transaldolase] [was critical for] the function of [Phosphoenolpyruvate] in the pentose phosphate pathway.",
        "b": "[TALDO1] [was essential in] the function of [PEP] in the pentose phosphate pathway.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7513484882927939,
        "token(a ~ b)": 0.4727272727272727,
        "domain": "1.7"
    },
    {
        "a": "[Enkephalin] [produced] [butyric acid] under acidic conditions.",
        "b": "[ENK] [generated] [butanoic acid] under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.818160638850294,
        "token(a ~ b)": 0.5288697788697789,
        "domain": "1.7"
    },
    {
        "a": "[Ivermectin] [facilitated] the progression of [Duchenne Muscular Dystrophy] in the mouse model.",
        "b": "[IVM] [enabled] the progression of [DMD] in the mouse model.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7630409356725145,
        "token(a ~ b)": 0.45833333333333337,
        "domain": "1.7"
    },
    {
        "a": "[Ziv-aflibercept] [was genetically correlated with] [Tuberous sclerosis complex] in clinical studies.",
        "b": "[Zaltrap] [was genetically associated with] [TSC] in clinical studies.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7711405426256911,
        "token(a ~ b)": 0.5533333333333333,
        "domain": "1.7"
    },
    {
        "a": "[Glyceraldehyde-3-phosphate] [included] [Octadecane] in the reaction mixture.",
        "b": "[G3P] [comprised] [n-octadecane] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7877927141085036,
        "token(a ~ b)": 0.5403726708074534,
        "domain": "1.7"
    },
    {
        "a": "In the recent clinical study, [Darolutamide] [was capable] of reducing the risk of [Gastric cancer].",
        "b": "In the recent clinical study, [Nubeqa] [was able] to reduce the risk of [Stomach cancer].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8946855286313794,
        "token(a ~ b)": 0.5435897435897437,
        "domain": "1.7"
    },
    {
        "a": "[Decane] [broadened] the reactivity of [Titanium(III) chloride] in the catalytic system.",
        "b": "[n-decane] [expanded] the reactivity of [TiCl3] in the catalytic system.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7822026232473994,
        "token(a ~ b)": 0.52,
        "domain": "1.7"
    },
    {
        "a": "[Formate] [affected] [N,N-Dimethylformamide] metabolism in the liver.",
        "b": "[HCOO-] [influenced] [DMF] metabolism in the liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6670697938764315,
        "token(a ~ b)": 0.37962962962962965,
        "domain": "1.7"
    },
    {
        "a": "[Heptadecanoic acid] [served as] an activator of [Nitryl fluoride] in the reaction mixture.",
        "b": "[margaric acid] [functioned as] an activator of [nitrogen dioxide fluoride] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7997348073613133,
        "token(a ~ b)": 0.5606060606060606,
        "domain": "1.7"
    },
    {
        "a": "[NO2I] [broadened] the spectrum of [methyl cyanide] in the reaction mixture.",
        "b": "[Nitryl iodide] [expanded] the spectrum of [acetonitrile] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8094906761424594,
        "token(a ~ b)": 0.4375,
        "domain": "1.7"
    },
    {
        "a": "[Chlorophyll d] [ameliorated] the symptoms of [Sickle Cell Disease] in experimental models.",
        "b": "[Chl d] [alleviated] the symptoms of [SCD] in experimental models.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8536729936729938,
        "token(a ~ b)": 0.5403726708074534,
        "domain": "1.7"
    },
    {
        "a": "[NAD(P)H:quinone oxidoreductase 1] [was genetically associated with] [Type 1 Diabetes Mellitus].",
        "b": "[NQO1] [was genetically linked to] [T1DM].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6051587301587302,
        "token(a ~ b)": 0.33512544802867383,
        "domain": "1.7"
    },
    {
        "a": "[Gadoleic acid] [was associated with] [Coenzyme A] in mitochondrial membranes.",
        "b": "[11-eicosenoic acid] [was related to] [CoA] in mitochondrial membranes.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8054466660100463,
        "token(a ~ b)": 0.5095238095238095,
        "domain": "1.7"
    },
    {
        "a": "[Dimethyl sulfide] [induced] the expression of [malate dehydrogenase] in bacterial cultures.",
        "b": "[DMS] [triggered] the expression of [MDH] in bacterial cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.679089026915114,
        "token(a ~ b)": 0.4397840531561462,
        "domain": "1.7"
    },
    {
        "a": "[IL-12] [displayed] increased expression in [SLC] under hypoxic conditions.",
        "b": "[Interleukin-12] [showed] increased expression in [Stratum lucidum cell] under hypoxic conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7841269841269841,
        "token(a ~ b)": 0.5883180858550316,
        "domain": "1.7"
    },
    {
        "a": "The [hydroperoxyl radical] [displayed] a strong interaction with [ethanal] in the reaction mixture.",
        "b": "The [perhydroxyl radical] [exhibited] a strong interaction with [acetaldehyde] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8802892691398798,
        "token(a ~ b)": 0.6688453159041394,
        "domain": "1.7"
    },
    {
        "a": "[Aluminum] [comprised] [Nitryl iodide] in the reaction mixture.",
        "b": "[Al] [included] [NO2I] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8192814671538077,
        "token(a ~ b)": 0.5288697788697789,
        "domain": "1.7"
    },
    {
        "a": "[N2H4] [accepted] the presence of [sulfate ion] in the reaction mixture.",
        "b": "[Hydrazine] [admitted] the presence of [Sulfate] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8166422048271362,
        "token(a ~ b)": 0.5448717948717948,
        "domain": "1.7"
    },
    {
        "a": "[Vitamin B12] [replaced] [Calcium] in the metabolic assay.",
        "b": "[Cobalamin] [substituted] [Ca] in the metabolic assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7694252873563218,
        "token(a ~ b)": 0.42995169082125606,
        "domain": "1.7"
    },
    {
        "a": "[n-undecane] [impacted] the expression of [azanone] in bacterial cultures.",
        "b": "[Undecane] [influenced] the expression of [Nitrosyl hydride] in bacterial cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7652126935259465,
        "token(a ~ b)": 0.48120567375886525,
        "domain": "1.7"
    },
    {
        "a": "[Nitrosyl azide] [increased] the activity of [Cationic amino acid transporter 1] in the experimental assay.",
        "b": "[N4O] [boosted] the activity of [SLC7A1] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6743122394259234,
        "token(a ~ b)": 0.4951923076923077,
        "domain": "1.7"
    },
    {
        "a": "The presence of [Proline] [facilitated] the formation of [Thiol] in the reaction mixture.",
        "b": "The presence of [Pro] [enabled] the formation of [mercaptan] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8947077465385463,
        "token(a ~ b)": 0.6640316205533596,
        "domain": "1.7"
    },
    {
        "a": "[1-Octyne] [orchestrated] the metabolism of [Fructose] in the liver.",
        "b": "[C8H14] [coordinated] the metabolism of [D-fructose] in the liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7730328495034376,
        "token(a ~ b)": 0.4895238095238095,
        "domain": "1.7"
    },
    {
        "a": "[ONOO-] [was associated with] [H2S] in the mitochondrial matrix.",
        "b": "[Peroxynitrite] [was linked to] [Hydrogen sulfide] in the mitochondrial matrix.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6638214093654339,
        "token(a ~ b)": 0.3937449879711307,
        "domain": "1.7"
    },
    {
        "a": "The [Hydroxide ion] [displayed] significant affinity for [Serine] in aqueous solution.",
        "b": "The [OH-] [showed] significant affinity for [Ser] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8632719218765731,
        "token(a ~ b)": 0.6689723320158103,
        "domain": "1.7"
    },
    {
        "a": "[NH3] [substituted] [methyl cyanide] in the reaction mixture.",
        "b": "[Ammonia] [replaced] [acetonitrile] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7323164647184603,
        "token(a ~ b)": 0.37962962962962965,
        "domain": "1.7"
    },
    {
        "a": "[Nitric acid] [emerged] as an alternative to [Palmitoleic acid] in the oxidation process.",
        "b": "[HNO3] [appeared] as an alternative to [hexadec-9-enoic acid] in the oxidation process.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7870430484727268,
        "token(a ~ b)": 0.5173697270471465,
        "domain": "1.7"
    },
    {
        "a": "[Chl f] [impacted] the expression of [SRXN1] in photosynthetic cells.",
        "b": "[Chlorophyll f] [influenced] the expression of [Sulfiredoxin] in photosynthetic cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8432510301488415,
        "token(a ~ b)": 0.5527295285359801,
        "domain": "1.7"
    },
    {
        "a": "In the cell culture experiment, [Oleic acid] [bound] to [Isoleucine].",
        "b": "In the cell culture experiment, [cis-9-octadecenoic acid] [coupled] to [Ile].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9141600428556951,
        "token(a ~ b)": 0.5679099225897255,
        "domain": "1.7"
    },
    {
        "a": "[Octadecane] [contained] [Dehydroepiandrosterone] in the reaction mixture.",
        "b": "[n-octadecane] [included] [DHEA] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7340013388001003,
        "token(a ~ b)": 0.487510766580534,
        "domain": "1.7"
    },
    {
        "a": "[Methanethiol] [boosted] the expression of [Ethylamine] in neuronal cells.",
        "b": "[methyl mercaptan] [elevated] the expression of [aminoethane] in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7964942827442828,
        "token(a ~ b)": 0.47903726708074534,
        "domain": "1.7"
    },
    {
        "a": "[tricalcium dicitrate] [was employed] to neutralize [HBr] in aqueous solution.",
        "b": "[Calcium citrate] [was used] to neutralize [Hydrogen bromide] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.807004377736085,
        "token(a ~ b)": 0.5733333333333334,
        "domain": "1.7"
    },
    {
        "a": "[Propyne] [induced] the formation of [Benzamide] in the reaction mixture.",
        "b": "[methylacetylene] [triggered] the formation of [benzenecarboxamide] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7688382440528324,
        "token(a ~ b)": 0.4702861335289802,
        "domain": "1.7"
    },
    {
        "a": "[Nitrosyl azide] [coordinated] the activity of [Nitric oxide] during the reaction.",
        "b": "[N4O] [orchestrated] the activity of [NO] during the reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7898043897012941,
        "token(a ~ b)": 0.4895238095238095,
        "domain": "1.7"
    },
    {
        "a": "[Dehydroepiandrosterone] [replaced] [Sulfur dioxide] in the experimental assay.",
        "b": "[DHEA] [substituted] [SO2] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6593532651569433,
        "token(a ~ b)": 0.3587848932676519,
        "domain": "1.7"
    },
    {
        "a": "The [hydroperoxyl radical] [was negatively associated with] [Al] accumulation in the tissue.",
        "b": "The [perhydroxyl radical] [was negatively correlated with] [aluminum] accumulation in the tissue.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.879565828613341,
        "token(a ~ b)": 0.740909090909091,
        "domain": "1.7"
    },
    {
        "a": "[N,N-Dimethylformamide] [replaced] [Sulfur trioxide] in the reaction mixture.",
        "b": "[DMF] [substituted] [SO3] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6522943722943723,
        "token(a ~ b)": 0.3587848932676519,
        "domain": "1.7"
    },
    {
        "a": "In the experimental setup, [Magnesium] [elevated] the uptake of [Barium ion] in the test solution.",
        "b": "In the experimental setup, [Mg] [boosted] the uptake of [Ba2+] in the test solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8962414965986395,
        "token(a ~ b)": 0.5782967032967032,
        "domain": "1.7"
    },
    {
        "a": "[Glutamic acid] [ameliorated] the effects of [Iodate] toxicity in cell cultures.",
        "b": "[L-glutamic acid] [alleviated] the effects of [IO3-] toxicity in cell cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8344618024603316,
        "token(a ~ b)": 0.5725683890577508,
        "domain": "1.7"
    },
    {
        "a": "[Tungstate] [broadened] the effect of [sodium phosphate] in solution.",
        "b": "[WO4^2-] [expanded] the effect of [Trisodium phosphate] in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7787459211570685,
        "token(a ~ b)": 0.5018315018315018,
        "domain": "1.7"
    },
    {
        "a": "[Palmitoleic acid] [bound] [tert-Butylamine] in the reaction mixture.",
        "b": "[hexadec-9-enoic acid] [coupled] [2-methyl-2-propanamine] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7503817603393425,
        "token(a ~ b)": 0.4705188679245283,
        "domain": "1.7"
    },
    {
        "a": "[Palladium(II) ion] [was genetically correlated with] [Nitrosyl bromide] in solution.",
        "b": "[Pd2+] [was genetically associated with] [NOBr] in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7721449792038027,
        "token(a ~ b)": 0.4349593495934959,
        "domain": "1.7"
    },
    {
        "a": "[Decane] [served as] a [thiol] derivative in the reaction mixture.",
        "b": "[n-decane] [functioned as] a [mercaptan] derivative in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7852753157110361,
        "token(a ~ b)": 0.5533333333333333,
        "domain": "1.7"
    },
    {
        "a": "In the recent experiment, [Coenzyme A] [demonstrated] a strong interaction with [Formaldehyde].",
        "b": "In the recent experiment, [CoA] [displayed] a strong interaction with [methanal].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9002806679999663,
        "token(a ~ b)": 0.5885668276972624,
        "domain": "1.7"
    },
    {
        "a": "[Diethylamine] [broke apart] [Tryptophan] in the reaction mixture.",
        "b": "[N,N-diethanamine] [disrupted] [Trp] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7591084421846235,
        "token(a ~ b)": 0.44136960600375236,
        "domain": "1.7"
    },
    {
        "a": "[Vasopressin] [affected] [Trichloroethylene] metabolism in the liver.",
        "b": "[arginine vasopressin] [influenced] [1,1,2-Trichloroethene] metabolism in the liver.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7762900143334925,
        "token(a ~ b)": 0.5243589743589744,
        "domain": "1.7"
    },
    {
        "a": "[Cysteine] [interacted] with [Nitrogen trioxide] in aqueous solution.",
        "b": "[Cys] [bound] with [dinitrogen trioxide] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8678921108901977,
        "token(a ~ b)": 0.6477272727272727,
        "domain": "1.7"
    },
    {
        "a": "In the in vitro system, [propanone] [regulated] the metabolism of [DMC].",
        "b": "In the in vitro system, [acetone] [controlled] the metabolism of [dimethyl carbonate].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8794106539455376,
        "token(a ~ b)": 0.6536796536796536,
        "domain": "1.7"
    },
    {
        "a": "[Dinitrogen tetroxide] [was associated with] [Azide ion] formation under high-pressure conditions.",
        "b": "[N2O4] [was linked to] [N3-] formation under high-pressure conditions.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6837515334002454,
        "token(a ~ b)": 0.42183908045977014,
        "domain": "1.7"
    },
    {
        "a": "[Hydrogen peroxide] was [was linked to] [Dimethylformamide] toxicity in cell cultures.",
        "b": "[H2O2] was [was associated with] [DMF] toxicity in cell cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7610321461484252,
        "token(a ~ b)": 0.4334415584415584,
        "domain": "1.7"
    },
    {
        "a": "[Methane] [induced] the activity of [Radium ion] in solution.",
        "b": "[CH4] [triggered] the activity of [Ra2+] in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6989849000365549,
        "token(a ~ b)": 0.4369369369369369,
        "domain": "1.7"
    },
    {
        "a": "[Estradiol] [was found] in [Dimethylamine] samples collected from the river.",
        "b": "[17\u03b2-estradiol] was [detected] in [N-methylmethanamine] samples collected from the river.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7879851313677453,
        "token(a ~ b)": 0.5431972789115647,
        "domain": "1.7"
    },
    {
        "a": "[Tropylium radical cation] [induced] the oxidation of [Nitrate ion] in solution.",
        "b": "[Tropylium radical] [triggered] the oxidation of [NO3-] in solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8728368121442125,
        "token(a ~ b)": 0.6236363636363637,
        "domain": "1.7"
    },
    {
        "a": "[Ethyl acetate] [broadened] the effects of [Carbon tetrachloride] in hepatocyte cultures.",
        "b": "[EtOAc] [expanded] the effects of [CCl4] in hepatocyte cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8002998676223686,
        "token(a ~ b)": 0.4270833333333333,
        "domain": "1.7"
    },
    {
        "a": "[NH4NO3] [was critical for] the activation of [Mn2+] uptake in plant roots.",
        "b": "[Ammonium nitrate] [was essential in] the activation of [Manganese(II) ion] uptake in plant roots.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.6794708994708994,
        "token(a ~ b)": 0.4457013574660633,
        "domain": "1.7"
    },
    {
        "a": "[Acetaldehyde] [broadened] the effects of [Citric acid] in the experimental assay.",
        "b": "[ethanal] [expanded] the effects of [2-hydroxypropane-1,2,3-tricarboxylic acid] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7715051860242842,
        "token(a ~ b)": 0.3989741302408564,
        "domain": "1.7"
    },
    {
        "a": "[Bicarbonate] [was critical for] the stability of [Nitryl bromide] in aqueous solution.",
        "b": "[hydrogen carbonate] [was essential in] the stability of [nitrogen dioxide bromide] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.764131299734748,
        "token(a ~ b)": 0.5506685432793808,
        "domain": "1.7"
    },
    {
        "a": "[Dihydroxyacetone] [bound] to [Acetyl chloride] in the reaction mixture.",
        "b": "[DHA] [interacted] with [ethanoyl chloride] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.836207744746644,
        "token(a ~ b)": 0.46575984990619135,
        "domain": "1.7"
    },
    {
        "a": "[Progesterone] [preceded] [Dichloromethane] exposure in the experimental protocol.",
        "b": "[Pregn-4-ene-3,20-dione] [came before] [DCM] exposure in the experimental protocol.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.821915495554672,
        "token(a ~ b)": 0.3376470588235294,
        "domain": "1.7"
    },
    {
        "a": "[Nitrosyl hydride] [raised] the expression of [Cysteine] in the experimental assay.",
        "b": "[azanone] [augmented] the expression of [Cys] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.766741967871486,
        "token(a ~ b)": 0.48291925465838514,
        "domain": "1.7"
    },
    {
        "a": "In the recent study, [Peptide YY] [revealed] a novel interaction with [Fructose-6-phosphate].",
        "b": "In the recent study, [PYY] [identified] a novel interaction with [F6P].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8763358253135626,
        "token(a ~ b)": 0.5811662726556344,
        "domain": "1.7"
    },
    {
        "a": "In the experimental setup, [Cl-] [substituted] [butanedioic acid] in the reaction mixture.",
        "b": "In the experimental setup, [Chloride ion] [replaced] [succinic acid] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.899820788530466,
        "token(a ~ b)": 0.5402298850574713,
        "domain": "1.7"
    },
    {
        "a": "[N-Methyl-2-pyrrolidone] [included] [Vitamin B12] in the test formulation.",
        "b": "[NMP] [comprised] [Cobalamin] in the test formulation.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7655655655655657,
        "token(a ~ b)": 0.3833333333333333,
        "domain": "1.7"
    },
    {
        "a": "[Nitrogen trioxide] [replaced] [Acetic anhydride] during the synthesis reaction.",
        "b": "[dinitrogen trioxide] [substituted] [ethanoic anhydride] during the synthesis reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7849425287356322,
        "token(a ~ b)": 0.6041666666666667,
        "domain": "1.7"
    },
    {
        "a": "[n-tridecane] [influenced] the expression of [NMP] in bacterial cultures.",
        "b": "[Tridecane] [affected] the expression of [N-Methyl-2-pyrrolidone] in bacterial cultures.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.7840063078672369,
        "token(a ~ b)": 0.5296774193548387,
        "domain": "1.7"
    },
    {
        "a": "[C6H10O] [impacted] the concentration of [cis-9-octadecenoic acid] in the culture medium.",
        "b": "[Cyclohexanone] [affected] the concentration of [oleic acid] in the culture medium.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.821129712357545,
        "token(a ~ b)": 0.483704974271012,
        "domain": "1.7"
    },
    {
        "a": "[Calcium ion] [contained] [Ethylene oxide] in the reaction mixture.",
        "b": "[Ca2+] [included] [oxirane] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8238518943742824,
        "token(a ~ b)": 0.43896103896103894,
        "domain": "1.7"
    },
    {
        "a": "[COS] [substituted] [aminomethane] during the chemical reaction.",
        "b": "[Carbonyl Sulfide] [replaced] [methylamine] during the chemical reaction.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8094618681406713,
        "token(a ~ b)": 0.3587848932676519,
        "domain": "1.7"
    },
    {
        "a": "[Sodium nitrate] [served as] a [magnesium citrate] supplement in the animal model.",
        "b": "[NaNO3] [functioned as] a [trimagnesium dicitrate] supplement in the animal model.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8036255767963085,
        "token(a ~ b)": 0.5506685432793808,
        "domain": "1.7"
    },
    {
        "a": "In the experimental model, [L-glutamic acid] [arose] in the presence of [NOBr].",
        "b": "In the experimental model, [Glutamic acid] [emerged] in the presence of [Nitrosyl bromide].",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.9094385942487208,
        "token(a ~ b)": 0.61,
        "domain": "1.7"
    },
    {
        "a": "The activity of [oxalacetic acid] [displayed] a strong interaction with [HF] in the assay.",
        "b": "The activity of [Oxaloacetate] [showed] a strong interaction with [Hydrogen fluoride] in the assay.",
        "a -> b": 1.0,
        "b -> a": 1.0,
        "char(a ~ b)": 0.8846513326031399,
        "token(a ~ b)": 0.5654290931223371,
        "domain": "1.7"
    },
    {
        "a": "[Macrophage Inflammatory Proteins] [displayed] [Tumor Necrosis Factor-alpha] binding capacity in vitro.",
        "b": "[Chemokine CCL18] [displayed] [Tumor Necrosis Factor-alpha] binding capacity in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.765172153613554,
        "token(a ~ b)": 0.6484110885733604,
        "domain": "2.1"
    },
    {
        "a": "[Complement System Proteins] [replaced] [Cystic fibrosis transmembrane conductance regulator] in the membrane assay.",
        "b": "[Complement C3] [replaced] [Cystic fibrosis transmembrane conductance regulator] in the membrane assay.",
        "a -> b": 1.0,
        "b -> a": 0.08695652173913043,
        "char(a ~ b)": 0.8890663170769705,
        "token(a ~ b)": 0.8668546365914787,
        "domain": "2.1"
    },
    {
        "a": "[dichlorophenyl dicarboximide fungicide] [was selected] for reaction with [1-Hexyne] in the catalytic assay.",
        "b": "[iprodione] [was selected] for reaction with [1-Hexyne] in the catalytic assay.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.7865330520393812,
        "token(a ~ b)": 0.6147186147186148,
        "domain": "2.1"
    },
    {
        "a": "[Lymphoid Progenitor Cells] [replaced] [1-Nonyne] during the experimental assay.",
        "b": "[B-Lymphoid Precursor Cells] [replaced] [1-Nonyne] during the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.8590277777777778,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "2.1"
    },
    {
        "a": "[neurotransmitter receptor] [regulated] [Melanocyte] function in the epidermis.",
        "b": "[serotonin receptor] [regulated] [Melanocyte] function in the epidermis.",
        "a -> b": 1.0,
        "b -> a": 0.09322033898305085,
        "char(a ~ b)": 0.8386930231176086,
        "token(a ~ b)": 0.7857142857142857,
        "domain": "2.1"
    },
    {
        "a": "[Hydrocarbons, Iodinated] [displayed] [vasopressin] binding activity in the in vitro assay.",
        "b": "[Iodobenzenes] [displayed] [vasopressin] binding activity in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 0.5555555555555556,
        "char(a ~ b)": 0.8023364135864135,
        "token(a ~ b)": 0.653220559531555,
        "domain": "2.1"
    },
    {
        "a": "[Voltage-Gated potassium channel] [inhibited] [Tumor-associated Macrophage] function in vitro.",
        "b": "[Shaker Superfamily of potassium channel] [inhibited] [Tumor-associated Macrophage] function in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.5294117647058824,
        "char(a ~ b)": 0.795610892926503,
        "token(a ~ b)": 0.703525641025641,
        "domain": "2.1"
    },
    {
        "a": "[Monocytes] [suppressed] the secretion of [growth hormone] in vitro.",
        "b": "[Monocyte-Macrophage Precursor Cells] [suppressed] the secretion of [growth hormone] in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8711514392991239,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "2.1"
    },
    {
        "a": "[1-alkylglycerone 3-phosphate] [bound] to [Leucine] in the cell-free assay.",
        "b": "[1-(9Z,12Z)-octadecadienylglycerone 3-phosphate] [bound] to [Leucine] in the cell-free assay.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.8445118083173762,
        "token(a ~ b)": 0.7133838383838383,
        "domain": "2.1"
    },
    {
        "a": "[Pigmentation Disorders] [were associated with] [Finasteride] treatment in clinical studies.",
        "b": "[Cafe-au-Lait Spots] [were associated with] [Finasteride] treatment in clinical studies.",
        "a -> b": 1.0,
        "b -> a": 0.05,
        "char(a ~ b)": 0.7971799939191244,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "2.1"
    },
    {
        "a": "[Macrophages] [suppressed] the function of [Stratum granulosum cell] in vitro.",
        "b": "[Osteoclasts] [suppressed] the function of [Stratum granulosum cell] in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.1,
        "char(a ~ b)": 0.841346153846154,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "2.1"
    },
    {
        "a": "[macrophage] [displayed] [Fast-twitch muscle fiber] characteristics under hypoxic conditions.",
        "b": "[Foreign-Body Giant Cells] [displayed] [Fast-twitch muscle fiber] characteristics under hypoxic conditions.",
        "a -> b": 1.0,
        "b -> a": 0.07692307692307693,
        "char(a ~ b)": 0.794236303340916,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "2.1"
    },
    {
        "a": "[Hereditary Autoinflammatory Diseases] [improved] with [Rucaparib] treatment.",
        "b": "[Cryopyrin-Associated Periodic Syndromes] [improved] with [Rucaparib] treatment.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.7677659840159841,
        "token(a ~ b)": 0.5125,
        "domain": "2.1"
    },
    {
        "a": "[Lysosphingolipid Receptors] [displayed] elevated expression of [T lymphocyte] markers after stimulation.",
        "b": "[Sphingosine Phosphorylcholine Receptors] [displayed] elevated expression of [T lymphocyte] markers after stimulation.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.816344295822657,
        "token(a ~ b)": 0.6383928571428572,
        "domain": "2.1"
    },
    {
        "a": "[Megakaryocyte-Erythroid Progenitor Cells] [coordinated] the response to [Interleukin-8] signaling.",
        "b": "[Erythroid Precursor Cells] [coordinated] the response to [Interleukin-8] signaling.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8023176010980889,
        "token(a ~ b)": 0.6993087557603687,
        "domain": "2.1"
    },
    {
        "a": "[Pentacyclic triterpenes] [contained] [dimethylformamide] in the tested solution.",
        "b": "[Oleanolic acid] [contained] [dimethylformamide] in the tested solution.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.7885088446655609,
        "token(a ~ b)": 0.5716783216783217,
        "domain": "2.1"
    },
    {
        "a": "[inorganic barium salt] [was required for] the synthesis of [Dimethylamine] in the experimental setup.",
        "b": "[barium carbonate] [was required for] the synthesis of [Dimethylamine] in the experimental setup.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.8469104082218889,
        "token(a ~ b)": 0.7733580018501387,
        "domain": "2.1"
    },
    {
        "a": "[Dicarboxylic Acids] [exhibited] [Hydrogen gas] evolution under acidic conditions.",
        "b": "[Oxalates] [exhibited] [Hydrogen gas] evolution under acidic conditions.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.8085844093735056,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "2.1"
    },
    {
        "a": "[Phenylacetates] [joined] [Junctional Adhesion Molecule A] in the membrane compartment.",
        "b": "[Homovanillic Acid] [joined] [Junctional Adhesion Molecule A] in the membrane compartment.",
        "a -> b": 1.0,
        "b -> a": 0.07142857142857142,
        "char(a ~ b)": 0.7897163755784445,
        "token(a ~ b)": 0.7148148148148148,
        "domain": "2.1"
    },
    {
        "a": "[Tachykinin Receptors] [bound] to [Glucose-6-phosphate isomerase] in neuronal membranes.",
        "b": "[Neurokinin-2 Receptors] [bound] to [Glucose-6-phosphate isomerase] in neuronal membranes.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.825886272362176,
        "token(a ~ b)": 0.8035714285714286,
        "domain": "2.1"
    },
    {
        "a": "[inorganic salt] [resulted in] the formation of [Titanium(III) chloride] under laboratory conditions.",
        "b": "[inorganic chloride] [resulted in] the formation of [Titanium(III) chloride] under laboratory conditions.",
        "a -> b": 1.0,
        "b -> a": 0.17154811715481172,
        "char(a ~ b)": 0.8990934195460362,
        "token(a ~ b)": 0.9553571428571428,
        "domain": "2.1"
    },
    {
        "a": "[bromoporphyrin] [contained] [Phenylalanine] in the final reaction mixture.",
        "b": "[meso-bromoporphyrin] [contained] [Phenylalanine] in the final reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.8412499999999999,
        "token(a ~ b)": 0.844812925170068,
        "domain": "2.1"
    },
    {
        "a": "[Vesiculobullous Skin Diseases] was [treated] with [Danaparoid] in clinical settings.",
        "b": "[Linear IgA Bullous Dermatosis] was [treated] with [Danaparoid] in clinical settings.",
        "a -> b": 1.0,
        "b -> a": 0.05555555555555555,
        "char(a ~ b)": 0.796677265500795,
        "token(a ~ b)": 0.5880893300248139,
        "domain": "2.1"
    },
    {
        "a": "[ergosterol] [joined] [Diethylamine] in the reaction mixture.",
        "b": "[ergosteryl 3-beta-D-glucoside] [joined] [Diethylamine] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.8770901639344263,
        "token(a ~ b)": 0.6236363636363637,
        "domain": "2.1"
    },
    {
        "a": "[Aminobenzoates] [affected] [Tetracosane] metabolism in vitro.",
        "b": "[meta-Aminobenzoates] [affected] [Tetracosane] metabolism in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.11538461538461539,
        "char(a ~ b)": 0.8421280693307656,
        "token(a ~ b)": 0.8523809523809525,
        "domain": "2.1"
    },
    {
        "a": "[macrophage] [produced] [antibody-secreting cell] in the inflamed tissue.",
        "b": "[Alveolar Macrophages] [produced] [antibody-secreting cell] in the inflamed tissue.",
        "a -> b": 1.0,
        "b -> a": 0.07692307692307693,
        "char(a ~ b)": 0.8144647081476591,
        "token(a ~ b)": 0.7967571644042233,
        "domain": "2.1"
    },
    {
        "a": "[Lymphoid Progenitor Cells] [was critical for] the regulation of [VE-cadherin] in endothelial tissues.",
        "b": "[B-Lymphoid Precursor Cells] [was critical for] the regulation of [VE-cadherin] in endothelial tissues.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.8502926162958427,
        "token(a ~ b)": 0.7906403940886699,
        "domain": "2.1"
    },
    {
        "a": "[Ionotropic Glutamate Receptors] [affected] [Endoplasmic reticulum resident protein 44] function in neurons.",
        "b": "[N-Methyl-D-Aspartate Receptors] [affected] [Endoplasmic reticulum resident protein 44] function in neurons.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.8058991981672395,
        "token(a ~ b)": 0.6712121212121213,
        "domain": "2.1"
    },
    {
        "a": "[CXC Chemokines] [displayed] enzymatic activity similar to [transketolase] under experimental conditions.",
        "b": "[Chemokine CXCL1] [displayed] enzymatic activity similar to [transketolase] under experimental conditions.",
        "a -> b": 1.0,
        "b -> a": 0.08333333333333333,
        "char(a ~ b)": 0.8642237427143088,
        "token(a ~ b)": 0.7252747252747254,
        "domain": "2.1"
    },
    {
        "a": "[Digoxin] [replaced] [zinc sulfate] in the formulation of cardiac drugs.",
        "b": "[Medigoxin] [replaced] [zinc sulfate] in the formulation of cardiac drugs.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8991641289176502,
        "token(a ~ b)": 0.8901162790697674,
        "domain": "2.1"
    },
    {
        "a": "[Ichthyosis] [contained] [Colesevelam] in the analyzed samples.",
        "b": "[Sjogren-Larsson Syndrome] [contained] [Colesevelam] in the analyzed samples.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.7619275461380723,
        "token(a ~ b)": 0.6071428571428572,
        "domain": "2.1"
    },
    {
        "a": "[Photoreceptor Cells] [was found in] [Acetic acid] during the extraction procedure.",
        "b": "[Vertebrate Photoreceptor Cells] [was found in] [Acetic acid] during the extraction procedure.",
        "a -> b": 1.0,
        "b -> a": 0.75,
        "char(a ~ b)": 0.8275442194309152,
        "token(a ~ b)": 0.8308080808080808,
        "domain": "2.1"
    },
    {
        "a": "[Pro-Opiomelanocortin] [induced] the function of [Cystic fibrosis transmembrane conductance regulator] in epithelial cells.",
        "b": "[beta-Endorphin] [induced] the function of [Cystic fibrosis transmembrane conductance regulator] in epithelial cells.",
        "a -> b": 1.0,
        "b -> a": 0.07692307692307693,
        "char(a ~ b)": 0.8299551157526551,
        "token(a ~ b)": 0.7273093989511901,
        "domain": "2.1"
    },
    {
        "a": "[Vasopressins] [preceded] [Neutrophil] migration in the tissue samples.",
        "b": "[Ornipressin] [preceded] [Neutrophil] migration in the tissue samples.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.8526394732028535,
        "token(a ~ b)": 0.7351778656126482,
        "domain": "2.1"
    },
    {
        "a": "[Autoantibodies] [identified] [Meperidine] in the cerebrospinal fluid samples.",
        "b": "[Antineutrophil Cytoplasmic Antibodies] [identified] [Meperidine] in the cerebrospinal fluid samples.",
        "a -> b": 1.0,
        "b -> a": 0.09090909090909091,
        "char(a ~ b)": 0.823034611153423,
        "token(a ~ b)": 0.6606918238993711,
        "domain": "2.1"
    },
    {
        "a": "[anabolic androgenic steroid] [was genetically associated with] [Gamma-aminobutyric acid (GABA)] in human tissue samples.",
        "b": "[Delta(1)-dihydrotestosterone] [was genetically associated with] [Gamma-aminobutyric acid (GABA)] in human tissue samples.",
        "a -> b": 1.0,
        "b -> a": 0.07692307692307693,
        "char(a ~ b)": 0.8034183354484425,
        "token(a ~ b)": 0.687246963562753,
        "domain": "2.1"
    },
    {
        "a": "[Vertebrate Photoreceptor Cells] [regulated] [endoplasmic reticulum oxidoreductin 1] under dark adaptation.",
        "b": "[Retinal Rod Photoreceptor Cells] [regulated] [endoplasmic reticulum oxidoreductin 1] under dark adaptation.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.8291516095534788,
        "token(a ~ b)": 0.8481646273637375,
        "domain": "2.1"
    },
    {
        "a": "[Melanocortins] [enhanced] the differentiation of [Mesenchymal Stem Cell] in vitro.",
        "b": "[Melanocyte-Stimulating Hormones] [enhanced] the differentiation of [Mesenchymal Stem Cell] in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8824287248001909,
        "token(a ~ b)": 0.7543800539083558,
        "domain": "2.1"
    },
    {
        "a": "[L-sorbofuranose] [broadened] the effects of [Barium ion] in solution.",
        "b": "[beta-L-sorbofuranose] [broadened] the effects of [Barium ion] in solution.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.842857142857143,
        "token(a ~ b)": 0.8766666666666667,
        "domain": "2.1"
    },
    {
        "a": "[Myoblasts] [contained] [Interleukin-32] in the experimental culture.",
        "b": "[Cardiac Myoblasts] [contained] [Interleukin-32] in the experimental culture.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.8297007340485602,
        "token(a ~ b)": 0.8656126482213439,
        "domain": "2.1"
    },
    {
        "a": "[Chorionic Gonadotropin] [was critical for] the function of [Mesenchymal Stem Cell] in differentiation assays.",
        "b": "[Human beta Subunit Chorionic Gonadotropin] [was critical for] the function of [Mesenchymal Stem Cell] in differentiation assays.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8249048625792812,
        "token(a ~ b)": 0.859375,
        "domain": "2.1"
    },
    {
        "a": "[Lysosphingolipid Receptors] [exhibited] increased binding to [Pancreatic polypeptide] under hypoxic conditions.",
        "b": "[Sphingosine-1-Phosphate Receptors] [exhibited] increased binding to [Pancreatic polypeptide] under hypoxic conditions.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8273830793999843,
        "token(a ~ b)": 0.680952380952381,
        "domain": "2.1"
    },
    {
        "a": "[2',3'-cyclic purine nucleotide] [revealed] the presence of [Decane] in the reaction mixture.",
        "b": "[adenosine-5'-phosphate-2',3'-cyclic phosphate] [revealed] the presence of [Decane] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 0.14285714285714285,
        "char(a ~ b)": 0.783750104192715,
        "token(a ~ b)": 0.7258064516129032,
        "domain": "2.1"
    },
    {
        "a": "[Pituitary Hormone-Releasing Hormones] [demonstrated] [Endoplasmic reticulum oxidoreductin 1] activity in the hypothalamus.",
        "b": "[Growth Hormone-Releasing Hormone] [demonstrated] [Endoplasmic reticulum oxidoreductin 1] activity in the hypothalamus.",
        "a -> b": 1.0,
        "b -> a": 0.1,
        "char(a ~ b)": 0.8347515973515599,
        "token(a ~ b)": 0.8501461988304093,
        "domain": "2.1"
    },
    {
        "a": "[T-Lymphocytes] [was employed] as a carrier for [Cystic fibrosis transmembrane conductance regulator] in gene therapy studies.",
        "b": "[Helper-Inducer T-Lymphocytes] [was employed] as a carrier for [Cystic fibrosis transmembrane conductance regulator] in gene therapy studies.",
        "a -> b": 1.0,
        "b -> a": 0.4,
        "char(a ~ b)": 0.8276089159067882,
        "token(a ~ b)": 0.8448200175592625,
        "domain": "2.1"
    },
    {
        "a": "[Angiotensins] [affected] [Malate dehydrogenase] during the experiment.",
        "b": "[Angiotensin II] [affected] [Malate dehydrogenase] during the experiment.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9689639205093574,
        "token(a ~ b)": 0.8901162790697674,
        "domain": "2.1"
    },
    {
        "a": "[butan-2-one] [led to] the formation of [acetic anhydride] in the reaction mixture.",
        "b": "[1,3-dihydroxybutan-2-one] [led to] the formation of [acetic anhydride] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 0.14285714285714285,
        "char(a ~ b)": 0.8220256024096386,
        "token(a ~ b)": 0.8259562841530055,
        "domain": "2.1"
    },
    {
        "a": "[Melanocortin Receptors] [coordinated] the expression of [Dystrophin] in neuronal cells.",
        "b": "[Type 4 Melanocortin Receptor] [coordinated] the expression of [Dystrophin] in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.8397677249383045,
        "token(a ~ b)": 0.8067340067340067,
        "domain": "2.1"
    },
    {
        "a": "[Long-Acting Insulin] [displayed] [phosphofructokinase, liver type] activity in the glucose tolerance assay.",
        "b": "[Ultralente Insulin] [displayed] [phosphofructokinase, liver type] activity in the glucose tolerance assay.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.8131761540640046,
        "token(a ~ b)": 0.7856045081967213,
        "domain": "2.1"
    },
    {
        "a": "[Voltage-Gated sodium channel] [preceded] [azide ion] in the experimental timeline.",
        "b": "[NAV1.6 voltage-gated sodium channel] [preceded] [azide ion] in the experimental timeline.",
        "a -> b": 1.0,
        "b -> a": 0.07142857142857142,
        "char(a ~ b)": 0.8416700950142031,
        "token(a ~ b)": 0.7038043478260869,
        "domain": "2.1"
    },
    {
        "a": "[Phenylcarbamates] [was capable] of binding [Iron(II) ion] in aqueous solution.",
        "b": "[Felbamate] [was capable] of binding [Iron(II) ion] in aqueous solution.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.8302423188922565,
        "token(a ~ b)": 0.7350863422291993,
        "domain": "2.1"
    },
    {
        "a": "[Melanocortin Receptors] [activated] [Interleukin-36] signaling in the inflammatory response.",
        "b": "[Type 3 Melanocortin Receptor] [activated] [Interleukin-36] signaling in the inflammatory response.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.8451272897275702,
        "token(a ~ b)": 0.8067340067340067,
        "domain": "2.1"
    },
    {
        "a": "[ion channel] [bound] [X-box binding protein 1]",
        "b": "[Ligand-Gated Ion channel] [bound] [X-box binding protein 1]",
        "a -> b": 1.0,
        "b -> a": 0.168141592920354,
        "char(a ~ b)": 0.8073404255319149,
        "token(a ~ b)": 0.6601307189542484,
        "domain": "2.1"
    },
    {
        "a": "[Betacoronavirus] [resulted in] the inhibition of [Indomethacin] in the in vitro assay.",
        "b": "[Middle East Respiratory Syndrome Coronavirus] [resulted in] the inhibition of [Indomethacin] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.7788133874239351,
        "token(a ~ b)": 0.6666666666666667,
        "domain": "2.1"
    },
    {
        "a": "[Lymphoid Progenitor Cells] [was employed] to generate [Inositol-requiring enzyme 1] in the differentiation assay.",
        "b": "[B-Lymphoid Precursor Cells] [was employed] to generate [Inositol-requiring enzyme 1] in the differentiation assay.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.8473367203409401,
        "token(a ~ b)": 0.7977011494252872,
        "domain": "2.1"
    },
    {
        "a": "The [Shaker Superfamily of potassium channel] [activated] [Apolipoprotein E] expression in the hippocampus.",
        "b": "The [Kv1.6 potassium channel] [activated] [Apolipoprotein E] expression in the hippocampus.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.8637121409344839,
        "token(a ~ b)": 0.7307692307692308,
        "domain": "2.1"
    },
    {
        "a": "[B-Cell Antigen Receptors] [regulated] [Purkinje cell] signaling in the cerebellum.",
        "b": "[Pre-B Cell Receptors] [regulated] [Purkinje cell] signaling in the cerebellum.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.8460429916278627,
        "token(a ~ b)": 0.7350863422291993,
        "domain": "2.1"
    },
    {
        "a": "[Tumor Necrosis Factors] [exhibited] [Eukaryotic release factor 1] binding activity in vitro.",
        "b": "[Lymphotoxin alpha1, beta2 Heterotrimer] [exhibited] [Eukaryotic release factor 1] binding activity in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.05555555555555555,
        "char(a ~ b)": 0.7735889739145139,
        "token(a ~ b)": 0.5948275862068966,
        "domain": "2.1"
    },
    {
        "a": "[Fibroblasts] [was employed] in the synthesis of [Olaparib].",
        "b": "[Cancer-Associated Fibroblasts] [was employed] in the synthesis of [Olaparib].",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.8057692307692308,
        "token(a ~ b)": 0.7822410147991543,
        "domain": "2.1"
    },
    {
        "a": "[leukotriene E4] [was sufficient for] [dihydrogen phosphate] transport in renal epithelial cells.",
        "b": "[20-oxoleukotriene E4] [was sufficient for] [dihydrogen phosphate] transport in renal epithelial cells.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.8835551996797117,
        "token(a ~ b)": 0.8714202220923437,
        "domain": "2.1"
    },
    {
        "a": "[Mitochondria] [was found in] [Interleukin-37] expressing cells in mouse tissue.",
        "b": "[Submitochondrial Particles] [was found in] [Interleukin-37] expressing cells in mouse tissue.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.8154662671694048,
        "token(a ~ b)": 0.76,
        "domain": "2.1"
    },
    {
        "a": "[Adipates] [preceded] [butyric acid] in the metabolic pathway.",
        "b": "[2-Aminoadipic Acid] [preceded] [butyric acid] in the metabolic pathway.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8041985602332787,
        "token(a ~ b)": 0.7351778656126482,
        "domain": "2.1"
    },
    {
        "a": "[Alkyne] [contained] [glucose] in the reaction mixture.",
        "b": "[1-hexyne] [contained] [glucose] in the reaction mixture.",
        "a -> b": 1.0,
        "b -> a": 0.14285714285714285,
        "char(a ~ b)": 0.8707821126242179,
        "token(a ~ b)": 0.7055555555555556,
        "domain": "2.1"
    },
    {
        "a": "[Macrophages] [influenced] [Maple Syrup Urine Disease] progression in pediatric patients.",
        "b": "[Alveolar Macrophages] [influenced] [Maple Syrup Urine Disease] progression in pediatric patients.",
        "a -> b": 1.0,
        "b -> a": 0.1,
        "char(a ~ b)": 0.8376175189176794,
        "token(a ~ b)": 0.8509803921568628,
        "domain": "2.1"
    },
    {
        "a": "[Immunoglobulin Fc Fragments] [produced] [Aldolase C] in vitro.",
        "b": "[Etanercept] [produced] [Aldolase C] in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.738198757763975,
        "token(a ~ b)": 0.6236363636363637,
        "domain": "2.1"
    },
    {
        "a": "[inorganic barium salt] [contained] [Dinitrogen pentoxide].",
        "b": "[barium carbonate] [contained] [Dinitrogen pentoxide].",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.8263725916268289,
        "token(a ~ b)": 0.6812144212523719,
        "domain": "2.1"
    },
    {
        "a": "[Cobalamins] [produced] [progesterone] in the adrenal cortex.",
        "b": "[Methylcobalamin] [produced] [progesterone] in the adrenal cortex.",
        "a -> b": 1.0,
        "b -> a": 0.06666666666666667,
        "char(a ~ b)": 0.8210576170148273,
        "token(a ~ b)": 0.6703296703296704,
        "domain": "2.1"
    },
    {
        "a": "[Interferons] [contained] [C/EBP homologous protein] in the cytoplasmic fraction.",
        "b": "[Interferon-gamma] [contained] [C/EBP homologous protein] in the cytoplasmic fraction.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.9085773758254378,
        "token(a ~ b)": 0.886039886039886,
        "domain": "2.1"
    },
    {
        "a": "[Purinergic P2X Receptors] [joined] [follicular dendritic cell] clusters in lymphoid tissues.",
        "b": "[Purinergic P2X3 Receptors] [joined] [follicular dendritic cell] clusters in lymphoid tissues.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.997872340425532,
        "token(a ~ b)": 0.9709090909090909,
        "domain": "2.1"
    },
    {
        "a": "[Myeloid Cells] [detected] [Dutasteride] in the tissue samples.",
        "b": "[Macrophages] [detected] [Dutasteride] in the tissue samples.",
        "a -> b": 1.0,
        "b -> a": 0.4782608695652174,
        "char(a ~ b)": 0.8226616936999451,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "2.1"
    },
    {
        "a": "[Pituitary Hormone-Releasing Hormones] [preceded] [Estrogen Receptor 1] signaling in the hypothalamus.",
        "b": "[Growth Hormone-Releasing Hormone] [preceded] [Estrogen Receptor 1] signaling in the hypothalamus.",
        "a -> b": 1.0,
        "b -> a": 0.1,
        "char(a ~ b)": 0.8269916477229189,
        "token(a ~ b)": 0.8060344827586207,
        "domain": "2.1"
    },
    {
        "a": "[Hydroxybutyrates] [bound] to [Chlorophyll a] in the in vitro assay.",
        "b": "[Sodium Oxybate] [bound] to [Chlorophyll a] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8234395546594195,
        "token(a ~ b)": 0.6958333333333333,
        "domain": "2.1"
    },
    {
        "a": "[Neuropeptide]s [prolonged] the effect of [Interleukin-17] in the in vitro assay.",
        "b": "[Vasopressins] [prolonged] the effect of [Interleukin-17] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 0.06818181818181818,
        "char(a ~ b)": 0.8299524524524525,
        "token(a ~ b)": 0.7321428571428572,
        "domain": "2.1"
    },
    {
        "a": "[N-Type calcium channel] [inhibited] [Peptide YY] release in neuronal cells.",
        "b": "[R-Type calcium channel] [inhibited] [Peptide YY] release in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9921052631578948,
        "token(a ~ b)": 0.914860681114551,
        "domain": "2.1"
    },
    {
        "a": "[Aquaporins] [served as] [Immunoglobulin M] transporters in the experimental system.",
        "b": "[Aquaglyceroporins] [served as] [Immunoglobulin M] transporters in the experimental system.",
        "a -> b": 1.0,
        "b -> a": 0.2857142857142857,
        "char(a ~ b)": 0.8989010989010989,
        "token(a ~ b)": 0.8766666666666667,
        "domain": "2.1"
    },
    {
        "a": "[Hematopoietic Stem Cells] [identified] [Follicular dendritic cell] markers in the bone marrow.",
        "b": "[Myeloid Progenitor Cells] [identified] [Follicular dendritic cell] markers in the bone marrow.",
        "a -> b": 1.0,
        "b -> a": 0.6153846153846154,
        "char(a ~ b)": 0.7991950464396285,
        "token(a ~ b)": 0.6606918238993711,
        "domain": "2.1"
    },
    {
        "a": "[CXC Chemokines] [joined] [follicular dendritic cell] populations in the spleen.",
        "b": "[Chemokine CXCL13] [joined] [follicular dendritic cell] populations in the spleen.",
        "a -> b": 1.0,
        "b -> a": 0.08333333333333333,
        "char(a ~ b)": 0.9666574045487291,
        "token(a ~ b)": 0.703525641025641,
        "domain": "2.1"
    },
    {
        "a": "[Endothelial Cells] [coupled] with [Bosutinib] in vitro.",
        "b": "[Endothelial Progenitor Cells] [coupled] with [Bosutinib] in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.8993070362473348,
        "token(a ~ b)": 0.8952380952380952,
        "domain": "2.1"
    },
    {
        "a": "[T-Lymphocytes] [detected] [Sulfiredoxin] in the cytoplasm.",
        "b": "[CD8-Positive T-Lymphocytes] [detected] [Sulfiredoxin] in the cytoplasm.",
        "a -> b": 1.0,
        "b -> a": 0.0625,
        "char(a ~ b)": 0.808545197740113,
        "token(a ~ b)": 0.7885714285714285,
        "domain": "2.1"
    },
    {
        "a": "[protoporphyrins] [was found] in [Nonadecane] samples collected from the experimental group.",
        "b": "[protoporphyrin monomethyl ester] [was found] in [Nonadecane] samples collected from the experimental group.",
        "a -> b": 1.0,
        "b -> a": 0.05,
        "char(a ~ b)": 0.8964573268921096,
        "token(a ~ b)": 0.8113636363636363,
        "domain": "2.1"
    },
    {
        "a": "All [auditory hair cells] [preceded] [hemoglobin] expression during embryonic development.",
        "b": "[Outer auditory hair cells] [preceded] [hemoglobin] expression during embryonic development.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8558304181242713,
        "token(a ~ b)": 0.7646341463414634,
        "domain": "2.1"
    },
    {
        "a": "[Vertebrate Photoreceptor Cells] [identified] [Eukaryotic elongation factor 1A] in the retina.",
        "b": "[Photoreceptor Connecting Cilium] [identified] [Eukaryotic elongation factor 1A] in the retina.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.7860350247574845,
        "token(a ~ b)": 0.7440476190476191,
        "domain": "2.1"
    },
    {
        "a": "[T-Lymphocytes] [induced] [Antibody-Secreting Cell] differentiation in vitro.",
        "b": "[Cytotoxic T-Lymphocytes] [induced] [Antibody-Secreting Cell] differentiation in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.8252575011195701,
        "token(a ~ b)": 0.844812925170068,
        "domain": "2.1"
    },
    {
        "a": "[Neuroepithelial Cells] [affected] [GAR1 Ribonucleoprotein] under hypoxic conditions.",
        "b": "[Vestibular Hair Cells] [affected] [GAR1 Ribonucleoprotein] under hypoxic conditions.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.8505882352941176,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "2.1"
    },
    {
        "a": "[Cysteine Loop Ligand-Gated Ion Channel Receptors] [regulated] [retinal pigment epithelium] function in the developing eye.",
        "b": "[Nicotinic Receptors] [regulated] [retinal pigment epithelium] function in the developing eye.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.7700795710084759,
        "token(a ~ b)": 0.6445639187574671,
        "domain": "2.1"
    },
    {
        "a": "[calcium carbonate] [was critical for] the uptake of [strontium ion] in the mineralization process.",
        "b": "[vaterite] [was critical for] the uptake of [strontium ion] in the mineralization process.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.822601880877743,
        "token(a ~ b)": 0.7981366459627328,
        "domain": "2.1"
    },
    {
        "a": "[Ionotropic Glutamate receptor] [was critical for] [Glycine transporter 1] function in the hippocampus.",
        "b": "[AMPA receptor] [was critical for] [Glycine transporter 1] function in the hippocampus.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.794219529608222,
        "token(a ~ b)": 0.7543800539083558,
        "domain": "2.1"
    },
    {
        "a": "[Acetates] [inhibited] [zinc] uptake in the experimental assay.",
        "b": "[Acetamides] [inhibited] [zinc] uptake in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 0.22727272727272727,
        "char(a ~ b)": 0.9585623695301114,
        "token(a ~ b)": 0.8782051282051282,
        "domain": "2.1"
    },
    {
        "a": "[Antitoxins] [were genetically associated with] [6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3].",
        "b": "[Botulinum Antitoxin] [were genetically associated with] [6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3].",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.8323655292076345,
        "token(a ~ b)": 0.8642289348171701,
        "domain": "2.1"
    },
    {
        "a": "[Macrophage Inflammatory Proteins] [was genetically associated with] [Heat shock factor 1].",
        "b": "[Chemokine CCL4] [was genetically associated with] [Heat shock factor 1].",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.7708484523041874,
        "token(a ~ b)": 0.5988372093023255,
        "domain": "2.1"
    },
    {
        "a": "[ketohexose] [broadened] the effects of [Hypochlorous acid] in solution.",
        "b": "[sorbose] [broadened] the effects of [Hypochlorous acid] in solution.",
        "a -> b": 1.0,
        "b -> a": 0.15714285714285714,
        "char(a ~ b)": 0.8619565217391304,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "2.1"
    },
    {
        "a": "[Chlamydia Infections] [improved] after treatment with [pravastatin sodium].",
        "b": "[Chlamydial Pneumonia] [improved] after treatment with [pravastatin sodium].",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9145292809488509,
        "token(a ~ b)": 0.6989966555183946,
        "domain": "2.1"
    },
    {
        "a": "[Systemic Vasculitis] [was sufficient for] the therapeutic effect of [Clopidogrel] in patients with vascular inflammation.",
        "b": "[Polyarteritis Nodosa] [was sufficient for] the therapeutic effect of [Clopidogrel] in patients with vascular inflammation.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.8478503335507902,
        "token(a ~ b)": 0.7440476190476191,
        "domain": "2.1"
    },
    {
        "a": "[B-Lymphocytes] [was critical for] the regulation of [Neuropeptide Y] signaling in the hypothalamus.",
        "b": "[B-Lymphoid Precursor Cells] [was critical for] the regulation of [Neuropeptide Y] signaling in the hypothalamus.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.8837370417193426,
        "token(a ~ b)": 0.8583916083916083,
        "domain": "2.1"
    },
    {
        "a": "[Vertebrate Photoreceptor Cells] [was found in] [Eukaryotic elongation factor 1A] distribution patterns in the retina.",
        "b": "[Retinal Cone Photoreceptor Cells] [was found in] [Eukaryotic elongation factor 1A] distribution patterns in the retina.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.836174334140436,
        "token(a ~ b)": 0.8563508064516129,
        "domain": "2.1"
    },
    {
        "a": "[Autoantibodies] [affected] [Superoxide dismutase] activity in vitro.",
        "b": "[Antinuclear Antibodies] [affected] [Superoxide dismutase] activity in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.09090909090909091,
        "char(a ~ b)": 0.8512409443355735,
        "token(a ~ b)": 0.7595137420718816,
        "domain": "2.1"
    },
    {
        "a": "[Gastrins] [was essential in] the activation of [Growth Hormone] signaling during digestion.",
        "b": "[Pentagastrin] [was essential in] the activation of [Growth Hormone] signaling during digestion.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8413949275362319,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "2.1"
    },
    {
        "a": "[Triterpenes] [was genetically associated with] [Tricosane] in the experimental samples.",
        "b": "[Dammaranes] [was genetically associated with] [Tricosane] in the experimental samples.",
        "a -> b": 1.0,
        "b -> a": 0.05555555555555555,
        "char(a ~ b)": 0.8258170788343202,
        "token(a ~ b)": 0.722943722943723,
        "domain": "2.1"
    },
    {
        "a": "[Cytokine-Induced Killer Cells] [included] [Cystic Fibrosis] as a target in the experimental protocol.",
        "b": "[Cytotoxic T-Lymphocytes] [included] [Cystic Fibrosis] as a target in the experimental protocol.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.8537340538625088,
        "token(a ~ b)": 0.6888888888888889,
        "domain": "2.1"
    },
    {
        "a": "[Nonheme Iron Proteins] [demonstrated] elevated levels of [X-box binding protein 1] in oxidative environments.",
        "b": "[Iron-Sulfur Proteins] [demonstrated] elevated levels of [X-box binding protein 1] in oxidative environments.",
        "a -> b": 1.0,
        "b -> a": 0.5925925925925926,
        "char(a ~ b)": 0.8206804690182996,
        "token(a ~ b)": 0.7525027808676307,
        "domain": "2.1"
    },
    {
        "a": "[Valproic acid] [was employed] to target the [Thalamus] in a rodent epilepsy model.",
        "b": "[Valproic acid] [was employed] to target the [Thalamic Nuclei] in a rodent epilepsy model.",
        "a -> b": 1.0,
        "b -> a": 0.9,
        "char(a ~ b)": 0.9456662422045907,
        "token(a ~ b)": 0.8043326345213138,
        "domain": "2.2"
    },
    {
        "a": "[Midostaurin] [broadened] the spectrum of [Yersinia Infections] in immunocompromised mice.",
        "b": "[Midostaurin] [broadened] the spectrum of [Yersinia pseudotuberculosis Infections] in immunocompromised mice.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9273598369011212,
        "token(a ~ b)": 0.8977011494252873,
        "domain": "2.2"
    },
    {
        "a": "[Polychlorinated biphenyls] [suppressed] [Vesiculobullous Skin Diseases] in the patient cohort.",
        "b": "[Polychlorinated biphenyls] [suppressed] [Blister] in the patient cohort.",
        "a -> b": 1.0,
        "b -> a": 0.05555555555555555,
        "char(a ~ b)": 0.9077206715418683,
        "token(a ~ b)": 0.7065712426805466,
        "domain": "2.2"
    },
    {
        "a": "[Interferon-beta] [affected] [Eosinophil Granule Proteins] in the peripheral blood of patients.",
        "b": "[Interferon-beta] [affected] [Eosinophil-Derived Neurotoxin] in the peripheral blood of patients.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9257973659547181,
        "token(a ~ b)": 0.734993614303959,
        "domain": "2.2"
    },
    {
        "a": "[Pemetrexed] [preceded] [Reperfusion Injury] in the clinical timeline of lung transplant patients.",
        "b": "[Pemetrexed] [preceded] [Primary Graft Dysfunction] in the clinical timeline of lung transplant patients.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.8953113553113553,
        "token(a ~ b)": 0.75,
        "domain": "2.2"
    },
    {
        "a": "[Interleukin-27] [induced] differentiation of [Helper-Inducer T-Lymphocytes] in vitro.",
        "b": "[Interleukin-27] [induced] differentiation of [Th1 Cells] in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9180069854217285,
        "token(a ~ b)": 0.695447409733124,
        "domain": "2.2"
    },
    {
        "a": "[Gastrin-releasing peptide] [was associated with] [Vertebrate Photoreceptor Cells] in the developing retina.",
        "b": "[Gastrin-releasing peptide] [was associated with] [Retinal Rod Photoreceptor Cells] in the developing retina.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.9307739795386266,
        "token(a ~ b)": 0.8269230769230769,
        "domain": "2.2"
    },
    {
        "a": "[Eukaryotic elongation factor 1A] [was critical for] [cytokine] signaling in activated T cells.",
        "b": "[Eukaryotic elongation factor 1A] [was critical for] [Chemokines] signaling in activated T cells.",
        "a -> b": 1.0,
        "b -> a": 0.30578512396694213,
        "char(a ~ b)": 0.9681575408714526,
        "token(a ~ b)": 0.8333333333333333,
        "domain": "2.2"
    },
    {
        "a": "[Gefitinib] [was genetically associated with] [Hypothalamus] abnormalities in patients with metabolic syndrome.",
        "b": "[Gefitinib] [was genetically associated with] [Anterior Hypothalamus] abnormalities in patients with metabolic syndrome.",
        "a -> b": 1.0,
        "b -> a": 0.2413793103448276,
        "char(a ~ b)": 0.9309459459459459,
        "token(a ~ b)": 0.8468137254901961,
        "domain": "2.2"
    },
    {
        "a": "[Sibutramine] [was critical for] the replication of [DNA Tumor Viruses] in cell culture.",
        "b": "[Sibutramine] [was critical for] the replication of [Polyomaviridae] in cell culture.",
        "a -> b": 1.0,
        "b -> a": 0.13513513513513514,
        "char(a ~ b)": 0.9278665916127217,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "2.2"
    },
    {
        "a": "[Cobimetinib] [broadened] the therapeutic spectrum of [Feeding and Eating Disorders] in clinical studies.",
        "b": "[Cobimetinib] [broadened] the therapeutic spectrum of [Rumination Syndrome] in clinical studies.",
        "a -> b": 1.0,
        "b -> a": 0.07692307692307693,
        "char(a ~ b)": 0.9234798020331728,
        "token(a ~ b)": 0.7450980392156863,
        "domain": "2.2"
    },
    {
        "a": "[Smooth muscle cell] [was found in] the [Antitoxins] of the rat brain during the experiment.",
        "b": "[Smooth muscle cell] [was found in] the [Botulinum Antitoxin] of the rat brain during the experiment.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9340680628024579,
        "token(a ~ b)": 0.7939622641509434,
        "domain": "2.2"
    },
    {
        "a": "[Selectin L] [coordinated] the activity of [catecholamine receptor] in neural tissues.",
        "b": "[Selectin L] [coordinated] the activity of [dopamine receptor] in neural tissues.",
        "a -> b": 1.0,
        "b -> a": 0.35714285714285715,
        "char(a ~ b)": 0.9382763295136959,
        "token(a ~ b)": 0.8308080808080808,
        "domain": "2.2"
    },
    {
        "a": "[Camphor] [induced] the biosynthesis of [C20 phytosphingosine] in cultured neurons.",
        "b": "[Camphor] [induced] the biosynthesis of [C20 phytoceramide] in cultured neurons.",
        "a -> b": 1.0,
        "b -> a": 0.8571428571428571,
        "char(a ~ b)": 0.9362862259850212,
        "token(a ~ b)": 0.8043326345213138,
        "domain": "2.2"
    },
    {
        "a": "[Ciprofloxacin] [attenuated] the cytotoxicity of [(R*,R*)-diepoxybutane] in the cell culture assay.",
        "b": "[Ciprofloxacin] [attenuated] the cytotoxicity of [(S,S)-diepoxybutane] in the cell culture assay.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9877954805789857,
        "token(a ~ b)": 0.8333333333333333,
        "domain": "2.2"
    },
    {
        "a": "[Alectinib] [served as] an inhibitor of [ketamine] in the clinical trial.",
        "b": "[Alectinib] [served as] an inhibitor of [(R)-ketamine] in the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9896103896103896,
        "token(a ~ b)": 0.8883399209486166,
        "domain": "2.2"
    },
    {
        "a": "[Tuberous sclerosis complex] [preceded] [Vertebrate Photoreceptor Cells] degeneration in the clinical records.",
        "b": "[Tuberous sclerosis complex] [preceded] [Retinal Rod Photoreceptor Cells] degeneration in the clinical records.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.9165476332466624,
        "token(a ~ b)": 0.8269230769230769,
        "domain": "2.2"
    },
    {
        "a": "[NADH] [was capable] of binding to [heme b] in the mitochondrial matrix.",
        "b": "[NADH] [was capable] of binding to [hematin] in the mitochondrial matrix.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.9430266031367878,
        "token(a ~ b)": 0.8140243902439024,
        "domain": "2.2"
    },
    {
        "a": "[Interleukin-22] [joined] [beta adrenergic receptor] complexes in the immune cells.",
        "b": "[Interleukin-22] [joined] [beta-3 adrenergic receptor] complexes in the immune cells.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9952941176470589,
        "token(a ~ b)": 0.9590301003344481,
        "domain": "2.2"
    },
    {
        "a": "[Formic acid] [affected] [Vitamin K] metabolism in rat hepatocytes.",
        "b": "[Formic acid] [affected] [Vitamin K 1] metabolism in rat hepatocytes.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9643521522820679,
        "token(a ~ b)": 0.9194444444444444,
        "domain": "2.2"
    },
    {
        "a": "[ATP synthase] [emerged] in [cytokine] populations during early development.",
        "b": "[ATP synthase] [emerged] in [Hematopoietic Cell Growth Factors] populations during early development.",
        "a -> b": 1.0,
        "b -> a": 0.09090909090909091,
        "char(a ~ b)": 0.8818651980554941,
        "token(a ~ b)": 0.6714402618657938,
        "domain": "2.2"
    },
    {
        "a": "[Serotonin] [emerged] in [Granulocyte-Macrophage Progenitor Cells] during stress response.",
        "b": "[Serotonin] [emerged] in [Monocyte-Macrophage Precursor Cells] during stress response.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.924455652065627,
        "token(a ~ b)": 0.7661538461538462,
        "domain": "2.2"
    },
    {
        "a": "The [hydroperoxyl radical] [was essential in] the function of the [Shaker Superfamily of potassium channel] during oxidative stress.",
        "b": "The [hydroperoxyl radical] [was essential in] the function of the [Kv1.3 potassium channel] during oxidative stress.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.9235250924906097,
        "token(a ~ b)": 0.7738095238095238,
        "domain": "2.2"
    },
    {
        "a": "[Ponatinib] [improved] [Parahippocampal Gyrus] function after ischemic injury.",
        "b": "[Ponatinib] [improved] [Periamygdaloid Cortex] function after ischemic injury.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9104826546003016,
        "token(a ~ b)": 0.6186206896551725,
        "domain": "2.2"
    },
    {
        "a": "[Lomitapide] [led to] the activation of [Varicellovirus] in cell culture.",
        "b": "[Lomitapide] [led to] the activation of [Suid Herpesvirus 1] in cell culture.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.9277368715929337,
        "token(a ~ b)": 0.7350863422291993,
        "domain": "2.2"
    },
    {
        "a": "[Ozone] [suppressed] [complement inactivator proteins] activity in vitro.",
        "b": "[Ozone] [suppressed] [complement C3b inactivator proteins] activity in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9430350471446362,
        "token(a ~ b)": 0.8861689106487147,
        "domain": "2.2"
    },
    {
        "a": "[Bicalutamide] [was critical for] the replication of [Human Papillomavirus Viruses] in epithelial cells.",
        "b": "[Bicalutamide] [was critical for] the replication of [Human papillomavirus 18] in epithelial cells.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.9452214452214452,
        "token(a ~ b)": 0.8333333333333333,
        "domain": "2.2"
    },
    {
        "a": "[Obsessive-Compulsive Disorder] [suppressed] [Clostridium Infections] in adolescent patients.",
        "b": "[Obsessive-Compulsive Disorder] [suppressed] [Enterotoxemia] in adolescent patients.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.9225192012288786,
        "token(a ~ b)": 0.703525641025641,
        "domain": "2.2"
    },
    {
        "a": "[Glucose-6-phosphate isomerase] [was genetically correlated with] [connective tissue cells] in the developing embryo.",
        "b": "[Glucose-6-phosphate isomerase] [was genetically correlated with] [Fibroblasts] in the developing embryo.",
        "a -> b": 1.0,
        "b -> a": 0.12121212121212122,
        "char(a ~ b)": 0.9354163614163614,
        "token(a ~ b)": 0.7710526315789473,
        "domain": "2.2"
    },
    {
        "a": "[L1 cell adhesion molecule] [bound] [iron-binding proteins] in neuronal tissue.",
        "b": "[L1 cell adhesion molecule] [bound] [transferrins] in neuronal tissue.",
        "a -> b": 1.0,
        "b -> a": 0.08823529411764706,
        "char(a ~ b)": 0.9253570058633349,
        "token(a ~ b)": 0.7352564102564103,
        "domain": "2.2"
    },
    {
        "a": "[Dostarlimab] [was found] in [leprostatic drug] formulations during the screening process.",
        "b": "[Dostarlimab] [was found] in [dapsone] formulations during the screening process.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.9253086419753086,
        "token(a ~ b)": 0.770048309178744,
        "domain": "2.2"
    },
    {
        "a": "[Nitric oxide] [produced] [2,5,7-trihydroxy-2-phenyl-2,3-dihydro-4H-chromen-4-one] under hypoxic conditions.",
        "b": "[Nitric oxide] [produced] [(2R)-2-hydroxypinocembrin] under hypoxic conditions.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8727623066104079,
        "token(a ~ b)": 0.41265655899802245,
        "domain": "2.2"
    },
    {
        "a": "[Midostaurin] [bound] to [cryolite] in the in vitro assay.",
        "b": "[Midostaurin] [bound] to [beta-cryolite] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9358511220580185,
        "token(a ~ b)": 0.8545454545454545,
        "domain": "2.2"
    },
    {
        "a": "[Eukaryotic elongation factor 2] [was found in] [Mitochondria] of the rat liver.",
        "b": "[Eukaryotic elongation factor 2] [was found in] [Liver Mitochondria] of the rat liver.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.9485465116279069,
        "token(a ~ b)": 0.9080882352941176,
        "domain": "2.2"
    },
    {
        "a": "[Malate] [broadened] the range of [heme a] in mitochondrial membranes.",
        "b": "[Malate] [broadened] the range of [ferriheme a3] in mitochondrial membranes.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9413533834586466,
        "token(a ~ b)": 0.8952380952380952,
        "domain": "2.2"
    },
    {
        "a": "The concentration of [hydrogen phosphate] [peaked] in [cytoplasmic granules] of endothelial cells.",
        "b": "The concentration of [hydrogen phosphate] [peaked] in [Weibel-Palade Bodies] of endothelial cells.",
        "a -> b": 1.0,
        "b -> a": 0.09090909090909091,
        "char(a ~ b)": 0.9252169833450622,
        "token(a ~ b)": 0.6623931623931625,
        "domain": "2.2"
    },
    {
        "a": "[Bexarotene] [regulated] the expression of [Selectins] in the developing mouse brain.",
        "b": "[Bexarotene] [regulated] the expression of [L-Selectin] in the developing mouse brain.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9644244674614032,
        "token(a ~ b)": 0.8612836438923395,
        "domain": "2.2"
    },
    {
        "a": "[Serine] [was associated with] [Immunoglobulin Heavy Chains] in the serum of patients.",
        "b": "[Serine] [was associated with] [Immunoglobulin mu-Chains] in the serum of patients.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.9438175959652563,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "2.2"
    },
    {
        "a": "[Goserelin] [was associated with] [Hypothalamus] function in the clinical study.",
        "b": "[Goserelin] [was associated with] [Middle Hypothalamus] function in the clinical study.",
        "a -> b": 1.0,
        "b -> a": 0.5862068965517241,
        "char(a ~ b)": 0.9339080459770115,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "2.2"
    },
    {
        "a": "[Sulfiredoxin] [was critical for] the function of [Immunoglobulin Heavy Chains] during immune response.",
        "b": "[Sulfiredoxin] [was critical for] the function of [Immunoglobulin mu-Chains] during immune response.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.965854669202282,
        "token(a ~ b)": 0.8566763425253991,
        "domain": "2.2"
    },
    {
        "a": "[Tetrahydrofuran] [suppressed] [reactive oxygen species] generation in vitro.",
        "b": "[Tetrahydrofuran] [suppressed] [hypochlorous acid] generation in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.1111111111111111,
        "char(a ~ b)": 0.9058904563746113,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "2.2"
    },
    {
        "a": "[Sonidegib] [affected] [T-Lymphocytes] proliferation in vitro.",
        "b": "[Sonidegib] [affected] [CD4-Positive T-Lymphocytes] proliferation in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.375,
        "char(a ~ b)": 0.9072688172043011,
        "token(a ~ b)": 0.7857142857142857,
        "domain": "2.2"
    },
    {
        "a": "[Interferon alfa-2b] [suppressed] [Podoviridae] replication in vitro.",
        "b": "[Interferon alfa-2b] [suppressed] [Bacteriophage T3] replication in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9147837278272061,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "2.2"
    },
    {
        "a": "[Norepinephrine] [produced] [Antiphospholipid Antibodies] in cell cultures.",
        "b": "[Norepinephrine] [produced] [Lupus Coagulation Inhibitor] in cell cultures.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.8975833333333334,
        "token(a ~ b)": 0.5431972789115647,
        "domain": "2.2"
    },
    {
        "a": "The [Phosphoenolpyruvate] level [was overexpressed] in [Erythrocytes] after treatment.",
        "b": "The [Phosphoenolpyruvate] level [was overexpressed] in [Abnormal Erythrocytes] after treatment.",
        "a -> b": 1.0,
        "b -> a": 0.625,
        "char(a ~ b)": 0.9531456548347613,
        "token(a ~ b)": 0.8952380952380952,
        "domain": "2.2"
    },
    {
        "a": "[Norepinephrine] [was found] in [Immunoglobulin Fab Fragments] during the experiment.",
        "b": "[Norepinephrine] [was found] in [Certolizumab Pegol] during the experiment.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.9085048329190831,
        "token(a ~ b)": 0.6134259259259259,
        "domain": "2.2"
    },
    {
        "a": "[Neural stem cell] [exhibited] [CC Chemokines] expression in the developing cortex.",
        "b": "[Neural stem cell] [exhibited] [Chemokine CCL4] expression in the developing cortex.",
        "a -> b": 1.0,
        "b -> a": 0.05555555555555555,
        "char(a ~ b)": 0.9708772371716832,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "2.2"
    },
    {
        "a": "[Fondaparinux] [improved] [Pontine Tegmentum] function in stroke patients.",
        "b": "[Fondaparinux] [improved] [Facial Nucleus] function in stroke patients.",
        "a -> b": 1.0,
        "b -> a": 0.1,
        "char(a ~ b)": 0.8842368343869152,
        "token(a ~ b)": 0.678030303030303,
        "domain": "2.2"
    },
    {
        "a": "[Simvastatin] [replaced] [myocardial infarction] as the primary concern in elderly patients.",
        "b": "[Simvastatin] [replaced] [anterior wall myocardial infarction] as the primary concern in elderly patients.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.9061936013125512,
        "token(a ~ b)": 0.8333333333333333,
        "domain": "2.2"
    },
    {
        "a": "The [Fast-twitch muscle fiber] [contained] [Classical Pathway Complement C3-C5 Convertases] in the experimental tissue sample.",
        "b": "The [Fast-twitch muscle fiber] [contained] [Classical Pathway Complement C5 Convertase] in the experimental tissue sample.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9674212854540724,
        "token(a ~ b)": 0.8952380952380952,
        "domain": "2.2"
    },
    {
        "a": "[Myeloid-derived suppressor cell] [was able] to recognize [Immunoglobulin Fab Fragments] in the tumor microenvironment.",
        "b": "[Myeloid-derived suppressor cell] [was able] to recognize [Immunoglobulin Variable Region] in the tumor microenvironment.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9484474433531569,
        "token(a ~ b)": 0.8714202220923437,
        "domain": "2.2"
    },
    {
        "a": "[Sodium-Monocarboxylate Transporter] [was found in] [Myeloid Progenitor Cells] during early hematopoiesis.",
        "b": "[Sodium-Monocarboxylate Transporter] [was found in] [Megakaryocyte-Erythroid Progenitor Cells] during early hematopoiesis.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9283395931833914,
        "token(a ~ b)": 0.7777983691623425,
        "domain": "2.2"
    },
    {
        "a": "[Interleukin-21] [was capable] of differentiating into [Embryonic Stem Cells] under hypoxic conditions.",
        "b": "[Interleukin-21] [was capable] of differentiating into [Human Embryonic Stem Cells] under hypoxic conditions.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.9482141266589472,
        "token(a ~ b)": 0.9181286549707601,
        "domain": "2.2"
    },
    {
        "a": "[E-cadherin] [broadened] the response of [neurotransmitter receptor] in hippocampal neurons.",
        "b": "[E-cadherin] [broadened] the response of [purinergic receptor] in hippocampal neurons.",
        "a -> b": 1.0,
        "b -> a": 0.16101694915254236,
        "char(a ~ b)": 0.9250561049594317,
        "token(a ~ b)": 0.8185776487663281,
        "domain": "2.2"
    },
    {
        "a": "The effect of [Mecamylamine] [suppressed] [dihydrocarveol] metabolism in neuronal cells.",
        "b": "The effect of [Mecamylamine] [suppressed] [(-)-neodihydrocarveol] metabolism in neuronal cells.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.9398086124401914,
        "token(a ~ b)": 0.8635477582846003,
        "domain": "2.2"
    },
    {
        "a": "[Zinc finger protein 143] [bound] to [CXC Chemokines] in the nuclear extract.",
        "b": "[Zinc finger protein 143] [bound] to [Chemokine CXCL2] in the nuclear extract.",
        "a -> b": 1.0,
        "b -> a": 0.08333333333333333,
        "char(a ~ b)": 0.9764849185901817,
        "token(a ~ b)": 0.7242553191489361,
        "domain": "2.2"
    },
    {
        "a": "[White adipocyte] [coordinated] the response of [Immunoglobulin Heavy Chains] during the experiment.",
        "b": "[White adipocyte] [coordinated] the response of [Immunoglobulin delta-Chains] during the experiment.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.9610833333333333,
        "token(a ~ b)": 0.8402839396628217,
        "domain": "2.2"
    },
    {
        "a": "[Parathyroid Hormone] [induced] [Antitoxins] production in the experimental model.",
        "b": "[Parathyroid Hormone] [induced] [Diphtheria Antitoxin] production in the experimental model.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9193269444771742,
        "token(a ~ b)": 0.7661538461538462,
        "domain": "2.2"
    },
    {
        "a": "[Aldesleukin] [improved] the symptoms of [organochlorine acaricide] exposure in animal studies.",
        "b": "[Aldesleukin] [improved] the symptoms of [hexythiazox] exposure in animal studies.",
        "a -> b": 1.0,
        "b -> a": 0.05263157894736842,
        "char(a ~ b)": 0.9058921694480103,
        "token(a ~ b)": 0.7065712426805466,
        "domain": "2.2"
    },
    {
        "a": "[Talimogene laherparepvec] [identified] [Cutaneous Tuberculosis] lesions in the biopsy samples.",
        "b": "[Talimogene laherparepvec] [identified] [Lupus Vulgaris] lesions in the biopsy samples.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.922167945830509,
        "token(a ~ b)": 0.7252747252747254,
        "domain": "2.2"
    },
    {
        "a": "[Venlafaxine] [was critical for] the treatment of [Enterobacteriaceae Infections] in hospitalized patients.",
        "b": "[Venlafaxine] [was critical for] the treatment of [Yersinia Infections] in hospitalized patients.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.9312174952287045,
        "token(a ~ b)": 0.7630094043887148,
        "domain": "2.2"
    },
    {
        "a": "[Gefitinib] [was sufficient for] the activation of [Olfactory Cortex] in the experimental setup.",
        "b": "[Gefitinib] [was sufficient for] the activation of [Olfactory Tubercle] in the experimental setup.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.9489869860987874,
        "token(a ~ b)": 0.8730434782608696,
        "domain": "2.2"
    },
    {
        "a": "[Immunoglobulin E] [was negatively associated with] [CCR Receptors] expression in human tissue.",
        "b": "[Immunoglobulin E] [was negatively associated with] [Chemokine Receptor D6] expression in human tissue.",
        "a -> b": 1.0,
        "b -> a": 0.1,
        "char(a ~ b)": 0.9353684654862144,
        "token(a ~ b)": 0.7661538461538462,
        "domain": "2.2"
    },
    {
        "a": "[Estradiol] [replaced] [anandamide] in the experimental assay.",
        "b": "[Estradiol] [replaced] [N-((5Z,8Z,11Z)-14,15-epoxyicosatrienoyl)ethanolamine] in the experimental assay.",
        "a -> b": 1.0,
        "b -> a": 0.14285714285714285,
        "char(a ~ b)": 0.8555996691480562,
        "token(a ~ b)": 0.4291171477079796,
        "domain": "2.2"
    },
    {
        "a": "[Methyllycaconitine] [was employed] against [Encephalitis Viruses] in a murine model.",
        "b": "[Methyllycaconitine] [was employed] against [California Encephalitis Virus] in a murine model.",
        "a -> b": 1.0,
        "b -> a": 0.09090909090909091,
        "char(a ~ b)": 0.9309260069062232,
        "token(a ~ b)": 0.829059829059829,
        "domain": "2.2"
    },
    {
        "a": "[Nonsteroidal anti-inflammatory drugs] [bound] to [mitomycin] in the in vitro assay.",
        "b": "[Nonsteroidal anti-inflammatory drugs] [bound] to [7-N-(2-((2-(gamma-L-Glutamylamino)ethyl)dithio)ethyl)mitomycin C] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 0.09090909090909091,
        "char(a ~ b)": 0.8875299760191847,
        "token(a ~ b)": 0.573943661971831,
        "domain": "2.2"
    },
    {
        "a": "[Protein disulfide isomerase] [contained] [Proinsulin] in the cytosol of the cell.",
        "b": "[Protein disulfide isomerase] [contained] [C-Peptide] in the cytosol of the cell.",
        "a -> b": 1.0,
        "b -> a": 0.2,
        "char(a ~ b)": 0.9415822326391431,
        "token(a ~ b)": 0.820979020979021,
        "domain": "2.2"
    },
    {
        "a": "[Valine] [contained] [S-organyl-L-cysteine] residues in the experimental peptide.",
        "b": "[Valine] [contained] [2-S-cysteinyl-DOPA] residues in the experimental peptide.",
        "a -> b": 1.0,
        "b -> a": 0.058823529411764705,
        "char(a ~ b)": 0.9051929566697499,
        "token(a ~ b)": 0.6309328968903437,
        "domain": "2.2"
    },
    {
        "a": "[Brigatinib] [suppressed] [Opioid-Related Disorders] in the clinical trial.",
        "b": "[Brigatinib] [suppressed] [Opiate Overdose] in the clinical trial.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9146060606060606,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "2.2"
    },
    {
        "a": "[Cytomegalovirus] infection [suppressed] [macrophages] in the spleen.",
        "b": "[Cytomegalovirus] infection [suppressed] [peritoneal macrophages] in the spleen.",
        "a -> b": 1.0,
        "b -> a": 0.1,
        "char(a ~ b)": 0.9377173913043478,
        "token(a ~ b)": 0.7796985815602837,
        "domain": "2.2"
    },
    {
        "a": "[Lovastatin] [was critical for] the treatment of [Infectious Skin Diseases] in immunocompromised patients.",
        "b": "[Lovastatin] [was critical for] the treatment of [Dermatomycoses] in immunocompromised patients.",
        "a -> b": 1.0,
        "b -> a": 0.2903225806451613,
        "char(a ~ b)": 0.9195232047826387,
        "token(a ~ b)": 0.734993614303959,
        "domain": "2.2"
    },
    {
        "a": "[Imatinib] [was required for] the replication of [Picornaviridae] in human cell culture.",
        "b": "[Imatinib] [was required for] the replication of [Cardiovirus] in human cell culture.",
        "a -> b": 1.0,
        "b -> a": 0.17857142857142858,
        "char(a ~ b)": 0.9475974957610538,
        "token(a ~ b)": 0.7350863422291993,
        "domain": "2.2"
    },
    {
        "a": "[Dasatinib] [produced] [Immunoglobulin Subunits] in the in vitro assay.",
        "b": "[Dasatinib] [produced] [Immunoglobulin J-Chains] in the in vitro assay.",
        "a -> b": 1.0,
        "b -> a": 0.07142857142857142,
        "char(a ~ b)": 0.9475885616730687,
        "token(a ~ b)": 0.8331721470019342,
        "domain": "2.2"
    },
    {
        "a": "The activity of [Mesenchymal Stem Cell] [was associated with] [D2 dopamine receptor] expression in the developing brain.",
        "b": "The activity of [Mesenchymal Stem Cell] [was associated with] [D4 dopamine receptor] expression in the developing brain.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9966666666666667,
        "token(a ~ b)": 0.9421428571428572,
        "domain": "2.2"
    },
    {
        "a": "[Pembrolizumab] [was critical for] the development of [Congenital Ichthyosiform Erythroderma] in infants.",
        "b": "[Pembrolizumab] [was critical for] the development of [Netherton Syndrome] in infants.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9222028312585892,
        "token(a ~ b)": 0.6147186147186148,
        "domain": "2.2"
    },
    {
        "a": "[Glucagon-like peptide-1] [was critical for] the function of [neuronal cell adhesion molecules] in the developing mouse brain.",
        "b": "[Glucagon-like peptide-1] [was critical for] the function of [Reelin Protein] in the developing mouse brain.",
        "a -> b": 1.0,
        "b -> a": 0.07692307692307693,
        "char(a ~ b)": 0.9230565730565731,
        "token(a ~ b)": 0.7553763440860215,
        "domain": "2.2"
    },
    {
        "a": "[Dapoxetine] [resulted in] infection with [Phlebovirus] in cell culture.",
        "b": "[Dapoxetine] [resulted in] infection with [Uukuniemi virus] in cell culture.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9325761543161386,
        "token(a ~ b)": 0.6689723320158103,
        "domain": "2.2"
    },
    {
        "a": "[Endoplasmic reticulum resident protein 44] [was critical for] the function of [KCNQ potassium channel] in cardiac tissue.",
        "b": "[Endoplasmic reticulum resident protein 44] [was critical for] the function of [KCNQ1 potassium channel] in cardiac tissue.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9983739837398374,
        "token(a ~ b)": 0.9750663129973476,
        "domain": "2.2"
    },
    {
        "a": "[Eukaryotic Initiation Factor 2] [replaced] [Immunological Memory Cells] in the spleen of mice.",
        "b": "[Eukaryotic Initiation Factor 2] [replaced] [Memory B Cells] in the spleen of mice.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9311975501492491,
        "token(a ~ b)": 0.8333333333333333,
        "domain": "2.2"
    },
    {
        "a": "[Succinic acid] [suppressed] [Vertebrate Photoreceptor Cells] function in vitro.",
        "b": "[Succinic acid] [suppressed] [Retinal Rod Photoreceptor Cells] function in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.921651023169288,
        "token(a ~ b)": 0.7954545454545454,
        "domain": "2.2"
    },
    {
        "a": "[Epinephrine] [induced] the production of [Paraproteins] in the experimental rat model.",
        "b": "[Epinephrine] [induced] the production of [Bence Jones Protein] in the experimental rat model.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9240268484060968,
        "token(a ~ b)": 0.76,
        "domain": "2.2"
    },
    {
        "a": "[Duloxetine] [bound] to [Caulimoviridae] in clinical samples.",
        "b": "[Duloxetine] [bound] to [Caulimovirus] in clinical samples.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9520354094460937,
        "token(a ~ b)": 0.8447368421052632,
        "domain": "2.2"
    },
    {
        "a": "[Acyclovir] [was employed] to reprogram [Adult Stem Cells] in the experimental protocol.",
        "b": "[Acyclovir] [was employed] to reprogram [Induced Pluripotent Stem Cells] in the experimental protocol.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9200396459524248,
        "token(a ~ b)": 0.7967571644042233,
        "domain": "2.2"
    },
    {
        "a": "[Rivaroxaban] [was employed] to treat [Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis] in elderly patients.",
        "b": "[Rivaroxaban] [was employed] to treat [Granulomatosis with Polyangiitis] in elderly patients.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.8915394791479476,
        "token(a ~ b)": 0.5077874484654146,
        "domain": "2.2"
    },
    {
        "a": "[Glucose-regulated protein 78] [was critical for] [beta adrenergic receptor] signaling in cardiac tissue.",
        "b": "[Glucose-regulated protein 78] [was critical for] [beta-1 adrenergic receptor] signaling in cardiac tissue.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9962616822429906,
        "token(a ~ b)": 0.9436813186813187,
        "domain": "2.2"
    },
    {
        "a": "[Tumor Protein p53] [coordinated] the expression of [Immunoglobulin Light Chains] in B cells.",
        "b": "[Tumor Protein p53] [coordinated] the expression of [Immunoglobulin kappa-Chains] in B cells.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.9604004449388209,
        "token(a ~ b)": 0.8509803921568628,
        "domain": "2.2"
    },
    {
        "a": "The activity of [Alveolar macrophage] [was critical for] the regulation of [Insulins] during inflammation.",
        "b": "The activity of [Alveolar macrophage] [was critical for] the regulation of [Long-Acting Insulin] during inflammation.",
        "a -> b": 1.0,
        "b -> a": 0.375,
        "char(a ~ b)": 0.9566480060819683,
        "token(a ~ b)": 0.7603383458646616,
        "domain": "2.2"
    },
    {
        "a": "[Chloride-Bicarbonate Exchanger] [was found in] [Nonheme Iron Proteins] during the experiment.",
        "b": "[Chloride-Bicarbonate Exchanger] [was found in] [Lipoxygenases] during the experiment.",
        "a -> b": 1.0,
        "b -> a": 0.18518518518518517,
        "char(a ~ b)": 0.9163629986408534,
        "token(a ~ b)": 0.7252747252747254,
        "domain": "2.2"
    },
    {
        "a": "[Bivalirudin] [served as] a treatment for [Cerebral Hemorrhage] in clinical studies.",
        "b": "[Bivalirudin] [served as] a treatment for [Cerebral Intraventricular Hemorrhage] in clinical studies.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.933003300330033,
        "token(a ~ b)": 0.8902116402116402,
        "domain": "2.2"
    },
    {
        "a": "[Interleukin-21] [coordinated] the production of [Murine-Derived Monoclonal Antibodies] during the immune response.",
        "b": "[Interleukin-21] [coordinated] the production of [Rituximab] during the immune response.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9080667286677517,
        "token(a ~ b)": 0.6313725490196078,
        "domain": "2.2"
    },
    {
        "a": "[Pravastatin] [detected] [Peripheral Vascular Diseases] in elderly patients.",
        "b": "[Pravastatin] [detected] [Livedo Reticularis] in elderly patients.",
        "a -> b": 1.0,
        "b -> a": 0.07692307692307693,
        "char(a ~ b)": 0.8865934095639716,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "2.2"
    },
    {
        "a": "[Retinal pigment epithelium] [was linked to] [bone marrow cell] proliferation in vitro.",
        "b": "[Retinal pigment epithelium] [was linked to] [Hematopoietic Stem Cells] proliferation in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.6842105263157895,
        "char(a ~ b)": 0.9196739114396589,
        "token(a ~ b)": 0.703525641025641,
        "domain": "2.2"
    },
    {
        "a": "[Vortioxetine] [was associated with] abnormalities in the [septum of brain] in adult patients.",
        "b": "[Vortioxetine] [was associated with] abnormalities in the [septum pellucidum] in adult patients.",
        "a -> b": 1.0,
        "b -> a": 0.5,
        "char(a ~ b)": 0.9479655783810222,
        "token(a ~ b)": 0.831304347826087,
        "domain": "2.2"
    },
    {
        "a": "[Polyethylene glycol] [was selected] for the treatment of [Autoimmune Diseases of the Nervous System] in clinical trials.",
        "b": "[Polyethylene glycol] [was selected] for the treatment of [Polyradiculoneuropathy] in clinical trials.",
        "a -> b": 1.0,
        "b -> a": 0.11538461538461539,
        "char(a ~ b)": 0.9038138849248043,
        "token(a ~ b)": 0.6250707413695529,
        "domain": "2.2"
    },
    {
        "a": "[transketolase] [exhibited] properties of [neuroglia] during early development.",
        "b": "[transketolase] [exhibited] properties of [Oligodendroglia] during early development.",
        "a -> b": 1.0,
        "b -> a": 0.125,
        "char(a ~ b)": 0.9451003302976497,
        "token(a ~ b)": 0.7796985815602837,
        "domain": "2.2"
    },
    {
        "a": "[Ammonia] [produced] [Granulocytes] in vitro.",
        "b": "[Ammonia] [produced] [Neutrophils] in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9395959595959595,
        "token(a ~ b)": 0.7055555555555556,
        "domain": "2.2"
    },
    {
        "a": "[Pembrolizumab] [improved] [Carotid Artery Diseases] outcomes in elderly patients.",
        "b": "[Pembrolizumab] [improved] [Carotid-Cavernous Sinus Fistula] outcomes in elderly patients.",
        "a -> b": 1.0,
        "b -> a": 0.16666666666666666,
        "char(a ~ b)": 0.9121494793895307,
        "token(a ~ b)": 0.7252747252747254,
        "domain": "2.2"
    },
    {
        "a": "[Fondaparinux] [suppressed] [Specific Learning Disorder] symptoms in the pediatric study.",
        "b": "[Fondaparinux] [suppressed] [Dyslexia] symptoms in the pediatric study.",
        "a -> b": 1.0,
        "b -> a": 0.25,
        "char(a ~ b)": 0.8943582845386928,
        "token(a ~ b)": 0.7595137420718816,
        "domain": "2.2"
    },
    {
        "a": "[Venlafaxine] [was sufficient for] the treatment of [Sleep Wake Disorders] in elderly patients.",
        "b": "[Venlafaxine] [was sufficient for] the treatment of [Parasomnias] in elderly patients.",
        "a -> b": 1.0,
        "b -> a": 0.45454545454545453,
        "char(a ~ b)": 0.9317379149855689,
        "token(a ~ b)": 0.7661538461538462,
        "domain": "2.2"
    },
    {
        "a": "[NHP2 ribonucleoprotein] [led to] [P2Y purinergic receptor] activation in vitro.",
        "b": "[NHP2 ribonucleoprotein] [led to] [P2Y12 purinergic receptor] activation in vitro.",
        "a -> b": 1.0,
        "b -> a": 0.3333333333333333,
        "char(a ~ b)": 0.9951219512195122,
        "token(a ~ b)": 0.9688269073010665,
        "domain": "2.2"
    },
    {
        "a": "[Phosphoribosyl pyrophosphate synthetase 2] [was overexpressed] in response to [phosphoenolpyruvate] treatment.",
        "b": "[PRPS2] [was underexpressed] in response to [phosphoenolpyruvate] treatment.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.766172250827551,
        "token(a ~ b)": 0.6428571428571428,
        "domain": "3.1"
    },
    {
        "a": "[N,N-Dimethylformamide] [combined with] [propyne] under standard laboratory conditions.",
        "b": "[DMF] [did not combine with] [propyne] under standard laboratory conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7983301807213518,
        "token(a ~ b)": 0.5333333333333333,
        "domain": "3.1"
    },
    {
        "a": "[Nitrosyl sulfate] [affected] [1-Pentyne] conversion in the reaction mixture.",
        "b": "[NOHSO4] [did not affect] [1-Pentyne] conversion in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8184485833800903,
        "token(a ~ b)": 0.5716783216783217,
        "domain": "3.1"
    },
    {
        "a": "[Oxymorphone] [ameliorated] symptoms of [Multiple Sclerosis] in animal models.",
        "b": "[Opana] [exacerbated] symptoms of [Multiple Sclerosis] in animal models.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8333500921736217,
        "token(a ~ b)": 0.678030303030303,
        "domain": "3.1"
    },
    {
        "a": "[Valproic acid] [bound] to [Tetrodotoxin] in the in vitro assay.",
        "b": "[2-propylpentanoic acid] [did not bind] to [Tetrodotoxin] in the in vitro assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8021572580645161,
        "token(a ~ b)": 0.6884531590413943,
        "domain": "3.1"
    },
    {
        "a": "[Ammonia] [accelerated] the conversion of [carbon dioxide] in the test system.",
        "b": "[NH3] [slowed down] the conversion of [carbon dioxide] in the test system.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7981288981288981,
        "token(a ~ b)": 0.5780038759689923,
        "domain": "3.1"
    },
    {
        "a": "[Magnesium] [affected] [Palmitoleic acid] concentration in the test sample.",
        "b": "[Mg] [did not affect] [Palmitoleic acid] concentration in the test sample.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8563008225616922,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "3.1"
    },
    {
        "a": "[Hydrogen bromide] [improved] the efficacy of [Relugolix] in clinical trials.",
        "b": "[HBr] [worsened] the efficacy of [Relugolix] in clinical trials.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8184275424029522,
        "token(a ~ b)": 0.6055555555555556,
        "domain": "3.1"
    },
    {
        "a": "[Methyllycaconitine] [relieved] the symptoms of [Polycystic Kidney Disease] in the mouse model.",
        "b": "[Methyllycaconitine citrate] [exacerbated] the symptoms of [Polycystic Kidney Disease] in the mouse model.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8981428922275256,
        "token(a ~ b)": 0.8259562841530055,
        "domain": "3.1"
    },
    {
        "a": "[Tetrahydrofuran] [produced] [dihydrogen phosphate] in the reaction mixture.",
        "b": "[THF] [degraded] [dihydrogen phosphate] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8212072188668393,
        "token(a ~ b)": 0.5888372093023255,
        "domain": "3.1"
    },
    {
        "a": "[Potassium nitrate] [joined] [hydrogen sulfide] in the reaction mixture.",
        "b": "[KNO3] [broke apart] [hydrogen sulfide] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.756547619047619,
        "token(a ~ b)": 0.5891304347826087,
        "domain": "3.1"
    },
    {
        "a": "[Glutathione] [bound] to [Glyceraldehyde-3-phosphate] in the cytosolic fraction.",
        "b": "[GSH] [did not bind] to [Glyceraldehyde-3-phosphate] in the cytosolic fraction.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8311861228316924,
        "token(a ~ b)": 0.7166666666666667,
        "domain": "3.1"
    },
    {
        "a": "[tert-Butylamine] [replaced] [Lithium aluminum hydride] in the reduction reaction.",
        "b": "[2-methyl-2-propanamine] [did not replace] [Lithium aluminum hydride] in the reduction reaction.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7991905294844088,
        "token(a ~ b)": 0.6378299120234604,
        "domain": "3.1"
    },
    {
        "a": "[2-Butyne] [was overexpressed] in [benzamide]-treated cells.",
        "b": "[dimethylacetylene] [was underexpressed] in [benzamide]-treated cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7798051948051948,
        "token(a ~ b)": 0.6328671328671329,
        "domain": "3.1"
    },
    {
        "a": "[E2F transcription factor 1] [was sufficient for] the activation of [nicotinic acetylcholine receptor] in neuronal cells.",
        "b": "[E2F1] [was not sufficient for] the activation of [nicotinic acetylcholine receptor] in neuronal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8886945358260452,
        "token(a ~ b)": 0.8940886699507389,
        "domain": "3.1"
    },
    {
        "a": "[Crotonaldehyde] [was employed] to modify [Perchlorate] in the reaction mixture.",
        "b": "[2-butenal] [was not employed] to modify [Perchlorate] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8267510548523207,
        "token(a ~ b)": 0.7125,
        "domain": "3.1"
    },
    {
        "a": "[Glutamate] [induced] the expression of [C/EBP homologous protein] under hypoxic conditions.",
        "b": "[Glutamic acid] [prevented] the expression of [C/EBP homologous protein] under hypoxic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9022216913521262,
        "token(a ~ b)": 0.8113636363636363,
        "domain": "3.1"
    },
    {
        "a": "[Apolipoprotein E] [coordinated] the response to [Interleukin-15] in macrophages.",
        "b": "[APOE] [disorganized] the response to [Interleukin-15] in macrophages.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8093031248586804,
        "token(a ~ b)": 0.7148148148148148,
        "domain": "3.1"
    },
    {
        "a": "[1-Heptyne] [preceded] [Galactose] in the reaction sequence under identical conditions.",
        "b": "[C7H12] [followed] [Galactose] in the reaction sequence under identical conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7888585095273919,
        "token(a ~ b)": 0.6387959866220736,
        "domain": "3.1"
    },
    {
        "a": "[Peracetic acid] [accelerated] the reaction rate of [Galactose] under acidic conditions.",
        "b": "[peroxyacetic acid] [slowed down] the reaction rate of [Galactose] under acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8006438182071094,
        "token(a ~ b)": 0.7350863422291993,
        "domain": "3.1"
    },
    {
        "a": "[Copper] [was critical for] the catalytic activity of [Gadoleic acid] in the reaction mixture.",
        "b": "[Cu] [was not required for] the catalytic activity of [Gadoleic acid] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8407434580582048,
        "token(a ~ b)": 0.8468137254901961,
        "domain": "3.1"
    },
    {
        "a": "[Lithium] [increased] the contractility of [smooth muscle cell] in vitro.",
        "b": "[Li] [decreased] the contractility of [smooth muscle cell] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8717729266883175,
        "token(a ~ b)": 0.7095238095238096,
        "domain": "3.1"
    },
    {
        "a": "[Phosphine] [broadened] the metabolic range of [1,1-Dimethylhydrazine] in the experimental setup.",
        "b": "[phosphorus trihydride] [narrowed] the metabolic range of [1,1-Dimethylhydrazine] in the experimental setup.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8169299412481987,
        "token(a ~ b)": 0.7220643939393939,
        "domain": "3.1"
    },
    {
        "a": "[Dichloromethane] [broadened] the signaling range of [Androgen Receptor] in prostate cells.",
        "b": "[DCM] [narrowed] the signaling range of [Androgen Receptor] in prostate cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8255238095238095,
        "token(a ~ b)": 0.5883180858550316,
        "domain": "3.1"
    },
    {
        "a": "[Dimethyl sulfoxide] [produced] [Hydroxide] in vitro.",
        "b": "[DMSO] [degraded] [Hydroxide] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7682536972215107,
        "token(a ~ b)": 0.5386100386100386,
        "domain": "3.1"
    },
    {
        "a": "[Tetrachloroethylene] [accelerated] the degradation of [cyanide ion] in aqueous solution.",
        "b": "[perchloroethylene] [slowed down] the degradation of [cyanide ion] in aqueous solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8011176347867554,
        "token(a ~ b)": 0.6352040816326531,
        "domain": "3.1"
    },
    {
        "a": "[Vitamin B12] [contained] [Iodobenzene] in the reaction mixture.",
        "b": "[Cobalamin] [excluded] [Iodobenzene] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7789045584596349,
        "token(a ~ b)": 0.6385809312638581,
        "domain": "3.1"
    },
    {
        "a": "The exposure to [Nitrosyl chloride] [produced] the [Nitroxyl anion] in the reaction vessel.",
        "b": "The exposure to [NOCl] [degraded] the [Nitroxyl anion] in the reaction vessel.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8848133848133848,
        "token(a ~ b)": 0.7260869565217392,
        "domain": "3.1"
    },
    {
        "a": "[Cemiplimab] [affected] the response of [Aspirin] in clinical trials.",
        "b": "[Libtayo] [did not affect] the response of [Aspirin] in clinical trials.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8020920991117344,
        "token(a ~ b)": 0.5888372093023255,
        "domain": "3.1"
    },
    {
        "a": "[Hydrogen bromide] [was employed] in the synthesis of [1,4-Benzoquinone].",
        "b": "[HBr] [was not employed] in the synthesis of [1,4-Benzoquinone].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8353549860067756,
        "token(a ~ b)": 0.7311783960720131,
        "domain": "3.1"
    },
    {
        "a": "[Bromate] [accelerated] the degradation of [perchlorate] under acidic conditions.",
        "b": "[BrO3-] [slowed down] the degradation of [perchlorate] under acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8344469584242103,
        "token(a ~ b)": 0.5809090909090908,
        "domain": "3.1"
    },
    {
        "a": "[Singlet oxygen] [bound] to [SO3^2-] under acidic conditions.",
        "b": "[dioxygen (1\u0394g)] [did not bind] to [SO3^2-] under acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.805482667614069,
        "token(a ~ b)": 0.5112443778110944,
        "domain": "3.1"
    },
    {
        "a": "[Ammonium nitrate] [broadened] the reactivity of [copper] under acidic conditions.",
        "b": "[NH4NO3] [narrowed] the reactivity of [copper] under acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7639438766746822,
        "token(a ~ b)": 0.5260454878943507,
        "domain": "3.1"
    },
    {
        "a": "[Dimethylamine] [identified] [Acetamide] in the reaction mixture.",
        "b": "[N-methylmethanamine] [obscured] [Acetamide] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7853834621150962,
        "token(a ~ b)": 0.6477272727272727,
        "domain": "3.1"
    },
    {
        "a": "[Nitrate] [was genetically correlated with] [1,4-Benzoquinone] metabolism in the experimental assay.",
        "b": "[NO3-] [was not genetically correlated with] [1,4-Benzoquinone] metabolism in the experimental assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8781935035608824,
        "token(a ~ b)": 0.783068783068783,
        "domain": "3.1"
    },
    {
        "a": "[Acetophenone] [orchestrated] the activation of [benzoyl chloride] in the reaction mixture.",
        "b": "[1-phenylethanone] [disorganized] the activation of [benzoyl chloride] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8453701910011358,
        "token(a ~ b)": 0.6370370370370371,
        "domain": "3.1"
    },
    {
        "a": "[Calcium phosphate] [was sufficient for] the crystallization of [Titanium(II) ion] in the reaction vessel.",
        "b": "[Ca3(PO4)2] [was not sufficient for] the crystallization of [Titanium(II) ion] in the reaction vessel.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8485466634131238,
        "token(a ~ b)": 0.7639225181598064,
        "domain": "3.1"
    },
    {
        "a": "[Arabinose] [broadened] the effect of [Hydrogen chloride] in the solution.",
        "b": "[Arabinofuranose] [narrowed] the effect of [Hydrogen chloride] in the solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8899485864898594,
        "token(a ~ b)": 0.75,
        "domain": "3.1"
    },
    {
        "a": "[Isopropylamine] [produced] [Tyrosine] under acidic conditions.",
        "b": "[2-aminopropane] [degraded] [Tyrosine] under acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8365367965367965,
        "token(a ~ b)": 0.5333333333333333,
        "domain": "3.1"
    },
    {
        "a": "[Dostarlimab] [was linked to] [Regorafenib] in clinical trials.",
        "b": "[Jemperli] [was not linked] to [Regorafenib] in clinical trials.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8239275451559934,
        "token(a ~ b)": 0.639751552795031,
        "domain": "3.1"
    },
    {
        "a": "[Benzaldehyde] [contained] [Nitrite ion] in the reaction mixture.",
        "b": "[benzenecarbaldehyde] [did not contain] [Nitrite ion] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8056009615384615,
        "token(a ~ b)": 0.570630081300813,
        "domain": "3.1"
    },
    {
        "a": "[Coenzyme A] [broadened] the metabolic range of [heptadecanoic acid] in hepatocytes.",
        "b": "[CoA] [narrowed] the metabolic range of [heptadecanoic acid] in hepatocytes.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8620278172909752,
        "token(a ~ b)": 0.7543800539083558,
        "domain": "3.1"
    },
    {
        "a": "[Goserelin] [bound] to [Entrectinib] in the cellular assay.",
        "b": "[Zoladex] [did not bind] to [Entrectinib] in the cellular assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8277012711864408,
        "token(a ~ b)": 0.6267232237539766,
        "domain": "3.1"
    },
    {
        "a": "[Tetrachloroethylene] [was genetically correlated with] [Dimethylformamide] metabolism in liver cells.",
        "b": "[perchloroethylene] [was not genetically correlated with] [Dimethylformamide] metabolism in liver cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8535791855203619,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "3.1"
    },
    {
        "a": "[Chlorophyll a] [was critical for] the generation of [singlet oxygen] in the photoreaction.",
        "b": "[Chl a] [was not required for] the generation of [singlet oxygen] in the photoreaction.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8897322218011873,
        "token(a ~ b)": 0.7913725490196079,
        "domain": "3.1"
    },
    {
        "a": "[Serotonin] [bound] to [Telomeric Repeat Binding Factor 1] in neuronal cells.",
        "b": "[5-HT] [did not bind] to [Telomeric Repeat Binding Factor 1] in neuronal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8528357718231137,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "3.1"
    },
    {
        "a": "[Chloroform] [accelerated] the conversion of [Lysine] in vitro.",
        "b": "[trichloromethane] [slowed down] the conversion of [Lysine] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7938816306132647,
        "token(a ~ b)": 0.5885668276972624,
        "domain": "3.1"
    },
    {
        "a": "[Nitryl bromide] [replaced] [magnesium sulfate] in the reaction mixture.",
        "b": "[Nitrogen dioxide bromide] [did not replace] [magnesium sulfate] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8717478152309612,
        "token(a ~ b)": 0.7125,
        "domain": "3.1"
    },
    {
        "a": "[Natural Killer Cell] [accelerated] the conversion of [Sedoheptulose-7-phosphate] in vitro.",
        "b": "[NK Cell] [slowed down] the conversion of [Sedoheptulose-7-phosphate] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7984714301169997,
        "token(a ~ b)": 0.7630094043887148,
        "domain": "3.1"
    },
    {
        "a": "[Gastrin-releasing peptide] [was employed] to modulate [Gadoleic acid] metabolism in neural tissues.",
        "b": "[GRP] [was not employed] to modulate [Gadoleic acid] metabolism in neural tissues.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.819475969949573,
        "token(a ~ b)": 0.7350863422291993,
        "domain": "3.1"
    },
    {
        "a": "[Glutamine] [was overexpressed] in the presence of [Iodobenzene].",
        "b": "[Gln] [was underexpressed] in the presence of [Iodobenzene].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9107721780135573,
        "token(a ~ b)": 0.7308488612836439,
        "domain": "3.1"
    },
    {
        "a": "[Undecane] level [was positively correlated with] [Toluene] concentration in the reaction mixture.",
        "b": "[n-undecane] level [was negatively correlated with] [Toluene] concentration in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8282100065832785,
        "token(a ~ b)": 0.7796985815602837,
        "domain": "3.1"
    },
    {
        "a": "[Carbonyl Sulfide] [affected] the expression of [Mannose] in cultured cells.",
        "b": "[COS] [did not affect] the expression of [Mannose] in cultured cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8442271687122946,
        "token(a ~ b)": 0.5716783216783217,
        "domain": "3.1"
    },
    {
        "a": "[Phenylhydrazine] [broadened] the reactivity of [benzoyl chloride] in the reaction mixture.",
        "b": "[hydrazinobenzene] [narrowed] the reactivity of [benzoyl chloride] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.83098645540506,
        "token(a ~ b)": 0.6712121212121213,
        "domain": "3.1"
    },
    {
        "a": "[Serine] [was bound] to [sodium chloride] in the crystal structure analysis.",
        "b": "[Ser] [was not bound] to [sodium chloride] in the crystal structure analysis.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9301878775562986,
        "token(a ~ b)": 0.9194444444444444,
        "domain": "3.1"
    },
    {
        "a": "The presence of [Immunoglobulin A] [detected] in the cytoplasm of [dopaminergic neuron] was confirmed by immunostaining.",
        "b": "The presence of [IgA] [undetected] in the cytoplasm of [dopaminergic neuron] was confirmed by immunostaining.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9046024464831804,
        "token(a ~ b)": 0.7561457418788411,
        "domain": "3.1"
    },
    {
        "a": "[Chloride ion] [replaced] [acetone] in the solvent mixture.",
        "b": "[Cl-] [did not replace] [acetone] in the solvent mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8744771533353156,
        "token(a ~ b)": 0.5894465894465895,
        "domain": "3.1"
    },
    {
        "a": "[Magnesium citrate] [enabled] the precipitation of [hydrogen phosphate] in aqueous solution.",
        "b": "[trimagnesium dicitrate] [blocked] the precipitation of [hydrogen phosphate] in aqueous solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8261669247381932,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "3.1"
    },
    {
        "a": "[Dichromate] [increased] [Tyrosine] uptake in neuronal cells.",
        "b": "[Cr2O7^2-] [suppressed] [Tyrosine] uptake in neuronal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7448155737704917,
        "token(a ~ b)": 0.5095238095238095,
        "domain": "3.1"
    },
    {
        "a": "[Triethylamine] [broadened] the effect of [Sodium nitrate] in the reaction mixture.",
        "b": "[N,N-Diethylethanamine] [narrowed] the effect of [Sodium nitrate] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8245732931726908,
        "token(a ~ b)": 0.5794871794871794,
        "domain": "3.1"
    },
    {
        "a": "[Methylamine] [joined] the [carbonyl functional group] during the reaction.",
        "b": "[aminomethane] [broke apart] the [carbonyl functional group] during the reaction.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7967729468599033,
        "token(a ~ b)": 0.6245059288537549,
        "domain": "3.1"
    },
    {
        "a": "[Acetylene] [affected] [N,N-Dimethylformamide] metabolism in the liver.",
        "b": "[ethyne] [did not affect] [N,N-Dimethylformamide] metabolism in the liver.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8100771706405508,
        "token(a ~ b)": 0.7125,
        "domain": "3.1"
    },
    {
        "a": "[Xylose] [accelerated] the differentiation of [neural stem cell] in vitro.",
        "b": "[D-xylose] [slowed down] the differentiation of [neural stem cell] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8047078454973192,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "3.1"
    },
    {
        "a": "[NADH] [replaced] [Nitryl bromide] in the enzymatic assay.",
        "b": "[reduced nicotinamide adenine dinucleotide] [did not replace] [Nitryl bromide] in the enzymatic assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.6720006010066862,
        "token(a ~ b)": 0.5264423076923077,
        "domain": "3.1"
    },
    {
        "a": "[Thymopentin] [was sufficient for] the activation of [Chlorophyll d] in vitro.",
        "b": "[TP5] [was not sufficient for] the activation of [Chlorophyll d] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8488256403749361,
        "token(a ~ b)": 0.7796985815602837,
        "domain": "3.1"
    },
    {
        "a": "[Fluoride] [improved] the symptoms of [Type 1 Diabetes Mellitus] in animal models.",
        "b": "[fluoride ion] [worsened] the symptoms of [Type 1 Diabetes Mellitus] in animal models.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8228434922989658,
        "token(a ~ b)": 0.7450980392156863,
        "domain": "3.1"
    },
    {
        "a": "[Potassium] [was capable] of activating [Potassium chloride] transport in neurons.",
        "b": "[K] [was incapable] of activating [Potassium chloride] transport in neurons.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8209450785830761,
        "token(a ~ b)": 0.7696078431372549,
        "domain": "3.1"
    },
    {
        "a": "[N-acetylcysteine] [replaced] [Tetracosane] in the experimental mixture.",
        "b": "[NAC] [did not replace] [Tetracosane] in the experimental mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8113131313131313,
        "token(a ~ b)": 0.6071428571428572,
        "domain": "3.1"
    },
    {
        "a": "[Substance P] [joined] [Phenethylamine] in the synaptic vesicle.",
        "b": "[SP] [broke apart] [Phenethylamine] in the synaptic vesicle.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8190656565656564,
        "token(a ~ b)": 0.7095238095238096,
        "domain": "3.1"
    },
    {
        "a": "[Nitrogen trioxide] [induced] the degradation of [methylhydrazine] in aqueous solution.",
        "b": "[dinitrogen trioxide] [blocked] the degradation of [methylhydrazine] in aqueous solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.841973243384917,
        "token(a ~ b)": 0.7967571644042233,
        "domain": "3.1"
    },
    {
        "a": "[Fluoride] [contained] [Aspartic acid] in the reaction mixture.",
        "b": "[fluoride ion] [did not contain] [Aspartic acid] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.828046367884679,
        "token(a ~ b)": 0.722943722943723,
        "domain": "3.1"
    },
    {
        "a": "[Nitrosyl thiocyanate] level [was reduced] in [Glutamate]-treated cells.",
        "b": "[Nitrilo(nitrososulfanyl)methane] level [was elevated] in [Glutamate]-treated cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8620528310826819,
        "token(a ~ b)": 0.5961538461538461,
        "domain": "3.1"
    },
    {
        "a": "[Glucagon-like peptide-1] [was overexpressed] in response to [Interleukin-32] stimulation in cultured cells.",
        "b": "[GLP-1] [was underexpressed] in response to [Interleukin-32] stimulation in cultured cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.827375426626363,
        "token(a ~ b)": 0.7685563997662186,
        "domain": "3.1"
    },
    {
        "a": "[Toluene] [was employed] to solubilize [Perchlorate] in aqueous solution.",
        "b": "[methylbenzene] [was not employed] to solubilize [Perchlorate] in aqueous solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8131960603362708,
        "token(a ~ b)": 0.7885714285714285,
        "domain": "3.1"
    },
    {
        "a": "[Nilutamide] [affected] [Niacin] absorption in the gastrointestinal tract.",
        "b": "[Nilandron] [did not affect] [Niacin] absorption in the gastrointestinal tract.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8806900933483212,
        "token(a ~ b)": 0.7095238095238096,
        "domain": "3.1"
    },
    {
        "a": "[Tin(II) chloride] [broadened] the effect of [Nitric oxide] in the cell culture.",
        "b": "[SnCl2] [narrowed] the effect of [Nitric oxide] in the cell culture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7864154411764706,
        "token(a ~ b)": 0.5476190476190476,
        "domain": "3.1"
    },
    {
        "a": "[Iodide ion] [produced] [xylene] under acidic conditions.",
        "b": "[I-] [degraded] [xylene] under acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8162694520981543,
        "token(a ~ b)": 0.6397058823529411,
        "domain": "3.1"
    },
    {
        "a": "[Interleukin-4] [was overexpressed] in [N-cadherin] deficient cells.",
        "b": "[IL-4] [was underexpressed] in [N-cadherin] deficient cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8369528961009691,
        "token(a ~ b)": 0.7950971322849214,
        "domain": "3.1"
    },
    {
        "a": "[Vasopressin] [activated] the expression of [Nitrosyl hydride] in cultured cells.",
        "b": "[arginine vasopressin] [suppressed] the expression of [Nitrosyl hydride] in cultured cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7938730372940899,
        "token(a ~ b)": 0.7450980392156863,
        "domain": "3.1"
    },
    {
        "a": "[Fumarate] [accelerated] the denaturation of [Myoglobin] in acidic conditions.",
        "b": "[fumaric acid] [slowed down] the denaturation of [Myoglobin] in acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7917366832531201,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "3.1"
    },
    {
        "a": "[Hydrogen sulfide] [inhibited] [carbon monoxide] production in the cell culture.",
        "b": "[H2S] [activated] [carbon monoxide] production in the cell culture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7899170812603648,
        "token(a ~ b)": 0.5891304347826087,
        "domain": "3.1"
    },
    {
        "a": "[Hydrogen gas] [accelerated] the formation of [nitryl chloride] in the reaction mixture.",
        "b": "[H2] [slowed down] the formation of [nitryl chloride] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.824981624981625,
        "token(a ~ b)": 0.6117021276595744,
        "domain": "3.1"
    },
    {
        "a": "[Chloride ion] [accelerated] the formation of [thiosulfate] in the reaction mixture.",
        "b": "[Cl-] [slowed down] the formation of [thiosulfate] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8243201430807064,
        "token(a ~ b)": 0.6442307692307692,
        "domain": "3.1"
    },
    {
        "a": "[Cyanide ion] [accelerated] the formation of [Nitryl iodide] in the reaction vessel.",
        "b": "[CN-] [slowed down] the formation of [Nitryl iodide] in the reaction vessel.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8278362573099416,
        "token(a ~ b)": 0.6365777080062794,
        "domain": "3.1"
    },
    {
        "a": "[Tin(II) chloride] [replaced] [Isopropylamine] in the reaction mixture.",
        "b": "[SnCl2] [did not replace] [Isopropylamine] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7882578564117764,
        "token(a ~ b)": 0.5555555555555556,
        "domain": "3.1"
    },
    {
        "a": "[Sulfate] [was capable] of binding to [Calcitonin gene-related peptide] under acidic conditions.",
        "b": "[sulfate ion] [was incapable] of binding to [Calcitonin gene-related peptide] under acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.843655185758514,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "3.1"
    },
    {
        "a": "[Parathyroid Hormone] [admitted] [Type 1 Diabetes Mellitus] in the clinical cohort.",
        "b": "[PTH] [rejected] [Type 1 Diabetes Mellitus] in the clinical cohort.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8055368595918857,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "3.1"
    },
    {
        "a": "[Calcium phosphate] [bound] to [Tin(II) chloride] in the reaction mixture.",
        "b": "[Ca3(PO4)2] [was not bound] to [Tin(II) chloride] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8603744369369369,
        "token(a ~ b)": 0.6377777777777778,
        "domain": "3.1"
    },
    {
        "a": "[Cyclohexylamine] [facilitated] the synthesis of [1-Decyne] in the reaction mixture.",
        "b": "[aminocyclohexane] [blocked] the synthesis of [1-Decyne] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8096349206349207,
        "token(a ~ b)": 0.6762166405023547,
        "domain": "3.1"
    },
    {
        "a": "[Piperidine] [displayed] binding to [Glycine receptor] in the hippocampal neurons.",
        "b": "[hexahydroazepine] [did not display] binding to [Glycine receptor] in the hippocampal neurons.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8092520757654385,
        "token(a ~ b)": 0.6251572327044025,
        "domain": "3.1"
    },
    {
        "a": "[Xylose] [was overexpressed] in [Acetylene] treated samples.",
        "b": "[D-xylose] [was underexpressed] in [Acetylene] treated samples.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8353759398496241,
        "token(a ~ b)": 0.7352564102564103,
        "domain": "3.1"
    },
    {
        "a": "[Tivozanib] [established] the efficacy of [Atezolizumab] in advanced renal cell carcinoma.",
        "b": "[Fotivda] [refuted] the efficacy of [Atezolizumab] in advanced renal cell carcinoma.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8039560439560439,
        "token(a ~ b)": 0.6888888888888889,
        "domain": "3.1"
    },
    {
        "a": "[Transfer RNA] [accelerated] the transport activity of [Small nuclear RNA] in the assay.",
        "b": "[tRNA] [slowed down] the transport activity of [Small nuclear RNA] in the assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8089318181818183,
        "token(a ~ b)": 0.6448202959830867,
        "domain": "3.1"
    },
    {
        "a": "[Nitrite] [extended] the half-life of [Iron(II) ion] in solution.",
        "b": "[Nitrite ion] [shortened] the half-life of [Iron(II) ion] in solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8904927330733782,
        "token(a ~ b)": 0.8795454545454545,
        "domain": "3.1"
    },
    {
        "a": "[Deoxyribonucleic acid] [contained] [Tricosane] in the experimental mixture.",
        "b": "[DNA] [excluded] [Tricosane] in the experimental mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8054439128123339,
        "token(a ~ b)": 0.608974358974359,
        "domain": "3.1"
    },
    {
        "a": "[Hexadecane] [was linked to] [phosphine] metabolism in aquatic bacteria.",
        "b": "[n-Hexadecane] [was not linked] to [phosphine] metabolism in aquatic bacteria.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8477564102564102,
        "token(a ~ b)": 0.7727272727272727,
        "domain": "3.1"
    },
    {
        "a": "[Rhamnose] [was sufficient for] the reduction of [hydride ion] in the cell-free assay.",
        "b": "[Rha] [was not sufficient for] the reduction of [hydride ion] in the cell-free assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9160282168345063,
        "token(a ~ b)": 0.8402839396628217,
        "domain": "3.1"
    },
    {
        "a": "[Nitrous oxide] [broadened] the absorption spectrum of [chlorophyll d] in solution.",
        "b": "[N2O] [narrowed] the absorption spectrum of [chlorophyll d] in solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8356964088237007,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "3.1"
    },
    {
        "a": "[Cysteine] [was overexpressed] in the presence of [Camphor].",
        "b": "[Cys] [was underexpressed] in the presence of [Camphor].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8950793650793651,
        "token(a ~ b)": 0.7710526315789473,
        "domain": "3.1"
    },
    {
        "a": "[Melanocyte] [suppressed] [Eukaryotic Initiation Factor 2] expression in cultured cells.",
        "b": "[pigment cell] [stimulated] [Eukaryotic Initiation Factor 2] expression in cultured cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8268939393939394,
        "token(a ~ b)": 0.6657142857142857,
        "domain": "3.1"
    },
    {
        "a": "[Larotrectinib] [was critical for] the therapeutic effect of [Cetuximab] in metastatic colorectal cancer.",
        "b": "[Larotrectinib] [was not required for] the therapeutic effect of [Erbitux] in metastatic colorectal cancer.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.898029078863456,
        "token(a ~ b)": 0.7785675232367414,
        "domain": "3.2"
    },
    {
        "a": "The administration of [Nonsteroidal anti-inflammatory drugs] [identified] a potential interaction with [Ibrutinib].",
        "b": "The administration of [Nonsteroidal anti-inflammatory drugs] [failed to identify] a potential interaction with [Imbruvica].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.935825001262435,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "3.2"
    },
    {
        "a": "[Interleukin-12] [was overexpressed] in [Sulfiredoxin] after stimulation with LPS.",
        "b": "[Interleukin-12] [was underexpressed] in [SRXN1] after stimulation with LPS.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9095278847525318,
        "token(a ~ b)": 0.7275862068965517,
        "domain": "3.2"
    },
    {
        "a": "The [Stratum corneum cell] [was found] in samples containing [Smooth muscle cell]s.",
        "b": "The [Stratum corneum cell] [was not observed] in samples containing [SMC]s.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9096270797475617,
        "token(a ~ b)": 0.7539525691699605,
        "domain": "3.2"
    },
    {
        "a": "[Relugolix] [served as] a ligand for [Entrectinib] in the binding assay.",
        "b": "[Relugolix] [did not serve] as a ligand for [Rozlytrek] in the binding assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8855102194654434,
        "token(a ~ b)": 0.6260454002389486,
        "domain": "3.2"
    },
    {
        "a": "[Thiocyanate] [was sufficient for] the catalytic activity of [gastrin-releasing peptide] in neuronal cells.",
        "b": "[Thiocyanate] [was not sufficient for] the catalytic activity of [GRP] in neuronal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8793015053338358,
        "token(a ~ b)": 0.774928774928775,
        "domain": "3.2"
    },
    {
        "a": "The binding of [Glucose-regulated protein 94] to [Protection of telomeres 1] [was critical for] telomere maintenance in vitro.",
        "b": "The binding of [Glucose-regulated protein 94] to [POT1] [was not required for] telomere maintenance in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9078281300758364,
        "token(a ~ b)": 0.7987179487179488,
        "domain": "3.2"
    },
    {
        "a": "The administration of [Cemiplimab] [was sufficient for] the therapeutic effect of [Alirocumab].",
        "b": "The administration of [Cemiplimab] [was not sufficient for] the therapeutic effect of [Praluent].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9239295834086936,
        "token(a ~ b)": 0.7741666666666667,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Interleukin-38] [was influenced] by [Gamma-aminobutyric acid] in neuronal cultures.",
        "b": "The activity of [Interleukin-38] [was not influenced] by [GABA] in neuronal cultures.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9081606886657102,
        "token(a ~ b)": 0.7407407407407407,
        "domain": "3.2"
    },
    {
        "a": "The administration of [Levomilnacipran] [was critical for] the therapeutic efficacy of [Eszopiclone] in patients with insomnia.",
        "b": "The administration of [Levomilnacipran] [was not required for] the therapeutic efficacy of [Lunesta] in patients with insomnia.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9188026065707304,
        "token(a ~ b)": 0.7561457418788411,
        "domain": "3.2"
    },
    {
        "a": "[Rifampicin] [stimulated] [Gamma-aminobutyric acid] release in neuronal cultures.",
        "b": "[Rifampicin] [suppressed] [GABA] release in neuronal cultures.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8445639187574672,
        "token(a ~ b)": 0.5888372093023255,
        "domain": "3.2"
    },
    {
        "a": "[Ozone] [affected] the activity of [ribose-5-phosphate isomerase] in vitro.",
        "b": "[Ozone] [did not affect] the activity of [RPIA] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8287719298245614,
        "token(a ~ b)": 0.5218855218855218,
        "domain": "3.2"
    },
    {
        "a": "[Interleukin-13] [affected] [Sedoheptulose-7-phosphate] levels in macrophages.",
        "b": "[Interleukin-13] [did not affect] [S7P] levels in macrophages.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8668669191589395,
        "token(a ~ b)": 0.6704619388418998,
        "domain": "3.2"
    },
    {
        "a": "In experimental conditions, [Epinephrine] [improved] symptoms of [Borderline Personality Disorder].",
        "b": "In experimental conditions, [Epinephrine] [worsened] symptoms of [BPD].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9071686685771193,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "3.2"
    },
    {
        "a": "The activity of [ERO1] [was critical for] the function of [Sodium-Monocarboxylate Transporter] in the assay.",
        "b": "The activity of [ERO1] [was not required for] the function of [SLC5A8] in the assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8711843711843712,
        "token(a ~ b)": 0.5511042629686698,
        "domain": "3.2"
    },
    {
        "a": "[Butyric acid] [preceded] [Camphor] in the metabolic pathway.",
        "b": "[Butyric acid] [followed] [bornan-2-one] in the metabolic pathway.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.878067560854446,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "3.2"
    },
    {
        "a": "[Cetuximab] [suppressed] the anxiolytic effect of [Alprazolam] in behavioral assays.",
        "b": "[Cetuximab] [did not alter] the anxiolytic effect of [Xanax] in behavioral assays.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8717958155436685,
        "token(a ~ b)": 0.6888888888888889,
        "domain": "3.2"
    },
    {
        "a": "[Nitrous acid] [accelerated] the degradation of [sodium nitrate] in solution.",
        "b": "[Nitrous acid] [slowed down] the degradation of [NaNO3] in solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8788369297048179,
        "token(a ~ b)": 0.5888372093023255,
        "domain": "3.2"
    },
    {
        "a": "[Sotorasib] [exhibited] strong binding to [Ibrutinib] in the cellular assay.",
        "b": "[Sotorasib] [did not exhibit] strong binding to [Imbruvica] in the cellular assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.902251674010339,
        "token(a ~ b)": 0.6634615384615384,
        "domain": "3.2"
    },
    {
        "a": "[Ceftriaxone] [was sufficient for] the inhibition of [Vismodegib] in clinical isolates.",
        "b": "[Ceftriaxone] [was not sufficient for] the inhibition of [Erivedge] in clinical isolates.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.902043702730712,
        "token(a ~ b)": 0.7543800539083558,
        "domain": "3.2"
    },
    {
        "a": "[Interleukin-37] [was detected] in [Androgen Receptor] samples from treated cells.",
        "b": "[Interleukin-37] [was not found] in [AR] samples from treated cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9096387113603756,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "3.2"
    },
    {
        "a": "[Iron(II) ion] [inhibited] the activity of [acetone] in the reaction mixture.",
        "b": "[Iron(II) ion] [activated] the activity of [propanone] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9165136902478674,
        "token(a ~ b)": 0.7984189723320159,
        "domain": "3.2"
    },
    {
        "a": "The concentration of [Hexane] [identified] the presence of [Phenethylamine] in the reaction mixture.",
        "b": "The concentration of [Hexane] [failed to identify] the presence of [2-phenylethan-1-amine] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9055274483970136,
        "token(a ~ b)": 0.6228956228956228,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Citrate synthase] [identified] the presence of [ATP synthase] in mitochondria.",
        "b": "The activity of [Citrate synthase] [failed to identify] the presence of [Complex V] in mitochondria.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9112631578947369,
        "token(a ~ b)": 0.7260869565217392,
        "domain": "3.2"
    },
    {
        "a": "[VE-cadherin] [was critical for] the differentiation of [megakaryocyte-erythroid progenitor] cells in vitro.",
        "b": "[VE-cadherin] [was not required for] the differentiation of [MEP] cells in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8547108512020792,
        "token(a ~ b)": 0.6292613636363636,
        "domain": "3.2"
    },
    {
        "a": "[Midostaurin] [induced] the expression of [Cemiplimab] in cultured cells.",
        "b": "[Midostaurin] [prevented] the expression of [Libtayo] in cultured cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8937452435312024,
        "token(a ~ b)": 0.6387959866220736,
        "domain": "3.2"
    },
    {
        "a": "[Glucokinase] [identified] [neural stem cell] populations in the developing cortex.",
        "b": "[Glucokinase] [failed to identify] [NSC] populations in the developing cortex.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8858871382967769,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "3.2"
    },
    {
        "a": "[Lorlatinib] [was employed] in the treatment of [Autism Spectrum Disorder].",
        "b": "[Lorlatinib] [was not employed] in the treatment of [ASD].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8959201451905626,
        "token(a ~ b)": 0.7304054054054054,
        "domain": "3.2"
    },
    {
        "a": "[Nicotinic acetylcholine receptor] [activated] [neural stem cell] proliferation in vitro.",
        "b": "[Nicotinic acetylcholine receptor] [inhibited] [NSC] proliferation in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9047510691726874,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "3.2"
    },
    {
        "a": "The concentration of [Phosphoribosyl pyrophosphate synthetase 1] in plasma [contained] [Thyrotropin-releasing hormone].",
        "b": "The concentration of [Phosphoribosyl pyrophosphate synthetase 1] in plasma [excluded] [TRH].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9261535198787161,
        "token(a ~ b)": 0.711111111111111,
        "domain": "3.2"
    },
    {
        "a": "The presence of [Trametinib] [included] [Fumonisin B1] in the assay.",
        "b": "The presence of [Trametinib] [excluded] [FB1] in the assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9222709065785101,
        "token(a ~ b)": 0.7167553191489362,
        "domain": "3.2"
    },
    {
        "a": "In the experiment, [Potassium nitrate] [was overexpressed] in the presence of [Beta-hydroxybutyrate].",
        "b": "In the experiment, [Potassium nitrate] [was underexpressed] in the presence of [BHB].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9138539994602043,
        "token(a ~ b)": 0.7110412299091544,
        "domain": "3.2"
    },
    {
        "a": "[NHP2 ribonucleoprotein] [was overexpressed] in [Epidermal Growth Factor Receptor] positive cells.",
        "b": "[NHP2 ribonucleoprotein] [was underexpressed] in [EGFR] positive cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9032984657426963,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "3.2"
    },
    {
        "a": "[Basal cell] [exhibited] markers of [white adipocyte] differentiation under hypoxic conditions.",
        "b": "[Basal cell] [did not exhibit] markers of [white adipose tissue] differentiation under hypoxic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8916912793242998,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "3.2"
    },
    {
        "a": "[Ipilimumab] [was vaccinated] with [methyllycaconitine citrate] during the clinical trial.",
        "b": "[Ipilimumab] [was not vaccinated] with [Methyllycaconitine] during the clinical trial.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.902768905077675,
        "token(a ~ b)": 0.8566763425253991,
        "domain": "3.2"
    },
    {
        "a": "[Acetaminophen] [was employed] to inhibit [Pitavastatin] metabolism in the liver.",
        "b": "[Acetaminophen] [was not employed] to inhibit [Livalo] metabolism in the liver.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9160037674805607,
        "token(a ~ b)": 0.7350863422291993,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Collagen Type I Alpha 1 Chain] [was critical for] the synthesis of [Hemoglobin Subunit Beta] in erythroid cells.",
        "b": "The activity of [Collagen Type I Alpha 1 Chain] [was not required for] the synthesis of [HBB] in erythroid cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9142061800259677,
        "token(a ~ b)": 0.7964721845318861,
        "domain": "3.2"
    },
    {
        "a": "[Tivozanib] [contained] [Pitavastatin] in the clinical formulation.",
        "b": "[Tivozanib] [excluded] [Livalo] in the clinical formulation.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8669510935886604,
        "token(a ~ b)": 0.608974358974359,
        "domain": "3.2"
    },
    {
        "a": "[Glycine] [affected] the activity of [ATP synthase] in mitochondria.",
        "b": "[Glycine] [did not affect] the activity of [Complex V] in mitochondria.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8719299846938059,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "3.2"
    },
    {
        "a": "[Cytoskeleton] [exhibited] binding to [Interleukin-22] in the cell culture assay.",
        "b": "[Cytoskeleton] [did not exhibit] binding to [IL-22] in the cell culture assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9016729761021999,
        "token(a ~ b)": 0.703525641025641,
        "domain": "3.2"
    },
    {
        "a": "[Cytochrome P450] [was genetically correlated with] [C/EBP homologous protein] expression in liver cells.",
        "b": "[Cytochrome P450] [was not genetically correlated with] [CHOP] expression in liver cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8945532370251471,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Avelumab] [was positively correlated with] [Hydromorphone] levels in the bloodstream.",
        "b": "The activity of [Avelumab] [was negatively correlated with] [Dilaudid] levels in the bloodstream.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9265542844034406,
        "token(a ~ b)": 0.6997978436657681,
        "domain": "3.2"
    },
    {
        "a": "The expression of [Phosphoenolpyruvate] [was selected] based on [Interleukin-17] levels in the experimental setup.",
        "b": "The expression of [Phosphoenolpyruvate] [was not selected] based on [IL-17] levels in the experimental setup.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.925743343992663,
        "token(a ~ b)": 0.8563508064516129,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Eukaryotic elongation factor 1A] [interacted] with [Carbonic anhydrase] in the cell-free assay.",
        "b": "The activity of [Eukaryotic elongation factor 1A] [did not interact] with [CA] in the cell-free assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9244387148798914,
        "token(a ~ b)": 0.746031746031746,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Thyrotropin-releasing hormone] [affected] [Inositol-requiring enzyme 1] signaling in neuronal cells.",
        "b": "The activity of [Thyrotropin-releasing hormone] [did not affect] [IRE1] signaling in neuronal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9165129967398008,
        "token(a ~ b)": 0.7132183908045977,
        "domain": "3.2"
    },
    {
        "a": "The expression of [Norepinephrine] [was genetically correlated with] [endothelial progenitor cell] counts in the blood.",
        "b": "The expression of [Norepinephrine] [was not genetically correlated with] [EPC] counts in the blood.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.89903393175452,
        "token(a ~ b)": 0.7574675324675324,
        "domain": "3.2"
    },
    {
        "a": "The binding of [Interleukin-9] to [Interferon-gamma] was [established] in vitro.",
        "b": "The binding of [Interleukin-9] to [IFN-\u03b3] was [refuted] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9008480453972257,
        "token(a ~ b)": 0.673654786862334,
        "domain": "3.2"
    },
    {
        "a": "[Acetophenone] [produced] [Cysteine] under oxidative conditions.",
        "b": "[Acetophenone] [degraded] [Cys] under oxidative conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9148305084745763,
        "token(a ~ b)": 0.7095238095238096,
        "domain": "3.2"
    },
    {
        "a": "[Lepirudin] [contained] [Indomethacin] in the pharmaceutical preparation.",
        "b": "[Lepirudin] [excluded] [Indocin] in the pharmaceutical preparation.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8844719650280886,
        "token(a ~ b)": 0.7250000000000001,
        "domain": "3.2"
    },
    {
        "a": "[Dihydroxyacetone phosphate] [served as] a cofactor for [Interleukin-18] signaling in the experimental model.",
        "b": "[Dihydroxyacetone phosphate] [did not serve] as a cofactor for [IL-18] signaling in the experimental model.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9131042865572878,
        "token(a ~ b)": 0.74375,
        "domain": "3.2"
    },
    {
        "a": "[Interferon-alpha] [affected] the pharmacokinetics of [Gemcitabine] in vitro.",
        "b": "[Interferon-alpha] [did not affect] the pharmacokinetics of [Gemzar] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9021839271839271,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "3.2"
    },
    {
        "a": "The [Mesenchymal Stem Cell] population [contained] [Bloom syndrome RecQ like helicase] in tissue culture.",
        "b": "The [Mesenchymal Stem Cell] population [did not contain] [BLM] in tissue culture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8975742775742775,
        "token(a ~ b)": 0.5943204868154158,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Metronidazole] [was capable] of being modulated by [Paroxetine] in neural cells.",
        "b": "The activity of [Metronidazole] [was incapable] of being modulated by [Paxil] in neural cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9376093155440266,
        "token(a ~ b)": 0.7939622641509434,
        "domain": "3.2"
    },
    {
        "a": "[Alprazolam] [contained] [Azithromycin] as an impurity in the final formulation.",
        "b": "[Alprazolam] [excluded] [Zithromax] as an impurity in the final formulation.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8787166285278413,
        "token(a ~ b)": 0.7967571644042233,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Sodium-Hydrogen Exchanger] [was employed] to neutralize [Phenoxide ion] in the reaction mixture.",
        "b": "The activity of [Sodium-Hydrogen Exchanger] [was not employed] to neutralize [phenolate] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9434119960668633,
        "token(a ~ b)": 0.8199883109292812,
        "domain": "3.2"
    },
    {
        "a": "[Catalase] [affected] the function of [Purkinje cell] in the cerebellum.",
        "b": "[Catalase] [did not affect] the function of [Purkinje neuron] in the cerebellum.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8883006535947712,
        "token(a ~ b)": 0.8070652173913043,
        "domain": "3.2"
    },
    {
        "a": "[Ponatinib] [displayed] inhibitory activity against [Metamizole] in vitro.",
        "b": "[Ponatinib] [did not exhibit] inhibitory activity against [Dipyrone] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8683255370755371,
        "token(a ~ b)": 0.6055555555555556,
        "domain": "3.2"
    },
    {
        "a": "[Natural Killer Cell] [included] [Basal cell] in the cytotoxicity assay.",
        "b": "[Natural Killer Cell] [excluded] [Basal keratinocyte] in the cytotoxicity assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9265873015873016,
        "token(a ~ b)": 0.7595137420718816,
        "domain": "3.2"
    },
    {
        "a": "The administration of [Dostarlimab] [was linked to] the development of [Borderline Personality Disorder] in certain patients.",
        "b": "The administration of [Dostarlimab] [was not linked] to the development of [BPD] in certain patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9081346534653465,
        "token(a ~ b)": 0.7835664335664335,
        "domain": "3.2"
    },
    {
        "a": "The activity of [NAD(P)H:quinone oxidoreductase 1] [was observed in] [Eukaryotic Initiation Factor 2] complexes in vitro.",
        "b": "The activity of [NAD(P)H:quinone oxidoreductase 1] [was not localized] in [eIF2] complexes in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.915155320780438,
        "token(a ~ b)": 0.7350981118104405,
        "domain": "3.2"
    },
    {
        "a": "The [Chloroplast] [was able] to differentiate into a [Neural stem cell] under specific conditions.",
        "b": "The [Chloroplast] [was unable] to differentiate into an [NSC] under specific conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9004329004329005,
        "token(a ~ b)": 0.6829710144927537,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Epidermal dendritic cell] [was observed in] [Phosphofructokinase, liver type] samples from the tissue.",
        "b": "The activity of [Epidermal dendritic cell] [was not localized] in [PFKL] samples from the tissue.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8986603964759369,
        "token(a ~ b)": 0.6286594761171032,
        "domain": "3.2"
    },
    {
        "a": "The [Nitroxyl anion] [was genetically correlated with] [Nitric oxide] in neuronal cells.",
        "b": "The [Nitroxyl anion] [was not genetically correlated with] [NO] in neuronal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.919440133037694,
        "token(a ~ b)": 0.8444444444444444,
        "domain": "3.2"
    },
    {
        "a": "[Sodium-Sulfate Cotransporter] [interacted] with [Phosphofructokinase, liver type] in vitro.",
        "b": "[Sodium-Sulfate Cotransporter] [did not interact] with [PFKL] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8836382996225242,
        "token(a ~ b)": 0.5591397849462365,
        "domain": "3.2"
    },
    {
        "a": "[Venlafaxine] [replaced] [Pembrolizumab] in the treatment protocol for advanced melanoma.",
        "b": "[Venlafaxine] [did not replace] [Keytruda] in the treatment protocol for advanced melanoma.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8961967602142993,
        "token(a ~ b)": 0.6445639187574671,
        "domain": "3.2"
    },
    {
        "a": "[Interleukin-21] [served as] a co-factor for [Epidermal Growth Factor Receptor] in cell signaling.",
        "b": "[Interleukin-21] [did not serve] as a co-factor for [EGFR] in cell signaling.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8893467434820818,
        "token(a ~ b)": 0.6383928571428572,
        "domain": "3.2"
    },
    {
        "a": "[SLC13A1] [was overexpressed] in response to [Interleukin-15] stimulation.",
        "b": "[SLC13A1] [was underexpressed] in response to [IL-15] stimulation.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.923084123084123,
        "token(a ~ b)": 0.7885714285714285,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Sodium-Dependent Multivitamin Transporter] [affected] [Tumor Protein p53] levels in the liver.",
        "b": "The activity of [Sodium-Dependent Multivitamin Transporter] [did not affect] [TP53] levels in the liver.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9467693047790134,
        "token(a ~ b)": 0.773728813559322,
        "domain": "3.2"
    },
    {
        "a": "[Atorvastatin] [improved] the clinical response to [Inotuzumab ozogamicin] in elderly patients.",
        "b": "[Atorvastatin] [worsened] the clinical response to [Besponsa] in elderly patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.876821566110398,
        "token(a ~ b)": 0.5878787878787879,
        "domain": "3.2"
    },
    {
        "a": "[Dalteparin] [was capable] of inhibiting [Ofatumumab] binding in plasma.",
        "b": "[Dalteparin] [was incapable] of inhibiting [Arzerra] binding in plasma.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9016711379387436,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "3.2"
    },
    {
        "a": "[Fluorouracil] [broadened] the clinical spectrum of [Obsessive-Compulsive Disorder] in the patient population.",
        "b": "[Fluorouracil] [restricted] the clinical spectrum of [OCD] in the patient population.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8688613538541802,
        "token(a ~ b)": 0.6651515151515152,
        "domain": "3.2"
    },
    {
        "a": "The [granular cell] [was able] to bind [Immunoglobulin D] in vitro.",
        "b": "The [granular cell] [was unable] to bind [IgD] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9171641791044776,
        "token(a ~ b)": 0.6536796536796536,
        "domain": "3.2"
    },
    {
        "a": "[Phenethylamine] [established] the effect of [Estrogen Receptor 1] in the experimental assay.",
        "b": "[Phenethylamine] [refuted] the effect of [ESR1] in the experimental assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8797913315405365,
        "token(a ~ b)": 0.6762166405023547,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Fragile X Mental Retardation Protein] [was sufficient for] the synthesis of [Serotonin] in neurons.",
        "b": "The activity of [Fragile X Mental Retardation Protein] [was not sufficient for] the synthesis of [5-HT] in neurons.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9409595202398802,
        "token(a ~ b)": 0.8650345260514751,
        "domain": "3.2"
    },
    {
        "a": "[Hydromorphone] [inhibited] the activity of [Celecoxib] in neuronal cells.",
        "b": "[Hydromorphone] [stimulated] the activity of [Celebrex] in neuronal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9143325143325143,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "3.2"
    },
    {
        "a": "[Pitavastatin] [inhibited] [Apalutamide] metabolism in liver microsomes.",
        "b": "[Pitavastatin] [promoted] [Erleada] metabolism in liver microsomes.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8960065265072487,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Nitric oxide] [affected] [Cyclohexanone] metabolism in vitro.",
        "b": "The activity of [Nitric oxide] [did not affect] [C6H10O] metabolism in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.898059651790995,
        "token(a ~ b)": 0.6117021276595744,
        "domain": "3.2"
    },
    {
        "a": "[Ponatinib] [contained] [Irinotecan] in the pharmaceutical formulation.",
        "b": "[Ponatinib] [did not contain] [Camptosar] in the pharmaceutical formulation.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8868724307567896,
        "token(a ~ b)": 0.5891304347826087,
        "domain": "3.2"
    },
    {
        "a": "Treatment with [Escitalopram] [produced] a significant increase in [Encorafenib] levels in plasma.",
        "b": "Treatment with [Escitalopram] [degraded] a significant increase in [Braftovi] levels in plasma.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9285516359116089,
        "token(a ~ b)": 0.6806184012066365,
        "domain": "3.2"
    },
    {
        "a": "The activity of [transketolase] [was critical for] the conversion of [Fructose-6-phosphate] in vitro.",
        "b": "The activity of [transketolase] [was not required for] the conversion of [F6P] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9023903896413737,
        "token(a ~ b)": 0.7222222222222222,
        "domain": "3.2"
    },
    {
        "a": "[Fluoxetine] [improved] the symptoms of [Bicalutamide]-induced fatigue in patients.",
        "b": "[Fluoxetine] [worsened] the symptoms of [Casodex]-induced fatigue in patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8995904497109317,
        "token(a ~ b)": 0.6607142857142857,
        "domain": "3.2"
    },
    {
        "a": "The presence of [Leuprolide] [resulted in] a significant increase in [Gemfibrozil] uptake.",
        "b": "The presence of [Leuprolide] [prevented] a significant increase in [Lopid] uptake.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9147601450040475,
        "token(a ~ b)": 0.6684615384615384,
        "domain": "3.2"
    },
    {
        "a": "[Dalteparin] [replaced] [Cystic Fibrosis] in the treatment protocol during the clinical trial.",
        "b": "[Dalteparin] [did not replace] [CF] in the treatment protocol during the clinical trial.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8987387643645466,
        "token(a ~ b)": 0.6629787234042553,
        "domain": "3.2"
    },
    {
        "a": "[Interleukin-22] [suppressed] [Pyruvate dehydrogenase] activity in liver cells.",
        "b": "[Interleukin-22] [boosted] [PDH] activity in liver cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8673119387913298,
        "token(a ~ b)": 0.6041666666666667,
        "domain": "3.2"
    },
    {
        "a": "[Erlotinib] [was critical for] the management of [Fragile X Syndrome] in pediatric patients.",
        "b": "[Erlotinib] [was not required for] the management of [FXS] in pediatric patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9009780740197177,
        "token(a ~ b)": 0.703525641025641,
        "domain": "3.2"
    },
    {
        "a": "[VE-cadherin] [affected] [Sedoheptulose-7-phosphate] levels in endothelial cells.",
        "b": "[VE-cadherin] [did not affect] [S7P] levels in endothelial cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8627635327635328,
        "token(a ~ b)": 0.6484110885733604,
        "domain": "3.2"
    },
    {
        "a": "[Glucokinase] [served as] a critical enzyme in [colony-forming unit-erythroid] development during the experiment.",
        "b": "[Glucokinase] [did not serve] as a critical enzyme in [CFU-E] development during the experiment.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8667920353982301,
        "token(a ~ b)": 0.5833333333333333,
        "domain": "3.2"
    },
    {
        "a": "The compound [Selenocysteine] [contained] [Sodium] in the reaction mixture.",
        "b": "The compound [Selenocysteine] [did not contain] [Na] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9258615938052558,
        "token(a ~ b)": 0.7793650793650794,
        "domain": "3.2"
    },
    {
        "a": "[E2F transcription factor 1] [affected] [Langerhans cell] function in vitro.",
        "b": "[E2F transcription factor 1] [did not affect] [Langerhans dendritic cell] function in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9073226544622426,
        "token(a ~ b)": 0.8125,
        "domain": "3.2"
    },
    {
        "a": "[Pyruvate dehydrogenase] [impacted] the activity of [Bloom syndrome RecQ like helicase] in the assay.",
        "b": "[Pyruvate dehydrogenase] [did not impact] the activity of [BLM] in the assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8792829862136793,
        "token(a ~ b)": 0.6276939655172413,
        "domain": "3.2"
    },
    {
        "a": "[Immunoglobulin A] [affected] [Nitrogen dioxide] concentrations in the assay.",
        "b": "[Immunoglobulin A] [did not affect] [NO2] concentrations in the assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.914708276797829,
        "token(a ~ b)": 0.6856984478935699,
        "domain": "3.2"
    },
    {
        "a": "[Gefitinib] [was overexpressed] in [6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3] under hypoxic conditions.",
        "b": "[Gefitinib] [was underexpressed] in [PFKFB3] under hypoxic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8291330891330891,
        "token(a ~ b)": 0.48049052396878483,
        "domain": "3.2"
    },
    {
        "a": "The activity of [Sodium-Hydrogen Exchanger] [affected] the levels of [Apolipoprotein E] in neuronal cells.",
        "b": "The activity of [Sodium-Hydrogen Exchanger] [did not affect] the levels of [APOE] in neuronal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9272987421383647,
        "token(a ~ b)": 0.7138535995160314,
        "domain": "3.2"
    },
    {
        "a": "The behavioral response of [Aldosterone] [was linked to] [Diethylstilbestrol] exposure in the experiment.",
        "b": "The behavioral response of [Aldosterone] [was not linked] to [DES] exposure in the experiment.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9162512664640324,
        "token(a ~ b)": 0.74,
        "domain": "3.2"
    },
    {
        "a": "[Superoxide dismutase] [identified] [glucose-regulated protein 78] in the cytosolic fraction.",
        "b": "[Superoxide dismutase] [obscured] [BiP] in the cytosolic fraction.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8692501047339757,
        "token(a ~ b)": 0.6484110885733604,
        "domain": "3.2"
    },
    {
        "a": "[Collagen Type I Alpha 1 Chain] [was genetically associated with] [Selectin E] in the tissue samples.",
        "b": "[Collagen Type I Alpha 1 Chain] [was not genetically correlated with] [E-selectin] in the tissue samples.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9294184322703257,
        "token(a ~ b)": 0.8043326345213138,
        "domain": "3.2"
    },
    {
        "a": "The activity of [carbonic anhydrase] [impacted] the function of [rhodopsin] in retinal cells.",
        "b": "The activity of [carbonic anhydrase] [did not impact] the function of [RHO] in retinal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9259176863181312,
        "token(a ~ b)": 0.7035714285714285,
        "domain": "3.2"
    },
    {
        "a": "[Hydrogen gas] [was capable] of oxidizing [Trifluoroacetic anhydride] under standard conditions.",
        "b": "[Hydrogen gas] [was incapable] of oxidizing [TFAA] under standard conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8869149994149994,
        "token(a ~ b)": 0.6029411764705883,
        "domain": "3.2"
    },
    {
        "a": "[Sipuleucel-T] [was employed] as an adjuvant with [Pembrolizumab] during the clinical trial.",
        "b": "[Sipuleucel-T] [was not employed] [MK-3475] as an adjuvant during the clinical trial.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8784379048061913,
        "token(a ~ b)": 0.6745689655172413,
        "domain": "3.2"
    },
    {
        "a": "[Cytochrome P450] activity [broadened] the effect of [Luteinizing Hormone] in the experimental assay.",
        "b": "[Cytochrome P450] activity [narrowed] the effect of [LH] in the experimental assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9258202576061308,
        "token(a ~ b)": 0.6819923371647509,
        "domain": "3.2"
    },
    {
        "a": "[Acetamide] [produced] [Messenger RNA] in the liver cells.",
        "b": "[ethanamide] [degraded] [mRNA] in the liver cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7960919540229885,
        "token(a ~ b)": 0.5476190476190476,
        "domain": "3.3"
    },
    {
        "a": "[n-docosane] [increased] the uptake of [SLC23A1] in the neuronal tissue.",
        "b": "[Docosane] [decreased] the uptake of [Sodium-Dependent Vitamin C Transporter] in the neuronal tissue.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.739370597507512,
        "token(a ~ b)": 0.483704974271012,
        "domain": "3.3"
    },
    {
        "a": "[Glyoxal] [was coupled] to [Phenylhydrazine] in aqueous solution.",
        "b": "[ethanedial] [was not bound] to [hydrazinobenzene] in aqueous solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7607859745887916,
        "token(a ~ b)": 0.49967083607636603,
        "domain": "3.3"
    },
    {
        "a": "[Azithromycin] [broadened] the therapeutic application of [Everolimus] in transplant patients.",
        "b": "[Zithromax] [restricted] the therapeutic application of [Afinitor] in transplant patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8657358156028369,
        "token(a ~ b)": 0.5555555555555556,
        "domain": "3.3"
    },
    {
        "a": "[Ozone] [increased] the concentration of [malic acid] in the assay.",
        "b": "[O3] [decreased] the concentration of [Malate] in the assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8281984019297451,
        "token(a ~ b)": 0.6369047619047619,
        "domain": "3.3"
    },
    {
        "a": "[Ozone] [was capable] of oxidizing [butyric acid] under acidic conditions.",
        "b": "[O3] [was incapable] of oxidizing [butanoic acid] under acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8568854568854569,
        "token(a ~ b)": 0.722943722943723,
        "domain": "3.3"
    },
    {
        "a": "[Iodide ion] [affected] [Malate] transport in mitochondria.",
        "b": "[I-] [did not affect] [malic acid] transport in mitochondria.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8480346049485625,
        "token(a ~ b)": 0.5047619047619047,
        "domain": "3.3"
    },
    {
        "a": "[Eukaryotic Initiation Factor 4E] [established] the interaction with [Aldolase C] in neuronal cells.",
        "b": "[eIF4E] [refuted] the interaction with [ALDOC] in neuronal cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.6965811965811964,
        "token(a ~ b)": 0.4575892857142857,
        "domain": "3.3"
    },
    {
        "a": "[Alectinib] [improved] the efficacy of [Oxaliplatin] in resistant tumor models.",
        "b": "[Alecensa] [worsened] the efficacy of [Eloxatin] in resistant tumor models.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8856003526670445,
        "token(a ~ b)": 0.5403726708074534,
        "domain": "3.3"
    },
    {
        "a": "The [Basal cell] [regulated] the differentiation of the [Melanocyte] in the epidermis.",
        "b": "The [Basal keratinocyte] [did not affect] the differentiation of the [pigment cell] in the epidermis.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8694623532120654,
        "token(a ~ b)": 0.6653846153846154,
        "domain": "3.3"
    },
    {
        "a": "[Immunoglobulin E] [displayed] binding to [Eukaryotic elongation factor 1A] in the cytoplasm.",
        "b": "[IgE] [lacked (property)] binding to [eEF1A] in the cytoplasm.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7681003584229391,
        "token(a ~ b)": 0.4302211302211302,
        "domain": "3.3"
    },
    {
        "a": "[Sodium phosphate] [accelerated] the uptake of [Alanine] in the cell culture assay.",
        "b": "[Trisodium phosphate] [slowed down] the uptake of [Ala] in the cell culture assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7944889313350966,
        "token(a ~ b)": 0.5785953177257526,
        "domain": "3.3"
    },
    {
        "a": "[Acetophenone] [displayed] a strong interaction with [Ethyl acetate] in the reaction mixture.",
        "b": "[1-phenylethanone] [did not exhibit] a strong interaction with [EtOAc] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7924978010514043,
        "token(a ~ b)": 0.5140080045740423,
        "domain": "3.3"
    },
    {
        "a": "[Lysine] [activated] [Interleukin-37] signaling in macrophages.",
        "b": "[Lys] [suppressed] [IL-37] signaling in macrophages.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.840346127302649,
        "token(a ~ b)": 0.6703296703296704,
        "domain": "3.3"
    },
    {
        "a": "[Epinephrine] [bound] to [Burst-forming unit-erythroid] in the bone marrow.",
        "b": "[Adrenaline] [did not interact] with [BFU-E] in the bone marrow.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.6942521367521367,
        "token(a ~ b)": 0.3959441489361702,
        "domain": "3.3"
    },
    {
        "a": "[Leucine] [activated] the [cyanide ion] in the reaction mixture.",
        "b": "[Leu] [inactivated] the [CN-] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8619893790849673,
        "token(a ~ b)": 0.6415362731152205,
        "domain": "3.3"
    },
    {
        "a": "[Hydride ion] [induced] the activity of [1-Decyne] in the reaction mixture.",
        "b": "[H-] [prevented] the activity of [C10H18] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7826772993088782,
        "token(a ~ b)": 0.46212121212121215,
        "domain": "3.3"
    },
    {
        "a": "[Nitrous oxide] [accelerated] the breakdown of [singlet oxygen] in solution.",
        "b": "[N2O] [slowed down] the breakdown of [dioxygen (1\u0394g)] in solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.784688995215311,
        "token(a ~ b)": 0.3896057347670251,
        "domain": "3.3"
    },
    {
        "a": "[Interleukin-22] [was overexpressed] in [Interleukin-35] stimulated cells.",
        "b": "[IL-22] [was underexpressed] in [IL-35] stimulated cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8052508648999877,
        "token(a ~ b)": 0.6945652173913044,
        "domain": "3.3"
    },
    {
        "a": "[Interleukin-22] [was positively associated with] [Sodium-Iodide Symporter] expression in thyroid cells.",
        "b": "[IL-22] [was negatively associated with] [NIS] expression in thyroid cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7734628626459613,
        "token(a ~ b)": 0.5574712643678161,
        "domain": "3.3"
    },
    {
        "a": "[Sulfur trioxide] [bound] to [Dimethyl carbonate] in the reaction mixture.",
        "b": "[SO3] [uncoupled] from [DMC] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7700379624907927,
        "token(a ~ b)": 0.39102564102564097,
        "domain": "3.3"
    },
    {
        "a": "[Styrene] [was positively associated with] [Lithium chloride] accumulation in the rat brain.",
        "b": "[phenylethene] [was negatively associated with] [LiCl] accumulation in the rat brain.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7864880260404559,
        "token(a ~ b)": 0.5555555555555556,
        "domain": "3.3"
    },
    {
        "a": "[Benzaldehyde] [was linked to] [FADH2] in the reaction mixture.",
        "b": "[benzenecarbaldehyde] [was not linked] to [Flavin adenine dinucleotide] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.6979223681809889,
        "token(a ~ b)": 0.4371811224489796,
        "domain": "3.3"
    },
    {
        "a": "[Peroxynitrite] [emerged] in the presence of [Undecane].",
        "b": "[ONOO\u2212] [disappeared] in the presence of [n-undecane].",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.6922559900202176,
        "token(a ~ b)": 0.4551282051282051,
        "domain": "3.3"
    },
    {
        "a": "[6-phosphogluconate dehydrogenase] [was overexpressed] in [peroxisome] during the experiment.",
        "b": "[PGD] [was underexpressed] in [P] during the experiment.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.6818011737366576,
        "token(a ~ b)": 0.46908602150537637,
        "domain": "3.3"
    },
    {
        "a": "[Norepinephrine] [was genetically associated with] [Epinephrine] in the developing neural tissue.",
        "b": "[Noradrenaline] [was not genetically correlated with] [Adrenaline] in the developing neural tissue.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8646219624994641,
        "token(a ~ b)": 0.5933333333333333,
        "domain": "3.3"
    },
    {
        "a": "[Ziv-aflibercept] [was used] in the [Multiple Sclerosis] clinical trial.",
        "b": "[Zaltrap] [was not employed] in the [MS] clinical trial.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7781512605042018,
        "token(a ~ b)": 0.511441647597254,
        "domain": "3.3"
    },
    {
        "a": "[Sertraline] [improved] the symptoms of [Oxycodone] withdrawal in patients.",
        "b": "[Zoloft] [worsened] the symptoms of [Oxy] withdrawal in patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7878335435056746,
        "token(a ~ b)": 0.474025974025974,
        "domain": "3.3"
    },
    {
        "a": "[Magnesium] [served as] a cofactor for [Chlorophyll a] in the photosynthetic reaction.",
        "b": "[Mg] [did not serve] as a cofactor for [Chl a] in the photosynthetic reaction.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8301965650802859,
        "token(a ~ b)": 0.651098901098901,
        "domain": "3.3"
    },
    {
        "a": "[Fluvastatin] [improved] the symptoms associated with [Imiquimod] therapy in patients.",
        "b": "[Lescol] [worsened] the symptoms associated with [Aldara] therapy in patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7669518550206115,
        "token(a ~ b)": 0.5007763975155279,
        "domain": "3.3"
    },
    {
        "a": "[Evolocumab] [improved] the efficacy of [Warfarin] in patients with hyperlipidemia.",
        "b": "[Repatha] [worsened] the efficacy of [Coumadin] in patients with hyperlipidemia.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8126549053356282,
        "token(a ~ b)": 0.5456730769230769,
        "domain": "3.3"
    },
    {
        "a": "[Ethyl acetate] [was critical for] the activation of [Hypochlorous acid] in the reaction mixture.",
        "b": "[EtOAc] [was not required for] the activation of [HOCl] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8262726386179994,
        "token(a ~ b)": 0.4774193548387097,
        "domain": "3.3"
    },
    {
        "a": "[Copper] [bound] to [Nitryl iodide] in the reaction vessel.",
        "b": "[Cu] [did not bind] to [NO2I] in the reaction vessel.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8195696976157482,
        "token(a ~ b)": 0.511441647597254,
        "domain": "3.3"
    },
    {
        "a": "[Zinc sulfate] [identified] [Sulfite] in the reaction mixture.",
        "b": "[ZnSO4] [obscured] [SO3^2-] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.6702424902660938,
        "token(a ~ b)": 0.4487179487179487,
        "domain": "3.3"
    },
    {
        "a": "[Eukaryotic elongation factor 1A] [served as] a scaffold for [Tumor-associated Macrophage] recruitment in the tumor microenvironment.",
        "b": "[eEF1A] [did not serve] as a scaffold for [TAM] recruitment in the tumor microenvironment.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7520568466621099,
        "token(a ~ b)": 0.5213009619789282,
        "domain": "3.3"
    },
    {
        "a": "The presence of [Tucatinib] [identified] [Ramucirumab] in plasma samples.",
        "b": "The presence of [Tukysa] [obscured] [Cyramza] in plasma samples.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8789235678704856,
        "token(a ~ b)": 0.4895330112721417,
        "domain": "3.3"
    },
    {
        "a": "[Calcium] [orchestrated] the release of [Potassium] ions in the synaptic cleft.",
        "b": "[Ca] [disorganized] the release of [K] ions in the synaptic cleft.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8258799868366168,
        "token(a ~ b)": 0.6329625884732053,
        "domain": "3.3"
    },
    {
        "a": "[Vitamin B12] [affected] [Magnesium chloride] uptake in the experimental assay.",
        "b": "[Cobalamin] [did not affect] [MgCl2] uptake in the experimental assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8007914869940187,
        "token(a ~ b)": 0.4164408310749774,
        "domain": "3.3"
    },
    {
        "a": "[Paroxetine] [improved] the clinical response to [Finasteride] in patients with depression.",
        "b": "[Paxil] [worsened] the clinical response to [5\u03b1-reductase inhibitor] in patients with depression.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.860331409180606,
        "token(a ~ b)": 0.46908602150537637,
        "domain": "3.3"
    },
    {
        "a": "[Diethylamine] [prolonged] the degradation time of [messenger RNA] in vitro.",
        "b": "[N,N-diethanamine] [shortened] the degradation time of [mRNA] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7767861555296692,
        "token(a ~ b)": 0.5218855218855218,
        "domain": "3.3"
    },
    {
        "a": "[Iodide ion] [was essential in] the function of [Bromide ion] transport in the renal tissue.",
        "b": "[I-] [was not essential in] the function of [Br-] transport in the renal tissue.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.835699228307924,
        "token(a ~ b)": 0.6925025329280649,
        "domain": "3.3"
    },
    {
        "a": "[Paracetamol] [produced] [Lenvatinib] in the in vitro assay.",
        "b": "[Acetaminophen] [degraded] [Lenvima] in the in vitro assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7966749750747757,
        "token(a ~ b)": 0.5104895104895105,
        "domain": "3.3"
    },
    {
        "a": "[Hexane] [induced] the activity of [Triethylamine] in solution.",
        "b": "[n-hexane] [prevented] the activity of [N,N-Diethylethanamine] in solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7625864661654136,
        "token(a ~ b)": 0.474025974025974,
        "domain": "3.3"
    },
    {
        "a": "[Dihydroxyacetone] [increased] [Sulfite] concentrations in the reaction mixture.",
        "b": "[DHA] [decreased] [SO3^2-] concentrations in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7887228214346858,
        "token(a ~ b)": 0.487510766580534,
        "domain": "3.3"
    },
    {
        "a": "[Nitrite] [was selected] for reaction with [3-Hexyne] in the experimental setup.",
        "b": "[Nitrite ion] [was not selected] for reaction with [hex-3-yne] in the experimental setup.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8940154316597924,
        "token(a ~ b)": 0.7242553191489361,
        "domain": "3.3"
    },
    {
        "a": "In the experimental setup, [Nitrite] [produced] [Potassium] ions in solution.",
        "b": "In the experimental setup, [Nitrite ion] [degraded] [K] ions in solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.915796573085471,
        "token(a ~ b)": 0.7142857142857143,
        "domain": "3.3"
    },
    {
        "a": "The [GAR1 Ribonucleoprotein] [was employed] in the isolation of [Follicular dendritic cell] populations from human tonsils.",
        "b": "The [GAR1] [was not employed] in the isolation of [FDC] populations from human tonsils.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8512607397879253,
        "token(a ~ b)": 0.6867055084745763,
        "domain": "3.3"
    },
    {
        "a": "Treatment with [Tivozanib] markedly [broadened] the activity profile of the [Gemtuzumab ozogamicin] in vitro.",
        "b": "Treatment with [Fotivda] markedly [narrowed] the activity profile of the [Mylotarg] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8799354722652601,
        "token(a ~ b)": 0.43658326143226917,
        "domain": "3.3"
    },
    {
        "a": "[Glucose-regulated protein 78] [contained] [Sedoheptulose-7-phosphate] in the cytosolic fraction.",
        "b": "[BiP] [excluded] [S7P] in the cytosolic fraction.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.5905367427333016,
        "token(a ~ b)": 0.4411764705882353,
        "domain": "3.3"
    },
    {
        "a": "[Leuprolide] [ameliorated] symptoms of [Spinal Muscular Atrophy] in pediatric patients.",
        "b": "[leuprorelin] [aggravated] symptoms of [SMA] in pediatric patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7853818193515183,
        "token(a ~ b)": 0.4492753623188406,
        "domain": "3.3"
    },
    {
        "a": "[Nitric oxide] [was capable] of activating [Interleukin-1 receptor antagonist] in inflamed tissues.",
        "b": "[NO] [was incapable] of activating [IL-1Ra] in inflamed tissues.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7627387260583982,
        "token(a ~ b)": 0.5403726708074534,
        "domain": "3.3"
    },
    {
        "a": "In the recent experiment, [Atezolizumab] [augmented] the binding affinity of [Desirudin] to its target protein.",
        "b": "In the recent experiment, [Tecentriq] [suppressed] the binding affinity of [Iprivask] to its target protein.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8774859966349329,
        "token(a ~ b)": 0.5148287385129491,
        "domain": "3.3"
    },
    {
        "a": "[Dimethylamine] [bound] to [Dinitrogen pentoxide] in aqueous solution.",
        "b": "[N-methylmethanamine] [did not bind] to [N2O5] in aqueous solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7621748400852879,
        "token(a ~ b)": 0.46130268199233715,
        "domain": "3.3"
    },
    {
        "a": "[Cetuximab] [displayed] affinity for [Hydromorphone] in the assay.",
        "b": "[Erbitux] [did not display] affinity for [Dilaudid] in the assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7436713286713287,
        "token(a ~ b)": 0.41666666666666663,
        "domain": "3.3"
    },
    {
        "a": "[Lithium aluminum hydride] [was employed] in the reduction of [N-acetylcysteine] during the synthesis process.",
        "b": "[LiAlH4] [was not employed] in the reduction of [NAC] during the synthesis process.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.819193136181088,
        "token(a ~ b)": 0.5117845117845118,
        "domain": "3.3"
    },
    {
        "a": "[Acetoacetate] [accelerated] the breakdown of [Chlorine dioxide] in solution.",
        "b": "[acetoacetic acid] [slowed down] the breakdown of [ClO2] in solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7804784976594233,
        "token(a ~ b)": 0.4550224887556222,
        "domain": "3.3"
    },
    {
        "a": "[Vilazodone] [improved] the efficacy of [Pravastatin] in patients with hyperlipidemia.",
        "b": "[Viibryd] [worsened] the efficacy of [pravastatin sodium] in patients with hyperlipidemia.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8644616709732988,
        "token(a ~ b)": 0.5745798319327731,
        "domain": "3.3"
    },
    {
        "a": "[Nitrous acid] [broadened] the metabolic effects of [Phenethylamine] in neural tissue.",
        "b": "[HNO2] [narrowed] the metabolic effects of [2-phenylethan-1-amine] in neural tissue.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7797490101488189,
        "token(a ~ b)": 0.4411057692307692,
        "domain": "3.3"
    },
    {
        "a": "[Dendritic epidermal T cell] [bound] to [Sodium-Iodide Symporter] in the epidermal tissue.",
        "b": "[DETC] [did not bind] to [NIS] in the epidermal tissue.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.6936415436415437,
        "token(a ~ b)": 0.42129032258064514,
        "domain": "3.3"
    },
    {
        "a": "[Calcitonin gene-related peptide] [admitted] [Hydrazine] into the experimental assay.",
        "b": "[CGRP] [rejected] [N2H4] into the experimental assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.6653525068764176,
        "token(a ~ b)": 0.37962962962962965,
        "domain": "3.3"
    },
    {
        "a": "[Lithium] [accelerated] the reaction rate of [2-Butyne] in the presence of a catalyst.",
        "b": "[Li] [slowed down] the reaction rate of [dimethylacetylene] in the presence of a catalyst.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8449079946754365,
        "token(a ~ b)": 0.4851116625310174,
        "domain": "3.3"
    },
    {
        "a": "[Granulocyte-Macrophage Colony-Stimulating Factor] [broadened] the contractile range of [Fast-twitch muscle fiber] in vitro.",
        "b": "[GM-CSF] [narrowed] the contractile range of [Type II muscle fiber] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.694902276983585,
        "token(a ~ b)": 0.44252873563218387,
        "domain": "3.3"
    },
    {
        "a": "[Molybdate] [shortened] the activity of [Coenzyme A] in mitochondria.",
        "b": "[tetraoxomolybdate(VI)] [extended] the activity of [CoA] in mitochondria.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7732793719915251,
        "token(a ~ b)": 0.5582298136645962,
        "domain": "3.3"
    },
    {
        "a": "[Imatinib] [improved] the efficacy of [Idelalisib] in resistant leukemia cells.",
        "b": "[Gleevec] [worsened] the efficacy of [Zydelig] in resistant leukemia cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7818504746835443,
        "token(a ~ b)": 0.4550224887556222,
        "domain": "3.3"
    },
    {
        "a": "[Nonane] [contained] [Estradiol] in the experimental mixture.",
        "b": "[n-Nonane] [did not contain] [17\u03b2-estradiol] in the experimental mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8116573096788681,
        "token(a ~ b)": 0.5805938494167551,
        "domain": "3.3"
    },
    {
        "a": "[Blinatumomab] [improved] the efficacy of [Diethylstilbestrol] in clinical trials.",
        "b": "[Blincyto] [worsened] the efficacy of [DES] in clinical trials.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8393835022094064,
        "token(a ~ b)": 0.41666666666666663,
        "domain": "3.3"
    },
    {
        "a": "[Phenylalanine] [was linked to] [Progesterone] metabolism in the human liver.",
        "b": "[Phe] [was not linked] [Pregn-4-ene-3,20-dione] metabolism in the human liver.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8627470568647039,
        "token(a ~ b)": 0.4064171122994652,
        "domain": "3.3"
    },
    {
        "a": "[Darolutamide] [improved] the efficacy of [Clopidogrel] in stroke prevention.",
        "b": "[Nubeqa] [worsened] the efficacy of [Plavix] in stroke prevention.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7551276309896999,
        "token(a ~ b)": 0.4397840531561462,
        "domain": "3.3"
    },
    {
        "a": "[Vasopressin] [was overexpressed] in [Lysine] treated cells.",
        "b": "[arginine vasopressin] [was underexpressed] in [Lys] treated cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8307359752959341,
        "token(a ~ b)": 0.7362579281183932,
        "domain": "3.3"
    },
    {
        "a": "[Erucic acid] [broadened] the efficacy of [Hexadecane] in the experimental assay.",
        "b": "[cis-13-docosenoic acid] [narrowed] the efficacy of [n-Hexadecane] in the experimental assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.82511717673008,
        "token(a ~ b)": 0.5335497835497836,
        "domain": "3.3"
    },
    {
        "a": "[Nitrate] [was employed] to treat [Phenylketonuria] in pediatric patients.",
        "b": "[NO3-] [was not employed] to treat [PKU] in pediatric patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.796382849014428,
        "token(a ~ b)": 0.5018315018315018,
        "domain": "3.3"
    },
    {
        "a": "[Transforming Growth Factor Beta] [was genetically correlated with] [Granulocyte-Macrophage Colony-Stimulating Factor] in the patient samples.",
        "b": "[TGF-\u03b2] [was not genetically correlated with] [GM-CSF] in the patient samples.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.683014642058378,
        "token(a ~ b)": 0.41203703703703703,
        "domain": "3.3"
    },
    {
        "a": "[Lithium] [was capable] of interacting with [Nitrosyl chloride] under standard laboratory conditions.",
        "b": "[Li] [was incapable] of interacting with [NOCl] under standard laboratory conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8425857635978806,
        "token(a ~ b)": 0.570630081300813,
        "domain": "3.3"
    },
    {
        "a": "[Chlorophyll a] [was critical for] the function of [Methanol] metabolism in the cell.",
        "b": "[Chl a] [was not required for] the function of [CH3OH] metabolism in the cell.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8461236802413273,
        "token(a ~ b)": 0.6266061980347695,
        "domain": "3.3"
    },
    {
        "a": "[Oxamide] [was genetically correlated with] [Tin(II) ion] concentration in solution.",
        "b": "[ethanediamide] [was not genetically correlated with] [Sn2+] concentration in solution.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7992870106300234,
        "token(a ~ b)": 0.4918831168831169,
        "domain": "3.3"
    },
    {
        "a": "[Trichloroethylene] [produced] [4-Octyne] in the reaction mixture.",
        "b": "[1,1,2-Trichloroethene] [degraded] [oct-4-yne] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8062483994878361,
        "token(a ~ b)": 0.5,
        "domain": "3.3"
    },
    {
        "a": "The compound [Acrolein] [contained] traces of [heptadecanoic acid] after the reaction.",
        "b": "The compound [propenal] [did not contain] traces of [margaric acid] after the reaction.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9071022775335912,
        "token(a ~ b)": 0.5476190476190476,
        "domain": "3.3"
    },
    {
        "a": "In the recent experiment, [Nitrosyl chloride] [replaced] [Malate] in the reaction mixture.",
        "b": "In the recent experiment, [NOCl] [did not replace] [malic acid] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.9019364531389847,
        "token(a ~ b)": 0.537037037037037,
        "domain": "3.3"
    },
    {
        "a": "[Acetic anhydride] [was capable] of reacting with [sulfite] under acidic conditions.",
        "b": "[Ethanoic anhydride] [was incapable] of reacting with [SO3^2-] under acidic conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8024778325123153,
        "token(a ~ b)": 0.5591397849462365,
        "domain": "3.3"
    },
    {
        "a": "[Thiol] [broadened] the activity range of [Arginine] in the cellular assay.",
        "b": "[mercaptan] [narrowed] the activity range of [Arg] in the cellular assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7877636986301371,
        "token(a ~ b)": 0.6136363636363636,
        "domain": "3.3"
    },
    {
        "a": "[Dacarbazine] [was critical for] the efficacy of [Zidovudine] in combination therapy.",
        "b": "[DTIC] [was not required for] the efficacy of [AZT] in combination therapy.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8158954248366013,
        "token(a ~ b)": 0.5075396825396825,
        "domain": "3.3"
    },
    {
        "a": "[Substance P] [was positively associated with] [Methionine] levels in the plasma.",
        "b": "[SP] [was negatively associated with] [Met] levels in the plasma.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8274303577081354,
        "token(a ~ b)": 0.608974358974359,
        "domain": "3.3"
    },
    {
        "a": "[Ibrutinib] [induced] the binding of [Trastuzumab] in the in vitro assay.",
        "b": "[Imbruvica] [blocked] the binding of [Herceptin] in the in vitro assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8045301948678372,
        "token(a ~ b)": 0.5025510204081632,
        "domain": "3.3"
    },
    {
        "a": "[Formate] [increased] the activity of [Docosane] in the catalytic assay.",
        "b": "[HCOO-] [suppressed] the activity of [n-docosane] in the catalytic assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7720647129276142,
        "token(a ~ b)": 0.5785953177257526,
        "domain": "3.3"
    },
    {
        "a": "[Benzylamine] [replaced] [Crotonaldehyde] in the reaction mixture.",
        "b": "[phenylmethanamine] [did not replace] [2-butenal] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7751676175404989,
        "token(a ~ b)": 0.487510766580534,
        "domain": "3.3"
    },
    {
        "a": "[Colestipol] [suppressed] the activity of [Baloxavir marboxil] in vitro.",
        "b": "[Colestid] [stimulated] the activity of [Xofluza] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8400382186773014,
        "token(a ~ b)": 0.474025974025974,
        "domain": "3.3"
    },
    {
        "a": "[Beta-hydroxybutyrate] [was genetically correlated with] [Testosterone] levels in plasma.",
        "b": "[BHB] [was not genetically correlated with] [Androst-4-en-17\u03b2-ol-3-one] levels in plasma.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7603430494490582,
        "token(a ~ b)": 0.4411057692307692,
        "domain": "3.3"
    },
    {
        "a": "[Nitrosyl fluoride] [was mixed with] [N,N-Dimethylacetamide] in the experimental conditions.",
        "b": "[Nitrogen oxyfluoride] [was not combined with] [Dimethylacetamide] in the experimental conditions.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8857225397742514,
        "token(a ~ b)": 0.5733333333333334,
        "domain": "3.3"
    },
    {
        "a": "[Vitamin B12] [produced] significant alterations in [Zinc sulfate] levels in the experimental assay.",
        "b": "[Cobalamin] [degraded] significant alterations in [ZnSO4] levels in the experimental assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8250360121805905,
        "token(a ~ b)": 0.5155775075987842,
        "domain": "3.3"
    },
    {
        "a": "[Rituximab] [improved] the therapeutic efficacy of [Zolpidem] in insomnia patients.",
        "b": "[Rituxan] [worsened] the therapeutic efficacy of [Ambien] in insomnia patients.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8719579333558158,
        "token(a ~ b)": 0.5978260869565217,
        "domain": "3.3"
    },
    {
        "a": "In the clinical trial, [Piroxicam] [was sufficient for] the inhibition of [Clopidogrel] metabolism.",
        "b": "In the clinical trial, [Feldene] [was not sufficient for] the inhibition of [Plavix] metabolism.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8851731601731602,
        "token(a ~ b)": 0.5998698763825634,
        "domain": "3.3"
    },
    {
        "a": "[Somatostatin] [inhibited] the expression of [Interleukin-23] in activated T cells.",
        "b": "[SST] [stimulated] the expression of [IL-23] in activated T cells.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7959383967934298,
        "token(a ~ b)": 0.6155555555555556,
        "domain": "3.3"
    },
    {
        "a": "[Sorafenib] [improved] the efficacy of [Entrectinib] in clinical trials.",
        "b": "[Nexavar] [worsened] the efficacy of [Rozlytrek] in clinical trials.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7731811145510836,
        "token(a ~ b)": 0.42183908045977014,
        "domain": "3.3"
    },
    {
        "a": "[Palmitic acid] [affected] the metabolic activity of [Benzylamine] in vitro.",
        "b": "[hexadecanoic acid] [did not affect] the metabolic activity of [phenylmethanamine] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7814931350114417,
        "token(a ~ b)": 0.5883180858550316,
        "domain": "3.3"
    },
    {
        "a": "[Ammonium nitrate] [displayed] a strong interaction with [N,N-Dimethylacetamide] in the reaction mixture.",
        "b": "[NH4NO3] [did not exhibit] a strong interaction with [Dimethylacetamide] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7831608348991926,
        "token(a ~ b)": 0.509090909090909,
        "domain": "3.3"
    },
    {
        "a": "[Sulfate] [increased] the activity of [Fumarate] in the mitochondrial assay.",
        "b": "[sulfate ion] [decreased] the activity of [fumaric acid] in the mitochondrial assay.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8214749201771552,
        "token(a ~ b)": 0.6603864734299516,
        "domain": "3.3"
    },
    {
        "a": "[Superoxide dismutase] [broadened] the differentiation capacity of [Dental Pulp Stem Cell] in vitro.",
        "b": "[SOD] [restricted] the differentiation capacity of [DPSC] in vitro.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.7712263681592039,
        "token(a ~ b)": 0.41666666666666663,
        "domain": "3.3"
    },
    {
        "a": "[Chlorophyll b] [included] [aniline] in the extraction mixture.",
        "b": "[Chl b] [excluded] [phenylamine] in the extraction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8955893071147308,
        "token(a ~ b)": 0.569377990430622,
        "domain": "3.3"
    },
    {
        "a": "[Dimethylamine] [produced] [Nonadecanoic acid] during the enzymatic reaction.",
        "b": "[N-methylmethanamine] [degraded] [Nonadecylic acid] during the enzymatic reaction.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.8302534051314538,
        "token(a ~ b)": 0.6041666666666667,
        "domain": "3.3"
    },
    {
        "a": "[Hydrogen phosphate] [produced] [1,4-Benzoquinone] in the reaction mixture.",
        "b": "[monohydrogen phosphate] [degraded] [para-benzoquinone] in the reaction mixture.",
        "a -> b": -1.0,
        "b -> a": -1.0,
        "char(a ~ b)": 0.790235294117647,
        "token(a ~ b)": 0.5883180858550316,
        "domain": "3.3"
    },
    {
        "a": "[Gastrin-releasing peptide] [replaced] [sodium phosphate] in the reaction mixture.",
        "b": "[Interleukin-23] [replaced] [sodium phosphate] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7839730177071297,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "4.1"
    },
    {
        "a": "[Leucine] [preceded] [Hydrogen sulfide] in the experimental reaction sequence.",
        "b": "[Pyruvate dehydrogenase] [preceded] [Hydrogen sulfide] in the experimental reaction sequence.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7943970223325061,
        "token(a ~ b)": 0.695447409733124,
        "domain": "4.1"
    },
    {
        "a": "[Dinitrogen pentoxide] [was critical for] the synthesis of [octadecane] in the experimental setup.",
        "b": "[T lymphocyte] [was critical for] the synthesis of [octadecane] in the experimental setup.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7933989017293666,
        "token(a ~ b)": 0.75,
        "domain": "4.1"
    },
    {
        "a": "The presence of [Potassium nitrate] [was positively associated with] [Hydrogen phosphate] levels in solution.",
        "b": "[Glycine receptor] expression [was positively associated with] [Hydrogen phosphate] levels in solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7882853710796395,
        "token(a ~ b)": 0.6134259259259259,
        "domain": "4.1"
    },
    {
        "a": "[Dihydroxyacetone] [ameliorated] [Sickle Cell Disease] symptoms in the mouse model.",
        "b": "[Thyroxine] [ameliorated] [Sickle Cell Disease] symptoms in the mouse model.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8311369689283449,
        "token(a ~ b)": 0.6714402618657938,
        "domain": "4.1"
    },
    {
        "a": "[Vasopressin] [was sufficient for] [Avelumab] binding in the assay.",
        "b": "[Immunoglobulin E] [was sufficient for] [Avelumab] binding in the assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7981480310312842,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "4.1"
    },
    {
        "a": "[Nitrosyl bromide] [affected] [Benzamide] concentrations in the reaction mixture.",
        "b": "[Peptide YY] [affected] [Benzamide] concentrations in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8064021164021166,
        "token(a ~ b)": 0.6477272727272727,
        "domain": "4.1"
    },
    {
        "a": "[Singlet oxygen] [was associated with] [Dimethyl carbonate] in the reaction mixture.",
        "b": "[Immunoglobulin D] [was associated with] [Dimethyl carbonate] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8267215342796739,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "4.1"
    },
    {
        "a": "[Pentadecane] [affected] [Proline] concentrations in the experimental assay.",
        "b": "[Neutrophil] [affected] [Proline] concentrations in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8026229379418696,
        "token(a ~ b)": 0.6303258145363408,
        "domain": "4.1"
    },
    {
        "a": "[Cyclohexane] [contained] [nitrosyl iodide] under high-pressure conditions.",
        "b": "[Immunoglobulin M] [contained] [nitrosyl iodide] under high-pressure conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7849216417910448,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "4.1"
    },
    {
        "a": "[Allylamine] [replaced] [Nitrosyl sulfate] in the reaction mixture.",
        "b": "[Eukaryotic Initiation Factor 4E] [replaced] [Nitrosyl sulfate] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7433839557799675,
        "token(a ~ b)": 0.5725683890577508,
        "domain": "4.1"
    },
    {
        "a": "[Testosterone] [accelerated] the synthesis of [Oxamide] in vitro.",
        "b": "[Dystrophin] [accelerated] the synthesis of [Oxamide] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8094000252620943,
        "token(a ~ b)": 0.7749999999999999,
        "domain": "4.1"
    },
    {
        "a": "[Formic acid] [was employed] to treat [Huntington's Disease] in the mouse model.",
        "b": "[Somatostatin] [was employed] to treat [Huntington's Disease] in the mouse model.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8167231100963979,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "4.1"
    },
    {
        "a": "[Calcium carbonate] [bound] to [Hydrogen iodide] in the reaction mixture.",
        "b": "[11-Deoxycorticosterone] [bound] to [Hydrogen iodide] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.773230044783983,
        "token(a ~ b)": 0.691304347826087,
        "domain": "4.1"
    },
    {
        "a": "[Coenzyme A] [replaced] [Nitroxyl] in the catalytic assay.",
        "b": "[Norepinephrine] [replaced] [Nitroxyl] in the catalytic assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7878861127748782,
        "token(a ~ b)": 0.6856984478935699,
        "domain": "4.1"
    },
    {
        "a": "[Heptane] [induced] the production of [hydrogen sulfide] in the reaction mixture.",
        "b": "[Dopaminergic neuron] [induced] the production of [hydrogen sulfide] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.818317378219379,
        "token(a ~ b)": 0.7167553191489362,
        "domain": "4.1"
    },
    {
        "a": "[Alkoxyl radical] [was critical for] the activity of [Hypochlorite] in solution.",
        "b": "[transaldolase] [was critical for] the activity of [Hypochlorite] in solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8260897435897436,
        "token(a ~ b)": 0.7350863422291993,
        "domain": "4.1"
    },
    {
        "a": "[Selenocysteine] [exhibited] enzymatic activity similar to [Hexose-6-phosphate dehydrogenase] in vitro.",
        "b": "[VE-cadherin] [exhibited] enzymatic activity similar to [Hexose-6-phosphate dehydrogenase] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8079383025367993,
        "token(a ~ b)": 0.7267552182163188,
        "domain": "4.1"
    },
    {
        "a": "[Perchlorate] [replaced] [ethyl acetate] in the extraction protocol.",
        "b": "[Tumor Protein p53] [replaced] [ethyl acetate] in the extraction protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8381084866378985,
        "token(a ~ b)": 0.6846153846153846,
        "domain": "4.1"
    },
    {
        "a": "[Sodium phosphate] [joined] [Mannose] in the reaction mixture.",
        "b": "[Epidermal stem cell] [joined] [Mannose] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7781570042860365,
        "token(a ~ b)": 0.6533783783783784,
        "domain": "4.1"
    },
    {
        "a": "The administration of [Rivaroxaban] [was overexpressed] in [Interneuron] populations during the experiment.",
        "b": "The presence of [Slow-twitch muscle fiber] [was overexpressed] in [Interneuron] populations during the experiment.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8466670897926154,
        "token(a ~ b)": 0.6997978436657681,
        "domain": "4.1"
    },
    {
        "a": "[Tryptophan] [improved] the efficacy of [Ibrutinib] in clinical trials.",
        "b": "[Tankyrase 2] [improved] the efficacy of [Ibrutinib] in clinical trials.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8701095461658841,
        "token(a ~ b)": 0.7796985815602837,
        "domain": "4.1"
    },
    {
        "a": "[Isobutane] [was critical for] the synthesis of [N,N-Dimethylacetamide] in the industrial process.",
        "b": "[Adipose-Derived Stem Cell] [was critical for] the synthesis of [N,N-Dimethylacetamide] in the industrial process.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7939468486885417,
        "token(a ~ b)": 0.7225806451612904,
        "domain": "4.1"
    },
    {
        "a": "[1-Hexyne] [affected] [Heptadecane] levels under experimental conditions.",
        "b": "[Stratum granulosum cell] [affected] [Heptadecane] levels under experimental conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7694231984535603,
        "token(a ~ b)": 0.678030303030303,
        "domain": "4.1"
    },
    {
        "a": "[Docosane] [regulated] [myoglobin] expression in cardiac tissue.",
        "b": "[Interleukin-10] [regulated] [myoglobin] expression in cardiac tissue.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7859636699507389,
        "token(a ~ b)": 0.6533783783783784,
        "domain": "4.1"
    },
    {
        "a": "[Hexane] [joined] [Platinum(II) ion] complexes in solution.",
        "b": "[VE-cadherin] [joined] [Platinum(II) ion] complexes in solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8133171912832932,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "4.1"
    },
    {
        "a": "[Sodium phosphate] [induced] the expression of [Dystrophin] in muscle tissue.",
        "b": "[Immunoglobulin E] [induced] the expression of [Dystrophin] in muscle tissue.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7877495638689668,
        "token(a ~ b)": 0.7125,
        "domain": "4.1"
    },
    {
        "a": "[Carbon dioxide] [demonstrated] an effect on [Lovastatin] metabolism in vitro.",
        "b": "[Adrenocorticotropic Hormone] [demonstrated] an effect on [Lovastatin] metabolism in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8022504892367905,
        "token(a ~ b)": 0.7350863422291993,
        "domain": "4.1"
    },
    {
        "a": "[Potassium sulfate] [bound] to [Ozone] under acidic conditions.",
        "b": "[Megakaryocyte-erythroid progenitor] [bound] to [Ozone] under acidic conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7374206349206349,
        "token(a ~ b)": 0.5170731707317073,
        "domain": "4.1"
    },
    {
        "a": "[2-Heptyne] [coordinated] the conversion of [Sulfur trioxide] in the reaction mixture.",
        "b": "[Epidermal Growth Factor Receptor] [coordinated] the conversion of [Sulfur trioxide] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7684568823143606,
        "token(a ~ b)": 0.6819923371647509,
        "domain": "4.1"
    },
    {
        "a": "[1-Nonyne] [affected] [Nitryl bromide] concentration in solution.",
        "b": "[Sodium-Dependent Vitamin C Transporter] [affected] [Nitryl bromide] concentration in solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7416207391928954,
        "token(a ~ b)": 0.5716783216783217,
        "domain": "4.1"
    },
    {
        "a": "[Butyric acid] [ameliorated] the cytotoxicity of [Docetaxel] in cultured cells.",
        "b": "[Heat shock factor 1] [ameliorated] the cytotoxicity of [Docetaxel] in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8044690923901427,
        "token(a ~ b)": 0.7543800539083558,
        "domain": "4.1"
    },
    {
        "a": "[Tridecane] [affected] [Trichloroethylene] metabolism in vitro.",
        "b": "[Interleukin-8] [affected] [Trichloroethylene] metabolism in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8230975871249081,
        "token(a ~ b)": 0.6764069264069263,
        "domain": "4.1"
    },
    {
        "a": "[Manganese(II) ion] [joined] [small nucleolar RNA] molecules in the experimental mixture.",
        "b": "[Interleukin-27] [joined] [small nucleolar RNA] molecules in the experimental mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.827322063878113,
        "token(a ~ b)": 0.6055555555555556,
        "domain": "4.1"
    },
    {
        "a": "[Calcitonin gene-related peptide] [induced] [Tuberous sclerosis complex] formation in neuronal cells.",
        "b": "[Pancreatic polypeptide] [induced] [Tuberous sclerosis complex] formation in neuronal cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8256153876257191,
        "token(a ~ b)": 0.6527777777777778,
        "domain": "4.1"
    },
    {
        "a": "[Bromine monoxide] [produced] [Formate] in the catalytic reaction.",
        "b": "[Regulatory B cell] [produced] [Formate] in the catalytic reaction.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7874345803450281,
        "token(a ~ b)": 0.6477272727272727,
        "domain": "4.1"
    },
    {
        "a": "[1-Octyne] [bound] to [Triethylamine] under standard laboratory conditions.",
        "b": "[Mesenchymal Stem Cell] [bound] to [Triethylamine] under standard laboratory conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8001212121212121,
        "token(a ~ b)": 0.6267232237539766,
        "domain": "4.1"
    },
    {
        "a": "[Dinitrogen pentoxide] [suppressed] [Titanium(II) ion] uptake in cultured cells.",
        "b": "[Corneocyte] [suppressed] [Titanium(II) ion] uptake in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8085421108742005,
        "token(a ~ b)": 0.7125,
        "domain": "4.1"
    },
    {
        "a": "[Succinic acid] [joined] [Allylamine] molecules in solution.",
        "b": "[Inositol-requiring enzyme 1] [joined] [Allylamine] molecules in solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7440158082610913,
        "token(a ~ b)": 0.570630081300813,
        "domain": "4.1"
    },
    {
        "a": "[Carbon dioxide] [bound] to [n-pentadecane] under high pressure conditions.",
        "b": "[Glucagon-like peptide-1] [bound] to [n-pentadecane] under high pressure conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8006894409937888,
        "token(a ~ b)": 0.7242553191489361,
        "domain": "4.1"
    },
    {
        "a": "[Citrate] [established] the role of [Vancomycin] in antibiotic therapy.",
        "b": "[Phosphofructokinase, liver type] [established] the role of [Vancomycin] in antibiotic therapy.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7839701366091284,
        "token(a ~ b)": 0.6041666666666667,
        "domain": "4.1"
    },
    {
        "a": "[Lithium aluminum hydride] [produced] [beryllium ion] under standard laboratory conditions.",
        "b": "[Glyceraldehyde 3-phosphate dehydrogenase] [produced] [beryllium ion] under standard laboratory conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7455353291568245,
        "token(a ~ b)": 0.5108173076923077,
        "domain": "4.1"
    },
    {
        "a": "The [Pentane] [was found in] the [Potassium sulfate] solution during the experiment.",
        "b": "The [Calcium phosphate] [was found in] the [Potassium sulfate] solution during the experiment.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8806889564336373,
        "token(a ~ b)": 0.7818181818181817,
        "domain": "4.1"
    },
    {
        "a": "[Selenocysteine] [detected] in [Nitrosyl thiocyanate] samples collected from the reaction mixture.",
        "b": "[transketolase] [detected] in [Nitrosyl thiocyanate] samples collected from the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8347400022657756,
        "token(a ~ b)": 0.7275862068965517,
        "domain": "4.1"
    },
    {
        "a": "[Calcium citrate] [served as] a cofactor for [magnesium sulfate] in the enzymatic reaction.",
        "b": "[Chloroplast] [served as] a cofactor for [magnesium sulfate] in the enzymatic reaction.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8370788286497098,
        "token(a ~ b)": 0.8043326345213138,
        "domain": "4.1"
    },
    {
        "a": "[N,N-Dimethylacetamide] [replaced] [Phenylalanine] in the synthesis assay.",
        "b": "[Tumor Necrosis Factor-alpha] [replaced] [Phenylalanine] in the synthesis assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7728969594594594,
        "token(a ~ b)": 0.6209613869188337,
        "domain": "4.1"
    },
    {
        "a": "[Proline] [bound] [Camphor] in the experimental assay.",
        "b": "[Interneuron] [bound] [Camphor] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8353617308992561,
        "token(a ~ b)": 0.7815126050420168,
        "domain": "4.1"
    },
    {
        "a": "[Dehydroepiandrosterone] [was critical for] the function of [N,N-Dimethylacetamide] in the cellular assay.",
        "b": "[Interleukin-21] [was critical for] the function of [N,N-Dimethylacetamide] in the cellular assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8042504665146174,
        "token(a ~ b)": 0.6964729259811226,
        "domain": "4.1"
    },
    {
        "a": "[Phosphine] [activated] [Interleukin-32] expression in stimulated macrophages.",
        "b": "[Cholecystokinin] [activated] [Interleukin-32] expression in stimulated macrophages.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8283186813186814,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "4.1"
    },
    {
        "a": "[Hydrogen gas] [accelerated] the reduction of [hydroxide ion] in alkaline solution.",
        "b": "[Leuprolide] [accelerated] the reduction of [hydroxide ion] in alkaline solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8528621151271754,
        "token(a ~ b)": 0.78,
        "domain": "4.1"
    },
    {
        "a": "[N,N-Dimethylacetamide] [was genetically associated with] [Hexamethylphosphoramide] in the cell culture assay.",
        "b": "[Cytoskeleton] [was genetically associated with] [Hexamethylphosphoramide] in the cell culture assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8023217584916387,
        "token(a ~ b)": 0.7392857142857143,
        "domain": "4.1"
    },
    {
        "a": "[Dinitrogen trioxide] [suppressed] [Pyramidal neuron] activity in the prefrontal cortex.",
        "b": "[Interleukin-23] [suppressed] [Pyramidal neuron] activity in the prefrontal cortex.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7956318095347897,
        "token(a ~ b)": 0.6657142857142857,
        "domain": "4.1"
    },
    {
        "a": "The [Nitrosyl cation] [joined] the [Granular cell] population in the experimental assay.",
        "b": "The [Common myeloid progenitor] [joined] the [Granular cell] population in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.876096407895031,
        "token(a ~ b)": 0.6538120567375887,
        "domain": "4.1"
    },
    {
        "a": "[Ozone] [contained] [tert-Butylamine] in the reaction mixture.",
        "b": "[Granular cell] [contained] [tert-Butylamine] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8061376239943763,
        "token(a ~ b)": 0.8140243902439024,
        "domain": "4.1"
    },
    {
        "a": "[Tridecanoic acid] [regulated] [Bromate] concentration in the reaction mixture.",
        "b": "[Huntingtin] [regulated] [Bromate] concentration in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7855021517410975,
        "token(a ~ b)": 0.6703296703296704,
        "domain": "4.1"
    },
    {
        "a": "[2-Hexyne] [enhanced] the expression of [E-cadherin] in cultured cells.",
        "b": "[Phosphofructokinase, liver type] [enhanced] the expression of [E-cadherin] in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7670776325146816,
        "token(a ~ b)": 0.6445639187574671,
        "domain": "4.1"
    },
    {
        "a": "[Hydrogen sulfide] [inhibited] [Nitric acid] production in vitro.",
        "b": "[Bloom syndrome RecQ like helicase] [inhibited] [Nitric acid] production in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7714352720450283,
        "token(a ~ b)": 0.5371198568872988,
        "domain": "4.1"
    },
    {
        "a": "The compound [Cyclohexane] [was employed] to modify the pharmacokinetics of [Venlafaxine] in the experimental setup.",
        "b": "The compound [Vortioxetine] [was employed] to modify the pharmacokinetics of [Venlafaxine] in the experimental setup.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.899507542266163,
        "token(a ~ b)": 0.7834101382488479,
        "domain": "4.1"
    },
    {
        "a": "[Magnesium] [regulated] [dihydroxyacetone phosphate] levels in the cytoplasm.",
        "b": "[Interleukin-7] [regulated] [dihydroxyacetone phosphate] levels in the cytoplasm.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8180194805194806,
        "token(a ~ b)": 0.7148148148148148,
        "domain": "4.1"
    },
    {
        "a": "[Allylamine] [improved] the efficacy of [Relugolix] in hormone therapy.",
        "b": "[Atezolizumab] [improved] the efficacy of [Relugolix] in hormone therapy.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8595761305377415,
        "token(a ~ b)": 0.6634615384615384,
        "domain": "4.1"
    },
    {
        "a": "[Acetaldehyde] [was employed] in the synthesis of [Entrectinib].",
        "b": "[Sodium-lithium countertransporter] [was employed] in the synthesis of [Entrectinib].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7630147058823529,
        "token(a ~ b)": 0.6171428571428572,
        "domain": "4.1"
    },
    {
        "a": "[Hypochlorous acid] [contained] [Glutamine] in the reaction mixture.",
        "b": "[NOP10 ribonucleoprotein] [contained] [Glutamine] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7737919935364488,
        "token(a ~ b)": 0.5533333333333333,
        "domain": "4.1"
    },
    {
        "a": "[Palmitoleic acid] [was selected] for interaction studies with [Acrolein].",
        "b": "[Growth Hormone] [was selected] for interaction studies with [Acrolein].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8036196911196911,
        "token(a ~ b)": 0.6411483253588517,
        "domain": "4.1"
    },
    {
        "a": "[Chloride ion] [was overexpressed] in [Water] samples collected from the reaction vessel.",
        "b": "[Triosephosphate isomerase] [was overexpressed] in [Water] samples collected from the reaction vessel.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8023992068737609,
        "token(a ~ b)": 0.6352040816326531,
        "domain": "4.1"
    },
    {
        "a": "[Cyclohexane] [orchestrated] the activity of [cationic amino acid transporter 1] in the cell membrane.",
        "b": "[Myoglobin] [orchestrated] the activity of [cationic amino acid transporter 1] in the cell membrane.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8286222910216718,
        "token(a ~ b)": 0.7777777777777778,
        "domain": "4.1"
    },
    {
        "a": "[Isobutane] [displayed] increased binding to [E-cadherin] in the cell adhesion assay.",
        "b": "[Sulfiredoxin] [displayed] increased binding to [E-cadherin] in the cell adhesion assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8463302139037432,
        "token(a ~ b)": 0.7466931216931216,
        "domain": "4.1"
    },
    {
        "a": "[Iron] [bound] to [Phenylhydrazine] in the reaction mixture.",
        "b": "[Megakaryocyte-erythroid progenitor] [bound] to [Phenylhydrazine] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7492937853107344,
        "token(a ~ b)": 0.6484110885733604,
        "domain": "4.1"
    },
    {
        "a": "[Alkoxyl radical] [was critical for] the synthesis of [Palmitoleic acid] in the reaction mixture.",
        "b": "[transaldolase] [was critical for] the synthesis of [Palmitoleic acid] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8349620489309687,
        "token(a ~ b)": 0.7484276729559749,
        "domain": "4.1"
    },
    {
        "a": "[Dimethyl carbonate] [was not correlated with] [Formamide] concentrations in the reaction mixture.",
        "b": "[Cytochrome c] [was not correlated with] [Formamide] concentrations in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8244641237051733,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "4.1"
    },
    {
        "a": "[Sodium] [inhibited] [Phenylhydrazine] activity in the in vitro assay.",
        "b": "[Thyrotropin-releasing hormone] [inhibited] [Phenylhydrazine] activity in the in vitro assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7644659192516681,
        "token(a ~ b)": 0.7110412299091544,
        "domain": "4.1"
    },
    {
        "a": "[Selenocysteine] [included] [Vanillin] in the reaction mixture.",
        "b": "[Interleukin-9] [included] [Vanillin] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.803705837173579,
        "token(a ~ b)": 0.5507246376811594,
        "domain": "4.1"
    },
    {
        "a": "[Histidine] [induced] the production of [Sulfur dioxide] in the experimental setup.",
        "b": "[Hemoglobin Subunit Beta] [induced] the production of [Sulfur dioxide] in the experimental setup.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8236260505941291,
        "token(a ~ b)": 0.7167553191489362,
        "domain": "4.1"
    },
    {
        "a": "[Nonadecane] [contained] [Coenzyme A] in the tested mixture.",
        "b": "[Endoplasmic reticulum resident protein 44] [contained] [Coenzyme A] in the tested mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7518984463812051,
        "token(a ~ b)": 0.5641025641025641,
        "domain": "4.1"
    },
    {
        "a": "[Sulfur hexafluoride] [was selected] for use in [Coenzyme A] assays during the experiment.",
        "b": "[Epidermal Growth Factor Receptor] [was selected] for use in [Coenzyme A] assays during the experiment.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7768024311311075,
        "token(a ~ b)": 0.5880893300248139,
        "domain": "4.1"
    },
    {
        "a": "[Thiyl radical] [was overexpressed] in [6-phosphogluconate dehydrogenase] assays.",
        "b": "[Eukaryotic elongation factor 1A] [was overexpressed] in [6-phosphogluconate dehydrogenase] assays.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7821548821548822,
        "token(a ~ b)": 0.6627634660421545,
        "domain": "4.1"
    },
    {
        "a": "[Lead] [included] [Pentadecane] in the reaction mixture.",
        "b": "[Granulocyte-Macrophage Colony-Stimulating Factor] [included] [Pentadecane] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.6804409171075839,
        "token(a ~ b)": 0.6209613869188337,
        "domain": "4.1"
    },
    {
        "a": "[Acetic anhydride] [induced] [Copper] accumulation in the test solution.",
        "b": "[Gamma-aminobutyric acid] [induced] [Copper] accumulation in the test solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7992686882045469,
        "token(a ~ b)": 0.6055555555555556,
        "domain": "4.1"
    },
    {
        "a": "[NQO1] [was overexpressed] in [pancreatic polypeptide] producing cells.",
        "b": "[SLC7A1] [was overexpressed] in [pancreatic polypeptide] producing cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9667759984564923,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "4.1"
    },
    {
        "a": "[1,4-Benzoquinone] [was critical for] the activity of [Leucine] in metabolic pathways.",
        "b": "[Neutrophil] [was critical for] the activity of [Leucine] in metabolic pathways.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8180719673161535,
        "token(a ~ b)": 0.6657142857142857,
        "domain": "4.1"
    },
    {
        "a": "[Hypochlorous acid] [was found] in the [nucleolus] of treated cells.",
        "b": "[Hydrogen peroxide] [was found] in the [nucleolus] of treated cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.851764705882353,
        "token(a ~ b)": 0.6387959866220736,
        "domain": "4.1"
    },
    {
        "a": "[Nitrate] [was critical for] the function of [Interneuron] in the developing cortex.",
        "b": "[Tumor-associated Macrophage] [was critical for] the function of [Interneuron] in the developing cortex.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7976882873224337,
        "token(a ~ b)": 0.7167553191489362,
        "domain": "4.1"
    },
    {
        "a": "[Glutamate] [identified] [Zinc sulfate] as a cofactor in the enzymatic reaction.",
        "b": "[Catalase] [identified] [Zinc sulfate] as a cofactor in the enzymatic reaction.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9420286475682879,
        "token(a ~ b)": 0.770048309178744,
        "domain": "4.1"
    },
    {
        "a": "[Glutathione] [replaced] [Chlorine dioxide] in the reaction mixture.",
        "b": "[NHP2 ribonucleoprotein] [replaced] [Chlorine dioxide] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.798828415860015,
        "token(a ~ b)": 0.6055555555555556,
        "domain": "4.1"
    },
    {
        "a": "[Sulfur hexafluoride] [was negatively associated with] [Iodate] concentration in solution.",
        "b": "[Myeloid-derived suppressor cell] [was negatively associated with] [Iodate] concentration in solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7864610234337638,
        "token(a ~ b)": 0.5885668276972624,
        "domain": "4.1"
    },
    {
        "a": "[Nitrate ion] [broadened] the effect of [Glutamate] signaling in neural tissue.",
        "b": "[Aldolase C] [broadened] the effect of [Glutamate] signaling in neural tissue.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8336741317753977,
        "token(a ~ b)": 0.7242553191489361,
        "domain": "4.1"
    },
    {
        "a": "[Palmitoleic acid] [broadened] the activity spectrum of [Oxamide] in vitro.",
        "b": "[Interleukin-35] [broadened] the activity spectrum of [Oxamide] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7775707762557078,
        "token(a ~ b)": 0.6840513983371126,
        "domain": "4.1"
    },
    {
        "a": "[Dithiothreitol] [produced] [Dinitrogen pentoxide] under oxidative conditions.",
        "b": "[NADH:ubiquinone oxidoreductase] [produced] [Dinitrogen pentoxide] under oxidative conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7822411048584176,
        "token(a ~ b)": 0.5296774193548387,
        "domain": "4.1"
    },
    {
        "a": "[Trifluoroacetic anhydride] [induced] the expression of [Parathyroid Hormone] in cultured cells.",
        "b": "[transaldolase] [induced] the expression of [Parathyroid Hormone] in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8044642857142857,
        "token(a ~ b)": 0.6445639187574671,
        "domain": "4.1"
    },
    {
        "a": "[Nitrosyl sulfate] [orchestrated] the assembly of [water] molecules in the reaction vessel.",
        "b": "[Selectin L] [orchestrated] the assembly of [water] molecules in the reaction vessel.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8035892049127343,
        "token(a ~ b)": 0.7043478260869566,
        "domain": "4.1"
    },
    {
        "a": "[Thiyl radical] [replaced] [Sulfur dioxide] in the oxidation reaction.",
        "b": "[Mesenchymal Stem Cell] [replaced] [Sulfur dioxide] in the oxidation reaction.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8032520604395605,
        "token(a ~ b)": 0.6236363636363637,
        "domain": "4.1"
    },
    {
        "a": "[N,N-Dimethylformamide] [joined] [Malate] in the reaction mixture.",
        "b": "[Excitatory amino acid transporter 1] [joined] [Malate] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7307954545454546,
        "token(a ~ b)": 0.5018315018315018,
        "domain": "4.1"
    },
    {
        "a": "[Nitrosyl hydride] [accelerated] the reaction of [isoprene] under experimental conditions.",
        "b": "[Midostaurin] [accelerated] the reaction of [isoprene] under experimental conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8262527233115468,
        "token(a ~ b)": 0.6527777777777778,
        "domain": "4.1"
    },
    {
        "a": "[Nitrogen trioxide] [was employed] to modify [Crotonaldehyde] in the reaction mixture.",
        "b": "[Tumor Protein p53] [was employed] to modify [Crotonaldehyde] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8018783542039356,
        "token(a ~ b)": 0.691304347826087,
        "domain": "4.1"
    },
    {
        "a": "[Nitryl fluoride] [affected] the activity of [Alcohol dehydrogenase] in vitro.",
        "b": "[Interleukin-38] [affected] the activity of [Alcohol dehydrogenase] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8037810016070884,
        "token(a ~ b)": 0.6527777777777778,
        "domain": "4.1"
    },
    {
        "a": "[Fluoride] [induced] the accumulation of [GAR1 Ribonucleoprotein] in neuronal cells.",
        "b": "[Interleukin-8] [induced] the accumulation of [GAR1 Ribonucleoprotein] in neuronal cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8326897925212532,
        "token(a ~ b)": 0.7440476190476191,
        "domain": "4.1"
    },
    {
        "a": "[Acetophenone] [was critical for] the synthesis of [Nitronium ion] under acidic conditions.",
        "b": "[Telomerase reverse transcriptase] [was critical for] the synthesis of [Nitronium ion] under acidic conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7874655633276323,
        "token(a ~ b)": 0.6484110885733604,
        "domain": "4.1"
    },
    {
        "a": "[Coenzyme A] [produced] [toluene] under experimental conditions.",
        "b": "[Excitatory amino acid transporter 1] [produced] [toluene] under experimental conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7534971910112358,
        "token(a ~ b)": 0.6267232237539766,
        "domain": "4.1"
    },
    {
        "a": "[Arginine] [was used] to modify [Aluminum] nanoparticles for drug delivery applications.",
        "b": "[Rituximab] [was used] to modify [Aluminum] nanoparticles for drug delivery applications.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8791206806347941,
        "token(a ~ b)": 0.722943722943723,
        "domain": "4.1"
    },
    {
        "a": "[Zinc sulfate] [contained] [Trimethylamine] in the reaction mixture.",
        "b": "[Pyramidal neuron] [contained] [Trimethylamine] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8166316526610644,
        "token(a ~ b)": 0.6783625730994152,
        "domain": "4.1"
    },
    {
        "a": "[Hypochlorite] [contained] [Magnesium chloride] in the reaction mixture.",
        "b": "[Myeloid-derived suppressor cell] [contained] [Magnesium chloride] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.7758420926899189,
        "token(a ~ b)": 0.570630081300813,
        "domain": "4.1"
    },
    {
        "a": "[Mipomersen] [activated] [E-cadherin] expression in cultured cells.",
        "b": "[Mipomersen] [activated] [Naproxen] metabolism in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9034286059580638,
        "token(a ~ b)": 0.6208791208791209,
        "domain": "4.2"
    },
    {
        "a": "[Docetaxel] [produced] [Galactose] in cultured cells.",
        "b": "[Docetaxel] [produced] [Protection of telomeres 1] in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8936067815149029,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "4.2"
    },
    {
        "a": "[Camphor] [peaked] in the presence of [Iodobenzene].",
        "b": "[Camphor] [peaked] in the presence of [B Lymphocyte].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9276487663280116,
        "token(a ~ b)": 0.6800699300699301,
        "domain": "4.2"
    },
    {
        "a": "[Glucagon-like peptide-1] [activated] the [Chloride-Bicarbonate Exchanger] in the experimental assay.",
        "b": "[Glucagon-like peptide-1] [activated] [Oxycodone] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8980282523273664,
        "token(a ~ b)": 0.6412466843501325,
        "domain": "4.2"
    },
    {
        "a": "[Lysine] [identified] [Tricosane] in the experimental sample.",
        "b": "[Lysine] [identified] [C-reactive protein] in the experimental sample.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.907776763386655,
        "token(a ~ b)": 0.7055555555555556,
        "domain": "4.2"
    },
    {
        "a": "[Pitavastatin] [inhibited] [NHP2 ribonucleoprotein] activity in vitro.",
        "b": "[Pitavastatin] [inhibited] [Nitryl chloride] activity in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9084153887543718,
        "token(a ~ b)": 0.6236363636363637,
        "domain": "4.2"
    },
    {
        "a": "[Methanol] [orchestrated] the activity of [Thiosulfate] in the reaction mixture.",
        "b": "[Methanol] [orchestrated] the activity of [Catalase] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.942072657072657,
        "token(a ~ b)": 0.7631313131313131,
        "domain": "4.2"
    },
    {
        "a": "[Pazopanib] [bound] to [Chlorophyll b] under experimental conditions.",
        "b": "[Pazopanib] [bound] to [Aldolase C] under experimental conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9190371282317112,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "4.2"
    },
    {
        "a": "[Danaparoid] [exhibited] interaction with [1-Decyne] in vitro.",
        "b": "[Danaparoid] [exhibited] interaction with [Interferon alfa-2b] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9240699542701767,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "4.2"
    },
    {
        "a": "[Milnacipran] [was used] to treat [Arachidonic acid] metabolism disorders in experimental models.",
        "b": "[Milnacipran] [was used] to treat [Atezolizumab] side effects in experimental models.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.890588707835524,
        "token(a ~ b)": 0.6018518518518519,
        "domain": "4.2"
    },
    {
        "a": "[Progesterone] [was associated with] [Vanillin] metabolism in liver cells.",
        "b": "[Progesterone] [was associated with] [Norepinephrine] metabolism in liver cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9213320463320464,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "4.2"
    },
    {
        "a": "[Desvenlafaxine] [identified] [Oleic acid] as a potential biomarker in the study.",
        "b": "[Desvenlafaxine] [identified] [Epinephrine] as a potential biomarker in the study.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9172579083148189,
        "token(a ~ b)": 0.7884615384615384,
        "domain": "4.2"
    },
    {
        "a": "[Myeloid Dendritic Cell] [accelerated] the response to [Potassium] in the in vitro assay.",
        "b": "[Myeloid Dendritic Cell] [accelerated] the response to [Interleukin-1 beta] in the in vitro assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9387640449438203,
        "token(a ~ b)": 0.7685563997662186,
        "domain": "4.2"
    },
    {
        "a": "[Isocitrate dehydrogenase] [affected] [Hexamethylphosphoramide] concentrations in the experimental assay.",
        "b": "[Isocitrate dehydrogenase] [affected] [Sodium-Monocarboxylate Transporter] concentrations in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.90257095941825,
        "token(a ~ b)": 0.6071428571428571,
        "domain": "4.2"
    },
    {
        "a": "[Binimetinib] [was genetically correlated with] [Clopidogrel] response in patients with cardiovascular disease.",
        "b": "[Binimetinib] [was genetically correlated with] [Glucagon-like peptide-2] levels in patients with cardiovascular disease.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.915123860578406,
        "token(a ~ b)": 0.653220559531555,
        "domain": "4.2"
    },
    {
        "a": "[Trifluoroacetic anhydride] [contained] [Thiocyanate] in the reaction mixture.",
        "b": "[Trifluoroacetic anhydride] [contained] [Binimetinib] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.935933550018057,
        "token(a ~ b)": 0.774928774928775,
        "domain": "4.2"
    },
    {
        "a": "[6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3] [regulated] [Epinephrine] levels in the experimental cells.",
        "b": "[6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3] [regulated] [Chloroform] levels in the experimental cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.946270649721868,
        "token(a ~ b)": 0.8712121212121212,
        "domain": "4.2"
    },
    {
        "a": "[Ammonium nitrate] [exhibited] catalytic activity with [Aluminum] under acidic conditions.",
        "b": "[Ammonium nitrate] [exhibited] catalytic activity with [Selectin P] under acidic conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.945436203466894,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "4.2"
    },
    {
        "a": "[Immunoglobulin E] [was capable] of binding to [Natural Killer Cell] in vitro.",
        "b": "[Immunoglobulin E] [was capable] of binding to [3-Heptyne] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.925198267892765,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "4.2"
    },
    {
        "a": "[Epidermal stem cell] [activated] [Glucagon-like peptide-1] signaling in vitro.",
        "b": "[Epidermal stem cell] [activated] [Atezolizumab] signaling in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9130417567871031,
        "token(a ~ b)": 0.5885668276972624,
        "domain": "4.2"
    },
    {
        "a": "The administration of [Tivozanib] [improved] the efficacy of [Brigatinib] in the treatment protocol.",
        "b": "The administration of [Tivozanib] [improved] the efficacy of [Hexose-6-phosphate dehydrogenase] in the treatment protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9162640207075065,
        "token(a ~ b)": 0.6666666666666667,
        "domain": "4.2"
    },
    {
        "a": "[Atezolizumab] [inhibited] [Tryptophan] metabolism in tumor cells.",
        "b": "[Atezolizumab] [inhibited] [Interleukin-18] production in tumor cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8832683982683982,
        "token(a ~ b)": 0.6634615384615384,
        "domain": "4.2"
    },
    {
        "a": "[Tumor Protein p53] [was overexpressed] in response to [Interleukin-13] stimulation in cultured cells.",
        "b": "[Tumor Protein p53] [was overexpressed] in response to [Linezolid] stimulation in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.939648095903534,
        "token(a ~ b)": 0.7484276729559749,
        "domain": "4.2"
    },
    {
        "a": "[Nitrogen trioxide] [was capable] of interacting with [carbon dioxide] under hypoxic conditions.",
        "b": "[Nitrogen trioxide] [was capable] of interacting with [epidermal stem cell] under hypoxic conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9256992342492676,
        "token(a ~ b)": 0.7796985815602837,
        "domain": "4.2"
    },
    {
        "a": "[Serine] [bound] to [Azide] in the experimental assay.",
        "b": "[Serine] [bound] to [Darolutamide] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9130843958712811,
        "token(a ~ b)": 0.7815126050420168,
        "domain": "4.2"
    },
    {
        "a": "[Paracetamol] [preceded] [Glucokinase] in the experimental timeline.",
        "b": "[Paracetamol] [preceded] [Nitrogen trioxide] in the experimental timeline.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8918176131773047,
        "token(a ~ b)": 0.722943722943723,
        "domain": "4.2"
    },
    {
        "a": "[Peroxynitrite] [affected] [thiol] concentrations in the experimental assay.",
        "b": "[Peroxynitrite] [affected] [ribosome] concentrations in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9276003212470225,
        "token(a ~ b)": 0.8362573099415205,
        "domain": "4.2"
    },
    {
        "a": "[Eukaryotic Initiation Factor 4E] [enhanced] the expression of [Zinc finger protein 143] in mammalian cells.",
        "b": "[Eukaryotic Initiation Factor 4E] [enhanced] the expression of [ERp44] in mammalian cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9360536398467433,
        "token(a ~ b)": 0.7903954802259887,
        "domain": "4.2"
    },
    {
        "a": "[Dopamine] [was positively associated with] [Phosphofructokinase, muscle type] levels in the prefrontal cortex.",
        "b": "[Dopamine] [was positively associated with] [Desvenlafaxine] levels in the prefrontal cortex.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9046240522046973,
        "token(a ~ b)": 0.6147186147186148,
        "domain": "4.2"
    },
    {
        "a": "[Eukaryotic Initiation Factor 2] [was overexpressed] in [Malate dehydrogenase] deficient cells.",
        "b": "[Eukaryotic Initiation Factor 2] [was overexpressed] in [Chloride ion] deficient cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9390354157100271,
        "token(a ~ b)": 0.734993614303959,
        "domain": "4.2"
    },
    {
        "a": "[Nitric oxide] [affected] [Hydride ion] concentrations in the reaction mixture.",
        "b": "[Nitric oxide] [affected] [C-reactive protein] concentrations in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9056253557060151,
        "token(a ~ b)": 0.7095238095238096,
        "domain": "4.2"
    },
    {
        "a": "[Hydrogen bromide] [produced] [Nitrous acid] under acidic conditions.",
        "b": "[Hydrogen bromide] [produced] [Werner syndrome RecQ like helicase] under acidic conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8909047474264865,
        "token(a ~ b)": 0.6387959866220736,
        "domain": "4.2"
    },
    {
        "a": "[Tumor-associated Macrophage] [was positively associated with] [Growth Hormone] levels in the tumor microenvironment.",
        "b": "[Tumor-associated Macrophage] [was positively associated with] [Evolocumab] levels in the tumor microenvironment.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9348449365146644,
        "token(a ~ b)": 0.7543800539083558,
        "domain": "4.2"
    },
    {
        "a": "[Hypobromous acid] [produced] [Nitrite] under acidic conditions.",
        "b": "[Hypobromous acid] [produced] [Myeloid Dendritic Cell] under acidic conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9087765414454879,
        "token(a ~ b)": 0.6996966632962589,
        "domain": "4.2"
    },
    {
        "a": "[Zanamivir] [identified] [Phenylalanine] in patient samples.",
        "b": "[Zanamivir] [identified] [Neurofibromatosis Type 1] in patient samples.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8775045142650776,
        "token(a ~ b)": 0.5716783216783217,
        "domain": "4.2"
    },
    {
        "a": "[Mesenchymal Stem Cell] [was capable] of differentiating into [Sodium-lithium countertransporter] under specific conditions.",
        "b": "[Mesenchymal Stem Cell] [was capable] of differentiating into [Fragile X Syndrome] cell types under specific conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9153046594982079,
        "token(a ~ b)": 0.6522931206380858,
        "domain": "4.2"
    },
    {
        "a": "[Radium-223 dichloride] [was chosen] as a treatment over [Metamizole] in the clinical trial.",
        "b": "[Radium-223 dichloride] [was chosen] as a treatment over [Immunoglobulin D] in the clinical trial.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9415364932626237,
        "token(a ~ b)": 0.7630094043887148,
        "domain": "4.2"
    },
    {
        "a": "[Axitinib] [suppressed] [Bicalutamide] metabolism in the patient-derived liver cells.",
        "b": "[Axitinib] [suppressed] [Neuropeptide Y] metabolism in the patient-derived liver cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9038653976179332,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "4.2"
    },
    {
        "a": "[Alanine] [established] the interaction with [Transfer RNA] in vitro.",
        "b": "[Alanine] [established] the interaction with [Eukaryotic Initiation Factor 2] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9028840418500427,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "4.2"
    },
    {
        "a": "[Glutamic acid] [accelerated] the activity of [Glucokinase] in vitro.",
        "b": "[Glutamic acid] [accelerated] the activity of [Sodium sulfate] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9474228911185433,
        "token(a ~ b)": 0.7858585858585858,
        "domain": "4.2"
    },
    {
        "a": "[Interleukin-27] [was found] in [Sodium-Iodide Symporter] expressing cells.",
        "b": "[Interleukin-27] [was found] in [Selectin E] expressing cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9141772339636632,
        "token(a ~ b)": 0.7038043478260869,
        "domain": "4.2"
    },
    {
        "a": "[2-Butyne] [exhibited] a strong interaction with [Octadecane] under high pressure conditions.",
        "b": "[2-Butyne] [exhibited] a strong interaction with [Vacuole] under high pressure conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9411736267400184,
        "token(a ~ b)": 0.7885714285714285,
        "domain": "4.2"
    },
    {
        "a": "[Estrogen Receptor 1] [exhibited] high affinity for [Formamide] in the binding assay.",
        "b": "[Estrogen Receptor 1] [exhibited] high affinity for [Nicotinic acetylcholine receptor] in the binding assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9134277414669572,
        "token(a ~ b)": 0.734993614303959,
        "domain": "4.2"
    },
    {
        "a": "[Immunoglobulin G] [bound] to [Potassium] in the cell-free assay.",
        "b": "[Immunoglobulin G] [bound] to [Neural stem cell] in the cell-free assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9177924898416702,
        "token(a ~ b)": 0.8127705627705628,
        "domain": "4.2"
    },
    {
        "a": "[Avelumab] [established] a relationship with [Fluvoxamine] in clinical studies.",
        "b": "[Avelumab] [established] a relationship with [Cytochrome P450] in clinical studies.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9226621587079284,
        "token(a ~ b)": 0.7125,
        "domain": "4.2"
    },
    {
        "a": "[Dinitrogen trioxide] [activated] [Benzene] synthesis in the experimental setup.",
        "b": "[Dinitrogen trioxide] [activated] [Serotonin] synthesis in the experimental setup.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9358921694480103,
        "token(a ~ b)": 0.8043184885290149,
        "domain": "4.2"
    },
    {
        "a": "[GAR1 Ribonucleoprotein] [suppressed] [Ipilimumab] activity in the in vitro assay.",
        "b": "[GAR1 Ribonucleoprotein] [suppressed] [Interleukin-27] activity in the in vitro assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9226363554945219,
        "token(a ~ b)": 0.7288359788359788,
        "domain": "4.2"
    },
    {
        "a": "[Glucokinase] [was overexpressed] in [chloroplast] under experimental conditions.",
        "b": "[Glucokinase] [was overexpressed] in [dimethylformamide] under experimental conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9149985436131837,
        "token(a ~ b)": 0.7954545454545454,
        "domain": "4.2"
    },
    {
        "a": "[Polyethylene glycol] [enhanced] the solubility of [Binimetinib] in aqueous solution.",
        "b": "[Polyethylene glycol] [enhanced] the solubility of [Xeloda] in aqueous solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9373039215686275,
        "token(a ~ b)": 0.7967571644042233,
        "domain": "4.2"
    },
    {
        "a": "[Pemetrexed] [affected] [Sulfate] transport in the experimental model.",
        "b": "[Pemetrexed] [affected] [Fast-twitch muscle fiber] function in the experimental model.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8875143461189973,
        "token(a ~ b)": 0.6477272727272727,
        "domain": "4.2"
    },
    {
        "a": "[Neuropeptide Y] [induced] morphological changes in [granular cell] populations after exposure to the compound.",
        "b": "[Neuropeptide Y] [induced] morphological changes in [Hematopoietic stem cell] populations after exposure to the compound.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9150574446028991,
        "token(a ~ b)": 0.7906403940886699,
        "domain": "4.2"
    },
    {
        "a": "[Tin(II) chloride] [accelerated] the reaction with [Nitric acid] under acidic conditions.",
        "b": "[Tin(II) chloride] [accelerated] the reaction with [Pitavastatin] under acidic conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9347845680703998,
        "token(a ~ b)": 0.7661538461538462,
        "domain": "4.2"
    },
    {
        "a": "[Interferon-alpha] [coordinated] the activity of [Glucose-6-phosphate isomerase] in vitro.",
        "b": "[Interferon-alpha] [coordinated] the activity of [Milnacipran] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.916470588235294,
        "token(a ~ b)": 0.6186206896551725,
        "domain": "4.2"
    },
    {
        "a": "[Glutamic acid] [broadened] the effect of [Xylose] in the experimental assay.",
        "b": "[Glutamic acid] [broadened] the effect of [Dopamine] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9388040778365037,
        "token(a ~ b)": 0.8070652173913043,
        "domain": "4.2"
    },
    {
        "a": "[Gefitinib] [induced] [gastric cancer] in laboratory models.",
        "b": "[Gefitinib] [induced] [Immunoglobulin D] in laboratory models.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8839569892473118,
        "token(a ~ b)": 0.6703296703296704,
        "domain": "4.2"
    },
    {
        "a": "[Calcitonin gene-related peptide] [activated] [Benzaldehyde] signaling in neuronal cultures.",
        "b": "[Calcitonin gene-related peptide] [activated] [Sodium-Dependent Vitamin C Transporter] signaling in neuronal cultures.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8975076021311378,
        "token(a ~ b)": 0.6352040816326531,
        "domain": "4.2"
    },
    {
        "a": "[Neuropeptide Y] [activated] [follicular dendritic cell] signaling pathways in vitro.",
        "b": "[Neuropeptide Y] [activated] [magnesium carbonate] transport in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8865703781512605,
        "token(a ~ b)": 0.570630081300813,
        "domain": "4.2"
    },
    {
        "a": "The expression of [Heat shock factor 1] [was linked to] [Luteinizing Hormone] levels in the experimental group.",
        "b": "The expression of [Heat shock factor 1] [was linked to] [Lepirudin] levels in the experimental group.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.938054345975138,
        "token(a ~ b)": 0.8135964912280702,
        "domain": "4.2"
    },
    {
        "a": "[Mebendazole] [was employed] as a reagent in the synthesis of [Dimethylformamide].",
        "b": "[Mebendazole] [was employed] as a reagent in the synthesis of [Ramucirumab].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9492279479185769,
        "token(a ~ b)": 0.7311783960720131,
        "domain": "4.2"
    },
    {
        "a": "[Malate dehydrogenase] [served as] a cofactor for [Nitrogen trioxide] in the reaction mixture.",
        "b": "[Malate dehydrogenase] [served as] a cofactor for [Werner syndrome RecQ like helicase] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9050815305400779,
        "token(a ~ b)": 0.7116244411326378,
        "domain": "4.2"
    },
    {
        "a": "[Bevacizumab] [identified] [Docetaxel] as a primary agent in the chemotherapy protocol.",
        "b": "[Bevacizumab] [identified] [Transfer RNA] as a primary agent in the chemotherapy protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9241858237547893,
        "token(a ~ b)": 0.8125,
        "domain": "4.2"
    },
    {
        "a": "The [macrophage] [was capable] of interacting with [Heat shock factor 1] during the immune response.",
        "b": "The [macrophage] [was capable] of interacting with [Duchenne Muscular Dystrophy] during the immune response.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9152399355877617,
        "token(a ~ b)": 0.653220559531555,
        "domain": "4.2"
    },
    {
        "a": "[Cyclopentane] [exhibited] increased activity of [arginine] in the in vitro assay.",
        "b": "[Cyclopentane] [exhibited] increased activity of [alcohol dehydrogenase] in the in vitro assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9286189694675094,
        "token(a ~ b)": 0.76,
        "domain": "4.2"
    },
    {
        "a": "[NHP2 ribonucleoprotein] [stimulated] [dopamine] release in the hippocampal neurons.",
        "b": "[NHP2 ribonucleoprotein] [stimulated] [1-Decyne] metabolism in the hippocampal neurons.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9266664588139927,
        "token(a ~ b)": 0.7884615384615384,
        "domain": "4.2"
    },
    {
        "a": "[Potassium nitrate] [facilitated] the transport of [Magnesium sulfate] in aqueous solution.",
        "b": "[Potassium nitrate] [facilitated] the transport of [Duloxetine] in aqueous solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9412494912494912,
        "token(a ~ b)": 0.8125,
        "domain": "4.2"
    },
    {
        "a": "The [Stratum lucidum cell] [identified] the presence of [Langerhans cell] in the epidermal layer.",
        "b": "The [Stratum lucidum cell] [identified] the presence of [Dihydroxyacetone] in the epidermal layer.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9359243245543323,
        "token(a ~ b)": 0.7343658679135009,
        "domain": "4.2"
    },
    {
        "a": "The administration of [Tinzaparin] [induced] the expression of [Thymopentin] in cultured cells.",
        "b": "The administration of [Tinzaparin] [induced] the expression of [Eukaryotic Initiation Factor 4E] in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9259954233409612,
        "token(a ~ b)": 0.6626436781609195,
        "domain": "4.2"
    },
    {
        "a": "[Triiodothyronine] [bound] to [Activating transcription factor 6] in the in vitro assay.",
        "b": "[Triiodothyronine] [bound] to [Peroxynitrite] in the in vitro assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8872060945590358,
        "token(a ~ b)": 0.6762166405023547,
        "domain": "4.2"
    },
    {
        "a": "The presence of [Cobimetinib] [induced] the formation of [Methyl isobutyl ketone] in the cell culture.",
        "b": "The presence of [Cobimetinib] [induced] the formation of [Granular cell] in the cell culture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9303178735860436,
        "token(a ~ b)": 0.7401129943502824,
        "domain": "4.2"
    },
    {
        "a": "[Sorafenib] [replaced] [Cetuximab] in the experimental protocol.",
        "b": "[Sorafenib] [replaced] [Magnesium] in the experimental protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9349999999999999,
        "token(a ~ b)": 0.7352564102564103,
        "domain": "4.2"
    },
    {
        "a": "[Succinate dehydrogenase] [facilitated] the activation of [6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3] during mitochondrial respiration.",
        "b": "[Succinate dehydrogenase] [facilitated] the activation of [Iron(II) ion] during mitochondrial respiration.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.887814380418154,
        "token(a ~ b)": 0.5221445221445221,
        "domain": "4.2"
    },
    {
        "a": "[Interleukin-12] [identified] [Acetaldehyde] in the experimental assay.",
        "b": "[Interleukin-12] [identified] [Nucleus] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9173653848801508,
        "token(a ~ b)": 0.7857142857142857,
        "domain": "4.2"
    },
    {
        "a": "[Polyethylene glycol] [was selected] for the stabilization of [Acetonitrile] in the formulation.",
        "b": "[Polyethylene glycol] [was selected] for the stabilization of [Pembrolizumab] in the formulation.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9464499111934824,
        "token(a ~ b)": 0.7076923076923077,
        "domain": "4.2"
    },
    {
        "a": "[Formamide] [served as] a cofactor for [Calcium] in the enzymatic assay.",
        "b": "[Formamide] [served as] a cofactor for [Tankyrase 2] in the enzymatic assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9236842105263158,
        "token(a ~ b)": 0.7885714285714285,
        "domain": "4.2"
    },
    {
        "a": "[Estrogen Receptor 1] [served as] a cofactor for [Glyceraldehyde 3-phosphate dehydrogenase] in the assay.",
        "b": "[Estrogen Receptor 1] [served as] a cofactor for [Vilazodone] in the assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9013650793650794,
        "token(a ~ b)": 0.6296452702702703,
        "domain": "4.2"
    },
    {
        "a": "The [C-reactive protein] [served as] a marker for [Bloom syndrome RecQ like helicase] activity in the assay.",
        "b": "The [C-reactive protein] [served as] a marker for [Ipilimumab] activity in the assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9084894698620188,
        "token(a ~ b)": 0.6762874929258631,
        "domain": "4.2"
    },
    {
        "a": "[Bicarbonate] [bound] to [Chlorophyll a] in the assay.",
        "b": "[Bicarbonate] [bound] to [Interleukin-7] in the assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8906115417743324,
        "token(a ~ b)": 0.608974358974359,
        "domain": "4.2"
    },
    {
        "a": "[Ticlopidine] [prolonged] the effect of [Gemcitabine] in clinical trials.",
        "b": "[Ticlopidine] [prolonged] the effect of [Serotonin] in clinical trials.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9364343804629354,
        "token(a ~ b)": 0.8211462450592886,
        "domain": "4.2"
    },
    {
        "a": "[Molybdate] [bound] [Iodobenzene] in the catalytic assay.",
        "b": "[Molybdate] [bound] [Pyramidal neuron] in the catalytic assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.888561536668997,
        "token(a ~ b)": 0.6856984478935699,
        "domain": "4.2"
    },
    {
        "a": "[Mannose] [was able] to interact with the [carbonyl functional group] under experimental conditions.",
        "b": "[Mannose] [was able] to interact with [Desvenlafaxine] under experimental conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8983127326880119,
        "token(a ~ b)": 0.6714402618657938,
        "domain": "4.2"
    },
    {
        "a": "[Tapentadol] [improved] [Oxycodone]-induced withdrawal symptoms in patients.",
        "b": "[Tapentadol] [improved] [Protein disulfide isomerase]-related stress in patients.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8614056048125092,
        "token(a ~ b)": 0.4914207275223061,
        "domain": "4.2"
    },
    {
        "a": "[transketolase] [induced] differentiation of [Endothelial progenitor cell] in vitro.",
        "b": "[transketolase] [induced] differentiation of [Plasmacytoid dendritic cell] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9199485199485199,
        "token(a ~ b)": 0.6527777777777778,
        "domain": "4.2"
    },
    {
        "a": "[Rituximab] [joined] [Dimethylformamide] in a molecular complex.",
        "b": "[Rituximab] [joined] [11-Deoxycorticosterone] in a molecular complex.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8840225625823451,
        "token(a ~ b)": 0.6429263565891472,
        "domain": "4.2"
    },
    {
        "a": "[Vismodegib] [was employed] to target [Fluvastatin] in clinical studies.",
        "b": "[Vismodegib] [was employed] to target [Peroxisome] in clinical studies.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9207187569863626,
        "token(a ~ b)": 0.7351778656126482,
        "domain": "4.2"
    },
    {
        "a": "[Alcohol dehydrogenase] [detected] [Vascular Endothelial Growth Factor A] in the tissue sample.",
        "b": "[Alcohol dehydrogenase] [detected] [Gemfibrozil] in the tissue sample.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8856333140543666,
        "token(a ~ b)": 0.6657142857142857,
        "domain": "4.2"
    },
    {
        "a": "[Succinyl-CoA synthetase] [joined] [Magnesium citrate] in the mitochondrial assay.",
        "b": "[Succinyl-CoA synthetase] [joined] [Protection of telomeres 1] in the mitochondrial assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9121494793895307,
        "token(a ~ b)": 0.6957282913165266,
        "domain": "4.2"
    },
    {
        "a": "[Venlafaxine] [resulted in] increased expression of [Common myeloid progenitor] in vitro.",
        "b": "[Venlafaxine] [resulted in] increased expression of [Potassium chloride] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9301328217776559,
        "token(a ~ b)": 0.7281632653061225,
        "domain": "4.2"
    },
    {
        "a": "[Ceritinib] [produced] [Oxalic acid] in the experimental assay.",
        "b": "[Ceritinib] [produced] [Chloride-Bicarbonate Exchanger] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8964320057947124,
        "token(a ~ b)": 0.6236363636363637,
        "domain": "4.2"
    },
    {
        "a": "[Granulocyte-Macrophage Colony-Stimulating Factor] [bound] to [Potassium chloride] in the experimental assay.",
        "b": "[Granulocyte-Macrophage Colony-Stimulating Factor] [bound] to [Junctional Adhesion Molecule A] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9319285551812658,
        "token(a ~ b)": 0.7431693989071038,
        "domain": "4.2"
    },
    {
        "a": "[Nitrous oxide] [bound] to the [chloride ion] under experimental conditions.",
        "b": "[Nitrous oxide] [bound] to the [antibody-secreting cell] under experimental conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9135004332826474,
        "token(a ~ b)": 0.6635610766045548,
        "domain": "4.2"
    },
    {
        "a": "[transketolase] [identified] [Fluoride] in the cytosol of liver cells.",
        "b": "[transketolase] [identified] [Myeloid-derived suppressor cell] in the cytosol of liver cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8991531423228478,
        "token(a ~ b)": 0.7386877828054299,
        "domain": "4.2"
    },
    {
        "a": "[Goserelin] [was selected] for combination with [Azithromycin] in the clinical protocol.",
        "b": "[Goserelin] [was selected] for combination with [Hexamethylphosphoramide] in the clinical protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9201685529998783,
        "token(a ~ b)": 0.6714402618657938,
        "domain": "4.2"
    },
    {
        "a": "[Alcohol dehydrogenase] [activated] [Malate dehydrogenase] in vitro.",
        "b": "[Alcohol dehydrogenase] [activated] [Lithium chloride] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9147058823529411,
        "token(a ~ b)": 0.7230576441102756,
        "domain": "4.2"
    },
    {
        "a": "[Gastrin] [joined] [Interleukin-4] in a regulatory protein complex.",
        "b": "[Gastrin] [joined] [Selenate] in a regulatory protein complex.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9088148649861681,
        "token(a ~ b)": 0.6846153846153846,
        "domain": "4.2"
    },
    {
        "a": "[Tryptophan] [suppressed] the production of [hydroxide ion] in cultured cells.",
        "b": "[Tryptophan] [suppressed] the production of [Tumor Necrosis Factor-alpha] in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9078037904124862,
        "token(a ~ b)": 0.691304347826087,
        "domain": "4.2"
    },
    {
        "a": "[Potassium] [served as] a co-factor for [Calcitonin gene-related peptide] in the enzymatic assay.",
        "b": "[Potassium] [served as] a co-factor for [Interleukin-10] in the enzymatic assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9048058419243986,
        "token(a ~ b)": 0.734993614303959,
        "domain": "4.2"
    },
    {
        "a": "[Chloramphenicol] [was employed] in the reduction of [Lithium aluminum hydride] during the experiment.",
        "b": "[Chloramphenicol] [was employed] in the reduction of [Cytochrome P450] during the experiment.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9212270714737508,
        "token(a ~ b)": 0.6819923371647509,
        "domain": "4.2"
    },
    {
        "a": "[Ethylamine] [was found] in [Tricosane] samples after the reaction.",
        "b": "[Ethylamine] [was found] in [Axitinib] samples after the reaction.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9142559927634555,
        "token(a ~ b)": 0.7479674796747967,
        "domain": "4.2"
    },
    {
        "a": "[Cyclohexanone] [broadened] the effect of [Benzamide] in the cellular assay.",
        "b": "[Cyclohexanone] [broadened] the effect of [Epinephrine] in the cellular assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9491750774552851,
        "token(a ~ b)": 0.7913725490196079,
        "domain": "4.2"
    },
    {
        "a": "[C-reactive protein] [preceded] [Hydrogen peroxide] in the inflammatory response model.",
        "b": "[C-reactive protein] [preceded] [Retinal pigment epithelium] in the inflammatory response model.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8930923961096375,
        "token(a ~ b)": 0.6577777777777778,
        "domain": "4.2"
    },
    {
        "a": "[Telomeric Repeat Binding Factor 2] [regulated] [Basal cell] differentiation in vitro.",
        "b": "[Telomeric Repeat Binding Factor 2] [orchestrated] [Basal cell] differentiation in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9313473386622003,
        "token(a ~ b)": 0.8656126482213439,
        "domain": "4.3"
    },
    {
        "a": "[Proton-coupled amino acid transporter 1] [was found] in [Basal cell].",
        "b": "[Proton-coupled amino acid transporter 1] [was positively associated with] [Basal cell].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9234199134199134,
        "token(a ~ b)": 0.8357487922705313,
        "domain": "4.3"
    },
    {
        "a": "[Interleukin-4] [affected] [Neuropeptide Y] in neuronal cultures.",
        "b": "[Interleukin-4] [was selected] for analysis with [Neuropeptide Y] in neuronal cultures.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8784245137046861,
        "token(a ~ b)": 0.8043478260869565,
        "domain": "4.3"
    },
    {
        "a": "[Cetuximab] [predicted] the activity of [Blinatumomab] in vitro.",
        "b": "[Cetuximab] [peaked] in its interaction with [Blinatumomab] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8909827130926062,
        "token(a ~ b)": 0.6956521739130435,
        "domain": "4.3"
    },
    {
        "a": "The concentration of [Calcium ion] [peaked] during the reaction with [Heptadecane].",
        "b": "The concentration of [Calcium ion] [coordinated] the reaction with [Heptadecane].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9470941968933937,
        "token(a ~ b)": 0.8308080808080808,
        "domain": "4.3"
    },
    {
        "a": "[Deoxyribonucleic acid] [was sufficient for] the synthesis of [Nonane] in the experimental system.",
        "b": "[Deoxyribonucleic acid] [emerged] as a factor in the synthesis of [Nonane] in the experimental system.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9051037806426919,
        "token(a ~ b)": 0.7700336700336701,
        "domain": "4.3"
    },
    {
        "a": "[Pemetrexed] [was employed] in combination with [Ipilimumab] during the clinical trial.",
        "b": "[Pemetrexed] [prolonged] the effect of [Ipilimumab] during the clinical trial.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8720302362361615,
        "token(a ~ b)": 0.6954787234042553,
        "domain": "4.3"
    },
    {
        "a": "[Urea] effect [amplified] the activity of [Pentadecane] in vitro.",
        "b": "[Urea] effect [preceded] the activity of [Pentadecane] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9286253259452412,
        "token(a ~ b)": 0.82281284606866,
        "domain": "4.3"
    },
    {
        "a": "[Meloxicam] [broadened] the therapeutic window of [Gemcitabine].",
        "b": "[Meloxicam] [accelerated] the therapeutic window of [Gemcitabine].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8993181818181818,
        "token(a ~ b)": 0.7821428571428571,
        "domain": "4.3"
    },
    {
        "a": "[Magnesium carbonate] [accelerated] the aggregation of [Zinc] in solution.",
        "b": "[Magnesium carbonate] [predicted] the aggregation of [Zinc] in solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.934674892283588,
        "token(a ~ b)": 0.8362573099415205,
        "domain": "4.3"
    },
    {
        "a": "[Uranium] [exhibited] similar binding affinity to [Bicarbonate] in solution.",
        "b": "[Uranium] [was sufficient for] the binding affinity of [Bicarbonate] in solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.873688448173574,
        "token(a ~ b)": 0.6856984478935699,
        "domain": "4.3"
    },
    {
        "a": "[Zinc Transporter] [activated] [Hematopoietic stem cell] differentiation in vitro.",
        "b": "[Zinc Transporter] [was genetically correlated with] [Hematopoietic stem cell] differentiation in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.884194403909851,
        "token(a ~ b)": 0.8308080808080808,
        "domain": "4.3"
    },
    {
        "a": "[Goserelin] [bound] to [Metronidazole] in the cellular assay.",
        "b": "[Goserelin] was [localized to] [Metronidazole] in the cellular assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8893143592138356,
        "token(a ~ b)": 0.8525641025641026,
        "domain": "4.3"
    },
    {
        "a": "[Azithromycin] [was overexpressed] in the presence of [Gefitinib].",
        "b": "[Azithromycin] [predicted] the response to [Gefitinib].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8889743589743591,
        "token(a ~ b)": 0.6576086956521738,
        "domain": "4.3"
    },
    {
        "a": "[Interleukin-33] [was linked to] [Fructose-6-phosphate] in activated immune cells.",
        "b": "[Interleukin-33] [encoded by] [Fructose-6-phosphate] in activated immune cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9056674148677853,
        "token(a ~ b)": 0.8468137254901961,
        "domain": "4.3"
    },
    {
        "a": "[Interferon-alpha] [activated] [Macrophage] in the in vitro assay.",
        "b": "[Interferon-alpha] [served as] [Macrophage] in the in vitro assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9106805762543467,
        "token(a ~ b)": 0.8471177944862156,
        "domain": "4.3"
    },
    {
        "a": "[Venetoclax] [was employed] in combination with [Belzutifan] to assess synergistic effects.",
        "b": "[Venetoclax] [served as] an adjunct to [Belzutifan] in the experimental protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8552962599910956,
        "token(a ~ b)": 0.5496277915632755,
        "domain": "4.3"
    },
    {
        "a": "[Darolutamide] [affected] [Oxaliplatin] in the clinical assay.",
        "b": "[Darolutamide] [accelerated] [Oxaliplatin] in the clinical assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9181637717121588,
        "token(a ~ b)": 0.8523809523809525,
        "domain": "4.3"
    },
    {
        "a": "[Undecane] [affected] the levels of [Chlorine dioxide] in the reaction mixture.",
        "b": "[Undecane] [preceded] [Chlorine dioxide] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8832151270534283,
        "token(a ~ b)": 0.8035714285714286,
        "domain": "4.3"
    },
    {
        "a": "[Eukaryotic elongation factor 1A] [was sufficient for] the stability of [E-cadherin].",
        "b": "[Eukaryotic elongation factor 1A] [was employed] for the stability of [E-cadherin].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9198507963743519,
        "token(a ~ b)": 0.9215384615384616,
        "domain": "4.3"
    },
    {
        "a": "[Brigatinib] [admitted] [Doxycycline] into the clinical protocol.",
        "b": "[Brigatinib] [was selected] for combination with [Doxycycline] in the clinical protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8736276223776224,
        "token(a ~ b)": 0.7242553191489361,
        "domain": "4.3"
    },
    {
        "a": "[Docetaxel] [accelerated] the degradation of [Ibuprofen] in plasma.",
        "b": "[Docetaxel] [was observed in] [Ibuprofen] in plasma.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.861493270146811,
        "token(a ~ b)": 0.7135306553911205,
        "domain": "4.3"
    },
    {
        "a": "[Indomethacin] [identified] a novel interaction with [Rucaparib].",
        "b": "[Indomethacin] [shortened] the half-life of [Rucaparib].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8727080062794349,
        "token(a ~ b)": 0.6366869918699187,
        "domain": "4.3"
    },
    {
        "a": "[Acetaminophen] [preceded] [Citalopram] in the treatment protocol.",
        "b": "[Acetaminophen] [peaked] before [Citalopram] in plasma concentration.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8818045522693199,
        "token(a ~ b)": 0.678030303030303,
        "domain": "4.3"
    },
    {
        "a": "[Nitrofurantoin] [preceded] [Crizotinib] in the analytical screening process.",
        "b": "[Nitrofurantoin] [was required for] [Crizotinib] in the analytical screening process.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8956216708352083,
        "token(a ~ b)": 0.844812925170068,
        "domain": "4.3"
    },
    {
        "a": "[Fluvastatin] [affected] the secretion of [Vancomycin] in experimental models.",
        "b": "[Fluvastatin] [was overexpressed] in the presence of [Vancomycin] in experimental models.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8772518282599858,
        "token(a ~ b)": 0.7608695652173914,
        "domain": "4.3"
    },
    {
        "a": "[Lorlatinib] [was critical for] the activity of [Darolutamide] in cell-based assays.",
        "b": "[Lorlatinib] [was positively correlated with] the activity of [Darolutamide] in cell-based assays.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8918533266965323,
        "token(a ~ b)": 0.8381128584643849,
        "domain": "4.3"
    },
    {
        "a": "[Dehydroepiandrosterone] [broadened] the activity of [Nitrosyl fluoride] in vitro.",
        "b": "[Dehydroepiandrosterone] [improved] the activity of [Nitrosyl fluoride] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9545517114622806,
        "token(a ~ b)": 0.8509803921568628,
        "domain": "4.3"
    },
    {
        "a": "[Ceftriaxone] [impacted] [Type 1 Diabetes Mellitus] in pediatric patients.",
        "b": "[Ceftriaxone] [contained] [Type 1 Diabetes Mellitus] in pediatric patients.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9727057057057057,
        "token(a ~ b)": 0.8952380952380952,
        "domain": "4.3"
    },
    {
        "a": "[Malate dehydrogenase] [produced] [Neuropeptide Y] in vitro.",
        "b": "[Malate dehydrogenase] [served as] a precursor for [Neuropeptide Y] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9024557927947758,
        "token(a ~ b)": 0.7463768115942029,
        "domain": "4.3"
    },
    {
        "a": "[Eukaryotic Initiation Factor 4E] [was found in] [Cytochrome c oxidase] complexes during cellular respiration.",
        "b": "[Eukaryotic Initiation Factor 4E] [served as] a regulatory subunit in [Cytochrome c oxidase] complexes during cellular respiration.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9001380214357313,
        "token(a ~ b)": 0.7830316742081449,
        "domain": "4.3"
    },
    {
        "a": "[Pravastatin] [induced] [Sickle Cell Disease] in a mouse model.",
        "b": "[Pravastatin] [predicted] [Sickle Cell Disease] in a mouse model.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9124906423267078,
        "token(a ~ b)": 0.8844672657252888,
        "domain": "4.3"
    },
    {
        "a": "[Encorafenib] [preceded] [Pitavastatin] in the treatment protocol.",
        "b": "[Encorafenib] [produced] [Pitavastatin] as a byproduct in the treatment protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8863390852974187,
        "token(a ~ b)": 0.7566666666666667,
        "domain": "4.3"
    },
    {
        "a": "[Hydrogen bromide] [served as] a catalyst for [Allylamine] in the reaction mixture.",
        "b": "[Hydrogen bromide] [was genetically correlated with] [Allylamine] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8865234096559398,
        "token(a ~ b)": 0.7148148148148148,
        "domain": "4.3"
    },
    {
        "a": "[Morphine] [broadened] the effect of [Tuberous sclerosis complex] in neural tissue.",
        "b": "[Morphine] [affected] the effect of [Tuberous sclerosis complex] in neural tissue.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9115290430012734,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "4.3"
    },
    {
        "a": "[Pembrolizumab] [established] a relationship with [Regorafenib] in clinical studies.",
        "b": "[Pembrolizumab] [was negatively associated with] [Regorafenib] in clinical studies.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.911732644865175,
        "token(a ~ b)": 0.7584219858156028,
        "domain": "4.3"
    },
    {
        "a": "[Obinutuzumab] [regulated] the activity of [Regorafenib].",
        "b": "[Obinutuzumab] [was positively associated with] the activity of [Regorafenib].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8686759634128055,
        "token(a ~ b)": 0.8282241014799154,
        "domain": "4.3"
    },
    {
        "a": "[Simvastatin] [orchestrated] the activity of [Dabrafenib].",
        "b": "[Simvastatin] [preceded] the activity of [Dabrafenib].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9098489970700924,
        "token(a ~ b)": 0.8199767711962833,
        "domain": "4.3"
    },
    {
        "a": "[Desvenlafaxine] [was found] to interact with [Naproxen] in clinical studies.",
        "b": "[Desvenlafaxine] [was linked to] increased levels of [Naproxen] in patient plasma.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8807241902618677,
        "token(a ~ b)": 0.6761204481792717,
        "domain": "4.3"
    },
    {
        "a": "[Nitric oxide] [was found in] samples containing [Cyclohexylamine].",
        "b": "[Nitric oxide] [orchestrated] the response to [Cyclohexylamine] in the same samples.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8526088767982746,
        "token(a ~ b)": 0.5735785953177257,
        "domain": "4.3"
    },
    {
        "a": "[Epidermal Growth Factor Receptor] [exhibited] interaction with [Interleukin-32] in vitro.",
        "b": "[Epidermal Growth Factor Receptor] [served as] a mediator for [Interleukin-32] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8971212121212121,
        "token(a ~ b)": 0.734993614303959,
        "domain": "4.3"
    },
    {
        "a": "[Trametinib] [was found] in the formulation of [Alectinib].",
        "b": "[Trametinib] [peaked] in the formulation of [Alectinib].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9081393183088099,
        "token(a ~ b)": 0.8471177944862156,
        "domain": "4.3"
    },
    {
        "a": "[Ipilimumab] [substituted] [Gemfibrozil] in the experimental drug regimen.",
        "b": "[Ipilimumab] [activated] [Gemfibrozil] metabolism in the experimental drug regimen.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8925536940300219,
        "token(a ~ b)": 0.8253968253968254,
        "domain": "4.3"
    },
    {
        "a": "[Paroxetine] [served as] an inhibitor of [Edoxaban].",
        "b": "[Paroxetine] [accelerated] the metabolism of [Edoxaban].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8854645354645354,
        "token(a ~ b)": 0.6029411764705883,
        "domain": "4.3"
    },
    {
        "a": "[Indomethacin] [served as] a ligand for [Nicotinic acetylcholine receptor].",
        "b": "[Indomethacin] [exhibited] affinity for [Nicotinic acetylcholine receptor].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8850833333333334,
        "token(a ~ b)": 0.7311783960720131,
        "domain": "4.3"
    },
    {
        "a": "[Ethylene oxide] [peaked] in concentration when mixed with [Hydrogen chloride].",
        "b": "[Ethylene oxide] [was selected] as a reagent for reaction with [Hydrogen chloride].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.871301438067983,
        "token(a ~ b)": 0.5641025641025641,
        "domain": "4.3"
    },
    {
        "a": "[Chlorine dioxide] [produced] [Nitrosyl fluoride] under laboratory conditions.",
        "b": "[Chlorine dioxide] [identified] [Nitrosyl fluoride] under laboratory conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9011863364945556,
        "token(a ~ b)": 0.8782051282051282,
        "domain": "4.3"
    },
    {
        "a": "[Mannose] [increased] the levels of [Glucose] in the reaction mixture.",
        "b": "[Mannose] [preceded] [Glucose] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.872457730948297,
        "token(a ~ b)": 0.7387387387387387,
        "domain": "4.3"
    },
    {
        "a": "[Crizotinib] [ameliorated] the toxicity of [Paracetamol] in hepatocytes.",
        "b": "[Crizotinib] [was found] in [Paracetamol] treated hepatocytes.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8790464063384267,
        "token(a ~ b)": 0.7029787234042553,
        "domain": "4.3"
    },
    {
        "a": "[Citalopram] [affected] the enzymatic activity of [Entrectinib].",
        "b": "[Citalopram] [extended] the enzymatic activity of [Entrectinib].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9316666666666666,
        "token(a ~ b)": 0.9181286549707601,
        "domain": "4.3"
    },
    {
        "a": "[Triosephosphate isomerase] [was genetically associated with] [Sodium-Monocarboxylate Transporter] in neural tissue.",
        "b": "[Triosephosphate isomerase] [was found in] [Sodium-Monocarboxylate Transporter] in neural tissue.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8941812708473577,
        "token(a ~ b)": 0.8936507936507936,
        "domain": "4.3"
    },
    {
        "a": "[Molybdate] [was selected] for interaction with [Dichromate].",
        "b": "[Molybdate] [served as] a catalyst for [Dichromate].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8667824850419897,
        "token(a ~ b)": 0.6640926640926641,
        "domain": "4.3"
    },
    {
        "a": "[C/EBP homologous protein] [was critical for] the regulation of [Eukaryotic Initiation Factor 4E] during cellular stress.",
        "b": "[C/EBP homologous protein] [broadened] the regulation of [Eukaryotic Initiation Factor 4E] during cellular stress.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9013194142380745,
        "token(a ~ b)": 0.8607954545454546,
        "domain": "4.3"
    },
    {
        "a": "[Trichloroethylene] [was critical for] the synthesis of [Tetrahydrofuran].",
        "b": "[Trichloroethylene] [was selected] as a solvent for [Tetrahydrofuran].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9089551158301158,
        "token(a ~ b)": 0.731304347826087,
        "domain": "4.3"
    },
    {
        "a": "[Naproxen] [was selected] for interaction studies with [Tetracycline].",
        "b": "[Naproxen] [was genetically correlated with] [Tetracycline].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8822943722943724,
        "token(a ~ b)": 0.7309941520467836,
        "domain": "4.3"
    },
    {
        "a": "[Pitavastatin] [affected] [Obinutuzumab] in clinical trials.",
        "b": "[Pitavastatin] [was capable] of interacting with [Obinutuzumab] in clinical trials.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8710234039606702,
        "token(a ~ b)": 0.8043478260869565,
        "domain": "4.3"
    },
    {
        "a": "[Cetuximab] [served as] an inhibitor of [Midostaurin] in clinical studies.",
        "b": "[Cetuximab] [was found in] [Midostaurin] formulations used in clinical studies.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8760744685739962,
        "token(a ~ b)": 0.6829787234042553,
        "domain": "4.3"
    },
    {
        "a": "[Somatostatin] [was employed] to modulate [Succinate dehydrogenase] activity in vitro.",
        "b": "[Somatostatin] [induced] a conformational change in [Succinate dehydrogenase] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8773431009196846,
        "token(a ~ b)": 0.6412466843501325,
        "domain": "4.3"
    },
    {
        "a": "[Tetradecane] [joined] [Xylene] under high-pressure conditions.",
        "b": "[Tetradecane] [affected] [Xylene] under high-pressure conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9010434386705574,
        "token(a ~ b)": 0.9097222222222222,
        "domain": "4.3"
    },
    {
        "a": "[Glyceraldehyde-3-phosphate dehydrogenase] [induced] the activity of [Catalase] in vitro.",
        "b": "[Glyceraldehyde-3-phosphate dehydrogenase] [was selected] for interaction studies with [Catalase] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9144442794878943,
        "token(a ~ b)": 0.7293603061782394,
        "domain": "4.3"
    },
    {
        "a": "[Warfarin] [contained] [Leuprolide] in the clinical formulation.",
        "b": "[Warfarin] [admitted] [Leuprolide] in the clinical formulation.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9046428571428571,
        "token(a ~ b)": 0.8782051282051282,
        "domain": "4.3"
    },
    {
        "a": "[Doxycycline] [was sufficient for] the inhibition of [Goserelin] in cultured cells.",
        "b": "[Doxycycline] [peaked] the inhibition of [Goserelin] in cultured cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8785363864539512,
        "token(a ~ b)": 0.8308080808080808,
        "domain": "4.3"
    },
    {
        "a": "[Ziv-aflibercept] [contained] [Binimetinib] in the test formulation.",
        "b": "[Ziv-aflibercept] [led to] [Binimetinib] accumulation in the test formulation.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9061671281601045,
        "token(a ~ b)": 0.8593073593073592,
        "domain": "4.3"
    },
    {
        "a": "[Palmitic acid] [replaced] [Fructose] in the experimental diet.",
        "b": "[Palmitic acid] [identified] as [Fructose] in the mass spectrometry analysis.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8692590933970245,
        "token(a ~ b)": 0.6267232237539766,
        "domain": "4.3"
    },
    {
        "a": "[Ibuprofen] [affected] the activity of [Vismodegib] in vitro.",
        "b": "[Ibuprofen] [replaced] [Vismodegib] in the treatment protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8689841457471408,
        "token(a ~ b)": 0.699134199134199,
        "domain": "4.3"
    },
    {
        "a": "[Interleukin-38] [accelerated] the function of [Cystic fibrosis transmembrane conductance regulator].",
        "b": "[Interleukin-38] [was employed] in studies involving [Cystic fibrosis transmembrane conductance regulator].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8819976764031543,
        "token(a ~ b)": 0.7316337719298245,
        "domain": "4.3"
    },
    {
        "a": "[Degarelix] [caused] an increase in [Belzutifan] levels in the bloodstream.",
        "b": "[Degarelix] [was positively associated with] [Belzutifan] concentrations in the bloodstream.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8704417228005715,
        "token(a ~ b)": 0.6829787234042553,
        "domain": "4.3"
    },
    {
        "a": "[Desirudin] [emerged] as an alternative to [Fenofibrate] in anticoagulant therapy.",
        "b": "[Desirudin] [was genetically correlated with] [Fenofibrate] response in certain patient populations.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8847342747111682,
        "token(a ~ b)": 0.5168504901960784,
        "domain": "4.3"
    },
    {
        "a": "[Ammonium nitrate] [broadened] the solubility profile of [Zinc sulfate].",
        "b": "[Ammonium nitrate] [was positively associated with] the solubility profile of [Zinc sulfate].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8704195656757326,
        "token(a ~ b)": 0.7855319148936171,
        "domain": "4.3"
    },
    {
        "a": "[Glucose] [resulted in] an increase in [Zinc finger protein 143] levels during the assay.",
        "b": "[Glucose] [was sufficient for] an increase in [Zinc finger protein 143] levels during the assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8887041634004006,
        "token(a ~ b)": 0.8358333333333333,
        "domain": "4.3"
    },
    {
        "a": "[Bromobenzene] [broadened] the effect of [Nitryl bromide] in the reaction mixture.",
        "b": "[Bromobenzene] [was observed in] the presence of [Nitryl bromide] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8892182614133833,
        "token(a ~ b)": 0.783076923076923,
        "domain": "4.3"
    },
    {
        "a": "[Copper] [was capable] of interacting with [Formate] under physiological conditions.",
        "b": "[Copper] [was sufficient for] the reduction of [Formate] under physiological conditions.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8826270221007063,
        "token(a ~ b)": 0.7211948790896159,
        "domain": "4.3"
    },
    {
        "a": "[Growth Hormone] [orchestrated] the activity of [6-phosphogluconate dehydrogenase] in liver cells.",
        "b": "[Growth Hormone] [was critical for] the activity of [6-phosphogluconate dehydrogenase] in liver cells.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.899030579973925,
        "token(a ~ b)": 0.8500000000000001,
        "domain": "4.3"
    },
    {
        "a": "[Bivalirudin] [was vaccinated] against [Ziv-aflibercept].",
        "b": "[Bivalirudin] [predicted] response to [Ziv-aflibercept].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8691674839272093,
        "token(a ~ b)": 0.7710526315789473,
        "domain": "4.3"
    },
    {
        "a": "[Magnesium] [bound] to [Tyrosine] in the in vitro assay.",
        "b": "[Magnesium] [degraded] [Tyrosine] in the in vitro assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8928571428571429,
        "token(a ~ b)": 0.8297213622291022,
        "domain": "4.3"
    },
    {
        "a": "[Phenethylamine] [was sufficient for] the oxidation of [Peroxynitrite] in the cell-free assay.",
        "b": "[Phenethylamine] [replaced] [Peroxynitrite] in the cell-free assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8707892615482327,
        "token(a ~ b)": 0.78,
        "domain": "4.3"
    },
    {
        "a": "[Epinephrine] [bound] to [Proton-coupled amino acid transporter 1]",
        "b": "[Epinephrine] [was positively associated with] [Proton-coupled amino acid transporter 1]",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8674242424242424,
        "token(a ~ b)": 0.8043478260869565,
        "domain": "4.3"
    },
    {
        "a": "[Gastrin] [was critical for] the function of [Interleukin-32]",
        "b": "[Gastrin] [positively correlated] with the function of [Interleukin-32]",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8845786988749911,
        "token(a ~ b)": 0.7396341463414634,
        "domain": "4.3"
    },
    {
        "a": "[Escitalopram] [broadened] the effects of [Rucaparib] in vitro.",
        "b": "[Escitalopram] [preceded] [Rucaparib] administration in the clinical protocol.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.863948332369385,
        "token(a ~ b)": 0.650163666121113,
        "domain": "4.3"
    },
    {
        "a": "[Granulocyte-Macrophage Colony-Stimulating Factor] [broadened] the differentiation potential of [Neural stem cell].",
        "b": "[Granulocyte-Macrophage Colony-Stimulating Factor] [identified] the differentiation potential of [Neural stem cell].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9483867525696611,
        "token(a ~ b)": 0.8928571428571428,
        "domain": "4.3"
    },
    {
        "a": "[Acetaldehyde] [preceded] [Magnesium ion] in the reaction sequence.",
        "b": "[Acetaldehyde] [was found in] the same compartment as [Magnesium ion].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8628784648187633,
        "token(a ~ b)": 0.5394736842105263,
        "domain": "4.3"
    },
    {
        "a": "[Citalopram] [emerged] as a potential modulator of [Atezolizumab] activity in clinical trials.",
        "b": "[Citalopram] [was not correlated with] [Atezolizumab] activity in clinical trials.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8818423748885607,
        "token(a ~ b)": 0.6888888888888889,
        "domain": "4.3"
    },
    {
        "a": "[Interleukin-37] [was found] in [Catalase] samples after incubation.",
        "b": "[Interleukin-37] [was capable] of interacting with [Catalase] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8820994762192297,
        "token(a ~ b)": 0.6695652173913043,
        "domain": "4.3"
    },
    {
        "a": "[White adipocyte] [was critical for] the function of [Glycine transporter 1] in metabolic regulation.",
        "b": "[White adipocyte] [was selected] for interaction studies with [Glycine transporter 1] in metabolic regulation.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9024634628411294,
        "token(a ~ b)": 0.7556980056980057,
        "domain": "4.3"
    },
    {
        "a": "[Interleukin-18] [substituted] [Interferon-gamma] in the experimental assay.",
        "b": "[Interleukin-18] [activated] [Interferon-gamma] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9048282869335501,
        "token(a ~ b)": 0.8674242424242424,
        "domain": "4.3"
    },
    {
        "a": "[Platinum(II) ion] [was employed] to modify [1,4-Benzoquinone] in the reaction mixture.",
        "b": "[Platinum(II) ion] [produced] [1,4-Benzoquinone] in the reaction mixture.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8869860764334075,
        "token(a ~ b)": 0.8392857142857143,
        "domain": "4.3"
    },
    {
        "a": "[Tetracycline] [broadened] the therapeutic range of [Ticlopidine].",
        "b": "[Tetracycline] [was capable] of interacting with [Ticlopidine].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8794516594516595,
        "token(a ~ b)": 0.6576086956521738,
        "domain": "4.3"
    },
    {
        "a": "[Magnesium sulfate] [exhibited] properties similar to [Iron] in the experimental assay.",
        "b": "[Magnesium sulfate] [replaced] [Iron] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8845597290640393,
        "token(a ~ b)": 0.7211948790896159,
        "domain": "4.3"
    },
    {
        "a": "[Belzutifan] [identified] [Binimetinib] in the screening assay.",
        "b": "[Belzutifan] [increased] [Binimetinib] in the screening assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.926396172113636,
        "token(a ~ b)": 0.8901162790697674,
        "domain": "4.3"
    },
    {
        "a": "[Cytochrome c] [evoked] the release of [Interleukin-38] in the cell culture assay.",
        "b": "[Cytochrome c] [served as] a cofactor for [Interleukin-38] in the cell culture assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8953974175035868,
        "token(a ~ b)": 0.7095238095238094,
        "domain": "4.3"
    },
    {
        "a": "[Flurbiprofen] [amplified] the activity of [Pemetrexed]",
        "b": "[Flurbiprofen] [preceded] [Pemetrexed] in pharmacokinetic studies",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8758898244612531,
        "token(a ~ b)": 0.5805938494167551,
        "domain": "4.3"
    },
    {
        "a": "[Glutamate] [predicted] the levels of [Sodium sulfate] in the experimental assay.",
        "b": "[Glutamate] [bound] to [Sodium sulfate] in the experimental assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8764490785996162,
        "token(a ~ b)": 0.7934210526315789,
        "domain": "4.3"
    },
    {
        "a": "[Nitrogen trioxide] [broadened] the activity range of [Chromate].",
        "b": "[Nitrogen trioxide] [replaced] [Chromate] in the catalytic assay.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8911888111888112,
        "token(a ~ b)": 0.5126829268292683,
        "domain": "4.3"
    },
    {
        "a": "[Hydrogen sulfide] [extended] the half-life of [Nitrogen trioxide] in solution.",
        "b": "[Hydrogen sulfide] [was employed] as a reducing agent for [Nitrogen trioxide] in solution.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.875627888286116,
        "token(a ~ b)": 0.6527777777777778,
        "domain": "4.3"
    },
    {
        "a": "[Carbonic anhydrase] [was linked to] [Flagellum] in the mutant bacterial strain.",
        "b": "[Carbonic anhydrase] [orchestrated] [Flagellum] in the mutant bacterial strain.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9015567019247442,
        "token(a ~ b)": 0.8043478260869565,
        "domain": "4.3"
    },
    {
        "a": "The concentration of [Magnesium ion] [was found] to interact with [Progesterone] in vitro.",
        "b": "The concentration of [Magnesium ion] [was capable] of interacting with [Progesterone] in vitro.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9396056031551747,
        "token(a ~ b)": 0.815734989648033,
        "domain": "4.3"
    },
    {
        "a": "[Interleukin-27] [was linked to] [Phosphoribosyl pyrophosphate synthetase 1] in immune signaling pathways.",
        "b": "[Interleukin-27] [prolonged] the activity of [Phosphoribosyl pyrophosphate synthetase 1] in immune signaling pathways.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9009547287794064,
        "token(a ~ b)": 0.8149980966882375,
        "domain": "4.3"
    },
    {
        "a": "The [Stratum corneum cell] [was critical for] the function of the [Smooth muscle cell].",
        "b": "The [Stratum corneum cell] [was vaccinated] with antigens derived from the [Smooth muscle cell].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.9055747126436781,
        "token(a ~ b)": 0.674645390070922,
        "domain": "4.3"
    },
    {
        "a": "[Acetaminophen] [broadened] the effects of [Bosutinib].",
        "b": "[Acetaminophen] [was found] in combination with [Bosutinib].",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.8684321475625824,
        "token(a ~ b)": 0.652093023255814,
        "domain": "4.3"
    },
    {
        "a": "[Crizotinib] [was sufficient for] the therapeutic effect of [Lenvatinib] in the experimental model.",
        "b": "[Crizotinib] [was overexpressed] in the presence of [Lenvatinib] in the experimental model.",
        "a -> b": 0.0,
        "b -> a": 0.0,
        "char(a ~ b)": 0.874991674991675,
        "token(a ~ b)": 0.7643356643356642,
        "domain": "4.3"
    }
]